data_2mog_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mog _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.693 0.283 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.1 p -128.77 162.39 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.1 112.17 2.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.449 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 t -74.66 -42.18 58.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 p -153.15 160.59 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.759 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -114.26 133.37 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.032 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.3 m -132.57 148.57 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.348 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mt -111.59 132.38 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.029 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 163.85 17.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -43.49 167.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 123.581 2.854 . . . . 0.0 112.13 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 14' ' ' ASN . 4.7 mm -87.44 162.17 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 110.234 1.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 13' ' ' ILE . 94.1 m-20 -48.92 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.797 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 p -85.7 96.03 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.469 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 79.4 m-20 -155.25 143.33 20.1 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.667 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.1 mm . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.631 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.486 ' CG1' ' H ' ' A' ' 22' ' ' SER . 19.1 t . . . . . 0 C--O 1.238 0.491 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.486 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 26.3 p -88.93 150.13 22.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.183 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 16' ' ' ASN . 83.9 tttt -136.7 128.87 29.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.452 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -110.06 144.64 38.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.45 151.03 49.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -111.42 146.79 36.55 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.915 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.661 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -115.74 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.742 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.65 132.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.413 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.09 146.89 16.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -114.79 125.89 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 110.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -83.59 148.5 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.024 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.0 p -55.09 -14.82 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.492 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.81 -2.34 46.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.7 83.59 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 20.4 m -86.35 157.37 19.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.868 0.366 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.2 mttt -130.31 149.71 51.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.394 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.34 153.87 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -85.55 122.01 29.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' SER . 92.4 mt -104.48 2.18 30.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.661 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 94.2 m -45.72 -33.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.438 . . . . 0.0 110.286 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.4 p -88.15 -19.01 27.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.71 -21.75 19.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.635 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' LEU . 3.3 m -98.21 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.328 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.3 m -103.38 122.99 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.711 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 12.6 m95 -92.33 141.42 28.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -153.41 166.54 32.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.989 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -132.32 140.29 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -40.0 87.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -89.4 87.59 7.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.171 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -81.53 -25.78 35.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.18 0.514 . . . . 0.0 109.801 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 t -69.43 -34.47 74.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -100.55 2.79 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.235 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.68 146.43 13.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.07 138.37 52.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.67 113.19 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.779 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -141.29 114.99 9.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -156.1 133.91 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.955 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -69.97 -178.28 1.54 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.614 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -59.19 -33.52 71.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.642 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -85.78 -7.07 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.759 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 21.5 p -118.1 0.2 11.75 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.628 0.251 . . . . 0.0 111.268 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -41.42 114.16 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.573 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.91 27.69 2.44 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.697 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 2.6 tp -117.88 120.67 38.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.914 0.388 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.07 134.77 62.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.069 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -111.95 126.44 55.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -122.96 109.51 1.38 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.758 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 96.8 mt -64.58 -45.89 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.251 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . 161.89 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.8 p -137.86 -2.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.6 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.22 3.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -154.17 80.63 4.78 Favored Pre-proline 0 N--CA 1.453 -0.29 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.203 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.16 147.53 16.43 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.797 2.331 . . . . 0.0 110.725 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 120.33 35.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.465 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.49 126.36 50.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 ' CG2' ' ND2' ' A' ' 85' ' ' ASN . 91.6 mt -110.37 127.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.067 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.84 128.2 52.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -118.94 126.28 51.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.85 103.28 6.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.114 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.51 -123.87 31.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.0 p -91.2 6.12 46.36 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.828 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.82 133.57 69.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.4 p -140.36 152.07 45.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 142.05 13.4 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' ND2' ' CG2' ' A' ' 76' ' ' ILE . 9.8 m120 -108.88 142.29 39.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 110.767 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.407 ' HG1' ' N ' ' A' ' 87' ' ' ILE . 3.8 t -142.36 150.88 41.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.821 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.407 ' N ' ' HG1' ' A' ' 86' ' ' THR . 73.4 mt -108.52 128.49 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.66 133.15 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.927 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -96.99 142.64 28.71 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.586 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 89.8 t -84.69 106.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.201 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 16.5 m120 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.837 0.351 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.3 p -131.01 163.8 26.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.22 111.08 17.31 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.49 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -77.53 -53.52 7.51 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.468 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -145.81 156.56 43.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.8 130.34 70.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.013 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.8 p -133.01 148.39 52.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.76 140.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.053 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 163.79 17.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -37.16 155.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.41 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.1 mm -86.63 159.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 123.928 0.891 . . . . 0.0 110.083 1.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 15' ' ' THR . 5.0 p30 -41.13 -98.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.979 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -153.84 94.39 1.76 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.109 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 29.0 m120 -156.36 140.63 16.58 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.663 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--O 1.232 0.169 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.406 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.237 0.398 0 CA-C-O 121.231 0.538 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -88.36 142.72 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.411 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 16' ' ' ASN . 81.4 tttt -134.89 130.04 35.32 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -109.74 144.83 37.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.38 153.43 47.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.115 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -111.06 152.2 27.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.63 128.94 55.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.685 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.67 133.51 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.186 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.36 151.59 18.48 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.7 m -118.84 127.77 53.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.922 0.392 . . . . 0.0 110.577 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.43 151.54 24.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.109 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.6 p -54.54 -14.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.519 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.91 0.85 37.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 3.06 90.67 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 23.6 m -86.13 160.21 19.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.334 . . . . 0.0 110.696 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -130.85 151.94 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.93 152.71 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 44.1 p-10 -80.85 124.27 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.9 mt -112.45 12.58 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.34 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.0 m -58.2 -34.88 70.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.9 p -88.76 -7.86 55.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.56 -29.09 11.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.918 0.389 . . . . 0.0 110.719 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 m -89.9 152.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.214 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 m -107.13 126.42 52.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.798 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.561 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 33.8 m95 -95.55 134.74 38.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.517 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.5 t -141.56 150.64 42.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -120.2 141.16 50.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.179 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.9 p -67.08 -32.96 74.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 83.6 m-20 -84.9 69.75 10.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.333 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.13 -38.82 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -68.57 -34.82 76.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.135 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -107.4 9.58 29.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 49' ' ' ASN . . . -158.89 144.44 16.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.097 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -129.33 145.74 51.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.882 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 8.6 p -125.88 114.41 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.037 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.0 t -139.29 105.92 5.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.759 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.81 130.66 18.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.091 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -67.64 -175.11 0.49 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.52 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 t -59.84 -35.82 75.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.474 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.97 -18.87 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 34.8 p -103.31 3.58 35.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.09 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -41.1 114.2 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.769 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.83 29.54 2.82 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -115.3 114.69 25.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.195 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.06 136.6 59.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.144 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.8 m -112.65 127.74 56.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.795 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.02 106.5 3.1 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.99 -43.83 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 169.52 128.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.0 t -167.54 -177.44 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.638 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 72' ' ' ASN . . . -114.23 -53.24 0.43 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 71' ' ' GLY . 23.5 m120 -142.79 82.73 12.08 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.461 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.29 155.65 16.79 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.94 2.426 . . . . 0.0 110.618 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.0 m -124.51 121.85 35.97 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.818 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 75' ' ' ILE . 38.9 mm -101.82 129.14 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.59 128.79 73.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.79 132.04 45.38 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -121.08 129.03 53.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.966 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.27 113.18 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.3 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 51.76 -125.61 27.04 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.5 p -93.97 8.59 40.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.78 132.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -136.7 153.9 50.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.4 143.39 14.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.1 142.77 46.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.985 0.421 . . . . 0.0 111.069 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -143.78 144.04 31.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.89 128.12 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 110.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 mt -112.12 149.29 32.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.1 m -118.66 143.42 46.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.958 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 72.8 t -86.86 104.81 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.526 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 99.3 m-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.439 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.684 0.278 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -135.75 163.87 29.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.245 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -68.43 110.93 4.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -74.98 -42.01 58.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 p -153.96 160.79 42.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.3 tt -120.44 127.97 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 17.5 p -130.28 149.62 51.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.608 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.0 134.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.051 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.06 163.62 17.98 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.885 0.374 . . . . 0.0 111.338 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 7.9 Cg_endo -43.87 172.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 124.083 3.189 . . . . 0.0 111.292 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 75.9 mt -102.63 110.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.581 0.753 . . . . 0.0 109.956 0.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.7 m120 35.78 -153.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.912 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.2 p -144.59 95.74 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.155 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -152.94 160.49 43.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 179.704 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.425 ' OG ' ' OG1' ' A' ' 66' ' ' THR . 5.4 m -90.39 147.64 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.135 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ILE . 63.6 tttm -141.8 132.46 25.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -109.84 142.55 40.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.86 152.72 47.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.808 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.08 153.9 27.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.951 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.17 129.94 55.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.911 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.411 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.4 t -117.53 130.14 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.6 148.59 16.79 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.0 m -113.9 125.88 54.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -81.19 146.09 30.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.145 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.5 p -51.93 -20.38 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.398 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.85 -5.54 44.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -0.36 76.75 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 6.7 m -85.55 156.38 20.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.555 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -126.37 153.17 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.12 157.77 21.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.756 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -82.55 129.19 34.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.332 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.3 mt -113.7 11.97 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.159 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.6 m -59.89 -31.61 69.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.5 p -90.93 -6.6 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.125 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -105.74 -27.48 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.566 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.52 155.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.242 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.9 m -111.62 124.14 51.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.583 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 26.7 m95 -96.1 137.82 34.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.214 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.6 p -145.67 161.37 40.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.935 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.1 t -133.82 146.16 50.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.95 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -69.29 -31.61 70.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 53' ' ' ALA . 80.3 m-20 -77.87 64.09 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.6 -42.25 74.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -72.69 -33.79 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -102.88 9.28 38.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.258 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -168.82 148.58 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.12 144.42 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.954 0.407 . . . . 0.0 110.699 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 11.4 p -121.3 112.91 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.95 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.5 p -140.9 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.854 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.574 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -153.33 131.95 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 -176.38 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -57.52 -36.74 71.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.563 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.93 -33.85 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.474 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -100.51 11.29 39.8 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -43.7 115.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 110.15 37.6 1.79 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' C ' ' CD1' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -116.97 115.49 25.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.61 133.79 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OG ' ' A' ' 22' ' ' SER . 74.4 m -117.24 122.97 45.48 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.15 114.0 4.49 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.79 -44.86 92.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.55 119.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.725 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.8 m -158.77 175.85 13.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.74 -67.61 0.83 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -131.48 80.71 66.59 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -71.78 152.79 58.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.396 2.064 . . . . 0.0 110.27 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -118.45 124.19 47.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.157 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.1 mm -100.91 122.38 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.7 mm -108.45 128.43 64.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.1 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.95 129.73 55.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -119.47 129.53 54.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.608 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -128.02 105.04 8.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.757 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 49.9 -120.28 7.82 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 98.1 p -90.6 6.14 44.98 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.257 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.14 131.31 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 p -136.24 148.34 48.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.62 143.85 14.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -108.14 140.32 41.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.206 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -133.49 158.76 42.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.322 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.4 mt -108.49 124.0 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.162 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.81 132.49 56.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.7 m -116.12 138.09 51.56 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.872 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.6 t -83.78 111.47 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.993 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.5 t30 . . . . . 0 C--N 1.33 -0.24 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.421 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.865 0.364 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -97.88 163.75 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 tp -86.53 115.08 23.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.712 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -75.44 -51.79 12.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.833 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.3 p -160.35 162.96 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.823 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.51 140.92 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.896 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -130.76 149.29 52.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -91.5 142.43 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.056 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -102.34 165.43 13.84 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -178.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.6 Cg_exo -38.3 163.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 124.008 3.139 . . . . 0.0 111.397 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' C ' ' A' ' 14' ' ' ASN . 4.3 mm -99.63 114.52 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.496 0.718 . . . . 0.0 110.021 0.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 13' ' ' ILE . 23.8 t-20 28.47 -115.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.524 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 24.4 p -155.58 91.79 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.07 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 15' ' ' THR . 34.9 m120 -156.26 140.94 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.8 mt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.768 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 22' ' ' SER . 71.9 t . . . . . 0 CA--C 1.523 -0.061 0 CA-C-O 121.005 0.431 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.428 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 14.1 t -112.77 131.49 55.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -128.57 138.06 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -110.26 144.72 38.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.85 153.71 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.869 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.74 153.47 26.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.89 129.36 53.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.881 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -111.96 127.49 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.481 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.18 143.51 18.0 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -116.03 122.2 44.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 33' ' ' ASP . 94.4 m-85 -80.69 149.3 29.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.107 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -55.63 -9.74 0.57 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' TYR . 73.2 m-20 -86.92 1.01 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.5 0.89 88.04 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 10.8 m -84.16 158.32 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.3 mttt -133.16 151.32 51.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.308 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.3 154.57 21.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.83 119.87 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.427 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.23 14.8 24.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.0 m -60.53 -29.21 68.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.82 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.7 p -91.18 -9.0 47.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.173 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.61 -28.6 11.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.66 149.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.5 m -106.66 122.63 46.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.773 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 28.3 m95 -92.47 137.33 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.245 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -151.07 160.92 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.963 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 t -137.88 147.8 44.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -63.97 -35.13 79.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -71.35 63.6 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.352 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 77.9 mt-30 -69.71 -43.61 72.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.6 m -72.9 -33.59 66.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.22 1.19 49.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.167 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -167.7 154.27 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.175 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -139.04 145.88 40.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.793 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.75 116.3 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.993 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 m -138.98 110.02 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.82 132.52 11.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.654 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.32 -177.11 2.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 96.0 p -58.9 -27.1 64.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.579 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -88.97 -12.67 40.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.481 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 80.1 p -116.38 0.76 12.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -40.17 111.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.738 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.52 27.71 2.3 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' C ' ' CD2' ' A' ' 64' ' ' LEU . 6.1 tt -119.31 119.31 33.65 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.61 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.24 135.37 64.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -115.75 127.28 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.92 117.08 4.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.38 -42.67 97.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.287 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 177.72 118.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.745 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.6 p -160.88 166.74 27.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.724 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.68 -67.9 0.9 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.87 81.66 51.71 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.12 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.18 148.8 16.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.495 2.13 . . . . 0.0 110.226 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -107.1 124.21 49.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.7 mp -100.16 131.3 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.902 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.1 mt -117.92 125.76 74.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.257 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.6 133.73 47.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -118.01 132.02 56.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.677 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 82' ' ' VAL . 71.3 t80 -136.93 111.27 8.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.718 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.43 -125.83 37.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.7 p -93.05 5.25 52.16 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.322 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 79' ' ' TYR . 50.2 t -125.67 133.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -130.84 156.74 44.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.48 147.22 16.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.3 135.63 54.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.015 0.436 . . . . 0.0 111.135 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -140.71 153.34 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.54 126.36 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 111.122 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 85.5 mt -110.05 147.25 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.506 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.3 m -120.91 142.74 49.42 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.879 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 70' ' ' SER . 76.5 t -82.69 103.92 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.923 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.3 m120 . . . . . 0 C--N 1.33 -0.267 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.395 179.66 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.672 0.272 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -121.5 164.31 17.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.0 tp -78.53 109.37 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.41 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -75.87 -45.13 37.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -148.09 167.18 25.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.835 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.0 132.83 66.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.983 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -127.87 147.78 50.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.395 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.92 137.27 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.61 163.71 17.61 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.063 0.459 . . . . 0.0 111.314 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -37.31 155.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 123.515 2.81 . . . . 0.0 112.199 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 14' ' ' ASN . 91.4 mt -87.71 159.16 3.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 123.926 0.89 . . . . 0.0 110.127 0.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 87.7 m-20 -48.56 -90.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 74.3 p -141.52 92.9 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 15' ' ' THR . 24.8 m120 -156.78 161.61 39.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 111.799 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.455 -0.218 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.624 179.71 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.655 ' CG1' ' H ' ' A' ' 22' ' ' SER . 2.4 t . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.655 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -112.75 148.17 35.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -133.77 131.36 39.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.58 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -110.6 146.05 36.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.102 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.89 155.09 44.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.164 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -109.18 145.71 35.34 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.754 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.699 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -117.55 130.25 56.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.79 132.96 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.21 146.92 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.7 m -112.38 128.19 56.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.55 149.26 24.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.975 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -54.94 -17.82 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.629 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -77.74 -6.95 55.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.497 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.25 1.29 72.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.3 m -80.69 157.7 25.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.747 0.308 . . . . 0.0 110.784 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.6 145.23 50.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.369 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.11 156.67 29.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.876 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -87.88 127.08 35.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.256 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.53 14.03 20.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.36 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.699 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 11.5 m -57.11 -32.59 66.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.053 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.8 p -88.12 -9.91 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.436 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.466 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -101.18 -26.2 13.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.93 152.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.204 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.5 m -109.96 119.74 40.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 19.1 m95 -89.59 140.76 29.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.519 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 p -149.29 160.56 43.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.893 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -134.37 143.24 47.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.1 p -62.41 -34.49 76.86 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ALA . 95.7 m-20 -71.8 62.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -68.61 -43.54 76.19 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.9 p -70.54 -33.57 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.0 7.46 36.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -165.1 148.77 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -134.27 142.1 47.2 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.65 114.57 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.775 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 m -139.36 110.36 6.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.91 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' CB ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -154.15 134.21 13.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.892 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.01 -176.92 1.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -58.75 -35.16 72.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.638 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -83.36 -20.49 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.649 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.5 p -104.48 4.03 32.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.099 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -42.36 115.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.855 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.417 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 114.44 33.26 1.79 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 3.7 tp -118.21 125.39 50.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.31 133.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.032 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -114.86 121.78 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.6 116.57 5.09 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 92.2 mt -65.42 -44.54 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.463 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.96 120.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.691 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 30.0 t -157.9 -173.78 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -114.27 -65.37 0.43 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.671 HD21 ' HG1' ' A' ' 89' ' ' THR . 34.2 m120 -134.31 80.55 52.1 Favored Pre-proline 0 C--N 1.332 -0.174 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.32 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.23 147.19 59.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.801 2.334 . . . . 0.0 110.626 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.4 m -110.78 115.84 30.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.738 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 75' ' ' ILE . 14.6 mm -92.73 126.61 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.15 127.34 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.157 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.76 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -118.9 130.26 55.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.949 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 69.8 t80 -137.43 110.03 7.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.69 -128.98 48.96 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.3 p -94.04 9.71 36.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.969 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.05 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.872 0.368 . . . . 0.0 110.812 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -139.8 151.92 46.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.64 142.44 13.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -111.43 152.71 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.114 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.516 ' HG1' ' N ' ' A' ' 87' ' ' ILE . 3.9 t -149.33 162.88 39.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.309 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' ' HG1' ' A' ' 86' ' ' THR . 31.5 mm -106.41 126.37 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -112.94 128.47 56.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.73 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.671 ' HG1' HD21 ' A' ' 72' ' ' ASN . 16.9 m -107.51 145.79 32.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.031 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.8 117.47 29.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.073 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 C--O 1.233 0.197 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.518 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.496 ' CG2' ' N ' ' A' ' 5' ' ' LEU . 20.7 m -90.24 162.3 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.279 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 4' ' ' THR . 57.6 tp -86.99 114.87 23.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -72.49 -46.37 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.78 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 p -157.63 164.8 36.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -124.38 131.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.933 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.2 m -132.77 148.71 52.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.538 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.0 mm -98.77 139.2 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.095 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.63 163.22 18.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 111.506 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -36.39 158.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.096 3.197 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ASN . 96.3 mt -84.72 158.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 123.501 0.721 . . . . 0.0 109.972 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' ILE . 92.2 m-20 -37.81 -92.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.824 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.506 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -160.25 93.25 1.03 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.105 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 15' ' ' THR . 22.7 m120 -154.57 140.29 18.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.328 0.585 . . . . 0.0 111.678 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mm . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.892 179.704 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.937 0.398 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -79.9 136.28 36.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.118 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -137.93 135.85 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 110.963 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -112.3 145.58 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.339 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.42 152.62 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.853 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -110.62 142.44 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.968 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.19 128.82 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.909 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.72 128.97 72.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.481 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.97 147.18 16.59 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -115.01 129.52 56.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -87.31 149.39 24.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.112 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -55.98 -15.3 3.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.448 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.3 -1.58 49.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.567 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 1.88 85.36 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.8 m -85.36 145.59 27.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.641 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.91 148.59 42.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.71 154.71 20.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.4 125.1 31.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.343 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' SER . 90.5 mt -106.99 7.24 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -50.07 -31.95 14.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.2 p -87.99 -9.32 53.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.197 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.7 -28.57 10.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.558 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.81 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 m -106.04 123.85 48.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.76 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.474 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 38.0 m95 -92.82 134.53 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -148.37 170.3 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.935 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.1 t -136.26 146.88 47.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.786 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -66.15 -33.76 76.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 0.0 109.37 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -94.89 84.21 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 53' ' ' ALA . 98.5 mm-40 -85.84 -22.79 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 t -71.02 -34.32 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.639 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.82 4.3 37.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -160.68 152.8 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.227 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -132.66 136.03 46.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.018 0.437 . . . . 0.0 110.701 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.04 113.28 43.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.988 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.7 t -138.98 104.49 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.834 HD21 ' H ' ' A' ' 63' ' ' GLY . 31.0 p30 -131.75 127.27 36.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.574 ' N ' ' HG1' ' A' ' 61' ' ' THR . . . -70.82 -179.56 2.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 t -58.86 -44.95 91.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.596 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 57.1 mp0 -83.46 -7.97 59.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.505 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.574 ' HG1' ' N ' ' A' ' 58' ' ' ALA . 19.4 p -113.0 8.8 18.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.357 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -42.13 114.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.834 ' H ' HD21 ' A' ' 57' ' ' ASN . . . 113.68 29.04 3.01 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.5 tp -118.02 121.0 39.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.575 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.14 134.11 67.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 p -102.47 131.47 49.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.24 105.28 2.05 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.05 -44.72 99.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 110.338 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 170.66 121.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -160.07 168.59 25.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.92 -49.09 1.19 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -149.69 82.73 6.6 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -84.24 159.05 13.15 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.488 2.125 . . . . 0.0 110.184 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.0 m -118.32 123.95 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 mm -98.29 125.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.938 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.2 mm -112.8 126.52 70.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.106 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.99 125.6 47.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 m -113.88 126.11 54.81 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.693 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 79' ' ' TYR . 64.4 t80 -134.64 87.76 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.41 -124.78 22.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -89.04 4.92 46.69 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.314 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.45 136.55 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 p -142.15 157.08 45.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . -127.45 142.93 13.93 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -123.14 130.84 53.3 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.204 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -136.71 157.18 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.341 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.7 mt -97.56 124.57 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.971 0.415 . . . . 0.0 111.179 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.2 tp -107.93 135.57 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.3 m -119.09 139.69 51.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.918 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.3 t -88.1 101.7 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.0 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.357 179.354 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.855 0.36 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -93.05 143.0 26.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.1 tp -60.57 116.65 4.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.404 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.3 t -75.92 -42.97 47.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -156.8 165.69 35.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.047 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.95 133.21 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -135.38 147.85 49.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 10' ' ' ILE . 15.1 mm -95.33 143.41 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.761 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.49 164.38 16.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.34 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.0 Cg_exo -37.27 164.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 123.326 2.684 . . . . 0.0 112.871 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' ASN . 86.7 mt -107.6 114.98 47.74 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 125.074 1.35 . . . . 0.0 110.798 -0.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' ILE . 97.3 m-20 33.96 -120.95 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.604 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 p -149.16 95.78 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.906 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 60.5 t30 -150.3 147.84 28.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.591 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.333 -0.137 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.735 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.52 0.676 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 m -96.37 141.45 29.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.936 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -120.47 140.6 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -109.34 143.54 38.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.71 153.62 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.181 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -111.03 152.35 26.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.66 129.91 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.583 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.97 128.41 67.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.07 143.41 14.52 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.521 ' OG1' ' NZ ' ' A' ' 36' ' ' LYS . 52.7 m -115.48 129.2 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.871 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -88.1 146.44 25.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.861 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.0 p -53.73 -15.79 1.4 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.748 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.02 -3.22 51.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.571 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.07 85.95 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 m -77.64 139.74 39.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 110.714 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.521 ' NZ ' ' OG1' ' A' ' 30' ' ' THR . 68.7 mmtt -110.99 139.47 46.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.45 25.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.085 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -90.1 126.04 35.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.202 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 2.5 mm? -103.81 9.2 37.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -53.45 -30.32 40.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.898 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.4 p -89.82 -9.11 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.22 -22.75 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 39' ' ' LEU . 6.3 m -95.12 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -104.29 120.32 40.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.637 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.0 m95 -89.07 134.72 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.536 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 p -143.21 162.49 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.885 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -135.94 144.64 45.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 111.235 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 p -67.78 -33.34 74.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.333 0.587 . . . . 0.0 109.527 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ALA . 16.2 m120 -77.58 62.47 2.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.566 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.09 -42.33 84.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.054 0.454 . . . . 0.0 109.956 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -69.85 -34.4 73.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -103.62 6.01 36.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.374 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -159.57 147.26 17.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.324 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -132.46 142.64 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 110.807 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.59 114.29 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 67.8 p -139.53 117.05 11.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.632 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.564 ' CA ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.29 134.4 12.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.22 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -75.03 178.8 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.751 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.2 p -54.3 -27.25 34.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.621 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -87.47 -25.28 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.717 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.564 ' HG1' ' CA ' ' A' ' 57' ' ' ASN . 18.6 p -103.87 8.27 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.655 0.265 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -42.16 115.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.962 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.83 35.94 2.12 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.9 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 25.0 tp -118.27 126.12 51.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.724 0.262 . . . . 0.0 110.514 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.74 133.7 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 111.051 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 m -102.66 127.84 49.61 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.67 102.1 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.678 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.26 -44.17 95.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.908 0.385 . . . . 0.0 110.069 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 167.75 118.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 t -160.42 170.82 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.45 -55.24 0.76 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -140.66 82.2 16.11 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -83.04 155.46 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.69 2.26 . . . . 0.0 110.732 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.5 m -121.27 123.9 43.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 2.1 mp -102.43 129.7 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.734 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.0 127.23 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.091 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.9 129.4 49.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.7 m -113.37 129.7 56.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -132.35 87.27 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.265 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.65 -125.2 25.5 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.3 p -87.18 3.97 44.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.539 0.209 . . . . 0.0 110.931 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.69 133.65 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.759 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -139.79 154.34 47.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.593 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.43 147.96 17.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.3 m120 -126.25 130.55 51.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.97 0.414 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.8 p -134.55 151.09 50.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.6 mt -97.92 127.01 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 0.0 110.799 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 10.5 mp -109.48 145.73 35.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -114.65 134.95 54.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.498 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -84.4 104.27 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 99.3 m-20 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.1 m -119.0 139.55 51.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.278 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.75 122.79 15.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -74.62 -43.3 56.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.9 p -159.29 162.39 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.45 129.59 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -125.27 148.59 48.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.527 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 10' ' ' ILE . 26.2 mm -104.18 139.75 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.027 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -101.19 162.31 20.94 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 0.0 111.302 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.3 Cg_exo -35.15 163.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 124.104 3.202 . . . . 0.0 111.322 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' ASN . 88.4 mt -109.09 108.13 24.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.599 0.759 . . . . 0.0 110.045 0.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 33.7 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.2 OUTLIER -127.76 97.47 4.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.147 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -154.5 160.08 41.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.258 0.551 . . . . 0.0 111.606 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 91' ' ' ASN . 47.4 mm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.718 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.912 0.387 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -86.02 152.27 23.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 88.1 tttt -137.5 135.01 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -111.27 143.43 42.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -130.08 153.2 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.896 179.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -119.8 146.59 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.771 0.32 . . . . 0.0 110.942 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.55 129.77 55.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.827 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.55 128.85 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.79 144.14 17.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 m -113.22 125.79 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.469 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' C ' ' H ' ' A' ' 33' ' ' ASP . 97.1 m-85 -83.4 143.84 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.15 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -49.92 -14.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.426 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' TYR . 89.0 m-20 -81.48 0.76 36.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.568 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.05 1.45 90.61 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -84.32 151.3 24.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.661 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.02 148.19 48.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.371 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.12 27.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.764 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.87 124.67 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.0 12.89 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.175 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.7 m -59.39 -26.38 65.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.081 0.467 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 95.2 p -93.55 -7.76 43.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.237 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.6 -26.4 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.49 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 m -90.63 149.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.4 m -106.45 126.39 52.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.711 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.529 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 23.3 m95 -95.79 137.47 34.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.262 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 p -148.9 168.6 22.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -139.24 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.838 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' A' ' 49' ' ' ASN . 78.1 p -62.34 -39.42 93.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.401 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.506 ' N ' ' HG ' ' A' ' 48' ' ' SER . 97.3 m-20 -91.13 88.47 6.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.328 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -88.86 -22.45 23.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 p -70.83 -32.19 69.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.34 1.97 36.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.161 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.07 148.43 15.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.126 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -127.87 139.15 52.79 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.745 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.93 111.19 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 t -139.67 103.87 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -139.57 130.29 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.623 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.699 ' H ' ' HG1' ' A' ' 61' ' ' THR . . . -73.3 -177.1 2.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -58.32 -34.91 71.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.568 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.8 mp0 -85.58 -22.3 28.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.534 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.699 ' HG1' ' H ' ' A' ' 58' ' ' ALA . 42.0 p -101.76 15.0 30.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.238 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -44.81 115.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.72 34.66 3.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -118.93 113.06 20.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.55 138.4 54.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.803 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -106.44 125.81 51.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.29 103.07 1.62 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.12 -44.96 97.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 169.52 149.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 5.4 t -179.15 -175.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.673 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.594 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -108.75 -62.47 0.54 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -136.26 80.5 40.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.123 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.3 153.98 61.47 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.507 2.138 . . . . 0.0 110.248 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.5 m -125.19 110.95 14.7 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.225 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 mm -96.07 126.51 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.79 128.65 76.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.08 135.48 39.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.0 m -122.1 132.14 54.33 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.669 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -136.59 107.96 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 48.87 -119.88 6.37 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.4 p -93.22 6.97 46.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.0 t -126.27 129.73 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.912 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -136.74 153.5 50.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 110.904 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.63 142.21 13.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.1 m-20 -121.8 139.11 54.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.936 0.398 . . . . 0.0 111.244 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.6 p -137.65 167.53 21.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.323 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.4 123.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 tp -109.12 130.32 55.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.5 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 m -116.11 141.27 48.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.961 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.87 121.02 36.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.956 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' ILE . 29.3 t-20 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.878 0.371 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -131.53 164.47 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.2 tp -64.89 105.81 1.1 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.631 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.6 m -76.21 -40.5 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 p -151.61 165.73 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.48 132.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.889 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 m -123.02 149.07 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.627 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.0 mt -118.25 132.58 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.14 164.24 15.89 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' SER . 57.8 Cg_exo -36.21 162.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.047 3.164 . . . . 0.0 111.396 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ASN . 3.5 mt -93.71 163.75 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.485 0.714 . . . . 0.0 109.99 0.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' O ' ' A' ' 13' ' ' ILE . 32.6 p30 -48.01 -172.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 89' ' ' THR . 53.5 p -85.29 93.51 8.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.417 ' OD1' ' OD1' ' A' ' 14' ' ' ASN . 27.8 m120 -154.45 142.02 19.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.319 0.58 . . . . 0.0 111.651 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.746 -179.827 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.933 0.396 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 m -82.42 136.92 34.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.104 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.68 132.91 39.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -112.02 144.73 40.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.91 153.8 47.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.802 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -112.53 138.63 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.923 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.34 124.39 52.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.952 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.79 129.45 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.386 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.19 142.11 16.46 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.0 m -109.2 122.69 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 110.417 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.401 ' C ' ' H ' ' A' ' 33' ' ' ASP . 78.6 m-85 -83.84 146.34 28.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.128 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.2 p -52.14 -14.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.413 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' TYR . 78.6 m-20 -79.67 -3.94 49.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 2.27 82.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -85.7 153.79 22.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.74 151.09 43.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.29 156.27 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -86.78 123.78 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.34 18.22 19.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 110.232 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.03 -30.42 70.3 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.9 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.0 p -89.61 -8.28 52.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.192 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.7 t -104.7 -27.9 11.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.5 m -88.11 150.6 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.268 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -108.52 117.64 34.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 18.8 m95 -87.25 136.64 32.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.7 p -141.2 162.66 34.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.987 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -138.45 143.31 39.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.888 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -68.94 -36.42 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 53' ' ' ALA . 99.1 m-20 -74.42 69.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.29 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.03 -43.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.4 m -70.04 -33.91 72.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.644 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.59 6.64 34.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -164.98 146.47 7.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.166 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -131.79 146.77 52.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.76 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 114.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.4 p -140.93 111.47 6.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.499 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.08 131.44 11.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.53 -177.03 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.9 t -56.3 -41.75 76.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.591 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -74.46 -31.39 62.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.522 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.2 p -95.22 2.49 54.94 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -41.31 116.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.845 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.81 33.8 1.8 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.57 118.92 32.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.31 135.72 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.773 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -112.17 128.85 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.53 134.77 12.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.659 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.01 -66.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' SER . . . -144.8 142.05 29.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.643 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 1.1 t 163.32 175.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -109.69 -48.69 0.78 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -140.64 81.12 17.45 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.18 144.07 85.74 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 0.0 110.242 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.0 m -118.29 121.31 40.1 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.78 129.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.8 128.09 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.163 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.5 131.17 54.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -115.65 133.91 55.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.633 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -136.53 94.2 2.97 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.7 -123.23 32.2 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.6 p -89.91 6.77 40.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.33 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.17 135.31 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 p -140.0 156.85 46.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.0 110.92 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.8 143.92 15.58 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -111.24 139.88 46.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.1 m -135.8 141.72 44.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.277 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.18 128.99 63.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.064 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.04 147.76 28.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.529 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.415 ' H ' ' HB ' ' A' ' 15' ' ' THR . 59.0 m -111.9 138.0 49.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.982 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 43.0 t -83.25 104.48 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.904 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 10.4 m120 . . . . . 0 C--N 1.331 -0.225 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.416 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.871 0.367 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -133.99 162.39 32.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.04 109.53 19.92 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.625 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -76.47 -53.09 8.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.775 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.8 p -156.46 169.79 23.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.906 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.69 144.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.849 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -135.81 149.12 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.674 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mm -95.29 141.77 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.36 165.55 14.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 120.762 0.315 . . . . 0.0 111.431 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 11' ' ' SER . 46.5 Cg_exo -38.19 165.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.095 3.197 . . . . 0.0 111.314 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 14' ' ' ASN . 78.7 mt -110.14 117.78 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.461 0.705 . . . . 0.0 110.008 0.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 13' ' ' ILE . 3.9 t-20 27.05 -131.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.756 0.312 . . . . 0.0 110.88 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.482 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -142.81 93.4 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.178 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -155.26 135.16 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.226 0.536 . . . . 0.0 111.66 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.789 179.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 m -104.32 145.48 30.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.102 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -131.11 140.22 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.901 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -109.54 143.48 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.383 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.606 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.14 152.96 48.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.881 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -111.08 149.75 30.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.923 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.79 127.8 55.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.825 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.38 128.34 69.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.461 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.12 148.35 17.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.8 m -119.6 130.09 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 0.0 110.432 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 33' ' ' ASP . 87.4 m-85 -89.08 149.33 23.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.122 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -55.3 -10.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.434 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 31' ' ' TYR . 96.3 m-20 -87.12 -0.75 57.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.56 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.7 87.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.6 m -84.22 146.26 27.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 110.654 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.13 146.98 48.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.08 156.12 28.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.834 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.15 122.97 28.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.42 9.2 29.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.6 m -55.0 -30.55 59.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.113 0.482 . . . . 0.0 109.866 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -89.67 -9.8 48.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.133 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.509 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -102.87 -26.35 13.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.599 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.72 144.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.302 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 123.13 47.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.606 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 10.8 m95 -92.94 136.46 33.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.277 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.3 t -139.93 144.86 37.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.888 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.7 t -113.4 140.15 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.3 p -62.82 -40.09 96.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 93.0 m-20 -71.64 70.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.322 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -74.45 -40.33 61.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.2 p -71.02 -32.89 69.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.643 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.55 11.05 27.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 49' ' ' ASN . . . -166.89 148.86 6.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.197 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -134.05 147.08 50.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.696 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.4 t -110.21 113.32 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.008 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -139.86 105.63 5.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.595 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.29 131.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.673 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.508 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.94 -176.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -56.48 -42.91 79.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.572 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.16 -27.18 60.71 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.533 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 51.9 p -99.44 2.18 44.81 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.35 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -40.34 114.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.595 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 112.81 39.72 1.15 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -119.44 127.89 53.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.305 . . . . 0.0 110.624 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.12 133.34 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.751 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -113.57 120.65 41.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.58 107.92 2.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.26 -45.4 93.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -169.72 118.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 p -164.25 168.15 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.15 -68.55 0.93 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -131.68 80.83 65.39 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.7 151.24 69.39 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.465 2.11 . . . . 0.0 110.218 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 m -120.01 124.12 45.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.272 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.4 mm -102.13 126.67 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.963 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.04 122.78 68.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.196 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.87 41.29 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -119.77 127.84 53.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.631 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.509 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 67.8 t80 -136.97 118.77 15.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.08 -125.4 30.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.5 p -97.55 8.64 44.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' TYR . 44.6 t -126.36 136.54 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.7 p -135.41 150.76 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.45 142.19 13.29 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -113.06 151.18 31.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.461 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -144.66 156.5 44.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.3 mm -108.87 123.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.6 mt -115.59 145.81 42.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.8 m -120.04 143.16 48.24 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.928 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 92.2 t -84.69 104.21 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 90.5 m-20 . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.411 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -92.16 164.64 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.66 118.24 25.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.0 110.612 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -75.65 -36.13 60.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -154.66 161.72 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.247 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -113.4 132.96 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.196 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -129.55 148.35 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.501 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.06 133.71 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.075 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.09 165.68 13.75 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.383 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -38.49 158.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.544 2.829 . . . . 0.0 112.019 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 91.2 mt -87.23 154.85 3.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 123.942 0.897 . . . . 0.0 110.578 1.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' ILE . 52.2 t30 -53.56 -113.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.548 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -134.58 92.04 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.981 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.711 ' H ' ' HZ2' ' A' ' 23' ' ' LYS . 71.6 m-80 -157.45 158.73 36.36 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.528 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 m -83.37 139.78 32.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.755 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.711 ' HZ2' ' H ' ' A' ' 16' ' ' ASN . 88.0 tttt -127.93 118.9 24.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.983 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.97 142.71 44.04 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.54 152.67 48.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.503 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -116.54 138.95 51.01 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.45 126.78 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.968 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.85 130.83 74.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.53 142.58 17.59 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.4 m -108.11 125.08 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 110.64 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -82.81 147.4 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.414 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p -54.32 -16.48 2.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.49 -5.19 46.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.32 1.14 79.01 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 36.1 m -86.7 160.63 18.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 0.0 110.686 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' N ' ' CG2' ' A' ' 35' ' ' THR . 68.5 mttm -130.67 151.62 50.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.9 156.49 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -84.77 123.33 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.101 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 42' ' ' SER . 79.2 mt -108.78 0.41 20.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.57 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -49.15 -33.45 12.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -86.63 -13.53 45.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.515 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -100.03 -21.9 15.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' LEU . 3.6 m -96.98 149.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -107.69 124.36 49.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.617 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.0 m95 -94.24 139.25 31.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.672 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -142.62 169.58 17.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -140.58 139.12 34.89 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.7 p -62.91 -32.69 74.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' OD1' ' OE1' ' A' ' 52' ' ' GLN . 12.8 m-80 -84.73 68.46 10.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.6 mm-40 -69.74 -41.34 75.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.997 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -70.75 -34.47 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.339 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 49' ' ' ASN . 89.9 mt-30 -100.01 2.79 43.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.053 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -158.75 145.38 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.157 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -127.23 140.54 52.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 9.8 p -120.64 113.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.094 0.473 . . . . 0.0 109.968 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -140.16 106.64 5.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.311 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -148.64 131.8 16.39 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.44 -176.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.651 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -58.74 -43.78 90.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.023 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.86 -33.81 72.76 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -96.38 5.56 50.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.51 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -42.28 115.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.632 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.87 32.14 2.13 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -117.31 115.26 24.91 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.63 133.97 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.896 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -116.04 126.2 53.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.619 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.96 113.8 4.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.33 -43.92 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.04 120.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 46.3 p -157.85 172.36 18.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.49 -53.63 0.92 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -150.05 82.64 6.43 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.836 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.91 155.87 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.556 2.171 . . . . 0.0 110.711 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 m -119.24 123.37 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.709 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.7 mp -99.26 123.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.596 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.14 125.69 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.342 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 134.62 47.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.1 m -124.08 130.54 52.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 111.14 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 58.3 t80 -136.19 108.81 7.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.49 -122.16 28.89 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.7 p -97.94 5.43 48.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.488 0.185 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.41 133.75 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.5 p -140.38 150.73 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.55 142.68 13.98 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -108.9 143.4 38.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.044 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -136.71 143.95 43.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 mm -102.62 126.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.252 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -108.42 141.71 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.824 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.484 ' N ' ' OG1' ' A' ' 15' ' ' THR . 60.5 m -118.16 137.51 52.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.421 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 70' ' ' SER . 72.5 t -85.21 112.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.727 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -139.46 160.68 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 tp -87.49 107.3 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.67 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -75.37 -46.19 34.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.763 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 p -157.37 164.78 37.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.8 pt -123.04 147.6 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.866 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 10.8 p -137.28 149.0 46.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.06 136.22 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -98.93 165.36 15.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.445 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.5 Cg_exo -37.26 165.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 124.055 3.17 . . . . 0.0 111.363 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 14' ' ' ASN . 74.4 mt -106.94 113.12 42.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.491 0.716 . . . . 0.0 110.031 0.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 13' ' ' ILE . 79.1 m-20 28.77 -126.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -149.92 95.55 2.32 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.137 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 3.8 p30 -155.62 136.84 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 111.617 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.0 mm . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.761 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 22' ' ' SER . 54.9 t . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.3 t -108.25 124.32 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -115.5 139.71 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tt0 -110.16 146.83 34.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.368 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.95 152.99 47.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 11' ' ' SER . 52.0 m-85 -112.07 151.57 29.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.988 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.35 128.45 51.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.869 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.2 t -120.24 130.59 74.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.22 151.94 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -114.79 126.67 55.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -83.76 150.59 25.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.136 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -55.1 -13.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.469 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.81 -4.03 57.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.665 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 4.05 79.61 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 18.2 m -88.51 154.54 20.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.1 mttt -125.53 146.66 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.285 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.77 41.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.96 121.14 29.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.369 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.41 11.64 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.146 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 m -57.27 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.791 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.9 p -90.49 -11.47 40.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.444 ' HG ' ' N ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -101.34 -29.69 11.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.551 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 42' ' ' SER . 5.2 m -87.22 153.68 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 m -110.6 124.57 52.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.726 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 29.3 m95 -94.84 133.57 38.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.9 p -147.08 161.36 41.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.977 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 t -136.17 146.98 47.46 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.95 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.0 p -65.69 -35.78 81.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' ALA . 87.8 m-20 -69.08 65.9 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.32 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' ALA . 75.5 mt-30 -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.9 t -71.45 -34.52 70.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -98.85 3.75 47.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -169.09 154.62 6.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.182 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -133.92 143.36 48.19 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.745 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.61 113.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.055 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.8 p -138.76 103.1 4.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.05 121.73 42.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.656 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.7 169.6 16.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 m -55.63 -35.61 66.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.607 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 54.7 mp0 -87.31 -7.44 57.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.536 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.8 p -131.54 31.54 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.268 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 68.0 mttm -47.16 117.11 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.79 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.51 43.54 2.7 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.9 tp -118.01 122.32 42.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.767 0.317 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.0 t -128.54 132.75 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -116.48 127.22 54.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.01 120.02 4.84 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.54 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 178.02 139.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.683 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 13.6 t -173.4 177.44 2.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.723 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -101.13 -69.42 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -133.88 81.45 52.25 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.178 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.29 153.41 66.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.462 2.108 . . . . 0.0 110.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -119.73 112.05 18.78 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.225 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.5 mp -94.67 127.32 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.991 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.0 mt -114.53 129.73 70.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.162 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.29 125.96 43.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -114.41 125.65 54.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.33 114.29 12.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.766 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.68 -127.08 39.51 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -94.93 8.58 42.34 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.349 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.29 130.45 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.7 p -137.42 150.83 47.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.74 142.66 13.85 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.2 m-20 -108.18 140.85 40.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.265 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -132.84 155.0 49.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.247 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 87' ' ' ILE . 13.8 mm -95.34 123.49 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 111.122 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.9 tp -114.21 128.05 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.551 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.4 m -112.12 139.85 47.29 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.9 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.65 102.07 8.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' ILE . 27.8 m120 . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.815 0.34 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -138.66 164.82 28.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.52 107.62 4.51 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.62 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -75.39 -38.31 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.8 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 p -150.49 162.75 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.69 133.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.859 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.8 t -129.5 146.58 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.65 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.84 134.45 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.67 163.55 17.9 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.438 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 6.5 Cg_endo -43.2 172.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.069 3.179 . . . . 0.0 111.283 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 82.9 mt -103.88 110.79 31.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.02 0.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' THR . 19.0 p30 35.19 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -139.79 95.7 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.122 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.66 159.29 39.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 111.653 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.723 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.0 m -98.14 118.98 35.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.065 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -113.12 136.81 52.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.72 143.4 41.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.53 153.93 47.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.884 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.41 147.82 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.09 129.01 56.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.905 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.88 132.42 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.499 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.77 149.52 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -120.12 125.46 48.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.43 151.07 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.11 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.4 p -53.94 -14.59 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.524 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -85.2 6.0 27.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.59 3.16 82.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 m -83.42 139.35 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.954 0.407 . . . . 0.0 110.661 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.07 147.24 44.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.369 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.12 164.71 37.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.952 0.406 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 29.1 p-10 -88.41 123.08 32.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.339 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.64 13.02 28.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -60.48 -31.59 70.61 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.87 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -90.32 -4.6 57.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.03 -27.94 9.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.6 142.94 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.0 m -103.31 116.18 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.744 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.8 m95 -83.91 133.7 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.228 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -137.0 163.82 29.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -134.83 140.94 46.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.885 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -64.23 -34.57 78.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 5.8 m120 -83.65 71.38 10.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 53' ' ' ALA . 87.0 mt-30 -74.23 -40.38 62.45 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 m -69.91 -33.68 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.607 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -103.74 3.31 34.02 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -158.35 150.1 21.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.176 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.14 145.24 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.739 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.39 115.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 32.9 t -140.43 114.47 9.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -152.74 132.82 13.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.579 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.97 -177.67 2.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.1 p -57.79 -30.3 65.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.507 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.93 -12.49 44.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 52.5 p -114.74 4.06 14.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.255 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -41.16 112.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 116.41 33.37 1.47 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -117.01 121.48 41.48 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 110.627 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.0 t -124.24 134.63 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -112.35 125.98 54.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.0 103.29 1.88 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 68' ' ' ILE . 27.6 mm -63.02 -44.99 99.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.733 0.301 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 179.89 118.16 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -161.04 167.8 25.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.722 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.31 -54.16 0.91 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -149.31 81.08 7.51 Favored Pre-proline 0 C--N 1.334 -0.105 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.141 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.53 158.76 19.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 0.0 110.204 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -116.37 124.49 50.19 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 75' ' ' ILE . 17.8 mm -100.08 121.18 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.93 126.09 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 133.76 48.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -113.68 133.4 55.34 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.549 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -131.56 86.41 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.677 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.95 -123.94 19.4 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -88.55 5.64 41.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.289 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -137.78 152.71 49.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.12 17.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -110.37 145.78 36.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.172 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.5 p -134.71 154.28 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.379 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.0 mt -100.59 121.57 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 111.177 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -109.47 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.544 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.6 m -117.6 138.44 51.94 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.91 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.1 t -83.4 107.76 15.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.972 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--N 1.331 -0.234 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.333 179.391 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.748 0.308 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -139.21 163.27 32.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.254 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.93 111.03 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -80.05 -46.29 16.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.815 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 p -154.17 163.15 40.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.9 pt -123.22 146.3 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.846 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 p -139.12 148.49 43.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.664 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.62 137.18 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.55 164.98 14.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.403 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.7 Cg_exo -37.49 166.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.981 3.121 . . . . 0.0 111.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.475 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 72.3 mt -112.18 111.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 C-N-CA 123.457 0.703 . . . . 0.0 110.044 0.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' ILE . 1.4 m120 34.37 -153.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.721 0.295 . . . . 0.0 110.855 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.559 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.1 OUTLIER -136.58 96.72 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.193 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 15' ' ' THR . 79.7 m-20 -157.26 155.92 31.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.321 0.581 . . . . 0.0 111.684 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.82 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.932 0.396 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 p -92.29 138.06 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.05 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 83.1 tttt -131.78 139.76 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.932 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 24.0 tt0 -109.43 144.93 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.421 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -126.94 152.78 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.969 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' O ' ' OG ' ' A' ' 11' ' ' SER . 42.5 m-85 -113.24 148.79 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.09 130.26 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.916 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.43 131.04 71.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.464 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.97 17.21 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.5 m -113.89 129.47 56.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 110.488 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 33' ' ' ASP . 91.5 m-85 -86.51 144.0 27.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.074 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p -52.22 -14.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.49 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 49.5 t0 -79.71 -6.86 58.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 -0.59 68.95 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 23.7 m -86.61 160.38 18.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.883 0.373 . . . . 0.0 110.649 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.0 mttt -131.71 151.15 51.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.313 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.01 160.2 35.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' OG1' ' A' ' 40' ' ' THR . 52.1 t0 -86.64 119.61 27.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.393 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 12.31 32.74 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.159 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' OD1' ' A' ' 38' ' ' ASP . 26.7 m -59.04 -28.2 66.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.841 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.5 p -91.32 -10.3 41.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -104.14 -27.39 12.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 m -88.2 150.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -106.04 126.47 52.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.545 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 49.9 m95 -97.3 135.24 39.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 m -148.14 168.88 21.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.3 t -137.93 147.36 44.27 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.79 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -68.08 -34.69 76.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -77.57 69.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.38 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' ALA . 85.0 mt-30 -72.45 -43.2 64.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.6 p -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.54 9.91 39.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.171 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.11 152.91 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.4 113.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.039 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -139.76 104.39 4.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.696 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.633 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -118.81 123.97 46.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.08 172.22 12.18 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -58.6 -31.03 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.609 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.38 -11.88 47.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.526 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -131.38 31.07 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.27 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.537 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.7 mttt -43.48 116.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.801 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.536 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.22 45.05 2.45 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 55.1 tp -117.25 123.27 46.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -127.25 136.08 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.832 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -110.46 128.52 55.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.34 107.86 2.81 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.35 -43.71 97.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 171.79 117.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.697 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 p -159.13 166.36 31.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.671 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 72' ' ' ASN . . . -95.08 -65.95 0.99 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 2.8 m120 -138.57 80.6 26.08 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.13 158.26 23.47 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.501 2.134 . . . . 0.0 110.286 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 m -113.29 128.28 56.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 75' ' ' ILE . 17.9 mm -100.44 120.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 76' ' ' ILE . 36.4 mm -109.26 126.42 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.99 126.15 50.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.7 m -115.45 125.8 53.55 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.692 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -134.8 90.6 2.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.05 -129.81 18.58 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.9 p -87.97 3.35 49.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.307 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.71 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 p -140.98 150.15 42.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.58 142.38 14.71 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.0 OUTLIER -118.84 130.41 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 111.16 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.3 p -134.67 156.68 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.278 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.75 124.29 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.55 151.32 28.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.6 m -132.72 145.3 50.92 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.974 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 91.2 t -83.87 127.19 40.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.919 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.356 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -130.36 164.4 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.312 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.03 107.76 14.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.563 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.776 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.67 162.98 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.893 0.378 . . . . 0.0 110.819 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -125.05 133.97 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 t -132.91 148.49 52.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.58 130.71 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.487 ' H ' ' HG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -101.1 162.75 19.58 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 8.1 Cg_endo -44.11 172.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 124.038 3.159 . . . . 0.0 111.348 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.519 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 76.5 mt -102.53 118.23 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.487 0.715 . . . . 0.0 109.958 0.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 t-20 30.61 -146.59 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.754 0.312 . . . . 0.0 110.911 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 p -152.88 95.4 1.98 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.06 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.96 160.75 43.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.5 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.791 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -96.95 123.62 40.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 64.5 tttm -112.78 144.03 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -110.37 143.46 40.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.36 151.57 49.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.898 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 11' ' ' SER . 56.8 m-85 -113.7 155.41 25.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.718 0.294 . . . . 0.0 110.907 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -123.1 130.64 53.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.925 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.3 t -113.44 131.03 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.76 151.22 17.27 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 m -117.84 126.07 51.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -81.16 151.57 28.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.102 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.1 p -55.3 -18.25 6.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -76.67 -4.1 41.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.42 0.23 82.55 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 92.5 m -83.39 162.09 21.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.2 mttt -131.1 148.68 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.355 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.68 20.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -78.1 124.96 28.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.8 13.48 24.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.625 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 99.9 m -60.83 -30.14 69.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.809 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -90.85 -9.54 45.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.253 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.08 -26.57 13.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.09 152.02 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.228 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -109.88 123.5 49.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.684 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.54 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 22.8 m95 -93.58 137.49 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.9 t -145.03 167.75 21.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.017 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -142.23 139.95 32.14 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.862 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.2 -26.38 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -78.79 65.16 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.336 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 88.6 mt-30 -67.15 -49.84 63.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.8 p -71.71 -33.67 68.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.612 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -93.65 -2.43 54.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.73 151.76 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.156 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -131.23 136.42 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.71 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.83 113.07 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -138.71 104.12 5.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.78 HD21 ' H ' ' A' ' 63' ' ' GLY . 29.9 p30 -132.45 128.23 37.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.664 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.72 -177.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 t -61.84 -42.33 98.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.649 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.9 mp0 -83.16 -12.41 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.532 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.2 p -110.73 8.88 22.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.185 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -41.58 112.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.73 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.78 ' H ' HD21 ' A' ' 57' ' ' ASN . . . 114.4 31.18 2.25 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.04 122.15 41.49 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.703 0.287 . . . . 0.0 110.573 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.32 134.4 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -104.74 125.72 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.04 102.86 2.39 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.32 -44.77 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.71 0.291 . . . . 0.0 110.264 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 173.4 118.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.584 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -162.43 167.02 24.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.25 -67.18 0.83 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -128.24 81.16 71.04 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.06 159.26 15.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.43 2.087 . . . . 0.0 110.149 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -123.22 129.58 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 75' ' ' ILE . 47.4 mm -102.11 129.59 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -115.79 126.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.51 135.92 43.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.5 m -121.81 128.44 51.68 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.682 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -128.94 88.75 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.63 -119.8 11.81 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.9 p -91.62 1.16 57.34 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.317 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.21 132.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.6 p -135.44 154.09 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.05 146.93 18.51 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -110.89 144.72 39.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.216 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.8 p -134.05 158.54 43.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.9 mm -98.64 124.55 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.016 0.436 . . . . 0.0 111.134 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.9 tp -114.15 135.02 54.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.504 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -125.75 132.13 52.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.893 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.05 109.16 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.952 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.353 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.847 0.356 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -91.13 163.89 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.262 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mt -81.79 124.05 29.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.555 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -74.35 -41.0 61.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.4 p -157.26 161.84 39.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -124.67 128.71 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.886 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -134.24 150.28 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.55 147.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.061 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.32 165.1 15.06 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 120.8 0.333 . . . . 0.0 111.376 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' SER . 52.0 Cg_exo -37.35 164.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 124.02 3.147 . . . . 0.0 111.384 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.5 mm -110.2 127.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.476 0.71 . . . . 0.0 109.952 0.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 13' ' ' ILE . 43.6 t30 29.72 -139.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -135.05 93.98 3.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 20.5 p30 -158.02 162.0 38.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 111.674 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.805 179.652 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 22' ' ' SER . 33.7 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.892 0.377 . . . . 0.0 111.395 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.484 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 24.0 m -110.42 147.59 33.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -122.65 147.15 46.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.0 tt0 -111.52 145.19 39.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.42 149.67 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.884 179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -110.18 147.86 32.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.937 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.87 128.86 56.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.889 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.71 131.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.431 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.02 149.07 18.0 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -117.2 126.02 52.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 110.43 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -84.63 147.68 26.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -53.26 -15.22 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.41 -1.65 46.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.557 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.96 88.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -85.62 142.47 29.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 0.0 110.593 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.37 148.97 41.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.363 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.59 152.44 16.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' OD1' ' OG1' ' A' ' 40' ' ' THR . 52.9 t0 -77.64 124.69 28.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.378 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.03 13.63 28.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 38' ' ' ASP . 24.9 m -61.43 -29.28 69.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 0.0 109.879 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 p -86.93 -18.33 31.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -30.28 12.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.532 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 m -87.29 141.35 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.15 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.3 m -101.06 124.23 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.657 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.526 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.4 m95 -91.74 133.13 35.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.225 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -147.74 163.37 36.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.578 ' HG ' ' H ' ' A' ' 49' ' ' ASN . 41.8 t -137.41 148.73 46.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.912 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.2 p -68.32 -25.63 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.578 ' H ' ' HG ' ' A' ' 47' ' ' SER . 10.8 m120 -87.58 69.64 9.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.8 mm-40 -78.34 -36.33 46.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 m -69.69 -34.37 73.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.652 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -104.15 8.47 36.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -165.89 153.57 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.199 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -130.23 137.17 49.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.887 0.375 . . . . 0.0 110.808 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.76 113.14 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.021 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -140.17 104.4 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.799 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.48 125.16 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' N ' ' HG1' ' A' ' 61' ' ' THR . . . -82.69 178.42 8.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 m -58.92 -38.79 79.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.626 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -86.65 -19.21 29.62 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.496 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 58' ' ' ALA . 69.8 p -109.58 21.87 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.359 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.579 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 35.8 pttt -40.71 118.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 47.63 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 42.1 tp -121.45 116.97 25.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.23 134.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.0 130.48 48.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.87 135.11 12.54 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 91.4 mt -99.64 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 110.33 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -175.88 120.11 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -161.74 175.24 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.58 -79.25 1.45 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -126.58 81.42 68.42 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.39 150.37 75.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.511 2.141 . . . . 0.0 110.171 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -116.62 113.13 22.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.186 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -86.47 126.14 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.962 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.1 mt -120.08 122.78 69.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.68 129.1 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.5 m -119.14 132.75 56.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.663 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -137.76 91.57 2.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.4 -122.29 26.47 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.5 p -90.54 4.11 52.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.376 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.64 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.0 p -147.86 153.54 39.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.46 141.06 12.37 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -115.55 148.81 39.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.969 0.414 . . . . 0.0 111.143 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 t -149.86 154.92 39.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.9 126.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 111.09 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mp -118.82 149.56 41.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.555 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 m -114.58 146.75 40.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.019 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.78 103.52 10.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p30 . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.387 179.486 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.824 0.345 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -100.37 164.48 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.508 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -76.76 125.92 30.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.407 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -85.77 -45.71 11.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.9 p -155.48 166.82 32.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.351 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.3 pt -119.25 147.22 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.1 m -134.05 149.22 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.677 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.04 128.61 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.759 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.35 165.87 13.34 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.577 -178.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.7 Cg_exo -39.06 166.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.581 2.854 . . . . 0.0 112.058 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 2.4 mp -104.55 110.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 110.402 -0.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ILE . 27.2 p30 31.41 -149.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 O-C-N 123.919 0.762 . . . . 0.0 110.717 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 95.99 2.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -154.99 161.76 41.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.785 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' ASN . 95.7 mt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 22' ' ' SER . 60.7 t . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.435 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 32.8 t -110.76 127.91 55.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.731 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -117.65 142.21 47.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 20.5 tt0 -108.92 144.5 36.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.86 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.13 150.18 50.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.984 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 11' ' ' SER . 49.5 m-85 -115.52 143.4 45.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.667 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.72 128.12 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.868 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -112.29 128.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.4 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.91 144.8 15.85 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -115.27 125.86 53.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.914 0.388 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' C ' ' H ' ' A' ' 33' ' ' ASP . 85.0 m-85 -86.2 147.86 25.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.295 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -54.38 -10.24 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' TYR . 31.2 t0 -84.23 -3.64 58.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.597 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.29 3.56 81.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 m -83.18 154.91 24.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -122.35 141.23 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 150.21 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -85.84 118.86 25.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' SER . 10.7 mp -106.15 8.97 32.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.2 m -49.86 -33.61 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.7 p -87.53 -13.05 44.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.304 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.506 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -97.84 -23.25 15.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 m -96.95 138.47 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.381 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -99.09 125.22 44.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.835 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 20.5 m95 -93.57 139.49 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 p -151.45 165.79 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.146 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -136.39 144.33 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.33 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -65.03 -32.56 74.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 71.6 m-20 -77.52 66.53 3.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -68.87 -43.95 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.01 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.7 p -70.11 -32.92 71.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.326 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -102.73 2.48 35.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.326 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -160.78 150.33 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.298 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -132.46 138.51 47.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.763 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.82 113.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -137.9 106.47 5.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.903 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.736 HD21 ' H ' ' A' ' 63' ' ' GLY . 33.6 p30 -133.03 126.01 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 111.105 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.06 171.53 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.8 p -59.11 -28.06 66.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.293 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -85.82 -11.53 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.639 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.2 p -130.47 31.47 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.464 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.6 mttt -48.01 125.46 9.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.044 0.449 . . . . 0.0 110.949 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.736 ' H ' HD21 ' A' ' 57' ' ' ASN . . . 95.47 40.05 4.29 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.045 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 31.3 tp -117.54 122.63 44.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.908 0.354 . . . . 0.0 110.522 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.8 137.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.271 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -119.05 127.03 53.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.91 119.3 6.47 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.29 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 110.363 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.35 120.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.53 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -162.17 172.72 15.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -61.49 0.76 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.68 82.17 51.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.567 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.82 159.52 21.4 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.501 2.134 . . . . 0.0 110.828 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -124.51 127.22 47.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.218 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.6 mm -100.06 126.02 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.945 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mm -108.07 122.97 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.121 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.16 118.62 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.724 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -114.26 124.59 52.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.506 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 53.5 t80 -128.29 117.1 20.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.35 -124.63 33.76 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -98.03 5.93 48.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.01 131.23 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 110.659 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -135.91 153.48 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.15 155.73 22.22 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.7 m-20 -114.37 147.33 39.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.853 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.9 p -135.02 155.4 50.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.066 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -96.97 121.59 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.962 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.71 134.44 54.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 m -124.31 137.7 54.46 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.966 0.412 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.6 t -85.5 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.215 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' ILE . 63.7 t30 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.535 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.369 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 p -132.3 162.43 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.45 103.97 2.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.707 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 t -75.47 -49.01 20.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 p -152.2 151.56 31.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.69 134.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.854 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 m -130.87 149.25 52.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.582 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.75 134.69 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.01 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.1 164.76 15.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.843 0.354 . . . . 0.0 111.327 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -37.91 157.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.005 3.136 . . . . 0.0 111.373 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.8 mm -85.78 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 123.536 0.734 . . . . 0.0 109.985 0.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -38.46 -92.65 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.702 0.287 . . . . 0.0 110.919 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -150.26 93.78 2.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.079 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 64.2 t30 -156.02 129.02 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 111.653 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.832 -179.591 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.888 0.375 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -110.38 128.91 55.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.084 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -113.3 145.83 40.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.032 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.2 tt0 -110.09 143.88 39.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.54 153.13 47.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -114.58 149.84 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.909 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -117.57 127.49 54.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.918 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.9 t -114.37 130.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.5 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.48 148.28 16.96 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 m -114.26 128.19 56.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.451 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -83.73 149.75 26.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.059 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -55.85 -16.28 4.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.407 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.79 -1.56 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.582 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.52 83.05 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 21.2 m -86.3 156.85 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.846 0.355 . . . . 0.0 110.681 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' N ' ' CG2' ' A' ' 35' ' ' THR . 54.4 mttp -130.81 151.89 50.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.02 158.55 28.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -80.74 120.95 25.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.357 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.8 5.54 33.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.165 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 85.2 m -57.09 -21.94 35.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 0.0 109.896 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.3 p -94.38 -11.38 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.261 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.414 ' H ' ' HG ' ' A' ' 42' ' ' SER . 4.8 p -107.06 -27.63 10.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.77 143.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.6 m -102.06 123.43 45.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.787 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.572 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 30.6 m95 -92.57 135.44 34.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.31 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -149.03 163.6 37.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.0 t -139.24 146.41 40.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.815 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.2 p -66.28 -33.19 75.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.341 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -78.34 68.97 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.377 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' ALA . 97.9 mt-30 -77.25 -38.18 51.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -72.28 -34.01 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.604 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -98.45 3.76 48.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.01 159.07 5.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.158 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.41 147.74 52.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.701 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.36 113.1 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.023 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -140.11 104.86 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.776 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.573 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -116.94 124.14 48.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.54 170.75 13.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -56.73 -33.61 66.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.508 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.56 -10.51 48.55 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.527 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.0 p -130.03 32.21 4.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.228 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -47.19 121.36 3.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.818 -179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 93.64 47.34 2.99 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.543 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 45.9 tp -118.92 120.41 37.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -126.56 135.46 63.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -113.01 130.59 56.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.05 110.94 2.87 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.04 -43.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.38 118.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.772 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 46.5 p -160.42 166.26 29.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.719 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.46 -48.02 1.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -157.29 81.87 3.18 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.44 158.61 17.02 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.468 2.112 . . . . 0.0 110.238 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.4 m -114.26 130.09 56.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -98.92 119.81 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.012 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.413 ' CG1' ' OD1' ' A' ' 85' ' ' ASN . 3.8 mp -102.86 118.32 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.136 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.48 121.32 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -108.65 129.41 55.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.662 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -139.8 96.22 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.16 -125.55 36.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.2 p -91.77 6.74 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.319 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.48 132.43 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.3 p -137.22 157.06 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.39 147.57 19.16 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.413 ' OD1' ' CG1' ' A' ' 76' ' ' ILE . 4.2 m-80 -131.99 133.38 44.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.439 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.2 p -131.54 160.4 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.304 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 121.96 50.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.18 0.514 . . . . 0.0 111.062 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 4.4 mm? -100.73 134.32 43.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.514 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.52 ' N ' ' OG1' ' A' ' 15' ' ' THR . 93.5 m -110.94 134.03 52.9 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.915 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 70' ' ' SER . 83.6 t -82.84 100.78 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.898 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 14.0 t-20 . . . . . 0 C--N 1.329 -0.306 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.343 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.857 0.36 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -139.6 162.71 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.285 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -84.16 108.4 17.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 m -76.65 -48.04 20.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.828 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -155.74 164.12 38.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -124.99 144.25 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.843 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.0 t -136.72 146.11 45.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 10' ' ' ILE . 11.3 mm -93.67 139.75 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.967 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -98.68 165.24 15.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.2 Cg_exo -38.25 166.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 124.017 3.145 . . . . 0.0 111.402 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' ASN . 95.9 mt -111.55 116.55 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 118.753 0.706 . . . . 0.0 109.995 0.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' ILE . 68.5 m-20 33.13 -134.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.872 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.41 93.74 2.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.113 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 52.7 p30 -157.37 147.1 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 111.718 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.805 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -98.67 148.61 23.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.085 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 88.7 tttt -137.95 137.84 38.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.931 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.0 143.9 37.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.7 152.61 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.8 153.05 27.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.949 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.3 129.55 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.867 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.23 131.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.461 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.72 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.5 m -118.51 128.42 54.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 0.0 110.364 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.24 149.31 25.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.116 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -54.42 -15.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.495 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.56 -1.58 38.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.66 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.68 86.73 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 17.3 m -86.09 156.59 20.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 110.582 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 35' ' ' THR . 98.6 mttt -128.27 150.46 50.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.395 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.36 17.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 42.3 p-10 -77.19 126.01 30.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.423 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.4 mt -109.78 14.31 23.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 m -59.78 -30.08 68.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.087 0.47 . . . . 0.0 109.898 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.2 p -90.33 -10.42 44.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.17 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 -26.16 13.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -93.05 151.45 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.228 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -108.63 123.74 49.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.591 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 31.9 m95 -93.85 138.82 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 p -151.05 160.56 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.984 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.4 t -132.13 143.46 50.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.847 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -61.66 -32.94 73.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' ALA . 2.3 m120 -75.83 63.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -69.97 -42.71 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -34.19 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.691 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -104.15 2.41 31.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -157.32 148.99 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.198 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.76 141.71 46.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.925 0.393 . . . . 0.0 110.694 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.09 114.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.993 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.5 t -139.55 108.48 6.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.497 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -147.75 132.84 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.654 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.495 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.93 178.43 4.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.8 m -54.39 -35.58 63.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.617 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.42 -24.68 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.487 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 61.4 p -104.6 16.47 26.01 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.224 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -49.59 120.55 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.784 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.497 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 104.36 32.34 4.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.24 118.05 30.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -122.24 134.5 65.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 p -105.3 132.12 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.46 108.24 2.41 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.53 -42.92 96.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.304 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 171.37 119.75 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.645 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 p -163.2 166.0 23.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.52 -71.41 1.1 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.653 HD21 ' HG1' ' A' ' 89' ' ' THR . 19.5 m120 -128.37 83.07 67.22 Favored Pre-proline 0 C--N 1.333 -0.146 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.58 158.57 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.532 2.155 . . . . 0.0 110.225 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.4 m -118.88 126.88 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 2.0 mp -101.05 126.1 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.882 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.3 mt -114.97 128.73 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.144 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.7 132.86 49.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -119.0 130.48 55.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.562 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -139.72 106.7 5.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.722 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.68 -125.08 31.41 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.7 p -92.6 8.21 39.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.371 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 135.74 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.6 p -146.89 151.82 37.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.986 0.422 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.73 146.57 18.37 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -125.02 137.5 54.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.01 0.433 . . . . 0.0 111.237 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -135.58 157.03 47.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.305 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 87' ' ' ILE . 30.1 mm -96.72 127.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.013 0.435 . . . . 0.0 111.135 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.73 147.7 37.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.571 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.653 ' HG1' HD21 ' A' ' 72' ' ' ASN . 91.2 m -125.49 132.34 52.67 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.917 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.48 107.86 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.895 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.372 179.608 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.778 0.323 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -139.28 163.23 33.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.91 112.16 9.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.302 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -74.92 -42.72 57.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 p -153.26 163.54 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.3 tt -119.13 134.4 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 t -131.78 148.03 52.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.745 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 mt -113.11 129.51 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.972 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.75 164.74 15.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -39.51 157.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.349 2.699 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' ASN . 89.9 mt -87.02 156.54 3.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 C-N-CA 123.998 0.919 . . . . 0.0 110.444 1.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -42.51 -97.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.725 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.403 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -165.89 96.13 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.355 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.724 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 81.9 m-20 -154.75 147.5 24.36 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.692 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.6 mm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.757 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' SER . 79.0 t . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.022 0.439 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.6 m -110.2 122.37 47.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.631 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.724 ' HZ3' ' H ' ' A' ' 16' ' ' ASN . 29.5 ttpt -112.46 137.68 50.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 15.0 tt0 -110.05 141.79 42.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.847 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.23 152.01 48.59 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.068 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.35 147.28 37.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.7 127.6 55.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.738 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.5 129.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.156 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.64 17.25 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 m -116.87 127.44 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.25 146.73 28.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 p -54.12 -16.81 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -78.73 -3.73 45.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.7 78.55 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.1 m -83.21 157.32 22.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.738 0.304 . . . . 0.0 110.799 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.55 149.22 52.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.504 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.28 152.24 20.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.69 122.35 26.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.49 7.9 33.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.5 m -55.74 -31.9 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.6 p -88.28 -9.92 51.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 -29.09 11.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.599 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 m -87.37 147.93 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.268 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.7 m -106.78 117.9 35.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.822 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m95 -87.41 140.1 29.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -147.75 164.96 31.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.161 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HG ' ' H ' ' A' ' 49' ' ' ASN . 33.5 t -135.45 143.61 46.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.327 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.67 -33.03 74.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.348 0.595 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' ALA . 96.2 m-20 -80.72 65.0 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 94.2 mm-40 -69.08 -43.81 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.466 . . . . 0.0 109.888 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.6 p -70.81 -33.14 70.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.937 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -104.0 9.38 36.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.505 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.59 153.98 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.73 142.86 48.14 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.49 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -138.24 108.78 6.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 16.0 p30 -132.66 128.8 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 -179.45 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.553 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.0 p -64.33 -16.91 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.388 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -89.08 -35.27 16.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 p -114.96 31.04 6.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.601 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.497 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -41.36 120.85 1.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 110.91 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.93 49.25 2.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.439 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 44.6 tp -118.52 121.24 39.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.648 0.261 . . . . 0.0 110.535 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.36 133.55 67.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -118.72 129.18 55.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.784 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.66 8.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.0 mt -90.61 -40.96 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.574 0.226 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.75 152.52 40.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.647 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -80.45 167.72 19.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.89 -136.1 7.78 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -130.06 81.13 69.57 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.573 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.79 153.98 58.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.867 2.378 . . . . 0.0 110.368 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -126.81 122.7 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -93.0 130.32 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 94.4 mt -120.86 119.75 60.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.04 123.47 45.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -115.77 126.4 53.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -129.69 103.69 6.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.982 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.63 -122.32 27.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -92.24 4.87 52.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.544 0.211 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.48 129.88 74.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 89.9 p -137.81 150.52 47.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.24 142.7 14.19 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -109.98 144.92 37.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 p -132.99 155.62 48.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.14 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.56 127.57 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.941 0.401 . . . . 0.0 111.13 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.81 134.64 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.709 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.5 m -113.25 128.98 56.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 111.403 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.14 106.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.133 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.522 HD22 ' CG ' ' A' ' 16' ' ' ASN . 25.3 p-10 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.352 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.52 97.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.03 144.16 48.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.534 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.1 p -128.77 162.39 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.1 112.17 2.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.449 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 t -74.66 -42.18 58.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 p -153.15 160.59 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.759 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -114.26 133.37 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.032 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.3 m -132.57 148.57 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.348 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mt -111.59 132.38 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.029 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 163.85 17.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -43.49 167.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 123.581 2.854 . . . . 0.0 112.13 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 14' ' ' ASN . 4.7 mm -87.44 162.17 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 110.234 1.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 13' ' ' ILE . 94.1 m-20 -48.92 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.797 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 p -85.7 96.03 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 79.4 m-20 -155.25 143.33 20.1 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.667 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.92 133.13 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.631 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -82.35 165.02 20.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.744 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -39.04 -69.17 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -150.5 59.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.486 ' CG1' ' H ' ' A' ' 22' ' ' SER . 19.1 t -130.38 171.3 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.486 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 26.3 p -88.93 150.13 22.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.183 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 16' ' ' ASN . 83.9 tttt -136.7 128.87 29.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.452 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -110.06 144.64 38.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.45 151.03 49.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -111.42 146.79 36.55 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.915 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.661 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -115.74 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.742 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.65 132.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.413 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.09 146.89 16.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -114.79 125.89 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 110.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -83.59 148.5 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.024 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.0 p -55.09 -14.82 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.492 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.81 -2.34 46.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.7 83.59 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 20.4 m -86.35 157.37 19.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.868 0.366 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.2 mttt -130.31 149.71 51.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.394 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.34 153.87 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -85.55 122.01 29.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 42' ' ' SER . 92.4 mt -104.48 2.18 30.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.661 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 94.2 m -45.72 -33.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.438 . . . . 0.0 110.286 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.4 p -88.15 -19.01 27.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.71 -21.75 19.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.635 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' LEU . 3.3 m -98.21 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.328 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.3 m -103.38 122.99 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.711 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 12.6 m95 -92.33 141.42 28.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -153.41 166.54 32.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.989 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -132.32 140.29 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -40.0 87.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -89.4 87.59 7.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.171 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -81.53 -25.78 35.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.18 0.514 . . . . 0.0 109.801 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 t -69.43 -34.47 74.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -100.55 2.79 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.235 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.68 146.43 13.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.07 138.37 52.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.67 113.19 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.779 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -141.29 114.99 9.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -156.1 133.91 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.955 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -69.97 -178.28 1.54 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.614 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -59.19 -33.52 71.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.642 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -85.78 -7.07 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.759 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 21.5 p -118.1 0.2 11.75 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.628 0.251 . . . . 0.0 111.268 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -41.42 114.16 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.573 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.91 27.69 2.44 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.697 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 2.6 tp -117.88 120.67 38.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.914 0.388 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.07 134.77 62.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.069 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -111.95 126.44 55.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -122.96 109.51 1.38 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.758 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 96.8 mt -64.58 -45.89 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.251 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . 161.89 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.8 p -137.86 -2.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.6 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.22 3.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -154.17 80.63 4.78 Favored Pre-proline 0 N--CA 1.453 -0.29 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.203 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.16 147.53 16.43 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.797 2.331 . . . . 0.0 110.725 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 120.33 35.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.465 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.49 126.36 50.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 ' CG2' ' ND2' ' A' ' 85' ' ' ASN . 91.6 mt -110.37 127.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.067 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.84 128.2 52.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -118.94 126.28 51.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.85 103.28 6.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.114 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.51 -123.87 31.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.0 p -91.2 6.12 46.36 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.828 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.82 133.57 69.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.4 p -140.36 152.07 45.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 142.05 13.4 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' ND2' ' CG2' ' A' ' 76' ' ' ILE . 9.8 m120 -108.88 142.29 39.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 110.767 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.407 ' HG1' ' N ' ' A' ' 87' ' ' ILE . 3.8 t -142.36 150.88 41.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.821 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.407 ' N ' ' HG1' ' A' ' 86' ' ' THR . 73.4 mt -108.52 128.49 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.66 133.15 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.927 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -96.99 142.64 28.71 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.586 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 89.8 t -84.69 106.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.201 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 16.5 m120 -140.12 117.94 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -93.76 136.14 34.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.603 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.6 p -66.48 -36.77 83.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -161.51 163.04 30.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.54 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.518 179.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -62.56 -41.29 98.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.701 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 51.62 175.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.3 p -131.01 163.8 26.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.22 111.08 17.31 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.49 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -77.53 -53.52 7.51 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.468 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -145.81 156.56 43.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.8 130.34 70.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.013 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.8 p -133.01 148.39 52.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.76 140.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.053 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 163.79 17.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -37.16 155.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.41 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.1 mm -86.63 159.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 123.928 0.891 . . . . 0.0 110.083 1.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 15' ' ' THR . 5.0 p30 -41.13 -98.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.979 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -153.84 94.39 1.76 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.109 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 29.0 m120 -156.36 140.63 16.58 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.663 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mm -120.79 131.98 71.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.406 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -82.2 167.13 19.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 20' ' ' THR . 80.4 p -37.47 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.457 ' N ' ' OG1' ' A' ' 19' ' ' THR . 79.3 p -134.3 62.47 1.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.06 163.13 32.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.231 0.538 . . . . 0.0 110.872 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -88.36 142.72 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.411 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 16' ' ' ASN . 81.4 tttt -134.89 130.04 35.32 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 110.62 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -109.74 144.83 37.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.38 153.43 47.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.115 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -111.06 152.2 27.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.63 128.94 55.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.685 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.67 133.51 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.186 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.36 151.59 18.48 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.7 m -118.84 127.77 53.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.922 0.392 . . . . 0.0 110.577 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.43 151.54 24.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.109 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.6 p -54.54 -14.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.519 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.91 0.85 37.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 3.06 90.67 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 23.6 m -86.13 160.21 19.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.334 . . . . 0.0 110.696 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -130.85 151.94 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.93 152.71 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 44.1 p-10 -80.85 124.27 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.9 mt -112.45 12.58 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.34 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.0 m -58.2 -34.88 70.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.9 p -88.76 -7.86 55.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.56 -29.09 11.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.918 0.389 . . . . 0.0 110.719 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 m -89.9 152.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.214 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 m -107.13 126.42 52.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.798 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.561 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 33.8 m95 -95.55 134.74 38.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.517 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.5 t -141.56 150.64 42.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -120.2 141.16 50.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.179 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.9 p -67.08 -32.96 74.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 83.6 m-20 -84.9 69.75 10.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.333 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.13 -38.82 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -68.57 -34.82 76.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.135 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -107.4 9.58 29.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 49' ' ' ASN . . . -158.89 144.44 16.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.097 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -129.33 145.74 51.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.882 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 8.6 p -125.88 114.41 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.037 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.0 t -139.29 105.92 5.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.759 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.81 130.66 18.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.091 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -67.64 -175.11 0.49 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.52 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 t -59.84 -35.82 75.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.474 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.97 -18.87 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 34.8 p -103.31 3.58 35.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.09 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -41.1 114.2 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.769 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.83 29.54 2.82 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -115.3 114.69 25.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.195 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.06 136.6 59.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.144 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.8 m -112.65 127.74 56.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.795 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.02 106.5 3.1 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.99 -43.83 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 169.52 128.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.0 t -167.54 -177.44 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.638 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 72' ' ' ASN . . . -114.23 -53.24 0.43 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 71' ' ' GLY . 23.5 m120 -142.79 82.73 12.08 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.461 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.29 155.65 16.79 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.94 2.426 . . . . 0.0 110.618 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.0 m -124.51 121.85 35.97 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.818 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 75' ' ' ILE . 38.9 mm -101.82 129.14 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.59 128.79 73.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.79 132.04 45.38 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -121.08 129.03 53.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.966 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.27 113.18 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.3 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 51.76 -125.61 27.04 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.5 p -93.97 8.59 40.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.78 132.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -136.7 153.9 50.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.4 143.39 14.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -115.1 142.77 46.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.985 0.421 . . . . 0.0 111.069 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -143.78 144.04 31.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.89 128.12 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 110.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 mt -112.12 149.29 32.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.1 m -118.66 143.42 46.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.958 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 72.8 t -86.86 104.81 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.526 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 99.3 m-20 -140.73 143.21 34.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.439 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.5 135.45 38.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.396 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 94' ' ' ASP . 29.3 p -103.14 -68.89 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.481 ' N ' ' OG1' ' A' ' 93' ' ' THR . 67.5 t0 -78.66 90.58 4.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.598 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.82 94.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.84 162.43 32.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.6 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -135.75 163.87 29.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.245 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -68.43 110.93 4.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -74.98 -42.01 58.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 p -153.96 160.79 42.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.3 tt -120.44 127.97 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 17.5 p -130.28 149.62 51.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.608 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.0 134.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.051 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.06 163.62 17.98 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.885 0.374 . . . . 0.0 111.338 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 7.9 Cg_endo -43.87 172.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 124.083 3.189 . . . . 0.0 111.292 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 75.9 mt -102.63 110.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.581 0.753 . . . . 0.0 109.956 0.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.7 m120 35.78 -153.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.912 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.2 p -144.59 95.74 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.155 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -152.94 160.49 43.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.6 mt -137.26 129.94 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 93' ' ' THR . 73.2 m-20 -102.48 165.39 11.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.783 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' ASN . 67.5 p -38.26 113.07 0.26 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.555 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m 39.68 61.97 1.3 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.034 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.9 t -131.46 138.83 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.332 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.425 ' OG ' ' OG1' ' A' ' 66' ' ' THR . 5.4 m -90.39 147.64 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.135 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ILE . 63.6 tttm -141.8 132.46 25.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -109.84 142.55 40.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.86 152.72 47.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.808 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.08 153.9 27.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.951 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.17 129.94 55.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.911 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.411 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.4 t -117.53 130.14 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.6 148.59 16.79 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.0 m -113.9 125.88 54.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -81.19 146.09 30.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.145 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.5 p -51.93 -20.38 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.398 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.85 -5.54 44.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -0.36 76.75 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 6.7 m -85.55 156.38 20.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.555 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -126.37 153.17 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.12 157.77 21.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.756 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -82.55 129.19 34.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.332 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.3 mt -113.7 11.97 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.159 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.6 m -59.89 -31.61 69.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.5 p -90.93 -6.6 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.125 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -105.74 -27.48 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.566 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.52 155.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.242 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.9 m -111.62 124.14 51.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.583 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 26.7 m95 -96.1 137.82 34.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.214 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.6 p -145.67 161.37 40.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.935 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.1 t -133.82 146.16 50.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.95 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -69.29 -31.61 70.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 53' ' ' ALA . 80.3 m-20 -77.87 64.09 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.6 -42.25 74.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -72.69 -33.79 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -102.88 9.28 38.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.258 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -168.82 148.58 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.12 144.42 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.954 0.407 . . . . 0.0 110.699 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 11.4 p -121.3 112.91 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.95 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.5 p -140.9 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.854 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.574 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -153.33 131.95 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 -176.38 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -57.52 -36.74 71.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.563 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.93 -33.85 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.474 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -100.51 11.29 39.8 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -43.7 115.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 110.15 37.6 1.79 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' C ' ' CD1' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -116.97 115.49 25.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.61 133.79 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' OG ' ' A' ' 22' ' ' SER . 74.4 m -117.24 122.97 45.48 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.15 114.0 4.49 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.79 -44.86 92.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.55 119.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.725 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.8 m -158.77 175.85 13.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.74 -67.61 0.83 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -131.48 80.71 66.59 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -71.78 152.79 58.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.396 2.064 . . . . 0.0 110.27 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -118.45 124.19 47.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.157 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.1 mm -100.91 122.38 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.7 mm -108.45 128.43 64.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.1 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.95 129.73 55.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -119.47 129.53 54.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.608 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -128.02 105.04 8.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.757 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 49.9 -120.28 7.82 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 98.1 p -90.6 6.14 44.98 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.257 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.14 131.31 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 p -136.24 148.34 48.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.62 143.85 14.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -108.14 140.32 41.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.206 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.8 m -133.49 158.76 42.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.322 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.4 mt -108.49 124.0 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.162 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.81 132.49 56.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.7 m -116.12 138.09 51.56 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.872 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.6 t -83.78 111.47 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.993 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -139.21 139.31 37.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.421 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -79.36 143.46 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 91.8 m -120.27 129.09 53.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 25.0 p-10 -91.92 0.67 57.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.557 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.19 -38.05 89.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.703 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.69 40.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.599 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -97.88 163.75 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 tp -86.53 115.08 23.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.712 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -75.44 -51.79 12.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.833 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.3 p -160.35 162.96 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.823 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.6 pt -123.51 140.92 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.896 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -130.76 149.29 52.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -91.5 142.43 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.056 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -102.34 165.43 13.84 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -178.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.6 Cg_exo -38.3 163.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 124.008 3.139 . . . . 0.0 111.397 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' C ' ' A' ' 14' ' ' ASN . 4.3 mm -99.63 114.52 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.496 0.718 . . . . 0.0 110.021 0.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 13' ' ' ILE . 23.8 t-20 28.47 -115.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.524 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 24.4 p -155.58 91.79 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.07 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 15' ' ' THR . 34.9 m120 -156.26 140.94 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.8 mt -135.17 139.59 46.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.768 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -95.85 159.41 14.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -64.11 137.59 58.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.539 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.29 42.55 22.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 22' ' ' SER . 71.9 t -133.45 155.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.288 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.428 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 14.1 t -112.77 131.49 55.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -128.57 138.06 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -110.26 144.72 38.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.85 153.71 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.869 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.74 153.47 26.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.89 129.36 53.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.881 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -111.96 127.49 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.481 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.18 143.51 18.0 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -116.03 122.2 44.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 33' ' ' ASP . 94.4 m-85 -80.69 149.3 29.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.107 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -55.63 -9.74 0.57 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' TYR . 73.2 m-20 -86.92 1.01 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.5 0.89 88.04 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 10.8 m -84.16 158.32 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.3 mttt -133.16 151.32 51.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.308 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.3 154.57 21.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.83 119.87 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.427 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.23 14.8 24.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.0 m -60.53 -29.21 68.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.82 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.7 p -91.18 -9.0 47.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.173 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.61 -28.6 11.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -87.66 149.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.5 m -106.66 122.63 46.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.773 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 28.3 m95 -92.47 137.33 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.245 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -151.07 160.92 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.963 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 t -137.88 147.8 44.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -63.97 -35.13 79.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -71.35 63.6 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.352 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 77.9 mt-30 -69.71 -43.61 72.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.6 m -72.9 -33.59 66.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.22 1.19 49.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.167 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -167.7 154.27 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.175 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -139.04 145.88 40.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.793 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.75 116.3 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.993 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 m -138.98 110.02 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.82 132.52 11.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.654 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.32 -177.11 2.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 96.0 p -58.9 -27.1 64.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.579 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -88.97 -12.67 40.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.481 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 80.1 p -116.38 0.76 12.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -40.17 111.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.738 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.52 27.71 2.3 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' C ' ' CD2' ' A' ' 64' ' ' LEU . 6.1 tt -119.31 119.31 33.65 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.61 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.24 135.37 64.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -115.75 127.28 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.92 117.08 4.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.38 -42.67 97.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.287 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 177.72 118.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.745 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.421 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 6.6 p -160.88 166.74 27.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.724 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.68 -67.9 0.9 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.87 81.66 51.71 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.12 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.18 148.8 16.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.495 2.13 . . . . 0.0 110.226 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -107.1 124.21 49.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.132 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.7 mp -100.16 131.3 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.902 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.1 mt -117.92 125.76 74.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.257 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.6 133.73 47.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -118.01 132.02 56.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.677 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 82' ' ' VAL . 71.3 t80 -136.93 111.27 8.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.718 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.43 -125.83 37.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.7 p -93.05 5.25 52.16 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.322 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 79' ' ' TYR . 50.2 t -125.67 133.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -130.84 156.74 44.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.48 147.22 16.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.3 135.63 54.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.015 0.436 . . . . 0.0 111.135 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -140.71 153.34 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.54 126.36 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 111.122 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 85.5 mt -110.05 147.25 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.506 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.3 m -120.91 142.74 49.42 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.879 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 70' ' ' SER . 76.5 t -82.69 103.92 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.923 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -134.49 152.38 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.92 143.65 26.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.1 m -120.69 129.82 53.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.526 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -94.99 114.16 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.439 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.561 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.87 79.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.78 147.92 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -121.5 164.31 17.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.0 tp -78.53 109.37 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.41 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -75.87 -45.13 37.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -148.09 167.18 25.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.835 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.0 132.83 66.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.983 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -127.87 147.78 50.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.395 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.92 137.27 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.61 163.71 17.61 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.063 0.459 . . . . 0.0 111.314 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -37.31 155.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 123.515 2.81 . . . . 0.0 112.199 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 14' ' ' ASN . 91.4 mt -87.71 159.16 3.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 123.926 0.89 . . . . 0.0 110.127 0.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 87.7 m-20 -48.56 -90.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 74.3 p -141.52 92.9 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 15' ' ' THR . 24.8 m120 -156.78 161.61 39.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 111.799 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -143.43 148.18 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.624 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -75.7 164.51 26.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.841 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.436 ' OG1' ' N ' ' A' ' 20' ' ' THR . 71.8 p -39.35 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.539 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.436 ' N ' ' OG1' ' A' ' 19' ' ' THR . 31.7 p -131.61 23.52 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.062 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.655 ' CG1' ' H ' ' A' ' 22' ' ' SER . 2.4 t -95.75 -160.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.062 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.655 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -112.75 148.17 35.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -133.77 131.36 39.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.58 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -110.6 146.05 36.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.102 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.89 155.09 44.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.164 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -109.18 145.71 35.34 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.754 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.699 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -117.55 130.25 56.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.79 132.96 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.21 146.92 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.7 m -112.38 128.19 56.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.55 149.26 24.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.975 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -54.94 -17.82 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.629 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -77.74 -6.95 55.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.497 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.25 1.29 72.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.3 m -80.69 157.7 25.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.747 0.308 . . . . 0.0 110.784 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.6 145.23 50.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.369 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.11 156.67 29.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.876 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -87.88 127.08 35.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.256 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.53 14.03 20.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.36 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.699 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 11.5 m -57.11 -32.59 66.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.053 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.8 p -88.12 -9.91 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.436 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.466 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -101.18 -26.2 13.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.93 152.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.204 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.5 m -109.96 119.74 40.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 19.1 m95 -89.59 140.76 29.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.519 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 p -149.29 160.56 43.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.893 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -134.37 143.24 47.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.1 p -62.41 -34.49 76.86 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ALA . 95.7 m-20 -71.8 62.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -68.61 -43.54 76.19 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.9 p -70.54 -33.57 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.0 7.46 36.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -165.1 148.77 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -134.27 142.1 47.2 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.65 114.57 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.775 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 m -139.36 110.36 6.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.91 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' CB ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -154.15 134.21 13.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.892 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.01 -176.92 1.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -58.75 -35.16 72.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.638 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -83.36 -20.49 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.649 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.5 p -104.48 4.03 32.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.099 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -42.36 115.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.855 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 114.44 33.26 1.79 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 3.7 tp -118.21 125.39 50.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.31 133.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.032 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -114.86 121.78 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.6 116.57 5.09 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 92.2 mt -65.42 -44.54 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.463 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.96 120.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.691 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 30.0 t -157.9 -173.78 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -114.27 -65.37 0.43 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.671 HD21 ' HG1' ' A' ' 89' ' ' THR . 34.2 m120 -134.31 80.55 52.1 Favored Pre-proline 0 C--N 1.332 -0.174 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.32 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.23 147.19 59.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.801 2.334 . . . . 0.0 110.626 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.4 m -110.78 115.84 30.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.738 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 75' ' ' ILE . 14.6 mm -92.73 126.61 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.15 127.34 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.157 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.76 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -118.9 130.26 55.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.949 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 69.8 t80 -137.43 110.03 7.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.69 -128.98 48.96 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.3 p -94.04 9.71 36.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.969 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.05 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.872 0.368 . . . . 0.0 110.812 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -139.8 151.92 46.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.64 142.44 13.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -111.43 152.71 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.114 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.516 ' HG1' ' N ' ' A' ' 87' ' ' ILE . 3.9 t -149.33 162.88 39.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.309 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' ' HG1' ' A' ' 86' ' ' THR . 31.5 mm -106.41 126.37 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -112.94 128.47 56.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.73 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.671 ' HG1' HD21 ' A' ' 72' ' ' ASN . 16.9 m -107.51 145.79 32.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.031 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.8 117.47 29.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.073 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -141.2 129.23 21.99 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.518 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -79.73 135.03 36.42 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.755 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.5 p -103.41 -55.6 2.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -78.23 80.56 4.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.475 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.429 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.415 ' H1 ' ' HG ' ' A' ' 1' ' ' SER . 1.4 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.23 56.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.665 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.57 145.09 55.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.639 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.496 ' CG2' ' N ' ' A' ' 5' ' ' LEU . 20.7 m -90.24 162.3 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.279 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 4' ' ' THR . 57.6 tp -86.99 114.87 23.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -72.49 -46.37 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.78 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 p -157.63 164.8 36.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -124.38 131.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.933 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.2 m -132.77 148.71 52.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.538 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.0 mm -98.77 139.2 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.095 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.63 163.22 18.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 111.506 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -36.39 158.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.096 3.197 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ASN . 96.3 mt -84.72 158.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 123.501 0.721 . . . . 0.0 109.972 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' ILE . 92.2 m-20 -37.81 -92.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.824 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.506 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -160.25 93.25 1.03 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.105 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 15' ' ' THR . 22.7 m120 -154.57 140.29 18.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.328 0.585 . . . . 0.0 111.678 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.53 132.72 45.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.892 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.09 165.66 12.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.836 0.351 . . . . 0.0 110.734 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.529 ' O ' ' C ' ' A' ' 20' ' ' THR . 65.4 p -49.29 127.84 15.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.564 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.529 ' C ' ' O ' ' A' ' 19' ' ' THR . 0.0 OUTLIER 30.0 63.76 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.998 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.72 134.63 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.379 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -79.9 136.28 36.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.118 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -137.93 135.85 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 110.963 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -112.3 145.58 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.339 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.42 152.62 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.853 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -110.62 142.44 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.968 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.19 128.82 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.909 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.72 128.97 72.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.481 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.97 147.18 16.59 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -115.01 129.52 56.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -87.31 149.39 24.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.112 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -55.98 -15.3 3.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.448 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.3 -1.58 49.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.567 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 1.88 85.36 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.8 m -85.36 145.59 27.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.641 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.91 148.59 42.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.71 154.71 20.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.4 125.1 31.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.343 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' SER . 90.5 mt -106.99 7.24 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -50.07 -31.95 14.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.2 p -87.99 -9.32 53.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.197 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.7 -28.57 10.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.558 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -87.81 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 m -106.04 123.85 48.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.76 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.474 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 38.0 m95 -92.82 134.53 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -148.37 170.3 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.935 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.1 t -136.26 146.88 47.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.786 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -66.15 -33.76 76.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 0.0 109.37 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -94.89 84.21 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 53' ' ' ALA . 98.5 mm-40 -85.84 -22.79 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 t -71.02 -34.32 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.639 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.82 4.3 37.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -160.68 152.8 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.227 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -132.66 136.03 46.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.018 0.437 . . . . 0.0 110.701 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.04 113.28 43.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.988 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.7 t -138.98 104.49 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.834 HD21 ' H ' ' A' ' 63' ' ' GLY . 31.0 p30 -131.75 127.27 36.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.574 ' N ' ' HG1' ' A' ' 61' ' ' THR . . . -70.82 -179.56 2.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 t -58.86 -44.95 91.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.596 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 57.1 mp0 -83.46 -7.97 59.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.505 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.574 ' HG1' ' N ' ' A' ' 58' ' ' ALA . 19.4 p -113.0 8.8 18.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.357 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -42.13 114.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.834 ' H ' HD21 ' A' ' 57' ' ' ASN . . . 113.68 29.04 3.01 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.5 tp -118.02 121.0 39.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.575 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.14 134.11 67.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 p -102.47 131.47 49.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.24 105.28 2.05 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.05 -44.72 99.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 110.338 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 170.66 121.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -160.07 168.59 25.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.92 -49.09 1.19 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -149.69 82.73 6.6 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -84.24 159.05 13.15 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.488 2.125 . . . . 0.0 110.184 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.0 m -118.32 123.95 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 mm -98.29 125.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.938 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.2 mm -112.8 126.52 70.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.106 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.99 125.6 47.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 m -113.88 126.11 54.81 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.693 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.473 ' O ' ' CD2' ' A' ' 79' ' ' TYR . 64.4 t80 -134.64 87.76 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.41 -124.78 22.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -89.04 4.92 46.69 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.314 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.45 136.55 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 p -142.15 157.08 45.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . -127.45 142.93 13.93 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -123.14 130.84 53.3 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.204 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -136.71 157.18 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.341 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.7 mt -97.56 124.57 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.971 0.415 . . . . 0.0 111.179 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.2 tp -107.93 135.57 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.3 m -119.09 139.69 51.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.918 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.3 t -88.1 101.7 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.0 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -137.0 149.61 47.6 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.357 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HZ1' ' C ' ' A' ' 95' ' ' THR . 44.4 tttm -72.76 136.3 45.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 32.7 m -44.13 -72.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 93' ' ' THR . 97.9 m-20 -139.49 -65.02 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.515 ' C ' ' HZ1' ' A' ' 92' ' ' LYS . 4.9 t . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.659 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ALA . 9.5 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 45.48 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.47 139.94 51.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -93.05 143.0 26.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.1 tp -60.57 116.65 4.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.404 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.3 t -75.92 -42.97 47.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -156.8 165.69 35.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.047 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.95 133.21 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -135.38 147.85 49.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 10' ' ' ILE . 15.1 mm -95.33 143.41 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.761 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.49 164.38 16.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.34 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.0 Cg_exo -37.27 164.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 123.326 2.684 . . . . 0.0 112.871 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' ASN . 86.7 mt -107.6 114.98 47.74 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 125.074 1.35 . . . . 0.0 110.798 -0.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' ILE . 97.3 m-20 33.96 -120.95 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.604 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 p -149.16 95.78 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.906 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 60.5 t30 -150.3 147.84 28.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.591 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.8 mt -138.4 132.23 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.735 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 21' ' ' VAL . 99.2 m-20 -104.54 133.21 49.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.605 ' C ' ' H ' ' A' ' 21' ' ' VAL . 8.7 p -65.3 152.39 43.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.282 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -16.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.707 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.605 ' H ' ' C ' ' A' ' 19' ' ' THR . 46.3 t -118.6 138.39 49.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.52 0.676 . . . . 0.0 111.422 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 m -96.37 141.45 29.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.936 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -120.47 140.6 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -109.34 143.54 38.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.71 153.62 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.181 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -111.03 152.35 26.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.66 129.91 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.583 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.97 128.41 67.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.07 143.41 14.52 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.521 ' OG1' ' NZ ' ' A' ' 36' ' ' LYS . 52.7 m -115.48 129.2 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.871 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -88.1 146.44 25.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.861 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.0 p -53.73 -15.79 1.4 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.748 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.02 -3.22 51.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.571 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.07 85.95 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 m -77.64 139.74 39.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 110.714 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.521 ' NZ ' ' OG1' ' A' ' 30' ' ' THR . 68.7 mmtt -110.99 139.47 46.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.45 25.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.085 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -90.1 126.04 35.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.202 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 2.5 mm? -103.81 9.2 37.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -53.45 -30.32 40.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.898 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.4 p -89.82 -9.11 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.22 -22.75 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 39' ' ' LEU . 6.3 m -95.12 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -104.29 120.32 40.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.637 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.0 m95 -89.07 134.72 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.536 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 p -143.21 162.49 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.885 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -135.94 144.64 45.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 111.235 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 p -67.78 -33.34 74.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.333 0.587 . . . . 0.0 109.527 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' ALA . 16.2 m120 -77.58 62.47 2.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.566 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.09 -42.33 84.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.054 0.454 . . . . 0.0 109.956 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -69.85 -34.4 73.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -103.62 6.01 36.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.374 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -159.57 147.26 17.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.324 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -132.46 142.64 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 110.807 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 p -122.59 114.29 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 67.8 p -139.53 117.05 11.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.632 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.564 ' CA ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -155.29 134.4 12.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.22 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -75.03 178.8 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.751 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.2 p -54.3 -27.25 34.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.621 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -87.47 -25.28 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.717 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.564 ' HG1' ' CA ' ' A' ' 57' ' ' ASN . 18.6 p -103.87 8.27 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.655 0.265 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -42.16 115.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.962 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.83 35.94 2.12 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.9 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 25.0 tp -118.27 126.12 51.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.724 0.262 . . . . 0.0 110.514 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.74 133.7 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 111.051 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 m -102.66 127.84 49.61 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.67 102.1 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.678 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.26 -44.17 95.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.908 0.385 . . . . 0.0 110.069 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 167.75 118.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 t -160.42 170.82 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.45 -55.24 0.76 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -140.66 82.2 16.11 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -83.04 155.46 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.69 2.26 . . . . 0.0 110.732 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.5 m -121.27 123.9 43.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.971 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 2.1 mp -102.43 129.7 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.734 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.0 127.23 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.091 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.9 129.4 49.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.7 m -113.37 129.7 56.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -132.35 87.27 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.265 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.65 -125.2 25.5 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.3 p -87.18 3.97 44.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.539 0.209 . . . . 0.0 110.931 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.69 133.65 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.759 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -139.79 154.34 47.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.593 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.43 147.96 17.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.3 m120 -126.25 130.55 51.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.97 0.414 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.8 p -134.55 151.09 50.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.6 mt -97.92 127.01 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 0.0 110.799 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 88' ' ' LEU . 10.5 mp -109.48 145.73 35.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -114.65 134.95 54.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.498 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -84.4 104.27 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 99.3 m-20 -140.18 155.8 46.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.514 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.01 154.66 31.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.479 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 96.5 m -60.68 -46.26 91.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.673 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 36.1 p-10 -132.78 132.26 42.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.606 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.91 60.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.749 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.67 163.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.58 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.1 m -119.0 139.55 51.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.278 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.75 122.79 15.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -74.62 -43.3 56.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.9 p -159.29 162.39 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.45 129.59 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -125.27 148.59 48.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.527 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 10' ' ' ILE . 26.2 mm -104.18 139.75 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.027 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -101.19 162.31 20.94 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 0.0 111.302 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.3 Cg_exo -35.15 163.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 124.104 3.202 . . . . 0.0 111.322 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' ASN . 88.4 mt -109.09 108.13 24.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.599 0.759 . . . . 0.0 110.045 0.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 33.7 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.2 OUTLIER -127.76 97.47 4.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.147 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -154.5 160.08 41.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.258 0.551 . . . . 0.0 111.606 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 91' ' ' ASN . 47.4 mm -124.4 132.39 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.718 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 19' ' ' THR . 2.7 m-80 -78.44 165.92 23.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 18' ' ' ASN . 80.7 p -38.55 -60.73 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 t -156.38 55.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.1 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.54 162.98 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.326 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -86.02 152.27 23.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 88.1 tttt -137.5 135.01 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -111.27 143.43 42.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -130.08 153.2 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.896 179.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -119.8 146.59 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.771 0.32 . . . . 0.0 110.942 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.55 129.77 55.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.827 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.55 128.85 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.79 144.14 17.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 m -113.22 125.79 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.469 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' C ' ' H ' ' A' ' 33' ' ' ASP . 97.1 m-85 -83.4 143.84 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.15 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -49.92 -14.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.426 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' TYR . 89.0 m-20 -81.48 0.76 36.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.568 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.05 1.45 90.61 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -84.32 151.3 24.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.661 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.02 148.19 48.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.371 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.12 27.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.764 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.87 124.67 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.0 12.89 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.175 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.7 m -59.39 -26.38 65.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.081 0.467 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 95.2 p -93.55 -7.76 43.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.237 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.6 -26.4 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.49 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 m -90.63 149.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.4 m -106.45 126.39 52.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.711 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.529 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 23.3 m95 -95.79 137.47 34.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.262 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 p -148.9 168.6 22.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -139.24 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.838 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' A' ' 49' ' ' ASN . 78.1 p -62.34 -39.42 93.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.401 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.506 ' N ' ' HG ' ' A' ' 48' ' ' SER . 97.3 m-20 -91.13 88.47 6.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.328 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -88.86 -22.45 23.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 p -70.83 -32.19 69.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.34 1.97 36.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.161 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.07 148.43 15.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.126 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -127.87 139.15 52.79 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.745 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.93 111.19 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 t -139.67 103.87 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -139.57 130.29 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.623 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.699 ' H ' ' HG1' ' A' ' 61' ' ' THR . . . -73.3 -177.1 2.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -58.32 -34.91 71.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.568 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.8 mp0 -85.58 -22.3 28.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.534 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.699 ' HG1' ' H ' ' A' ' 58' ' ' ALA . 42.0 p -101.76 15.0 30.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.238 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -44.81 115.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.72 34.66 3.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -118.93 113.06 20.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.55 138.4 54.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.803 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -106.44 125.81 51.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.29 103.07 1.62 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.12 -44.96 97.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.334 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 169.52 149.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 5.4 t -179.15 -175.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.673 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.594 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -108.75 -62.47 0.54 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -136.26 80.5 40.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.123 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.3 153.98 61.47 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.507 2.138 . . . . 0.0 110.248 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.5 m -125.19 110.95 14.7 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.225 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 mm -96.07 126.51 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.79 128.65 76.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.08 135.48 39.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.0 m -122.1 132.14 54.33 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.669 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -136.59 107.96 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 48.87 -119.88 6.37 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.4 p -93.22 6.97 46.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.0 t -126.27 129.73 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.912 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -136.74 153.5 50.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 110.904 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.63 142.21 13.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.1 m-20 -121.8 139.11 54.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.936 0.398 . . . . 0.0 111.244 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.6 p -137.65 167.53 21.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.323 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.4 123.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 tp -109.12 130.32 55.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.5 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 m -116.11 141.27 48.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.961 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.87 121.02 36.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.956 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' ILE . 29.3 t-20 -142.04 126.66 17.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.08 123.36 38.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 99.7 m -62.5 -48.83 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.467 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.53 71.15 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.508 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.624 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.31 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.26 154.56 41.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -131.53 164.47 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.2 tp -64.89 105.81 1.1 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.631 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.6 m -76.21 -40.5 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 p -151.61 165.73 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.48 132.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.889 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 m -123.02 149.07 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.627 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.0 mt -118.25 132.58 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.14 164.24 15.89 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' SER . 57.8 Cg_exo -36.21 162.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.047 3.164 . . . . 0.0 111.396 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ASN . 3.5 mt -93.71 163.75 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.485 0.714 . . . . 0.0 109.99 0.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' O ' ' A' ' 13' ' ' ILE . 32.6 p30 -48.01 -172.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 89' ' ' THR . 53.5 p -85.29 93.51 8.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' OD1' ' OD1' ' A' ' 14' ' ' ASN . 27.8 m120 -154.45 142.02 19.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.319 0.58 . . . . 0.0 111.651 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.6 mm -135.85 134.25 51.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.746 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -101.79 157.17 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.822 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 20' ' ' THR . 80.8 p -39.22 121.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 19' ' ' THR . 11.3 p 31.87 66.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.41 137.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 m -82.42 136.92 34.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.104 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.68 132.91 39.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -112.02 144.73 40.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.91 153.8 47.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.802 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -112.53 138.63 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.923 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.34 124.39 52.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.952 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.79 129.45 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.386 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.19 142.11 16.46 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.0 m -109.2 122.69 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 110.417 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.401 ' C ' ' H ' ' A' ' 33' ' ' ASP . 78.6 m-85 -83.84 146.34 28.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.128 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.2 p -52.14 -14.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.413 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' TYR . 78.6 m-20 -79.67 -3.94 49.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 2.27 82.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -85.7 153.79 22.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.74 151.09 43.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.29 156.27 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -86.78 123.78 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.34 18.22 19.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 110.232 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.03 -30.42 70.3 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.9 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.0 p -89.61 -8.28 52.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.192 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.7 t -104.7 -27.9 11.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.5 m -88.11 150.6 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.268 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -108.52 117.64 34.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 18.8 m95 -87.25 136.64 32.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.7 p -141.2 162.66 34.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.987 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -138.45 143.31 39.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.888 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -68.94 -36.42 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 53' ' ' ALA . 99.1 m-20 -74.42 69.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.29 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.03 -43.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.4 m -70.04 -33.91 72.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.644 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.59 6.64 34.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -164.98 146.47 7.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.166 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -131.79 146.77 52.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.76 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 114.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.963 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.4 p -140.93 111.47 6.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.499 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.08 131.44 11.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.53 -177.03 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.9 t -56.3 -41.75 76.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.591 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -74.46 -31.39 62.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.522 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.2 p -95.22 2.49 54.94 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -41.31 116.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.845 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.81 33.8 1.8 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.57 118.92 32.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.31 135.72 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.773 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -112.17 128.85 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.53 134.77 12.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.659 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.01 -66.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' SER . . . -144.8 142.05 29.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.643 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 1.1 t 163.32 175.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -109.69 -48.69 0.78 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -140.64 81.12 17.45 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.18 144.07 85.74 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 0.0 110.242 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.0 m -118.29 121.31 40.1 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.78 129.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.8 128.09 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.163 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.5 131.17 54.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -115.65 133.91 55.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.633 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -136.53 94.2 2.97 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.7 -123.23 32.2 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.6 p -89.91 6.77 40.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.33 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.17 135.31 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 p -140.0 156.85 46.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.0 110.92 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.8 143.92 15.58 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -111.24 139.88 46.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.1 m -135.8 141.72 44.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.277 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.18 128.99 63.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.064 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.04 147.76 28.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.529 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.415 ' H ' ' HB ' ' A' ' 15' ' ' THR . 59.0 m -111.9 138.0 49.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.982 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 43.0 t -83.25 104.48 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.904 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 10.4 m120 -136.0 130.77 34.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.416 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 94' ' ' ASP . 97.4 mttt -94.86 153.96 17.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.899 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -79.97 34.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.588 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 92' ' ' LYS . 97.2 m-20 -74.99 121.57 22.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.527 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.597 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.475 ' H2 ' ' H ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' H ' ' H2 ' ' A' ' 1' ' ' SER . . . -134.47 148.95 50.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.63 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.95 179.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.631 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -133.99 162.39 32.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.04 109.53 19.92 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.625 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -76.47 -53.09 8.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.775 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.8 p -156.46 169.79 23.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.906 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.69 144.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.849 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -135.81 149.12 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.674 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mm -95.29 141.77 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.36 165.55 14.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 120.762 0.315 . . . . 0.0 111.431 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 11' ' ' SER . 46.5 Cg_exo -38.19 165.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.095 3.197 . . . . 0.0 111.314 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 14' ' ' ASN . 78.7 mt -110.14 117.78 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.461 0.705 . . . . 0.0 110.008 0.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 13' ' ' ILE . 3.9 t-20 27.05 -131.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.756 0.312 . . . . 0.0 110.88 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.482 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -142.81 93.4 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.178 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -155.26 135.16 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.226 0.536 . . . . 0.0 111.66 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -156.35 141.45 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.789 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -107.53 164.81 11.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.737 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.5 p -67.34 143.49 56.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.81 4.5 5.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.053 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.33 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 m -104.32 145.48 30.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.102 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -131.11 140.22 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.901 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -109.54 143.48 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.383 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.606 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.14 152.96 48.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.881 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -111.08 149.75 30.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.923 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.79 127.8 55.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.825 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.38 128.34 69.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.461 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.12 148.35 17.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.8 m -119.6 130.09 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 0.0 110.432 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 33' ' ' ASP . 87.4 m-85 -89.08 149.33 23.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.122 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -55.3 -10.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.434 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 31' ' ' TYR . 96.3 m-20 -87.12 -0.75 57.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.56 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.7 87.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.6 m -84.22 146.26 27.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 110.654 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.13 146.98 48.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.08 156.12 28.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.834 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.15 122.97 28.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.42 9.2 29.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.211 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.6 m -55.0 -30.55 59.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.113 0.482 . . . . 0.0 109.866 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -89.67 -9.8 48.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.133 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.509 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -102.87 -26.35 13.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.599 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.72 144.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.302 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 123.13 47.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.606 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 10.8 m95 -92.94 136.46 33.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.277 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.3 t -139.93 144.86 37.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.888 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.7 t -113.4 140.15 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.3 p -62.82 -40.09 96.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 93.0 m-20 -71.64 70.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.322 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -74.45 -40.33 61.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.2 p -71.02 -32.89 69.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.643 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.55 11.05 27.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 49' ' ' ASN . . . -166.89 148.86 6.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.197 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -134.05 147.08 50.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.696 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.4 t -110.21 113.32 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.008 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -139.86 105.63 5.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.595 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.29 131.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.673 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.508 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.94 -176.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -56.48 -42.91 79.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.572 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.16 -27.18 60.71 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.533 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 51.9 p -99.44 2.18 44.81 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.35 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -40.34 114.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.595 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 112.81 39.72 1.15 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -119.44 127.89 53.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.305 . . . . 0.0 110.624 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.12 133.34 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.751 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -113.57 120.65 41.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.58 107.92 2.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.26 -45.4 93.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -169.72 118.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 p -164.25 168.15 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.15 -68.55 0.93 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -131.68 80.83 65.39 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.7 151.24 69.39 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.465 2.11 . . . . 0.0 110.218 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 m -120.01 124.12 45.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.272 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 38.4 mm -102.13 126.67 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.963 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.04 122.78 68.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.196 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.87 41.29 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -119.77 127.84 53.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.631 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.509 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 67.8 t80 -136.97 118.77 15.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.08 -125.4 30.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.5 p -97.55 8.64 44.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' TYR . 44.6 t -126.36 136.54 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.7 p -135.41 150.76 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.45 142.19 13.29 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -113.06 151.18 31.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.461 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -144.66 156.5 44.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.3 mm -108.87 123.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.6 mt -115.59 145.81 42.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.8 m -120.04 143.16 48.24 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.928 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.435 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 92.2 t -84.69 104.21 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 90.5 m-20 -140.87 151.18 44.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.411 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.91 148.27 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.903 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 94' ' ' ASP . 51.5 m -84.56 -97.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 93' ' ' THR . 88.1 m-20 56.53 20.25 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.602 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 147.11 49.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.4 148.57 45.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -92.16 164.64 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.66 118.24 25.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.0 110.612 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -75.65 -36.13 60.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -154.66 161.72 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.247 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -113.4 132.96 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.196 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -129.55 148.35 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.501 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.06 133.71 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.075 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.09 165.68 13.75 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.383 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -38.49 158.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.544 2.829 . . . . 0.0 112.019 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 91.2 mt -87.23 154.85 3.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 123.942 0.897 . . . . 0.0 110.578 1.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' ILE . 52.2 t30 -53.56 -113.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.548 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -134.58 92.04 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.981 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.711 ' H ' ' HZ2' ' A' ' 23' ' ' LYS . 71.6 m-80 -157.45 158.73 36.36 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.528 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 tp -145.63 144.94 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -113.26 162.15 16.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.7 0.286 . . . . 0.0 110.48 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 p -38.95 107.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.5 p 36.9 72.36 0.11 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.22 153.76 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.982 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 m -83.37 139.78 32.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.755 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.711 ' HZ2' ' H ' ' A' ' 16' ' ' ASN . 88.0 tttt -127.93 118.9 24.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.983 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.97 142.71 44.04 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.54 152.67 48.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.503 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -116.54 138.95 51.01 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.45 126.78 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.968 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.85 130.83 74.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.53 142.58 17.59 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.4 m -108.11 125.08 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 110.64 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -82.81 147.4 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.414 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p -54.32 -16.48 2.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.49 -5.19 46.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.32 1.14 79.01 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 36.1 m -86.7 160.63 18.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 0.0 110.686 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' N ' ' CG2' ' A' ' 35' ' ' THR . 68.5 mttm -130.67 151.62 50.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.9 156.49 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -84.77 123.33 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.101 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 42' ' ' SER . 79.2 mt -108.78 0.41 20.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.57 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -49.15 -33.45 12.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -86.63 -13.53 45.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.515 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -100.03 -21.9 15.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' LEU . 3.6 m -96.98 149.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -107.69 124.36 49.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.617 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.0 m95 -94.24 139.25 31.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.672 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -142.62 169.58 17.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -140.58 139.12 34.89 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.7 p -62.91 -32.69 74.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' OD1' ' OE1' ' A' ' 52' ' ' GLN . 12.8 m-80 -84.73 68.46 10.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.6 mm-40 -69.74 -41.34 75.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.997 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -70.75 -34.47 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.339 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 49' ' ' ASN . 89.9 mt-30 -100.01 2.79 43.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.053 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -158.75 145.38 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.157 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -127.23 140.54 52.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 9.8 p -120.64 113.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.094 0.473 . . . . 0.0 109.968 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -140.16 106.64 5.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.311 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -148.64 131.8 16.39 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.44 -176.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.651 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -58.74 -43.78 90.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.023 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.86 -33.81 72.76 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -96.38 5.56 50.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.51 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -42.28 115.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.632 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.87 32.14 2.13 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -117.31 115.26 24.91 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.63 133.97 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.896 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -116.04 126.2 53.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.619 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.96 113.8 4.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.33 -43.92 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.04 120.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 46.3 p -157.85 172.36 18.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.49 -53.63 0.92 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -150.05 82.64 6.43 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.836 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.91 155.87 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.556 2.171 . . . . 0.0 110.711 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.7 m -119.24 123.37 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.709 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.7 mp -99.26 123.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.596 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.14 125.69 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.342 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 134.62 47.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.1 m -124.08 130.54 52.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 111.14 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 58.3 t80 -136.19 108.81 7.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.49 -122.16 28.89 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.7 p -97.94 5.43 48.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.488 0.185 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.41 133.75 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.5 p -140.38 150.73 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.55 142.68 13.98 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -108.9 143.4 38.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.044 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -136.71 143.95 43.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 mm -102.62 126.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.252 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -108.42 141.71 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.824 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.484 ' N ' ' OG1' ' A' ' 15' ' ' THR . 60.5 m -118.16 137.51 52.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.421 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 70' ' ' SER . 72.5 t -85.21 112.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -141.06 128.93 21.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.727 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.32 119.27 32.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.641 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.7 p -67.35 -38.34 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 54.12 55.97 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.3 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.464 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -95.9 30.83 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.713 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 41.71 -168.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -139.46 160.68 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 tp -87.49 107.3 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.67 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -75.37 -46.19 34.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.763 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 p -157.37 164.78 37.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.8 pt -123.04 147.6 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.866 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 10.8 p -137.28 149.0 46.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.06 136.22 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -98.93 165.36 15.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.445 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.5 Cg_exo -37.26 165.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 124.055 3.17 . . . . 0.0 111.363 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 14' ' ' ASN . 74.4 mt -106.94 113.12 42.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.491 0.716 . . . . 0.0 110.031 0.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 13' ' ' ILE . 79.1 m-20 28.77 -126.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -149.92 95.55 2.32 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.137 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 3.8 p30 -155.62 136.84 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 111.617 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.0 mm -122.87 132.55 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.761 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' THR . 1.0 OUTLIER -80.61 167.38 20.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.863 0.363 . . . . 0.0 110.81 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 18' ' ' ASN . 30.8 p -36.03 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.565 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 t -113.93 66.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.089 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 22' ' ' SER . 54.9 t -131.94 160.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 9.3 t -108.25 124.32 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -115.5 139.71 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tt0 -110.16 146.83 34.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.368 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.95 152.99 47.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 11' ' ' SER . 52.0 m-85 -112.07 151.57 29.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.988 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.35 128.45 51.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.869 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.2 t -120.24 130.59 74.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.22 151.94 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -114.79 126.67 55.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -83.76 150.59 25.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.136 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -55.1 -13.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.469 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.81 -4.03 57.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.665 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 4.05 79.61 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 18.2 m -88.51 154.54 20.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.1 mttt -125.53 146.66 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.285 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.77 41.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.96 121.14 29.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.369 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.41 11.64 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.146 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 m -57.27 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.791 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.9 p -90.49 -11.47 40.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.444 ' HG ' ' N ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -101.34 -29.69 11.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.551 -179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 42' ' ' SER . 5.2 m -87.22 153.68 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 m -110.6 124.57 52.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.726 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.527 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 29.3 m95 -94.84 133.57 38.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.9 p -147.08 161.36 41.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.977 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 t -136.17 146.98 47.46 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.95 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.0 p -65.69 -35.78 81.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' ALA . 87.8 m-20 -69.08 65.9 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.32 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' ALA . 75.5 mt-30 -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.9 t -71.45 -34.52 70.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -98.85 3.75 47.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -169.09 154.62 6.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.182 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -133.92 143.36 48.19 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.745 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.61 113.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.055 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.8 p -138.76 103.1 4.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.05 121.73 42.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.656 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.7 169.6 16.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 m -55.63 -35.61 66.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.607 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 54.7 mp0 -87.31 -7.44 57.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.536 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.8 p -131.54 31.54 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.268 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 68.0 mttm -47.16 117.11 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.79 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.51 43.54 2.7 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.9 tp -118.01 122.32 42.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.767 0.317 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.0 t -128.54 132.75 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -116.48 127.22 54.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.01 120.02 4.84 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.54 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 178.02 139.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.683 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 13.6 t -173.4 177.44 2.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.723 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -101.13 -69.42 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -133.88 81.45 52.25 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.178 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.29 153.41 66.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.462 2.108 . . . . 0.0 110.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.1 m -119.73 112.05 18.78 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.225 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.5 mp -94.67 127.32 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.991 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.0 mt -114.53 129.73 70.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.162 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.29 125.96 43.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -114.41 125.65 54.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.33 114.29 12.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.766 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.68 -127.08 39.51 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -94.93 8.58 42.34 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.349 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.29 130.45 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.7 p -137.42 150.83 47.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.74 142.66 13.85 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.2 m-20 -108.18 140.85 40.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.265 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -132.84 155.0 49.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.247 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 87' ' ' ILE . 13.8 mm -95.34 123.49 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 111.122 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.9 tp -114.21 128.05 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.551 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.4 m -112.12 139.85 47.29 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.9 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.65 102.07 8.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' ILE . 27.8 m120 -123.79 151.34 43.42 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.77 153.71 17.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -99.4 66.36 1.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.592 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 45.66 46.79 11.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.498 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.571 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.533 ' HG ' ' H ' ' A' ' 2' ' ' ALA . 30.2 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.533 ' H ' ' HG ' ' A' ' 1' ' ' SER . . . -153.67 149.88 28.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.714 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.44 -162.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.599 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -138.66 164.82 28.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.52 107.62 4.51 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.62 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -75.39 -38.31 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.8 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 p -150.49 162.75 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.69 133.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.859 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.8 t -129.5 146.58 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.65 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.84 134.45 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.67 163.55 17.9 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.438 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 6.5 Cg_endo -43.2 172.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.069 3.179 . . . . 0.0 111.283 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 82.9 mt -103.88 110.79 31.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.02 0.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' THR . 19.0 p30 35.19 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -139.79 95.7 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.122 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.66 159.29 39.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 111.653 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.5 mt -136.17 129.88 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.723 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' THR . 99.6 m-20 -98.35 164.54 12.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 110.732 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 20' ' ' THR . 6.1 p -37.95 117.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.499 ' C ' ' O ' ' A' ' 19' ' ' THR . 6.5 p 32.44 65.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.012 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.06 142.35 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.0 m -98.14 118.98 35.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.065 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -113.12 136.81 52.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.72 143.4 41.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.53 153.93 47.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.884 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.41 147.82 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.09 129.01 56.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.905 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.88 132.42 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.499 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.77 149.52 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -120.12 125.46 48.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.43 151.07 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.11 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.4 p -53.94 -14.59 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.524 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -85.2 6.0 27.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.59 3.16 82.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 m -83.42 139.35 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.954 0.407 . . . . 0.0 110.661 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.07 147.24 44.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.369 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.12 164.71 37.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.952 0.406 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 29.1 p-10 -88.41 123.08 32.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.339 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.64 13.02 28.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -60.48 -31.59 70.61 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.87 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -90.32 -4.6 57.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.03 -27.94 9.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.6 142.94 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.25 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.0 m -103.31 116.18 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.744 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.8 m95 -83.91 133.7 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.228 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -137.0 163.82 29.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -134.83 140.94 46.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.885 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -64.23 -34.57 78.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 5.8 m120 -83.65 71.38 10.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 53' ' ' ALA . 87.0 mt-30 -74.23 -40.38 62.45 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 m -69.91 -33.68 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.607 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -103.74 3.31 34.02 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -158.35 150.1 21.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.176 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.14 145.24 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.739 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.39 115.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 32.9 t -140.43 114.47 9.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -152.74 132.82 13.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.579 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.97 -177.67 2.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.1 p -57.79 -30.3 65.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.507 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.93 -12.49 44.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 52.5 p -114.74 4.06 14.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.255 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -41.16 112.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 116.41 33.37 1.47 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -117.01 121.48 41.48 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 110.627 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.0 t -124.24 134.63 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -112.35 125.98 54.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.0 103.29 1.88 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 68' ' ' ILE . 27.6 mm -63.02 -44.99 99.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.733 0.301 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 179.89 118.16 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 p -161.04 167.8 25.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.722 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.31 -54.16 0.91 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -149.31 81.08 7.51 Favored Pre-proline 0 C--N 1.334 -0.105 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.141 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.53 158.76 19.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 0.0 110.204 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -116.37 124.49 50.19 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 75' ' ' ILE . 17.8 mm -100.08 121.18 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.913 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.0 mt -111.93 126.09 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.225 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 133.76 48.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -113.68 133.4 55.34 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.549 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -131.56 86.41 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.677 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.95 -123.94 19.4 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -88.55 5.64 41.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.289 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -137.78 152.71 49.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.12 17.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -110.37 145.78 36.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.172 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.5 p -134.71 154.28 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.379 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.0 mt -100.59 121.57 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 111.177 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -109.47 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.544 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.6 m -117.6 138.44 51.94 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.91 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.1 t -83.4 107.76 15.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.972 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -139.2 139.41 37.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.333 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -79.06 144.12 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.4 m -119.87 128.66 53.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.64 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.96 43.25 31.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.83 147.54 47.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.739 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.27 149.47 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.633 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -139.21 163.27 32.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.254 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.93 111.03 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -80.05 -46.29 16.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.815 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 p -154.17 163.15 40.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.9 pt -123.22 146.3 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.846 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 p -139.12 148.49 43.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.664 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.62 137.18 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.55 164.98 14.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.403 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.7 Cg_exo -37.49 166.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.981 3.121 . . . . 0.0 111.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.475 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 72.3 mt -112.18 111.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 C-N-CA 123.457 0.703 . . . . 0.0 110.044 0.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' ILE . 1.4 m120 34.37 -153.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.721 0.295 . . . . 0.0 110.855 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.559 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.1 OUTLIER -136.58 96.72 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.193 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 15' ' ' THR . 79.7 m-20 -157.26 155.92 31.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.321 0.581 . . . . 0.0 111.684 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -138.59 131.82 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.82 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.74 167.0 13.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.848 0.356 . . . . 0.0 110.744 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.4 p -39.42 110.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.449 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.7 p 42.09 62.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.081 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.0 t -130.36 139.25 51.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.344 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 p -92.29 138.06 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.05 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 83.1 tttt -131.78 139.76 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.932 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 24.0 tt0 -109.43 144.93 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.421 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -126.94 152.78 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.969 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' O ' ' OG ' ' A' ' 11' ' ' SER . 42.5 m-85 -113.24 148.79 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.09 130.26 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.916 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.43 131.04 71.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.464 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.97 17.21 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.5 m -113.89 129.47 56.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 110.488 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 33' ' ' ASP . 91.5 m-85 -86.51 144.0 27.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.074 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p -52.22 -14.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.49 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 49.5 t0 -79.71 -6.86 58.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 -0.59 68.95 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 23.7 m -86.61 160.38 18.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.883 0.373 . . . . 0.0 110.649 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.0 mttt -131.71 151.15 51.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.313 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.01 160.2 35.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' OG1' ' A' ' 40' ' ' THR . 52.1 t0 -86.64 119.61 27.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.393 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.84 12.31 32.74 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.159 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' OD1' ' A' ' 38' ' ' ASP . 26.7 m -59.04 -28.2 66.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.841 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.5 p -91.32 -10.3 41.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -104.14 -27.39 12.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 m -88.2 150.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -106.04 126.47 52.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.545 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 49.9 m95 -97.3 135.24 39.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 m -148.14 168.88 21.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.3 t -137.93 147.36 44.27 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.79 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -68.08 -34.69 76.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -77.57 69.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.38 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' ALA . 85.0 mt-30 -72.45 -43.2 64.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.6 p -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.54 9.91 39.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.171 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.11 152.91 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.4 113.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.039 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -139.76 104.39 4.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.696 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.633 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -118.81 123.97 46.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.08 172.22 12.18 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -58.6 -31.03 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.609 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.38 -11.88 47.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.526 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -131.38 31.07 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.27 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.7 mttt -43.48 116.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.801 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.536 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.22 45.05 2.45 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 55.1 tp -117.25 123.27 46.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -127.25 136.08 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.832 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -110.46 128.52 55.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.34 107.86 2.81 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.35 -43.71 97.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 171.79 117.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.697 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 p -159.13 166.36 31.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.671 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 72' ' ' ASN . . . -95.08 -65.95 0.99 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 2.8 m120 -138.57 80.6 26.08 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.13 158.26 23.47 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.501 2.134 . . . . 0.0 110.286 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 m -113.29 128.28 56.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 75' ' ' ILE . 17.9 mm -100.44 120.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 76' ' ' ILE . 36.4 mm -109.26 126.42 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.99 126.15 50.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.7 m -115.45 125.8 53.55 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.692 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -134.8 90.6 2.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.05 -129.81 18.58 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.9 p -87.97 3.35 49.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.307 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.71 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 p -140.98 150.15 42.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.58 142.38 14.71 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.0 OUTLIER -118.84 130.41 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 111.16 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.3 p -134.67 156.68 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.278 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.75 124.29 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.55 151.32 28.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.6 m -132.72 145.3 50.92 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.974 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 91.2 t -83.87 127.19 40.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.919 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -139.39 122.93 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.356 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.23 128.38 38.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.8 p -67.58 -36.29 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.525 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 95' ' ' THR . 26.6 t0 58.42 -179.21 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.489 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.525 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 58.3 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.671 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.86 20.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.708 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' A' ' 1' ' ' SER . . . -125.94 168.22 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.612 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -130.36 164.4 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.312 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.03 107.76 14.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.563 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.776 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.67 162.98 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.893 0.378 . . . . 0.0 110.819 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -125.05 133.97 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 t -132.91 148.49 52.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.58 130.71 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.487 ' H ' ' HG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -101.1 162.75 19.58 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 8.1 Cg_endo -44.11 172.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 124.038 3.159 . . . . 0.0 111.348 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.519 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 76.5 mt -102.53 118.23 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.487 0.715 . . . . 0.0 109.958 0.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 t-20 30.61 -146.59 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.754 0.312 . . . . 0.0 110.911 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 p -152.88 95.4 1.98 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.06 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.96 160.75 43.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.43 132.8 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.791 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' C ' ' HZ2' ' A' ' 92' ' ' LYS . 11.9 m120 -100.24 166.71 10.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 110.771 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' THR . 18.3 p -37.71 111.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.557 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 1.7 m 38.95 62.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.08 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.34 139.86 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.377 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -96.95 123.62 40.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 64.5 tttm -112.78 144.03 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -110.37 143.46 40.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.36 151.57 49.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.898 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 11' ' ' SER . 56.8 m-85 -113.7 155.41 25.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.718 0.294 . . . . 0.0 110.907 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -123.1 130.64 53.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.925 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.3 t -113.44 131.03 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.76 151.22 17.27 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 m -117.84 126.07 51.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -81.16 151.57 28.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.102 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.1 p -55.3 -18.25 6.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -76.67 -4.1 41.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.42 0.23 82.55 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 92.5 m -83.39 162.09 21.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.2 mttt -131.1 148.68 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.355 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.68 20.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -78.1 124.96 28.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.8 13.48 24.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.625 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 99.9 m -60.83 -30.14 69.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.809 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -90.85 -9.54 45.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.253 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.08 -26.57 13.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.09 152.02 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.228 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -109.88 123.5 49.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.684 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.54 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 22.8 m95 -93.58 137.49 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.9 t -145.03 167.75 21.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.017 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -142.23 139.95 32.14 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.862 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.2 -26.38 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -78.79 65.16 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.336 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 88.6 mt-30 -67.15 -49.84 63.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.8 p -71.71 -33.67 68.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.612 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -93.65 -2.43 54.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.73 151.76 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.156 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -131.23 136.42 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.71 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.83 113.07 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -138.71 104.12 5.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.78 HD21 ' H ' ' A' ' 63' ' ' GLY . 29.9 p30 -132.45 128.23 37.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.664 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.72 -177.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 t -61.84 -42.33 98.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.649 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.9 mp0 -83.16 -12.41 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.532 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.2 p -110.73 8.88 22.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.185 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -41.58 112.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.73 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.78 ' H ' HD21 ' A' ' 57' ' ' ASN . . . 114.4 31.18 2.25 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.04 122.15 41.49 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.703 0.287 . . . . 0.0 110.573 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.32 134.4 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -104.74 125.72 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.04 102.86 2.39 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.32 -44.77 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.71 0.291 . . . . 0.0 110.264 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 173.4 118.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.584 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -162.43 167.02 24.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.25 -67.18 0.83 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -128.24 81.16 71.04 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.06 159.26 15.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.43 2.087 . . . . 0.0 110.149 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -123.22 129.58 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 75' ' ' ILE . 47.4 mm -102.11 129.59 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -115.79 126.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.51 135.92 43.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.5 m -121.81 128.44 51.68 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.682 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -128.94 88.75 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.63 -119.8 11.81 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.9 p -91.62 1.16 57.34 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.317 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.21 132.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.6 p -135.44 154.09 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.05 146.93 18.51 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -110.89 144.72 39.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.216 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.8 p -134.05 158.54 43.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.9 mm -98.64 124.55 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.016 0.436 . . . . 0.0 111.134 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.9 tp -114.15 135.02 54.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.504 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -125.75 132.13 52.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.893 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.05 109.16 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.952 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 92' ' ' LYS . 54.6 t-20 -139.63 129.52 24.81 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.353 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HZ2' ' C ' ' A' ' 18' ' ' ASN . 62.0 mmtt -90.99 127.08 36.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.45 ' H ' ' ND2' ' A' ' 18' ' ' ASN . 96.8 m -63.76 -46.79 83.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.14 -50.24 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.612 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.62 145.65 18.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.707 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.84 146.83 52.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -91.13 163.89 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.262 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mt -81.79 124.05 29.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.555 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -74.35 -41.0 61.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.4 p -157.26 161.84 39.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -124.67 128.71 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.886 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -134.24 150.28 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.55 147.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.061 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.32 165.1 15.06 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 120.8 0.333 . . . . 0.0 111.376 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' SER . 52.0 Cg_exo -37.35 164.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 124.02 3.147 . . . . 0.0 111.384 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.5 mm -110.2 127.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.476 0.71 . . . . 0.0 109.952 0.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 13' ' ' ILE . 43.6 t30 29.72 -139.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -135.05 93.98 3.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 20.5 p30 -158.02 162.0 38.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 111.674 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.53 160.53 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.805 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -105.11 140.65 37.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -81.91 -26.17 34.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.458 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 p -104.53 -12.99 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.093 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 22' ' ' SER . 33.7 t -132.69 169.31 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.484 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 24.0 m -110.42 147.59 33.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -122.65 147.15 46.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.0 tt0 -111.52 145.19 39.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.42 149.67 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.884 179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -110.18 147.86 32.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.937 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.87 128.86 56.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.889 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.71 131.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.431 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.02 149.07 18.0 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -117.2 126.02 52.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 110.43 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -84.63 147.68 26.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -53.26 -15.22 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.41 -1.65 46.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.557 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.96 88.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -85.62 142.47 29.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 0.0 110.593 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.37 148.97 41.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.363 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.59 152.44 16.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' OD1' ' OG1' ' A' ' 40' ' ' THR . 52.9 t0 -77.64 124.69 28.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.378 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.03 13.63 28.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 38' ' ' ASP . 24.9 m -61.43 -29.28 69.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 0.0 109.879 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 p -86.93 -18.33 31.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -30.28 12.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.532 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 m -87.29 141.35 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.15 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.3 m -101.06 124.23 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.657 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.526 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.4 m95 -91.74 133.13 35.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.225 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -147.74 163.37 36.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.578 ' HG ' ' H ' ' A' ' 49' ' ' ASN . 41.8 t -137.41 148.73 46.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.912 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.2 p -68.32 -25.63 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.578 ' H ' ' HG ' ' A' ' 47' ' ' SER . 10.8 m120 -87.58 69.64 9.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.8 mm-40 -78.34 -36.33 46.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 m -69.69 -34.37 73.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.652 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -104.15 8.47 36.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -165.89 153.57 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.199 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -130.23 137.17 49.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.887 0.375 . . . . 0.0 110.808 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.76 113.14 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.021 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -140.17 104.4 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.799 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.48 125.16 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' N ' ' HG1' ' A' ' 61' ' ' THR . . . -82.69 178.42 8.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 m -58.92 -38.79 79.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.626 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -86.65 -19.21 29.62 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.496 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 58' ' ' ALA . 69.8 p -109.58 21.87 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.359 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.579 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 35.8 pttt -40.71 118.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 47.63 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 42.1 tp -121.45 116.97 25.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.23 134.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.0 130.48 48.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.87 135.11 12.54 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 91.4 mt -99.64 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 110.33 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -175.88 120.11 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -161.74 175.24 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.58 -79.25 1.45 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -126.58 81.42 68.42 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.39 150.37 75.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.511 2.141 . . . . 0.0 110.171 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -116.62 113.13 22.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.186 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -86.47 126.14 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.962 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 98.1 mt -120.08 122.78 69.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.68 129.1 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.5 m -119.14 132.75 56.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.663 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -137.76 91.57 2.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.4 -122.29 26.47 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.5 p -90.54 4.11 52.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.376 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.64 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.0 p -147.86 153.54 39.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.46 141.06 12.37 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -115.55 148.81 39.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.969 0.414 . . . . 0.0 111.143 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 t -149.86 154.92 39.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.4 mt -102.9 126.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 111.09 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mp -118.82 149.56 41.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.555 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 m -114.58 146.75 40.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.019 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.78 103.52 10.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -144.38 155.33 43.72 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.387 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -94.34 142.98 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.457 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 56.1 m -100.98 -63.28 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 93' ' ' THR . 90.9 m-20 -144.59 120.77 10.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.639 -179.825 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.54 94.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.69 145.55 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.518 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -100.37 164.48 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.508 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -76.76 125.92 30.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.407 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -85.77 -45.71 11.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.9 p -155.48 166.82 32.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.351 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.3 pt -119.25 147.22 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.1 m -134.05 149.22 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.677 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.04 128.61 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.759 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.35 165.87 13.34 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.577 -178.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.7 Cg_exo -39.06 166.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.581 2.854 . . . . 0.0 112.058 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 2.4 mp -104.55 110.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 110.402 -0.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ILE . 27.2 p30 31.41 -149.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 O-C-N 123.919 0.762 . . . . 0.0 110.717 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 95.99 2.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -154.99 161.76 41.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.785 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' ASN . 95.7 mt -132.53 131.35 60.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -94.49 166.06 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.751 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 p -37.98 106.03 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.7 p 38.8 65.74 0.61 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 22' ' ' SER . 60.7 t -130.89 161.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.435 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 32.8 t -110.76 127.91 55.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.731 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -117.65 142.21 47.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 20.5 tt0 -108.92 144.5 36.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.86 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.13 150.18 50.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.984 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 11' ' ' SER . 49.5 m-85 -115.52 143.4 45.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.667 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.72 128.12 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.868 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -112.29 128.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.4 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.91 144.8 15.85 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -115.27 125.86 53.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.914 0.388 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' C ' ' H ' ' A' ' 33' ' ' ASP . 85.0 m-85 -86.2 147.86 25.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.295 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -54.38 -10.24 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' TYR . 31.2 t0 -84.23 -3.64 58.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.597 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.29 3.56 81.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 m -83.18 154.91 24.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -122.35 141.23 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 150.21 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -85.84 118.86 25.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' SER . 10.7 mp -106.15 8.97 32.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.2 m -49.86 -33.61 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.7 p -87.53 -13.05 44.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.304 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.506 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -97.84 -23.25 15.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 m -96.95 138.47 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.381 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -99.09 125.22 44.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.835 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 20.5 m95 -93.57 139.49 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 p -151.45 165.79 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.146 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -136.39 144.33 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.33 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -65.03 -32.56 74.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 53' ' ' ALA . 71.6 m-20 -77.52 66.53 3.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -68.87 -43.95 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.01 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.7 p -70.11 -32.92 71.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.326 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -102.73 2.48 35.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.326 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -160.78 150.33 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.298 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -132.46 138.51 47.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.763 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.82 113.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -137.9 106.47 5.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.903 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.736 HD21 ' H ' ' A' ' 63' ' ' GLY . 33.6 p30 -133.03 126.01 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 111.105 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.06 171.53 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.8 p -59.11 -28.06 66.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.293 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -85.82 -11.53 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.639 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.2 p -130.47 31.47 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.464 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.6 mttt -48.01 125.46 9.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.044 0.449 . . . . 0.0 110.949 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.736 ' H ' HD21 ' A' ' 57' ' ' ASN . . . 95.47 40.05 4.29 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.045 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 31.3 tp -117.54 122.63 44.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.908 0.354 . . . . 0.0 110.522 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.8 137.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.271 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -119.05 127.03 53.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.91 119.3 6.47 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.29 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 110.363 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 172.35 120.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.53 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -162.17 172.72 15.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -61.49 0.76 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.68 82.17 51.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.567 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.82 159.52 21.4 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.501 2.134 . . . . 0.0 110.828 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -124.51 127.22 47.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.218 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.6 mm -100.06 126.02 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.945 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mm -108.07 122.97 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.121 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.16 118.62 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.724 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -114.26 124.59 52.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.506 ' CD1' ' OG ' ' A' ' 42' ' ' SER . 53.5 t80 -128.29 117.1 20.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.35 -124.63 33.76 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -98.03 5.93 48.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.01 131.23 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 110.659 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -135.91 153.48 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.15 155.73 22.22 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.43 ' N ' ' OD1' ' A' ' 85' ' ' ASN . 1.7 m-20 -114.37 147.33 39.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.853 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.9 p -135.02 155.4 50.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.066 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -96.97 121.59 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.962 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.71 134.44 54.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 m -124.31 137.7 54.46 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.966 0.412 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 67.6 t -85.5 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.215 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' ILE . 63.7 t30 -138.15 135.9 36.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.535 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 116.95 29.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.449 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 99.5 m -62.23 -47.19 85.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -89.46 77.91 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.499 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.65 155.98 47.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.09 152.73 41.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 p -132.3 162.43 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.45 103.97 2.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.707 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 t -75.47 -49.01 20.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 p -152.2 151.56 31.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.69 134.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.854 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 m -130.87 149.25 52.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.582 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.75 134.69 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.01 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.1 164.76 15.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.843 0.354 . . . . 0.0 111.327 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -37.91 157.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.005 3.136 . . . . 0.0 111.373 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.8 mm -85.78 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 123.536 0.734 . . . . 0.0 109.985 0.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -38.46 -92.65 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.702 0.287 . . . . 0.0 110.919 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -150.26 93.78 2.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.079 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 64.2 t30 -156.02 129.02 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 111.653 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -137.81 135.62 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.662 HD22 ' N ' ' A' ' 93' ' ' THR . 4.2 m-80 -108.83 151.96 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.863 0.363 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -64.97 135.81 56.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.571 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.5 13.84 9.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.117 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.29 137.82 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.394 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -110.38 128.91 55.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.084 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -113.3 145.83 40.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.032 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.2 tt0 -110.09 143.88 39.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.54 153.13 47.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -114.58 149.84 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.909 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' H ' ' HG1' ' A' ' 40' ' ' THR . . . -117.57 127.49 54.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.918 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.9 t -114.37 130.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.5 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.48 148.28 16.96 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 m -114.26 128.19 56.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.451 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -83.73 149.75 26.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.059 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -55.85 -16.28 4.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.407 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.79 -1.56 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.582 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.52 83.05 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 21.2 m -86.3 156.85 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.846 0.355 . . . . 0.0 110.681 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' N ' ' CG2' ' A' ' 35' ' ' THR . 54.4 mttp -130.81 151.89 50.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.02 158.55 28.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -80.74 120.95 25.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.357 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.8 5.54 33.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.165 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 85.2 m -57.09 -21.94 35.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 0.0 109.896 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.3 p -94.38 -11.38 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.261 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.414 ' H ' ' HG ' ' A' ' 42' ' ' SER . 4.8 p -107.06 -27.63 10.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.77 143.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.6 m -102.06 123.43 45.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.787 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.572 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 30.6 m95 -92.57 135.44 34.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.31 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -149.03 163.6 37.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.0 t -139.24 146.41 40.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.815 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.2 p -66.28 -33.19 75.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.341 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -78.34 68.97 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.377 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' ALA . 97.9 mt-30 -77.25 -38.18 51.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -72.28 -34.01 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.604 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -98.45 3.76 48.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.01 159.07 5.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.158 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.41 147.74 52.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.701 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.36 113.1 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.023 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -140.11 104.86 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.776 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.573 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -116.94 124.14 48.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.54 170.75 13.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -56.73 -33.61 66.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.508 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.56 -10.51 48.55 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.527 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.0 p -130.03 32.21 4.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.228 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -47.19 121.36 3.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.818 -179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 93.64 47.34 2.99 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.543 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 45.9 tp -118.92 120.41 37.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -126.56 135.46 63.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -113.01 130.59 56.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.05 110.94 2.87 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.04 -43.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.38 118.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.772 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 46.5 p -160.42 166.26 29.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.719 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.46 -48.02 1.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -157.29 81.87 3.18 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.44 158.61 17.02 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.468 2.112 . . . . 0.0 110.238 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.4 m -114.26 130.09 56.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -98.92 119.81 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.012 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.413 ' CG1' ' OD1' ' A' ' 85' ' ' ASN . 3.8 mp -102.86 118.32 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.136 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.48 121.32 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -108.65 129.41 55.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.662 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -139.8 96.22 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.16 -125.55 36.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.2 p -91.77 6.74 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.319 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.48 132.43 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.3 p -137.22 157.06 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.39 147.57 19.16 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.413 ' OD1' ' CG1' ' A' ' 76' ' ' ILE . 4.2 m-80 -131.99 133.38 44.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.439 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.2 p -131.54 160.4 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.304 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 121.96 50.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.18 0.514 . . . . 0.0 111.062 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 4.4 mm? -100.73 134.32 43.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.514 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.52 ' N ' ' OG1' ' A' ' 15' ' ' THR . 93.5 m -110.94 134.03 52.9 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.915 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 70' ' ' SER . 83.6 t -82.84 100.78 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.898 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 14.0 t-20 -143.0 155.74 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.343 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -70.85 144.58 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.946 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.662 ' N ' HD22 ' A' ' 18' ' ' ASN . 98.4 m -62.25 -48.09 81.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -151.2 127.63 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.571 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.46 143.01 56.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.745 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.07 -173.73 3.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -139.6 162.71 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.285 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -84.16 108.4 17.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 m -76.65 -48.04 20.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.828 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -155.74 164.12 38.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -124.99 144.25 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.843 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.0 t -136.72 146.11 45.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 10' ' ' ILE . 11.3 mm -93.67 139.75 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.967 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -98.68 165.24 15.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.2 Cg_exo -38.25 166.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 124.017 3.145 . . . . 0.0 111.402 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' ASN . 95.9 mt -111.55 116.55 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 118.753 0.706 . . . . 0.0 109.995 0.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' ILE . 68.5 m-20 33.13 -134.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.872 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.41 93.74 2.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.113 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 52.7 p30 -157.37 147.1 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 111.718 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.8 132.03 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.9 OUTLIER -87.58 166.93 14.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.739 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 20' ' ' THR . 54.8 p -58.69 138.99 56.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' O ' ' A' ' 19' ' ' THR . 34.2 p 39.33 44.19 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.22 139.41 51.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.314 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -98.67 148.61 23.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.085 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 88.7 tttt -137.95 137.84 38.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.931 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.0 143.9 37.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.7 152.61 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.8 153.05 27.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.949 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.3 129.55 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.867 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.23 131.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.461 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.72 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.5 m -118.51 128.42 54.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 0.0 110.364 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.24 149.31 25.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.116 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -54.42 -15.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.495 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.56 -1.58 38.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.66 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.68 86.73 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 17.3 m -86.09 156.59 20.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 110.582 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 35' ' ' THR . 98.6 mttt -128.27 150.46 50.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.395 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.36 17.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 42.3 p-10 -77.19 126.01 30.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.423 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.4 mt -109.78 14.31 23.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 m -59.78 -30.08 68.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.087 0.47 . . . . 0.0 109.898 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.2 p -90.33 -10.42 44.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.17 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 -26.16 13.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -93.05 151.45 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.228 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -108.63 123.74 49.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.591 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 31.9 m95 -93.85 138.82 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 p -151.05 160.56 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.984 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.4 t -132.13 143.46 50.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.847 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -61.66 -32.94 73.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 53' ' ' ALA . 2.3 m120 -75.83 63.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -69.97 -42.71 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -34.19 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.691 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -104.15 2.41 31.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -157.32 148.99 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.198 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.76 141.71 46.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.925 0.393 . . . . 0.0 110.694 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.09 114.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.993 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.5 t -139.55 108.48 6.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.497 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -147.75 132.84 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.654 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.495 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.93 178.43 4.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.8 m -54.39 -35.58 63.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.617 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.42 -24.68 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.487 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 61.4 p -104.6 16.47 26.01 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.224 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -49.59 120.55 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.784 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 104.36 32.34 4.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.24 118.05 30.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.7 t -122.24 134.5 65.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 p -105.3 132.12 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.46 108.24 2.41 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.53 -42.92 96.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.304 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 171.37 119.75 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.645 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 p -163.2 166.0 23.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.52 -71.41 1.1 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.653 HD21 ' HG1' ' A' ' 89' ' ' THR . 19.5 m120 -128.37 83.07 67.22 Favored Pre-proline 0 C--N 1.333 -0.146 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.58 158.57 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.532 2.155 . . . . 0.0 110.225 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.4 m -118.88 126.88 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 2.0 mp -101.05 126.1 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.882 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.3 mt -114.97 128.73 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.144 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.7 132.86 49.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -119.0 130.48 55.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.562 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -139.72 106.7 5.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.722 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.68 -125.08 31.41 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.7 p -92.6 8.21 39.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.371 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 135.74 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.6 p -146.89 151.82 37.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.986 0.422 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.73 146.57 18.37 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -125.02 137.5 54.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.01 0.433 . . . . 0.0 111.237 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.9 p -135.58 157.03 47.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.305 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 87' ' ' ILE . 30.1 mm -96.72 127.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.013 0.435 . . . . 0.0 111.135 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.73 147.7 37.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.571 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.653 ' HG1' HD21 ' A' ' 72' ' ' ASN . 91.2 m -125.49 132.34 52.67 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.917 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.48 107.86 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.895 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.16 155.17 50.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.372 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -84.97 137.0 33.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -117.63 125.94 51.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.571 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -63.8 -41.5 97.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.422 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.688 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.73 93.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.577 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.73 -175.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -139.28 163.23 33.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.91 112.16 9.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.302 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -74.92 -42.72 57.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 p -153.26 163.54 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.3 tt -119.13 134.4 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 t -131.78 148.03 52.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.745 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 mt -113.11 129.51 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.972 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.75 164.74 15.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -39.51 157.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.349 2.699 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' ASN . 89.9 mt -87.02 156.54 3.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 C-N-CA 123.998 0.919 . . . . 0.0 110.444 1.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -42.51 -97.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.725 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.403 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -165.89 96.13 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.355 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.724 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 81.9 m-20 -154.75 147.5 24.36 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.692 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.6 mm -122.53 130.97 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.757 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -103.28 166.44 10.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.623 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.2 p -37.45 98.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.921 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.6 m 40.02 72.94 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' SER . 79.0 t -131.59 160.35 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.022 0.439 . . . . 0.0 110.993 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 6.6 m -110.2 122.37 47.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.631 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.724 ' HZ3' ' H ' ' A' ' 16' ' ' ASN . 29.5 ttpt -112.46 137.68 50.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 15.0 tt0 -110.05 141.79 42.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.847 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.23 152.01 48.59 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.068 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.35 147.28 37.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.7 127.6 55.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.738 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.5 129.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.156 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.64 17.25 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 m -116.87 127.44 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.25 146.73 28.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 p -54.12 -16.81 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -78.73 -3.73 45.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.7 78.55 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.1 m -83.21 157.32 22.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.738 0.304 . . . . 0.0 110.799 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.55 149.22 52.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.504 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.28 152.24 20.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.69 122.35 26.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.49 7.9 33.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.5 m -55.74 -31.9 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.6 p -88.28 -9.92 51.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 -29.09 11.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.599 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 m -87.37 147.93 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.268 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.7 m -106.78 117.9 35.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.822 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m95 -87.41 140.1 29.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -147.75 164.96 31.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.161 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.471 ' HG ' ' H ' ' A' ' 49' ' ' ASN . 33.5 t -135.45 143.61 46.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.327 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.67 -33.03 74.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.348 0.595 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 53' ' ' ALA . 96.2 m-20 -80.72 65.0 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 94.2 mm-40 -69.08 -43.81 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.466 . . . . 0.0 109.888 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.6 p -70.81 -33.14 70.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.937 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -104.0 9.38 36.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.505 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.59 153.98 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.73 142.86 48.14 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.49 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -138.24 108.78 6.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 16.0 p30 -132.66 128.8 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 -179.45 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.553 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.0 p -64.33 -16.91 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.388 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -89.08 -35.27 16.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 p -114.96 31.04 6.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.601 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.497 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -41.36 120.85 1.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 110.91 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.93 49.25 2.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.439 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 44.6 tp -118.52 121.24 39.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.648 0.261 . . . . 0.0 110.535 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.36 133.55 67.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -118.72 129.18 55.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.784 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.66 8.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.0 mt -90.61 -40.96 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.574 0.226 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.75 152.52 40.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.647 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -80.45 167.72 19.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.89 -136.1 7.78 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -130.06 81.13 69.57 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.573 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.79 153.98 58.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.867 2.378 . . . . 0.0 110.368 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -126.81 122.7 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -93.0 130.32 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 94.4 mt -120.86 119.75 60.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.04 123.47 45.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -115.77 126.4 53.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -129.69 103.69 6.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.982 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.63 -122.32 27.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -92.24 4.87 52.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.544 0.211 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.48 129.88 74.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 89.9 p -137.81 150.52 47.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.24 142.7 14.19 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -109.98 144.92 37.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 p -132.99 155.62 48.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.14 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.56 127.57 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.941 0.401 . . . . 0.0 111.13 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.81 134.64 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.709 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.5 m -113.25 128.98 56.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 111.403 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.14 106.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.133 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.522 HD22 ' CG ' ' A' ' 16' ' ' ASN . 25.3 p-10 -136.61 127.41 27.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.352 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -94.64 136.92 34.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 m -63.55 -44.76 93.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 55.93 52.94 9.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.483 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.693 0.283 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.1 p -128.77 162.39 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.1 112.17 2.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.449 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 t -74.66 -42.18 58.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 p -153.15 160.59 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.759 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -114.26 133.37 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.032 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.3 m -132.57 148.57 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.348 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mt -111.59 132.38 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.029 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 163.85 17.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -43.49 167.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 123.581 2.854 . . . . 0.0 112.13 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 14' ' ' ASN . 4.7 mm -87.44 162.17 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 110.234 1.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 13' ' ' ILE . 94.1 m-20 -48.92 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.797 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 p -85.7 96.03 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' H ' ' NZ ' ' A' ' 23' ' ' LYS . 79.4 m-20 -155.25 143.33 20.1 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.667 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.1 mm . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.631 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' N ' ' A' ' 22' ' ' SER . 19.1 t . . . . . 0 C--O 1.238 0.491 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.652 ' N ' HG12 ' A' ' 21' ' ' VAL . 26.3 p -88.93 150.13 22.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.183 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' NZ ' ' H ' ' A' ' 16' ' ' ASN . 83.9 tttt -136.7 128.87 29.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.452 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -110.06 144.64 38.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.45 151.03 49.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -111.42 146.79 36.55 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.915 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.74 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.742 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.65 132.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.413 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.09 146.89 16.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -114.79 125.89 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 110.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -83.59 148.5 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.024 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.0 p -55.09 -14.82 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.492 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.81 -2.34 46.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.7 83.59 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 36' ' ' LYS . 20.4 m -86.35 157.37 19.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.868 0.366 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -130.31 149.71 51.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.394 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.34 153.87 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -85.55 122.01 29.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 43' ' ' VAL . 92.4 mt -104.48 2.18 30.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.2 m -45.72 -33.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.438 . . . . 0.0 110.286 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.4 p -88.15 -19.01 27.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.71 -21.75 19.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.635 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.3 m -98.21 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.328 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.3 m -103.38 122.99 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.711 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 12.6 m95 -92.33 141.42 28.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -153.41 166.54 32.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.989 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -132.32 140.29 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -40.0 87.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -89.4 87.59 7.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.171 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -81.53 -25.78 35.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.18 0.514 . . . . 0.0 109.801 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 t -69.43 -34.47 74.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -100.55 2.79 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.235 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.68 146.43 13.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.07 138.37 52.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 65' ' ' VAL . 47.2 t -111.67 113.19 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.779 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -141.29 114.99 9.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -156.1 133.91 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.955 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -69.97 -178.28 1.54 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.614 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -59.19 -33.52 71.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.642 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -85.78 -7.07 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.759 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 21.5 p -118.1 0.2 11.75 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.628 0.251 . . . . 0.0 111.268 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -41.42 114.16 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.573 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.91 27.69 2.44 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.697 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 2.6 tp -117.88 120.67 38.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.914 0.388 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 55' ' ' VAL . 54.8 t -130.07 134.77 62.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.069 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -111.95 126.44 55.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -122.96 109.51 1.38 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.758 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.8 mt -64.58 -45.89 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.251 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 161.89 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.8 p -137.86 -2.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.6 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.22 3.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -154.17 80.63 4.78 Favored Pre-proline 0 N--CA 1.453 -0.29 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.203 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.16 147.53 16.43 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.797 2.331 . . . . 0.0 110.725 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 120.33 35.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.465 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.45 ' CG1' HD22 ' A' ' 88' ' ' LEU . 33.4 mm -97.49 126.36 50.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.471 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 ' OD1' ' A' ' 85' ' ' ASN . 91.6 mt -110.37 127.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.067 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.84 128.2 52.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -118.94 126.28 51.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.0 t80 -129.85 103.28 6.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.114 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.51 -123.87 31.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.0 p -91.2 6.12 46.36 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.828 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.82 133.57 69.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.4 p -140.36 152.07 45.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 142.05 13.4 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.721 ' OD1' HG23 ' A' ' 76' ' ' ILE . 79.6 m-20 -108.88 142.29 39.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 110.767 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t -142.36 150.88 41.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.821 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 88' ' ' LEU . 73.4 mt -108.52 128.49 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 88' ' ' LEU . 11.1 mp -103.66 133.15 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.927 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -96.99 142.64 28.71 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.586 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.69 106.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.201 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.9 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.837 0.351 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.3 p -131.01 163.8 26.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.603 ' C ' HD13 ' A' ' 5' ' ' LEU . 3.1 tm? -81.22 111.08 17.31 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.49 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -77.53 -53.52 7.51 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.468 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -145.81 156.56 43.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 19.5 tt -127.8 130.34 70.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.013 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.8 p -133.01 148.39 52.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.76 140.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.053 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 163.79 17.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -37.16 155.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.41 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.1 mm -86.63 159.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 123.928 0.891 . . . . 0.0 110.083 1.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 15' ' ' THR . 5.0 p30 -41.13 -98.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.979 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -153.84 94.39 1.76 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.109 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -156.36 140.63 16.58 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.663 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--O 1.232 0.169 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.406 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.237 0.398 0 CA-C-O 121.231 0.538 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.426 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 3.8 m -88.36 142.72 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.411 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -134.89 130.04 35.32 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 110.62 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -109.74 144.83 37.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.38 153.43 47.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.115 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -111.06 152.2 27.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.63 128.94 55.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.685 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.67 133.51 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.186 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.36 151.59 18.48 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.7 m -118.84 127.77 53.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.922 0.392 . . . . 0.0 110.577 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.43 151.54 24.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.109 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.6 p -54.54 -14.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.519 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.91 0.85 37.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 3.06 90.67 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.524 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.6 m -86.13 160.21 19.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.334 . . . . 0.0 110.696 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 35' ' ' THR . 99.5 mttt -130.85 151.94 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.93 152.71 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 44.1 p-10 -80.85 124.27 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.658 ' O ' HG13 ' A' ' 43' ' ' VAL . 65.9 mt -112.45 12.58 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.0 m -58.2 -34.88 70.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.9 p -88.76 -7.86 55.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.56 -29.09 11.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.918 0.389 . . . . 0.0 110.719 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 79' ' ' TYR . 7.2 m -89.9 152.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.214 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 m -107.13 126.42 52.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.798 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.561 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 33.8 m95 -95.55 134.74 38.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.517 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.5 t -141.56 150.64 42.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -120.2 141.16 50.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.179 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.9 p -67.08 -32.96 74.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.1 m120 -84.9 69.75 10.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.333 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.13 -38.82 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -68.57 -34.82 76.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.135 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -107.4 9.58 29.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.89 144.44 16.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.097 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -129.33 145.74 51.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.882 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.6 p -125.88 114.41 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.037 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.0 t -139.29 105.92 5.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.759 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.81 130.66 18.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.091 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -67.64 -175.11 0.49 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.52 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 t -59.84 -35.82 75.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.474 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.97 -18.87 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 34.8 p -103.31 3.58 35.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.09 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -41.1 114.2 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.769 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.83 29.54 2.82 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -115.3 114.69 25.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.195 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' N ' HD13 ' A' ' 64' ' ' LEU . 46.7 t -128.06 136.6 59.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.426 ' HG1' ' HG ' ' A' ' 22' ' ' SER . 51.8 m -112.65 127.74 56.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.795 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.02 106.5 3.1 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 36.4 mm -63.99 -43.83 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.195 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 128.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 90' ' ' VAL . 25.0 t -167.54 -177.44 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.638 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.23 -53.24 0.43 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -142.79 82.73 12.08 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.461 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.29 155.65 16.79 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.94 2.426 . . . . 0.0 110.618 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.0 m -124.51 121.85 35.97 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.818 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.432 HG12 HD12 ' A' ' 88' ' ' LEU . 38.9 mm -101.82 129.14 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.8 mt -116.59 128.79 73.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.79 132.04 45.38 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -121.08 129.03 53.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.966 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.709 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.5 t80 -138.27 113.18 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.3 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 51.76 -125.61 27.04 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.5 p -93.97 8.59 40.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.78 132.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -136.7 153.9 50.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.4 143.39 14.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.654 ' OD1' HG23 ' A' ' 76' ' ' ILE . 10.2 m-20 -115.1 142.77 46.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.985 0.421 . . . . 0.0 111.069 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -143.78 144.04 31.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.89 128.12 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 110.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 HG12 ' A' ' 75' ' ' ILE . 56.1 mt -112.12 149.29 32.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.1 m -118.66 143.42 46.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.958 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 72.8 t -86.86 104.81 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.526 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 99.3 m-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.439 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.684 0.278 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -135.75 163.87 29.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.245 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -68.43 110.93 4.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -74.98 -42.01 58.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 p -153.96 160.79 42.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.3 tt -120.44 127.97 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -130.28 149.62 51.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.608 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.0 134.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.051 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.06 163.62 17.98 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.885 0.374 . . . . 0.0 111.338 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.422 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 Cg_endo -43.87 172.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 124.083 3.189 . . . . 0.0 111.292 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 75.9 mt -102.63 110.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.581 0.753 . . . . 0.0 109.956 0.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.7 m120 35.78 -153.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.912 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.2 p -144.59 95.74 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.155 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -152.94 160.49 43.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 90' ' ' VAL . 89.6 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -90.39 147.64 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.135 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ILE . 63.6 tttm -141.8 132.46 25.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -109.84 142.55 40.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.86 152.72 47.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.808 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.08 153.9 27.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.951 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.17 129.94 55.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.911 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.53 130.14 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.6 148.59 16.79 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.0 m -113.9 125.88 54.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -81.19 146.09 30.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.145 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.5 p -51.93 -20.38 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.398 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.85 -5.54 44.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -0.36 76.75 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 6.7 m -85.55 156.38 20.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.555 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -126.37 153.17 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.12 157.77 21.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.756 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -82.55 129.19 34.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.332 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.665 ' O ' HG13 ' A' ' 43' ' ' VAL . 95.3 mt -113.7 11.97 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.6 m -59.89 -31.61 69.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.5 p -90.93 -6.6 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.125 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -105.74 -27.48 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.566 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.4 m -90.52 155.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.242 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.9 m -111.62 124.14 51.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.583 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 26.7 m95 -96.1 137.82 34.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.214 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.6 p -145.67 161.37 40.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.935 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.1 t -133.82 146.16 50.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.95 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -69.29 -31.61 70.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 80.3 m-20 -77.87 64.09 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.6 -42.25 74.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -72.69 -33.79 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -102.88 9.28 38.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.258 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -168.82 148.58 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.12 144.42 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.954 0.407 . . . . 0.0 110.699 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 55' ' ' VAL . 11.4 p -121.3 112.91 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.95 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.5 p -140.9 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.854 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -153.33 131.95 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 -176.38 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -57.52 -36.74 71.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.563 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.93 -33.85 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.474 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -100.51 11.29 39.8 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -43.7 115.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.61 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 110.15 37.6 1.79 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -116.97 115.49 25.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 64' ' ' LEU . 24.7 t -126.61 133.79 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -117.24 122.97 45.48 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.15 114.0 4.49 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 88.8 mt -65.79 -44.86 92.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.55 119.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.725 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.8 m -158.77 175.85 13.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.74 -67.61 0.83 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -131.48 80.71 66.59 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.581 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.7 Cg_exo -71.78 152.79 58.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.396 2.064 . . . . 0.0 110.27 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -118.45 124.19 47.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.157 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.1 mm -100.91 122.38 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.562 HG23 ' OD1' ' A' ' 85' ' ' ASN . 34.7 mm -108.45 128.43 64.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.95 129.73 55.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -119.47 129.53 54.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.608 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -128.02 105.04 8.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.757 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 49.9 -120.28 7.82 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 98.1 p -90.6 6.14 44.98 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.257 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.14 131.31 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 p -136.24 148.34 48.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.62 143.85 14.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.562 ' OD1' HG23 ' A' ' 76' ' ' ILE . 72.3 m-20 -108.14 140.32 41.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.206 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 87' ' ' ILE . 84.8 m -133.49 158.76 42.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.322 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.488 ' N ' HG22 ' A' ' 86' ' ' THR . 79.4 mt -108.49 124.0 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.81 132.49 56.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.7 m -116.12 138.09 51.56 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.872 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.581 HG23 ' CD ' ' A' ' 73' ' ' PRO . 65.6 t -83.78 111.47 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.993 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.5 t30 . . . . . 0 C--N 1.33 -0.24 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.421 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.865 0.364 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -97.88 163.75 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.702 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.1 tp -86.53 115.08 23.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.712 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -75.44 -51.79 12.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.833 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.3 p -160.35 162.96 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.823 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.702 ' CG2' HD21 ' A' ' 5' ' ' LEU . 18.6 pt -123.51 140.92 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.896 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -130.76 149.29 52.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -91.5 142.43 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.056 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -102.34 165.43 13.84 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -178.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.6 Cg_exo -38.3 163.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 124.008 3.139 . . . . 0.0 111.397 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' C ' ' A' ' 14' ' ' ASN . 4.3 mm -99.63 114.52 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.496 0.718 . . . . 0.0 110.021 0.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 13' ' ' ILE . 23.8 t-20 28.47 -115.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 14' ' ' ASN . 24.4 p -155.58 91.79 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.07 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -156.26 140.94 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.8 mt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.768 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 22' ' ' SER . 71.9 t . . . . . 0 CA--C 1.523 -0.061 0 CA-C-O 121.005 0.431 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.743 ' OG ' HD21 ' A' ' 64' ' ' LEU . 14.1 t -112.77 131.49 55.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -128.57 138.06 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -110.26 144.72 38.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.85 153.71 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.869 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.74 153.47 26.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.89 129.36 53.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.881 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -111.96 127.49 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.481 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.18 143.51 18.0 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -116.03 122.2 44.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' C ' ' N ' ' A' ' 33' ' ' ASP . 94.4 m-85 -80.69 149.3 29.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.107 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -55.63 -9.74 0.57 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 3' ' ' ALA . 73.2 m-20 -86.92 1.01 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.5 0.89 88.04 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 36' ' ' LYS . 10.8 m -84.16 158.32 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 35' ' ' THR . 99.3 mttt -133.16 151.32 51.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.308 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.3 154.57 21.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.83 119.87 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.427 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' VAL . 84.9 mt -108.23 14.8 24.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.0 m -60.53 -29.21 68.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.82 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.7 p -91.18 -9.0 47.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.173 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.61 -28.6 11.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 79' ' ' TYR . 15.3 m -87.66 149.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.5 m -106.66 122.63 46.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.773 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 28.3 m95 -92.47 137.33 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.245 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -151.07 160.92 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.963 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 t -137.88 147.8 44.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -63.97 -35.13 79.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 7.4 m-20 -71.35 63.6 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.352 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 77.9 mt-30 -69.71 -43.61 72.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.6 m -72.9 -33.59 66.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.22 1.19 49.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.167 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.7 154.27 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.175 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -139.04 145.88 40.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.793 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.1 p -112.75 116.3 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.993 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 m -138.98 110.02 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.82 132.52 11.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.654 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.32 -177.11 2.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 96.0 p -58.9 -27.1 64.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.579 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -88.97 -12.67 40.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.481 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 80.1 p -116.38 0.76 12.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HA ' HD22 ' A' ' 57' ' ' ASN . 73.1 mttt -40.17 111.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.738 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.52 27.71 2.3 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.743 HD21 ' OG ' ' A' ' 22' ' ' SER . 6.1 tt -119.31 119.31 33.65 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.61 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 64' ' ' LEU . 48.7 t -125.24 135.37 64.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -115.75 127.28 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.92 117.08 4.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 95.4 mt -63.38 -42.67 97.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.287 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 177.72 118.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.745 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.756 ' O ' HG21 ' A' ' 90' ' ' VAL . 6.6 p -160.88 166.74 27.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.724 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.68 -67.9 0.9 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.87 81.66 51.71 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.12 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.18 148.8 16.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.495 2.13 . . . . 0.0 110.226 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 75' ' ' ILE . 24.6 m -107.1 124.21 49.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.132 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.7 mp -100.16 131.3 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.902 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.1 mt -117.92 125.76 74.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.257 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.6 133.73 47.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -118.01 132.02 56.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.677 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.688 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.3 t80 -136.93 111.27 8.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.718 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.43 -125.83 37.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.7 p -93.05 5.25 52.16 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.322 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 79' ' ' TYR . 50.2 t -125.67 133.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -130.84 156.74 44.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.48 147.22 16.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' HG23 ' A' ' 76' ' ' ILE . 2.9 m-20 -123.3 135.63 54.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.015 0.436 . . . . 0.0 111.135 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -140.71 153.34 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.54 126.36 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 111.122 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.566 HD12 HD13 ' A' ' 75' ' ' ILE . 85.5 mt -110.05 147.25 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.506 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.3 m -120.91 142.74 49.42 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.879 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.756 HG21 ' O ' ' A' ' 70' ' ' SER . 76.5 t -82.69 103.92 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.923 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 C--N 1.33 -0.267 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.395 179.66 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.672 0.272 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -121.5 164.31 17.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 8' ' ' ILE . 39.0 tp -78.53 109.37 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.41 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -75.87 -45.13 37.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -148.09 167.18 25.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.835 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 5' ' ' LEU . 96.8 mt -118.0 132.83 66.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.983 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -127.87 147.78 50.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.395 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.92 137.27 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.61 163.71 17.61 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.063 0.459 . . . . 0.0 111.314 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -37.31 155.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 123.515 2.81 . . . . 0.0 112.199 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.688 HD12 ' HE2' ' A' ' 23' ' ' LYS . 91.4 mt -87.71 159.16 3.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 123.926 0.89 . . . . 0.0 110.127 0.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' ILE . 87.7 m-20 -48.56 -90.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.3 p -141.52 92.9 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -156.78 161.61 39.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 111.799 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.455 -0.218 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.624 179.71 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 22' ' ' SER . 2.4 t . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.979 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.8 m -112.75 148.17 35.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.688 ' HE2' HD12 ' A' ' 13' ' ' ILE . 64.3 tttm -133.77 131.36 39.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.58 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -110.6 146.05 36.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.102 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.89 155.09 44.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.164 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -109.18 145.71 35.34 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.754 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.55 130.25 56.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.79 132.96 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.21 146.92 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.7 m -112.38 128.19 56.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.55 149.26 24.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.975 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -54.94 -17.82 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.629 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -77.74 -6.95 55.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.497 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.25 1.29 72.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 36' ' ' LYS . 87.3 m -80.69 157.7 25.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.747 0.308 . . . . 0.0 110.784 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mtmt -126.6 145.23 50.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.369 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.11 156.67 29.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.876 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 39' ' ' LEU . 91.1 m-20 -87.88 127.08 35.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.256 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.1 mp -112.53 14.03 20.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.36 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.5 m -57.11 -32.59 66.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.053 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.8 p -88.12 -9.91 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.436 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.426 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -101.18 -26.2 13.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.1 m -91.93 152.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.5 m -109.96 119.74 40.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 19.1 m95 -89.59 140.76 29.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.519 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 p -149.29 160.56 43.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.893 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -134.37 143.24 47.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.1 p -62.41 -34.49 76.86 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 7.1 m120 -71.8 62.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -68.61 -43.54 76.19 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.9 p -70.54 -33.57 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.0 7.46 36.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.1 148.77 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -134.27 142.1 47.2 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 65' ' ' VAL . 22.0 t -108.65 114.57 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 m -139.36 110.36 6.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.91 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.15 134.21 13.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.892 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.01 -176.92 1.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -58.75 -35.16 72.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.638 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -83.36 -20.49 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.649 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.5 p -104.48 4.03 32.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.099 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -42.36 115.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.855 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 114.44 33.26 1.79 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 3.7 tp -118.21 125.39 50.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 55' ' ' VAL . 56.0 t -129.31 133.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -114.86 121.78 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.6 116.57 5.09 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 92.2 mt -65.42 -44.54 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.463 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.96 120.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.691 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 30.0 t -157.9 -173.78 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -114.27 -65.37 0.43 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -134.31 80.55 52.1 Favored Pre-proline 0 C--N 1.332 -0.174 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.32 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HD3' HG23 ' A' ' 90' ' ' VAL . 14.5 Cg_exo -70.23 147.19 59.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.801 2.334 . . . . 0.0 110.626 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.4 m -110.78 115.84 30.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.738 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.73 126.61 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.593 HG23 ' OD1' ' A' ' 85' ' ' ASN . 97.4 mt -117.15 127.34 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.157 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.76 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -118.9 130.26 55.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.949 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.8 t80 -137.43 110.03 7.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.69 -128.98 48.96 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.3 p -94.04 9.71 36.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.969 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 8' ' ' ILE . 47.7 t -129.05 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.872 0.368 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -139.8 151.92 46.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.64 142.44 13.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.593 ' OD1' HG23 ' A' ' 76' ' ' ILE . 57.3 m-20 -111.43 152.71 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.114 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 162.88 39.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.309 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.41 126.37 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 111.039 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -112.94 128.47 56.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.73 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.9 m -107.51 145.79 32.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.031 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' HD3' ' A' ' 73' ' ' PRO . 64.2 t -83.8 117.47 29.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 C--O 1.233 0.197 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.518 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 5' ' ' LEU . 20.7 m -90.24 162.3 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.279 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 4' ' ' THR . 57.6 tp -86.99 114.87 23.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -72.49 -46.37 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.78 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 p -157.63 164.8 36.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -124.38 131.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.933 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.2 m -132.77 148.71 52.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.538 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.0 mm -98.77 139.2 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.095 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.63 163.22 18.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 111.506 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -36.39 158.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.096 3.197 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' HE3' ' A' ' 23' ' ' LYS . 96.3 mt -84.72 158.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 123.501 0.721 . . . . 0.0 109.972 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 13' ' ' ILE . 92.2 m-20 -37.81 -92.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.824 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 93.25 1.03 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.105 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -154.57 140.29 18.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.328 0.585 . . . . 0.0 111.678 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 88' ' ' LEU . 3.3 mm . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.892 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.937 0.398 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -79.9 136.28 36.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.118 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 13' ' ' ILE . 87.3 tttt -137.93 135.85 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 110.963 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -112.3 145.58 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.339 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.42 152.62 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.853 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -110.62 142.44 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.968 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.19 128.82 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.909 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.72 128.97 72.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.481 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.97 147.18 16.59 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -115.01 129.52 56.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -87.31 149.39 24.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.112 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -55.98 -15.3 3.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.448 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.3 -1.58 49.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.567 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 1.88 85.36 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.8 m -85.36 145.59 27.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.641 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.91 148.59 42.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.71 154.71 20.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.4 125.1 31.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.343 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.5 mt -106.99 7.24 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -50.07 -31.95 14.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.2 p -87.99 -9.32 53.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.197 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.7 -28.57 10.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.558 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.5 m -87.81 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 m -106.04 123.85 48.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.76 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.474 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 38.0 m95 -92.82 134.53 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -148.37 170.3 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.935 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.1 t -136.26 146.88 47.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.786 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -66.15 -33.76 76.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 0.0 109.37 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -94.89 84.21 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 53' ' ' ALA . 30.1 mm100 -85.84 -22.79 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 t -71.02 -34.32 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.639 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.82 4.3 37.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -160.68 152.8 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.227 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -132.66 136.03 46.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.018 0.437 . . . . 0.0 110.701 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.3 p -107.04 113.28 43.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.988 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.7 t -138.98 104.49 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.634 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -131.75 127.27 36.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -178.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.82 -179.56 2.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 t -58.86 -44.95 91.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.596 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 57.1 mp0 -83.46 -7.97 59.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.505 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.4 p -113.0 8.8 18.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.357 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -42.13 114.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.68 29.04 3.01 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 64' ' ' LEU . 28.5 tp -118.02 121.0 39.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.575 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.14 134.11 67.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 p -102.47 131.47 49.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.24 105.28 2.05 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.6 mt -63.05 -44.72 99.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 170.66 121.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -160.07 168.59 25.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.92 -49.09 1.19 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -149.69 82.73 6.6 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -84.24 159.05 13.15 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.488 2.125 . . . . 0.0 110.184 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.0 m -118.32 123.95 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 mm -98.29 125.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.938 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.2 mm -112.8 126.52 70.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.106 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.99 125.6 47.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 m -113.88 126.11 54.81 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.693 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.589 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.4 t80 -134.64 87.76 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.41 -124.78 22.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -89.04 4.92 46.69 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.314 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.45 136.55 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 p -142.15 157.08 45.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . -127.45 142.93 13.93 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -123.14 130.84 53.3 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.204 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -136.71 157.18 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.341 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.7 mt -97.56 124.57 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.971 0.415 . . . . 0.0 111.179 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 17' ' ' ILE . 67.2 tp -107.93 135.57 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.568 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.3 m -119.09 139.69 51.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.918 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.3 t -88.1 101.7 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.0 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.357 179.354 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.855 0.36 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -93.05 143.0 26.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.1 tp -60.57 116.65 4.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.404 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.3 t -75.92 -42.97 47.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -156.8 165.69 35.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.047 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.95 133.21 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -135.38 147.85 49.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 86' ' ' THR . 15.1 mm -95.33 143.41 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.761 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.49 164.38 16.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.34 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.0 Cg_exo -37.27 164.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 123.326 2.684 . . . . 0.0 112.871 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' ASN . 86.7 mt -107.6 114.98 47.74 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 125.074 1.35 . . . . 0.0 110.798 -0.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' ILE . 97.3 m-20 33.96 -120.95 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.604 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 p -149.16 95.78 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.906 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 60.5 t30 -150.3 147.84 28.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.591 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.333 -0.137 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.735 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.52 0.676 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 m -96.37 141.45 29.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.936 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -120.47 140.6 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -109.34 143.54 38.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.71 153.62 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.181 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -111.03 152.35 26.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.66 129.91 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.583 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.97 128.41 67.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.07 143.41 14.52 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.498 ' HG1' ' HZ3' ' A' ' 36' ' ' LYS . 52.7 m -115.48 129.2 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.871 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -88.1 146.44 25.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.861 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.0 p -53.73 -15.79 1.4 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.748 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.02 -3.22 51.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.571 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.07 85.95 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 m -77.64 139.74 39.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 110.714 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HZ3' ' HG1' ' A' ' 30' ' ' THR . 68.7 mmtt -110.99 139.47 46.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.45 25.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.085 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.533 ' C ' HD22 ' A' ' 39' ' ' LEU . 50.2 t0 -90.1 126.04 35.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.735 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.5 mm? -103.81 9.2 37.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -53.45 -30.32 40.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.898 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.4 p -89.82 -9.11 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.22 -22.75 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.3 m -95.12 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -104.29 120.32 40.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.637 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.0 m95 -89.07 134.72 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.536 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 p -143.21 162.49 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.885 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -135.94 144.64 45.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 111.235 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 p -67.78 -33.34 74.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.333 0.587 . . . . 0.0 109.527 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 16.2 m120 -77.58 62.47 2.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.566 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.09 -42.33 84.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.054 0.454 . . . . 0.0 109.956 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -69.85 -34.4 73.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -103.62 6.01 36.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.374 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -159.57 147.26 17.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.324 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -132.46 142.64 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 110.807 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 55' ' ' VAL . 6.6 p -122.59 114.29 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 67.8 p -139.53 117.05 11.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.632 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -155.29 134.4 12.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.22 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -75.03 178.8 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.751 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.2 p -54.3 -27.25 34.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.621 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -87.47 -25.28 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.717 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 18.6 p -103.87 8.27 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.655 0.265 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -42.16 115.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.962 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 109.83 35.94 2.12 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.9 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 25.0 tp -118.27 126.12 51.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.724 0.262 . . . . 0.0 110.514 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.74 133.7 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 111.051 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 m -102.66 127.84 49.61 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.67 102.1 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.678 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.7 mt -65.26 -44.17 95.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.908 0.385 . . . . 0.0 110.069 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 167.75 118.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 t -160.42 170.82 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.45 -55.24 0.76 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -140.66 82.2 16.11 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' HG23 ' A' ' 90' ' ' VAL . 71.0 Cg_endo -83.04 155.46 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.69 2.26 . . . . 0.0 110.732 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 75' ' ' ILE . 95.5 m -121.27 123.9 43.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.971 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.873 HD13 HD22 ' A' ' 88' ' ' LEU . 2.1 mp -102.43 129.7 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.734 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.0 127.23 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.091 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.9 129.4 49.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.7 m -113.37 129.7 56.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.607 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.8 t80 -132.35 87.27 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.265 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.65 -125.2 25.5 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.3 p -87.18 3.97 44.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.539 0.209 . . . . 0.0 110.931 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.69 133.65 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.759 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -139.79 154.34 47.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.593 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.43 147.96 17.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.3 m120 -126.25 130.55 51.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.97 0.414 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 81.8 p -134.55 151.09 50.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.577 ' C ' HD12 ' A' ' 88' ' ' LEU . 78.6 mt -97.92 127.01 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 0.0 110.799 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.873 HD22 HD13 ' A' ' 75' ' ' ILE . 10.5 mp -109.48 145.73 35.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -114.65 134.95 54.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.498 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 73' ' ' PRO . 71.4 t -84.4 104.27 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.084 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 99.3 m-20 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.1 m -119.0 139.55 51.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.278 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.75 122.79 15.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -74.62 -43.3 56.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.9 p -159.29 162.39 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.531 HD11 HG12 ' A' ' 82' ' ' VAL . 96.6 mt -112.45 129.59 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -125.27 148.59 48.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.527 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 86' ' ' THR . 26.2 mm -104.18 139.75 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.027 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -101.19 162.31 20.94 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 0.0 111.302 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.3 Cg_exo -35.15 163.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 124.104 3.202 . . . . 0.0 111.322 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' ASN . 88.4 mt -109.09 108.13 24.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.599 0.759 . . . . 0.0 110.045 0.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 33.7 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.2 OUTLIER -127.76 97.47 4.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.147 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -154.5 160.08 41.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.258 0.551 . . . . 0.0 111.606 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 91' ' ' ASN . 47.4 mm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.718 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' SER . 14.2 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.912 0.387 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.9 m -86.02 152.27 23.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.067 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -137.5 135.01 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.9 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -111.27 143.43 42.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -130.08 153.2 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.896 179.048 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -119.8 146.59 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.771 0.32 . . . . 0.0 110.942 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.55 129.77 55.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.827 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.55 128.85 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.79 144.14 17.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 m -113.22 125.79 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.469 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.432 ' C ' ' N ' ' A' ' 33' ' ' ASP . 97.1 m-85 -83.4 143.84 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.15 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -49.92 -14.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.426 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.432 ' N ' ' C ' ' A' ' 31' ' ' TYR . 89.0 m-20 -81.48 0.76 36.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.568 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.05 1.45 90.61 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -84.32 151.3 24.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.661 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.02 148.19 48.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.371 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.12 27.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.764 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.87 124.67 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.6 mt -111.0 12.89 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.175 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.7 m -59.39 -26.38 65.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.081 0.467 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 95.2 p -93.55 -7.76 43.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.237 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.6 -26.4 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.49 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -90.63 149.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.4 m -106.45 126.39 52.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.711 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.529 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 23.3 m95 -95.79 137.47 34.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.262 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 p -148.9 168.6 22.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -139.24 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.838 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -62.34 -39.42 93.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.401 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -91.13 88.47 6.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.328 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -88.86 -22.45 23.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 p -70.83 -32.19 69.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.34 1.97 36.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.161 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.07 148.43 15.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.126 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -127.87 139.15 52.79 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.745 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.6 p -114.93 111.19 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.033 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 t -139.67 103.87 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -139.57 130.29 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.623 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.541 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.3 -177.1 2.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -58.32 -34.91 71.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.568 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.8 mp0 -85.58 -22.3 28.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.534 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 42.0 p -101.76 15.0 30.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.238 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -44.81 115.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.72 34.66 3.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -118.93 113.06 20.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.547 ' N ' HD13 ' A' ' 64' ' ' LEU . 50.5 t -128.55 138.4 54.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.803 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -106.44 125.81 51.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.29 103.07 1.62 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.8 mt -64.12 -44.96 97.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.334 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 149.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 5.4 t -179.15 -175.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.673 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.594 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -108.75 -62.47 0.54 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -136.26 80.5 40.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.123 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.4 Cg_exo -71.3 153.98 61.47 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.507 2.138 . . . . 0.0 110.248 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.5 m -125.19 110.95 14.7 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.225 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 mm -96.07 126.51 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.79 128.65 76.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.08 135.48 39.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.0 m -122.1 132.14 54.33 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.669 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.652 ' HB2' HG12 ' A' ' 43' ' ' VAL . 77.1 t80 -136.59 107.96 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 48.87 -119.88 6.37 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.4 p -93.22 6.97 46.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 8' ' ' ILE . 53.0 t -126.27 129.73 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.912 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -136.74 153.5 50.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 110.904 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.63 142.21 13.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.1 m-20 -121.8 139.11 54.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.936 0.398 . . . . 0.0 111.244 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.578 HG21 HG13 ' A' ' 10' ' ' ILE . 41.6 p -137.65 167.53 21.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.323 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.4 123.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 17' ' ' ILE . 50.5 tp -109.12 130.32 55.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.5 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 m -116.11 141.27 48.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.961 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.458 HG23 ' CD ' ' A' ' 73' ' ' PRO . 26.1 t -84.87 121.02 36.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' ILE . 29.3 t-20 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.878 0.371 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -131.53 164.47 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.61 HD21 HG12 ' A' ' 8' ' ' ILE . 46.2 tp -64.89 105.81 1.1 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.631 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.6 m -76.21 -40.5 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 p -151.61 165.73 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.61 HG12 HD21 ' A' ' 5' ' ' LEU . 96.7 mt -115.48 132.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.889 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 m -123.02 149.07 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.627 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.0 mt -118.25 132.58 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.14 164.24 15.89 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' SER . 57.8 Cg_exo -36.21 162.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.047 3.164 . . . . 0.0 111.396 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ASN . 3.5 mt -93.71 163.75 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.485 0.714 . . . . 0.0 109.99 0.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.576 ' CG ' HD21 ' A' ' 16' ' ' ASN . 32.6 p30 -48.01 -172.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 89' ' ' THR . 53.5 p -85.29 93.51 8.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.576 HD21 ' CG ' ' A' ' 14' ' ' ASN . 66.6 m-80 -154.45 142.02 19.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.319 0.58 . . . . 0.0 111.651 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.746 -179.827 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.933 0.396 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 m -82.42 136.92 34.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.104 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.68 132.91 39.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -112.02 144.73 40.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.91 153.8 47.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.802 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -112.53 138.63 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.923 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.34 124.39 52.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.952 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.79 129.45 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.386 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.19 142.11 16.46 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.0 m -109.2 122.69 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 110.417 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -83.84 146.34 28.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.128 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.2 p -52.14 -14.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.413 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.67 -3.94 49.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 2.27 82.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 36' ' ' LYS . 22.0 m -85.7 153.79 22.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -123.74 151.09 43.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.31 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.29 156.27 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 39' ' ' LEU . 34.8 p-10 -86.78 123.78 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.0 mp -111.34 18.22 19.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.03 -30.42 70.3 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.9 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.0 p -89.61 -8.28 52.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.192 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.7 t -104.7 -27.9 11.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 39' ' ' LEU . 16.5 m -88.11 150.6 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.268 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -108.52 117.64 34.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 18.8 m95 -87.25 136.64 32.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.7 p -141.2 162.66 34.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.987 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -138.45 143.31 39.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.888 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -68.94 -36.42 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 99.1 m-20 -74.42 69.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.29 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.03 -43.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.4 m -70.04 -33.91 72.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.644 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.59 6.64 34.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -164.98 146.47 7.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.166 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -131.79 146.77 52.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.76 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.3 p -122.46 114.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.963 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.4 p -140.93 111.47 6.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.08 131.44 11.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.53 -177.03 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.9 t -56.3 -41.75 76.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.591 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -74.46 -31.39 62.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.522 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.2 p -95.22 2.49 54.94 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 57' ' ' ASN . 53.7 mttt -41.31 116.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.81 33.8 1.8 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.57 118.92 32.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.31 135.72 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.773 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -112.17 128.85 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.53 134.77 12.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.659 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.01 -66.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' SER . . . -144.8 142.05 29.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.643 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 1.1 t 163.32 175.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -109.69 -48.69 0.78 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -140.64 81.12 17.45 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD3' HG23 ' A' ' 90' ' ' VAL . 26.3 Cg_exo -64.18 144.07 85.74 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 0.0 110.242 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.0 m -118.29 121.31 40.1 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.78 129.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.704 HG23 ' OD1' ' A' ' 85' ' ' ASN . 86.8 mt -110.8 128.09 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.163 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.5 131.17 54.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -115.65 133.91 55.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.633 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 43' ' ' VAL . 87.8 t80 -136.53 94.2 2.97 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.7 -123.23 32.2 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.6 p -89.91 6.77 40.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.33 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 8' ' ' ILE . 48.0 t -126.17 135.31 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 p -140.0 156.85 46.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.0 110.92 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.8 143.92 15.58 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.704 ' OD1' HG23 ' A' ' 76' ' ' ILE . 65.6 m-20 -111.24 139.88 46.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.1 m -135.8 141.72 44.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.277 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.18 128.99 63.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.064 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.04 147.76 28.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.529 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.422 ' H ' ' HB ' ' A' ' 15' ' ' THR . 59.0 m -111.9 138.0 49.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.982 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 73' ' ' PRO . 43.0 t -83.25 104.48 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.904 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 C--N 1.331 -0.225 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.416 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.871 0.367 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -133.99 162.39 32.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 8' ' ' ILE . 3.7 tt -88.04 109.53 19.92 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -76.47 -53.09 8.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.775 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.8 p -156.46 169.79 23.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.906 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 5' ' ' LEU . 35.9 pt -130.69 144.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.849 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -135.81 149.12 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.674 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mm -95.29 141.77 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.36 165.55 14.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 120.762 0.315 . . . . 0.0 111.431 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 11' ' ' SER . 46.5 Cg_exo -38.19 165.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.095 3.197 . . . . 0.0 111.314 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 14' ' ' ASN . 78.7 mt -110.14 117.78 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.461 0.705 . . . . 0.0 110.008 0.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 13' ' ' ILE . 64.1 t30 27.05 -131.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.756 0.312 . . . . 0.0 110.88 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -142.81 93.4 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.178 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -155.26 135.16 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.226 0.536 . . . . 0.0 111.66 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.789 179.571 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 m -104.32 145.48 30.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.102 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -131.11 140.22 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.901 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -109.54 143.48 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.383 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.606 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.14 152.96 48.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.881 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -111.08 149.75 30.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.923 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.79 127.8 55.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.825 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.38 128.34 69.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.461 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.12 148.35 17.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.8 m -119.6 130.09 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 0.0 110.432 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -89.08 149.33 23.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.122 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -55.3 -10.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.434 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.12 -0.75 57.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.56 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.7 87.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.6 m -84.22 146.26 27.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 110.654 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.13 146.98 48.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.08 156.12 28.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.834 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.15 122.97 28.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.635 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.0 mt -107.42 9.2 29.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.211 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.6 m -55.0 -30.55 59.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.113 0.482 . . . . 0.0 109.866 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -89.67 -9.8 48.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.133 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -102.87 -26.35 13.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.599 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -93.72 144.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.302 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 123.13 47.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.606 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 10.8 m95 -92.94 136.46 33.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.277 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.3 t -139.93 144.86 37.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.888 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.7 t -113.4 140.15 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.3 p -62.82 -40.09 96.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.742 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 93.0 m-20 -71.64 70.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.322 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -74.45 -40.33 61.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.2 p -71.02 -32.89 69.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.643 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.55 11.05 27.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -166.89 148.86 6.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.197 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -134.05 147.08 50.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.696 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 65' ' ' VAL . 23.4 t -110.21 113.32 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.008 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -139.86 105.63 5.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.29 131.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.673 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.508 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.94 -176.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -56.48 -42.91 79.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.572 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.16 -27.18 60.71 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.533 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 51.9 p -99.44 2.18 44.81 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.35 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' HD22 ' A' ' 57' ' ' ASN . 23.5 mttt -40.34 114.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.627 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 112.81 39.72 1.15 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -119.44 127.89 53.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.305 . . . . 0.0 110.624 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 55' ' ' VAL . 37.5 t -127.12 133.34 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.751 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -113.57 120.65 41.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.58 107.92 2.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.26 -45.4 93.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -169.72 118.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 p -164.25 168.15 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.15 -68.55 0.93 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.583 ' OD1' HG23 ' A' ' 89' ' ' THR . 80.7 m-20 -131.68 80.83 65.39 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 90' ' ' VAL . 16.6 Cg_exo -69.7 151.24 69.39 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.465 2.11 . . . . 0.0 110.218 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 m -120.01 124.12 45.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.272 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 88' ' ' LEU . 38.4 mm -102.13 126.67 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.963 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.696 HG23 ' OD1' ' A' ' 85' ' ' ASN . 91.4 mt -114.04 122.78 68.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.87 41.29 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -119.77 127.84 53.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.631 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.683 ' HB2' HG12 ' A' ' 43' ' ' VAL . 67.8 t80 -136.97 118.77 15.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.08 -125.4 30.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.5 p -97.55 8.64 44.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' TYR . 44.6 t -126.36 136.54 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.7 p -135.41 150.76 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.45 142.19 13.29 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.696 ' OD1' HG23 ' A' ' 76' ' ' ILE . 14.3 m-20 -113.06 151.18 31.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.461 . . . . 0.0 111.198 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -144.66 156.5 44.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.3 mm -108.87 123.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 75' ' ' ILE . 89.6 mt -115.59 145.81 42.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.583 HG23 ' OD1' ' A' ' 72' ' ' ASN . 75.8 m -120.04 143.16 48.24 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.504 HG23 ' HD3' ' A' ' 73' ' ' PRO . 92.2 t -84.69 104.21 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 90.5 m-20 . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.411 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -92.16 164.64 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.66 118.24 25.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.0 110.612 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -75.65 -36.13 60.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -154.66 161.72 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.247 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -113.4 132.96 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.196 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -129.55 148.35 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.501 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.06 133.71 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.075 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.09 165.68 13.75 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.383 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -38.49 158.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.544 2.829 . . . . 0.0 112.019 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 91.2 mt -87.23 154.85 3.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 123.942 0.897 . . . . 0.0 110.578 1.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CG ' HG22 ' A' ' 15' ' ' THR . 52.2 t30 -53.56 -113.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.548 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -134.58 92.04 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.981 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' H ' ' HZ1' ' A' ' 23' ' ' LYS . 71.6 m-80 -157.45 158.73 36.36 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.528 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.444 ' CG2' HG13 ' A' ' 90' ' ' VAL . 1.6 tp . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 m -83.37 139.78 32.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.755 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HZ3' ' HG ' ' A' ' 88' ' ' LEU . 88.0 tttt -127.93 118.9 24.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.983 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.97 142.71 44.04 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.54 152.67 48.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.503 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -116.54 138.95 51.01 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.45 126.78 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.968 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.85 130.83 74.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.53 142.58 17.59 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.4 m -108.11 125.08 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 110.64 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -82.81 147.4 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.414 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p -54.32 -16.48 2.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.49 -5.19 46.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.32 1.14 79.01 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 36' ' ' LYS . 36.1 m -86.7 160.63 18.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 0.0 110.686 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' N ' HG22 ' A' ' 35' ' ' THR . 68.5 mttm -130.67 151.62 50.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.9 156.49 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -84.77 123.33 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.101 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.63 ' O ' HG13 ' A' ' 43' ' ' VAL . 79.2 mt -108.78 0.41 20.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.57 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -49.15 -33.45 12.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -86.63 -13.53 45.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.515 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -100.03 -21.9 15.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.656 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -96.98 149.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -107.69 124.36 49.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.617 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.0 m95 -94.24 139.25 31.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.672 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -142.62 169.58 17.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -140.58 139.12 34.89 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.7 p -62.91 -32.69 74.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.8 m-80 -84.73 68.46 10.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.6 mm-40 -69.74 -41.34 75.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.997 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -70.75 -34.47 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.339 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.551 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 31.3 mt-30 -100.01 2.79 43.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.053 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.75 145.38 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.157 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -127.23 140.54 52.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.8 p -120.64 113.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.094 0.473 . . . . 0.0 109.968 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -140.16 106.64 5.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.311 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -148.64 131.8 16.39 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.44 -176.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.651 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -58.74 -43.78 90.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.023 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.86 -33.81 72.76 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -96.38 5.56 50.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.51 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -42.28 115.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.632 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.87 32.14 2.13 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -117.31 115.26 24.91 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' N ' HD13 ' A' ' 64' ' ' LEU . 42.5 t -127.63 133.97 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.896 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -116.04 126.2 53.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.619 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.96 113.8 4.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 40.5 mm -65.33 -43.92 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.04 120.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.789 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.3 p -157.85 172.36 18.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.49 -53.63 0.92 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -150.05 82.64 6.43 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.836 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.91 155.87 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.556 2.171 . . . . 0.0 110.711 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.482 ' C ' HD12 ' A' ' 75' ' ' ILE . 64.7 m -119.24 123.37 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -99.26 123.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.596 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' OD1' ' A' ' 85' ' ' ASN . 85.7 mt -111.14 125.69 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 134.62 47.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.1 m -124.08 130.54 52.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 111.14 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 43' ' ' VAL . 58.3 t80 -136.19 108.81 7.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.49 -122.16 28.89 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.7 p -97.94 5.43 48.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.488 0.185 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.41 133.75 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.5 p -140.38 150.73 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.55 142.68 13.98 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 76' ' ' ILE . 50.8 m-20 -108.9 143.4 38.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.044 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -136.71 143.95 43.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.547 ' C ' HD12 ' A' ' 88' ' ' LEU . 21.8 mm -102.62 126.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.252 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 75' ' ' ILE . 10.7 mp -108.42 141.71 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.516 ' N ' ' OG1' ' A' ' 15' ' ' THR . 60.5 m -118.16 137.51 52.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.421 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 70' ' ' SER . 72.5 t -85.21 112.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.727 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -139.46 160.68 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.743 HD21 ' CG2' ' A' ' 8' ' ' ILE . 47.0 tp -87.49 107.3 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.67 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -75.37 -46.19 34.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.763 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 p -157.37 164.78 37.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.743 ' CG2' HD21 ' A' ' 5' ' ' LEU . 45.8 pt -123.04 147.6 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.866 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 10.8 p -137.28 149.0 46.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.06 136.22 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -98.93 165.36 15.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.445 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.5 Cg_exo -37.26 165.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 124.055 3.17 . . . . 0.0 111.363 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 14' ' ' ASN . 74.4 mt -106.94 113.12 42.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.491 0.716 . . . . 0.0 110.031 0.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 13' ' ' ILE . 79.1 m-20 28.77 -126.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.461 ' CB ' HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -149.92 95.55 2.32 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.137 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 3.8 p30 -155.62 136.84 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 111.617 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.0 mm . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.761 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 22' ' ' SER . 54.9 t . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 t -108.25 124.32 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -115.5 139.71 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tt0 -110.16 146.83 34.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.368 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.95 152.99 47.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -112.07 151.57 29.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.35 128.45 51.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.869 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.2 t -120.24 130.59 74.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.22 151.94 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -114.79 126.67 55.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -83.76 150.59 25.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.136 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -55.1 -13.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.469 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.81 -4.03 57.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.665 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 4.05 79.61 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 36' ' ' LYS . 18.2 m -88.51 154.54 20.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 35' ' ' THR . 99.1 mttt -125.53 146.66 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.285 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.77 41.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.96 121.14 29.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.369 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.672 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.6 mp -107.41 11.64 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.146 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 m -57.27 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.791 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.9 p -90.49 -11.47 40.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.34 -29.69 11.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.551 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 39' ' ' LEU . 5.2 m -87.22 153.68 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 m -110.6 124.57 52.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.726 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.735 ' O ' HG11 ' A' ' 55' ' ' VAL . 29.3 m95 -94.84 133.57 38.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 55' ' ' VAL . 20.9 p -147.08 161.36 41.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 t -136.17 146.98 47.46 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.95 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.0 p -65.69 -35.78 81.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 6.1 m120 -69.08 65.9 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.32 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' ALA . 75.5 mt-30 -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.9 t -71.45 -34.52 70.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -98.85 3.75 47.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -169.09 154.62 6.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.182 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -133.92 143.36 48.19 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.745 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 ' O ' ' A' ' 45' ' ' TRP . 98.8 t -109.61 113.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.055 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.8 p -138.76 103.1 4.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.05 121.73 42.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.656 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.7 169.6 16.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 m -55.63 -35.61 66.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.607 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 54.7 mp0 -87.31 -7.44 57.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.536 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.8 p -131.54 31.54 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.268 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 68.0 mttm -47.16 117.11 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.79 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.51 43.54 2.7 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.9 tp -118.01 122.32 42.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.767 0.317 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 55' ' ' VAL . 40.0 t -128.54 132.75 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -116.48 127.22 54.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.01 120.02 4.84 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.54 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 178.02 139.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.683 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 13.6 t -173.4 177.44 2.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.723 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -101.13 -69.42 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -133.88 81.45 52.25 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.178 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HD3' HG23 ' A' ' 90' ' ' VAL . 15.3 Cg_exo -70.29 153.41 66.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.462 2.108 . . . . 0.0 110.253 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 75' ' ' ILE . 53.1 m -119.73 112.05 18.78 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.5 mp -94.67 127.32 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.991 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.0 mt -114.53 129.73 70.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.162 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.29 125.96 43.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -114.41 125.65 54.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.8 t80 -134.33 114.29 12.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.68 -127.08 39.51 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -94.93 8.58 42.34 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.349 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.29 130.45 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.7 p -137.42 150.83 47.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.74 142.66 13.85 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.2 m-20 -108.18 140.85 40.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.265 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -132.84 155.0 49.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.247 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.34 123.49 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD12 ' CB ' ' A' ' 15' ' ' THR . 44.9 tp -114.21 128.05 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.551 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.4 m -112.12 139.85 47.29 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.9 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.52 HG23 ' HD3' ' A' ' 73' ' ' PRO . 67.5 t -82.65 102.07 8.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.961 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' ILE . 27.8 m120 . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.815 0.34 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -138.66 164.82 28.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.671 HD11 ' O ' ' A' ' 7' ' ' SER . 63.9 tp -71.52 107.62 4.51 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.62 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -75.39 -38.31 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.8 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.671 ' O ' HD11 ' A' ' 5' ' ' LEU . 32.4 p -150.49 162.75 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.69 133.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.859 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.8 t -129.5 146.58 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.65 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.84 134.45 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.67 163.55 17.9 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.438 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' SER . 6.5 Cg_endo -43.2 172.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.069 3.179 . . . . 0.0 111.283 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 82.9 mt -103.88 110.79 31.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.02 0.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' THR . 19.0 p30 35.19 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -139.79 95.7 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.122 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.66 159.29 39.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 111.653 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.744 HD11 HD21 ' A' ' 88' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.723 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 66' ' ' THR . 58.0 m -98.14 118.98 35.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.065 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -113.12 136.81 52.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.72 143.4 41.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.53 153.93 47.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.884 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.41 147.82 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.09 129.01 56.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.905 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.88 132.42 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.499 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.77 149.52 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -120.12 125.46 48.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.43 151.07 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.11 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.4 p -53.94 -14.59 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.524 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -85.2 6.0 27.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.59 3.16 82.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 m -83.42 139.35 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.954 0.407 . . . . 0.0 110.661 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.07 147.24 44.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.369 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.12 164.71 37.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.952 0.406 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 29.1 p-10 -88.41 123.08 32.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.339 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 43' ' ' VAL . 88.9 mt -106.64 13.02 28.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -60.48 -31.59 70.61 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.87 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -90.32 -4.6 57.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.03 -27.94 9.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 39' ' ' LEU . 19.7 m -90.6 142.94 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.0 m -103.31 116.18 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.744 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.8 m95 -83.91 133.7 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.228 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -137.0 163.82 29.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -134.83 140.94 46.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.885 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -64.23 -34.57 78.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.8 m120 -83.65 71.38 10.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 53' ' ' ALA . 87.0 mt-30 -74.23 -40.38 62.45 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 m -69.91 -33.68 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.607 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -103.74 3.31 34.02 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.35 150.1 21.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.176 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.14 145.24 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.739 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.0 p -122.39 115.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 32.9 t -140.43 114.47 9.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.74 132.82 13.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.579 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.97 -177.67 2.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.1 p -57.79 -30.3 65.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.507 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.93 -12.49 44.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 52.5 p -114.74 4.06 14.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.255 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -41.16 112.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 116.41 33.37 1.47 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -117.01 121.48 41.48 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 110.627 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.0 t -124.24 134.63 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.849 HG22 ' OG ' ' A' ' 22' ' ' SER . 41.2 p -112.35 125.98 54.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.0 103.29 1.88 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.02 -44.99 99.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.733 0.301 . . . . 0.0 110.247 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 179.89 118.16 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.722 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.6 p -161.04 167.8 25.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.722 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.31 -54.16 0.91 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -149.31 81.08 7.51 Favored Pre-proline 0 C--N 1.334 -0.105 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.141 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.53 158.76 19.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 0.0 110.204 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -116.37 124.49 50.19 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 mm -100.08 121.18 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.62 HG23 ' OD1' ' A' ' 85' ' ' ASN . 80.0 mt -111.93 126.09 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.225 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 133.76 48.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -113.68 133.4 55.34 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.549 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 43' ' ' VAL . 72.9 t80 -131.56 86.41 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.677 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.95 -123.94 19.4 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -88.55 5.64 41.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.289 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -137.78 152.71 49.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.12 17.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.62 ' OD1' HG23 ' A' ' 76' ' ' ILE . 22.2 m-20 -110.37 145.78 36.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.172 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.5 p -134.71 154.28 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.379 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.0 mt -100.59 121.57 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 111.177 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 17' ' ' ILE . 53.7 tp -109.47 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.6 m -117.6 138.44 51.94 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.91 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 70' ' ' SER . 88.1 t -83.4 107.76 15.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--N 1.331 -0.234 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.333 179.391 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.748 0.308 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -139.21 163.27 32.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.254 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 8' ' ' ILE . 53.3 tp -68.93 111.03 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -80.05 -46.29 16.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.815 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 p -154.17 163.15 40.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.805 ' CG2' HD21 ' A' ' 5' ' ' LEU . 32.9 pt -123.22 146.3 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.846 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 p -139.12 148.49 43.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.664 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.62 137.18 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.55 164.98 14.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.403 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.7 Cg_exo -37.49 166.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.981 3.121 . . . . 0.0 111.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' ASN . 72.3 mt -112.18 111.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 C-N-CA 123.457 0.703 . . . . 0.0 110.044 0.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' ILE . 2.6 m-20 34.37 -153.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.721 0.295 . . . . 0.0 110.855 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.559 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.1 OUTLIER -136.58 96.72 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.193 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 15' ' ' THR . 79.7 m-20 -157.26 155.92 31.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.321 0.581 . . . . 0.0 111.684 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.583 ' CD1' HD21 ' A' ' 88' ' ' LEU . 2.9 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.82 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.932 0.396 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.6 p -92.29 138.06 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.05 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -131.78 139.76 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.932 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 24.0 tt0 -109.43 144.93 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.421 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -126.94 152.78 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.969 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' C ' ' HG ' ' A' ' 11' ' ' SER . 42.5 m-85 -113.24 148.79 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.09 130.26 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.916 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.43 131.04 71.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.464 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.97 17.21 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.5 m -113.89 129.47 56.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 110.488 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.51 144.0 27.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.074 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p -52.22 -14.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.49 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 49.5 t0 -79.71 -6.86 58.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 -0.59 68.95 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.7 m -86.61 160.38 18.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.883 0.373 . . . . 0.0 110.649 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.53 ' N ' HG22 ' A' ' 35' ' ' THR . 99.0 mttt -131.71 151.15 51.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.313 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.01 160.2 35.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -86.64 119.61 27.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.393 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.674 ' O ' HG13 ' A' ' 43' ' ' VAL . 91.6 mt -104.84 12.31 32.74 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.159 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -59.04 -28.2 66.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.841 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.5 p -91.32 -10.3 41.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -104.14 -27.39 12.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 79' ' ' TYR . 10.4 m -88.2 150.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.174 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -106.04 126.47 52.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 55' ' ' VAL . 49.9 m95 -97.3 135.24 39.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 m -148.14 168.88 21.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.3 t -137.93 147.36 44.27 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.79 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -68.08 -34.69 76.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 32.4 m-20 -77.57 69.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' ALA . 85.0 mt-30 -72.45 -43.2 64.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.6 p -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.54 9.91 39.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.171 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -171.11 152.91 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 45' ' ' TRP . 7.1 p -109.4 113.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.039 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -139.76 104.39 4.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.696 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.633 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -118.81 123.97 46.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.08 172.22 12.18 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -58.6 -31.03 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.609 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.38 -11.88 47.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.526 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -131.38 31.07 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.27 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.537 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.7 mttt -43.48 116.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.801 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.559 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.22 45.05 2.45 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 55.1 tp -117.25 123.27 46.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 55' ' ' VAL . 24.2 t -127.25 136.08 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -110.46 128.52 55.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.34 107.86 2.81 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.1 mt -64.35 -43.71 97.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.79 117.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.697 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.4 p -159.13 166.36 31.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.671 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 72' ' ' ASN . . . -95.08 -65.95 0.99 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 2.8 m120 -138.57 80.6 26.08 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.13 158.26 23.47 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.501 2.134 . . . . 0.0 110.286 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 m -113.29 128.28 56.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 mm -100.44 120.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mm -109.26 126.42 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.99 126.15 50.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.7 m -115.45 125.8 53.55 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.692 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.679 ' HB2' HG12 ' A' ' 43' ' ' VAL . 45.2 t80 -134.8 90.6 2.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.05 -129.81 18.58 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.9 p -87.97 3.35 49.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.307 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.71 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 p -140.98 150.15 42.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.58 142.38 14.71 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.0 OUTLIER -118.84 130.41 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 111.16 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.3 p -134.67 156.68 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.278 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.75 124.29 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' CD1' ' A' ' 17' ' ' ILE . 7.4 tt -111.55 151.32 28.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.436 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.6 m -132.72 145.3 50.92 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.974 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 70' ' ' SER . 91.2 t -83.87 127.19 40.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.919 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.356 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -130.36 164.4 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.312 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 5' ' ' LEU . 47.9 tp -81.03 107.76 14.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.563 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.776 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.67 162.98 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.893 0.378 . . . . 0.0 110.819 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -125.05 133.97 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 t -132.91 148.49 52.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.58 130.71 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.1 162.75 19.58 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 8.1 Cg_endo -44.11 172.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 124.038 3.159 . . . . 0.0 111.348 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 14' ' ' ASN . 76.5 mt -102.53 118.23 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.487 0.715 . . . . 0.0 109.958 0.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 t-20 30.61 -146.59 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.754 0.312 . . . . 0.0 110.911 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 p -152.88 95.4 1.98 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.06 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.96 160.75 43.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 90' ' ' VAL . 97.5 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.791 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -96.95 123.62 40.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 64.5 tttm -112.78 144.03 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -110.37 143.46 40.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.36 151.57 49.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.898 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' A' ' 11' ' ' SER . 56.8 m-85 -113.7 155.41 25.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.718 0.294 . . . . 0.0 110.907 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.1 130.64 53.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.925 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.3 t -113.44 131.03 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.76 151.22 17.27 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 m -117.84 126.07 51.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -81.16 151.57 28.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.102 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.1 p -55.3 -18.25 6.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -76.67 -4.1 41.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.42 0.23 82.55 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 36' ' ' LYS . 92.5 m -83.39 162.09 21.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -131.1 148.68 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.355 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.68 20.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -78.1 124.96 28.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 43' ' ' VAL . 93.9 mt -108.8 13.48 24.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.9 m -60.83 -30.14 69.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.809 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -90.85 -9.54 45.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.253 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.08 -26.57 13.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 39' ' ' LEU . 13.8 m -91.09 152.02 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.228 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -109.88 123.5 49.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.684 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.54 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 22.8 m95 -93.58 137.49 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.9 t -145.03 167.75 21.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.017 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -142.23 139.95 32.14 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.862 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.2 -26.38 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -78.79 65.16 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.336 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 88.6 mt-30 -67.15 -49.84 63.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.8 p -71.71 -33.67 68.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.612 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -93.65 -2.43 54.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.73 151.76 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.156 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -131.23 136.42 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.71 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 55' ' ' VAL . 3.9 p -107.83 113.07 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -138.71 104.12 5.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -132.45 128.23 37.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.664 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.72 -177.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 t -61.84 -42.33 98.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.649 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.9 mp0 -83.16 -12.41 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.532 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.2 p -110.73 8.88 22.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.185 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -41.58 112.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.73 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.4 31.18 2.25 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.04 122.15 41.49 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.703 0.287 . . . . 0.0 110.573 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.32 134.4 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -104.74 125.72 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.04 102.86 2.39 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 93.9 mt -62.32 -44.77 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.71 0.291 . . . . 0.0 110.264 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 173.4 118.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -162.43 167.02 24.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.25 -67.18 0.83 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -128.24 81.16 71.04 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.06 159.26 15.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.43 2.087 . . . . 0.0 110.149 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -123.22 129.58 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.4 mm -102.11 129.59 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.656 HG23 ' OD1' ' A' ' 85' ' ' ASN . 86.3 mt -115.79 126.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.51 135.92 43.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.5 m -121.81 128.44 51.68 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.682 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' HB2' HG12 ' A' ' 43' ' ' VAL . 65.6 t80 -128.94 88.75 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.63 -119.8 11.81 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.9 p -91.62 1.16 57.34 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.317 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.21 132.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.6 p -135.44 154.09 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.05 146.93 18.51 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.656 ' OD1' HG23 ' A' ' 76' ' ' ILE . 71.5 m-20 -110.89 144.72 39.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.216 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.8 p -134.05 158.54 43.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.9 mm -98.64 124.55 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.016 0.436 . . . . 0.0 111.134 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 17' ' ' ILE . 50.9 tp -114.15 135.02 54.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.504 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -125.75 132.13 52.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.893 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.631 HG22 HD12 ' A' ' 17' ' ' ILE . 89.6 t -84.05 109.16 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.952 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.353 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.847 0.356 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -91.13 163.89 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.262 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mt -81.79 124.05 29.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.555 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -74.35 -41.0 61.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.4 p -157.26 161.84 39.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.2 tt -124.67 128.71 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.886 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -134.24 150.28 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.55 147.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.061 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.32 165.1 15.06 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 120.8 0.333 . . . . 0.0 111.376 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' SER . 52.0 Cg_exo -37.35 164.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 124.02 3.147 . . . . 0.0 111.384 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.5 mm -110.2 127.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.476 0.71 . . . . 0.0 109.952 0.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 13' ' ' ILE . 43.6 t30 29.72 -139.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -135.05 93.98 3.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 20.5 p30 -158.02 162.0 38.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 111.674 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.805 179.652 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 22' ' ' SER . 33.7 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.892 0.377 . . . . 0.0 111.395 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.687 ' N ' HG12 ' A' ' 21' ' ' VAL . 24.0 m -110.42 147.59 33.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -122.65 147.15 46.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.0 tt0 -111.52 145.19 39.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.42 149.67 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.884 179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -110.18 147.86 32.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.937 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.87 128.86 56.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.889 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.71 131.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.431 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.02 149.07 18.0 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -117.2 126.02 52.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 110.43 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -84.63 147.68 26.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -53.26 -15.22 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.41 -1.65 46.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.557 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.96 88.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -85.62 142.47 29.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 0.0 110.593 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.37 148.97 41.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.363 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.59 152.44 16.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -77.64 124.69 28.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.697 ' O ' HG13 ' A' ' 43' ' ' VAL . 72.9 mt -106.03 13.63 28.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.43 -29.28 69.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 0.0 109.879 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 p -86.93 -18.33 31.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -30.28 12.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.532 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.0 m -87.29 141.35 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.15 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.3 m -101.06 124.23 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.657 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.669 ' O ' HG11 ' A' ' 55' ' ' VAL . 25.4 m95 -91.74 133.13 35.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.225 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -147.74 163.37 36.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t -137.41 148.73 46.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.2 p -68.32 -25.63 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.8 m120 -87.58 69.64 9.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.8 mm-40 -78.34 -36.33 46.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 m -69.69 -34.37 73.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.652 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -104.15 8.47 36.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.89 153.57 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.199 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -130.23 137.17 49.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.887 0.375 . . . . 0.0 110.808 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 45' ' ' TRP . 57.6 t -107.76 113.14 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.021 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -140.17 104.4 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.799 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.48 125.16 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.42 8.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 m -58.92 -38.79 79.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.626 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -86.65 -19.21 29.62 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.496 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.8 p -109.58 21.87 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.359 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.579 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 35.8 pttt -40.71 118.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 47.63 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 42.1 tp -121.45 116.97 25.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.624 HG22 HG22 ' A' ' 55' ' ' VAL . 38.9 t -123.23 134.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.0 130.48 48.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.87 135.11 12.54 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 91.4 mt -99.64 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 110.33 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -175.88 120.11 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 90' ' ' VAL . 7.8 p -161.74 175.24 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.58 -79.25 1.45 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -126.58 81.42 68.42 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 90' ' ' VAL . 21.1 Cg_exo -68.39 150.37 75.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.511 2.141 . . . . 0.0 110.171 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -116.62 113.13 22.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.186 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 88' ' ' LEU . 8.3 mm -86.47 126.14 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 85' ' ' ASN . 98.1 mt -120.08 122.78 69.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.123 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.68 129.1 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.5 m -119.14 132.75 56.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.663 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.696 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.2 t80 -137.76 91.57 2.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.752 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.4 -122.29 26.47 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.5 p -90.54 4.11 52.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.376 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.64 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.0 p -147.86 153.54 39.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.46 141.06 12.37 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.699 ' OD1' HG23 ' A' ' 76' ' ' ILE . 9.1 m-20 -115.55 148.81 39.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.969 0.414 . . . . 0.0 111.143 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 t -149.86 154.92 39.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.705 ' C ' HD12 ' A' ' 88' ' ' LEU . 71.4 mt -102.9 126.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 111.09 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 87' ' ' ILE . 11.1 mp -118.82 149.56 41.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.555 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 m -114.58 146.75 40.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.019 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.559 HG21 ' OG ' ' A' ' 70' ' ' SER . 61.4 t -82.78 103.52 10.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.005 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p30 . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.387 179.486 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.824 0.345 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -100.37 164.48 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.508 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -76.76 125.92 30.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.407 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -85.77 -45.71 11.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.9 p -155.48 166.82 32.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.351 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.3 pt -119.25 147.22 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.1 m -134.05 149.22 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.677 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.04 128.61 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.759 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.35 165.87 13.34 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.577 -178.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.496 ' C ' HD12 ' A' ' 13' ' ' ILE . 59.7 Cg_exo -39.06 166.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.581 2.854 . . . . 0.0 112.058 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 13' ' ' ILE . 2.4 mp -104.55 110.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 110.402 -0.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ILE . 27.2 p30 31.41 -149.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 O-C-N 123.919 0.762 . . . . 0.0 110.717 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 95.99 2.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -154.99 161.76 41.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.785 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 90' ' ' VAL . 95.7 mt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 22' ' ' SER . 60.7 t . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 32.8 t -110.76 127.91 55.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.731 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -117.65 142.21 47.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 20.5 tt0 -108.92 144.5 36.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.86 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.13 150.18 50.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.984 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.49 ' C ' ' HG ' ' A' ' 11' ' ' SER . 49.5 m-85 -115.52 143.4 45.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.667 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.72 128.12 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.868 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -112.29 128.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.4 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.91 144.8 15.85 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -115.27 125.86 53.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.914 0.388 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.407 ' C ' ' N ' ' A' ' 33' ' ' ASP . 85.0 m-85 -86.2 147.86 25.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.295 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -54.38 -10.24 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 31' ' ' TYR . 31.2 t0 -84.23 -3.64 58.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.597 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.29 3.56 81.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 36' ' ' LYS . 31.9 m -83.18 154.91 24.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 35' ' ' THR . 27.8 mmtp -122.35 141.23 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 150.21 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' LEU . 48.4 t0 -85.84 118.86 25.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.7 mp -106.15 8.97 32.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.2 m -49.86 -33.61 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.7 p -87.53 -13.05 44.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.304 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.506 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -97.84 -23.25 15.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.9 m -96.95 138.47 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.381 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -99.09 125.22 44.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.835 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 20.5 m95 -93.57 139.49 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.531 ' HA ' HG21 ' A' ' 55' ' ' VAL . 30.4 p -151.45 165.79 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.146 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -136.39 144.33 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.33 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -65.03 -32.56 74.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 71.6 m-20 -77.52 66.53 3.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -68.87 -43.95 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.01 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.7 p -70.11 -32.92 71.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.326 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -102.73 2.48 35.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.326 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -160.78 150.33 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.298 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -132.46 138.51 47.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.763 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 65' ' ' VAL . 97.6 t -107.82 113.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -137.9 106.47 5.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.903 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -133.03 126.01 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 111.105 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.06 171.53 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.8 p -59.11 -28.06 66.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.293 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -85.82 -11.53 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.639 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.2 p -130.47 31.47 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.464 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.6 mttt -48.01 125.46 9.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.044 0.449 . . . . 0.0 110.949 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.47 40.05 4.29 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.045 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.505 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 31.3 tp -117.54 122.63 44.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.908 0.354 . . . . 0.0 110.522 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 55' ' ' VAL . 43.0 t -129.8 137.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.271 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -119.05 127.03 53.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.91 119.3 6.47 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.7 mt -64.29 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 172.35 120.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -162.17 172.72 15.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -61.49 0.76 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.68 82.17 51.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.567 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.441 ' HB3' HD22 ' A' ' 49' ' ' ASN . 73.7 Cg_endo -80.82 159.52 21.4 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.501 2.134 . . . . 0.0 110.828 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -124.51 127.22 47.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.218 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.6 mm -100.06 126.02 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.945 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mm -108.07 122.97 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.121 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.16 118.62 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.724 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -114.26 124.59 52.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.617 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.5 t80 -128.29 117.1 20.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.35 -124.63 33.76 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -98.03 5.93 48.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.01 131.23 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 110.659 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -135.91 153.48 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.15 155.73 22.22 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.7 m-20 -114.37 147.33 39.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.853 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.9 p -135.02 155.4 50.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.066 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -96.97 121.59 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.962 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.71 134.44 54.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 m -124.31 137.7 54.46 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.966 0.412 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.648 HG22 HD12 ' A' ' 17' ' ' ILE . 67.6 t -85.5 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.215 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' ILE . 63.7 t30 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.535 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.369 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 p -132.3 162.43 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.45 103.97 2.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.707 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.412 ' N ' HD13 ' A' ' 5' ' ' LEU . 4.5 t -75.47 -49.01 20.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 p -152.2 151.56 31.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.69 134.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.854 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 m -130.87 149.25 52.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.582 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.75 134.69 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.01 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.1 164.76 15.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.843 0.354 . . . . 0.0 111.327 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -37.91 157.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.005 3.136 . . . . 0.0 111.373 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.8 mm -85.78 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 123.536 0.734 . . . . 0.0 109.985 0.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -38.46 -92.65 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.702 0.287 . . . . 0.0 110.919 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -150.26 93.78 2.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.079 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 64.2 t30 -156.02 129.02 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 111.653 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.832 -179.591 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.888 0.375 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -110.38 128.91 55.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.084 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -113.3 145.83 40.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.032 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.2 tt0 -110.09 143.88 39.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.54 153.13 47.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -114.58 149.84 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.909 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.57 127.49 54.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.918 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.9 t -114.37 130.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.5 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.48 148.28 16.96 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 m -114.26 128.19 56.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.451 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -83.73 149.75 26.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.059 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -55.85 -16.28 4.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.407 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.79 -1.56 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.582 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.52 83.05 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 36' ' ' LYS . 21.2 m -86.3 156.85 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.846 0.355 . . . . 0.0 110.681 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mttp -130.81 151.89 50.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.02 158.55 28.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -80.74 120.95 25.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.357 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 43' ' ' VAL . 81.4 mt -104.8 5.54 33.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.165 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -57.09 -21.94 35.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 0.0 109.896 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.3 p -94.38 -11.38 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.261 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -107.06 -27.63 10.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 79' ' ' TYR . 5.1 m -85.77 143.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.6 m -102.06 123.43 45.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.787 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.572 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 30.6 m95 -92.57 135.44 34.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.31 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -149.03 163.6 37.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.0 t -139.24 146.41 40.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.815 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.2 p -66.28 -33.19 75.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.341 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -78.34 68.97 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.377 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' ALA . 97.9 mt-30 -77.25 -38.18 51.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -72.28 -34.01 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.604 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -98.45 3.76 48.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.01 159.07 5.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.158 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.41 147.74 52.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.701 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.8 p -117.36 113.1 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.023 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -140.11 104.86 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.776 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.574 ' CG ' ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -116.94 124.14 48.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.54 170.75 13.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -56.73 -33.61 66.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.508 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.56 -10.51 48.55 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.527 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.0 p -130.03 32.21 4.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.228 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -47.19 121.36 3.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.818 -179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 93.64 47.34 2.99 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.574 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 45.9 tp -118.92 120.41 37.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -126.56 135.46 63.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -113.01 130.59 56.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.05 110.94 2.87 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.04 -43.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.38 118.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.772 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.763 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.5 p -160.42 166.26 29.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.719 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.46 -48.02 1.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -157.29 81.87 3.18 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.44 158.61 17.02 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.468 2.112 . . . . 0.0 110.238 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.4 m -114.26 130.09 56.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -98.92 119.81 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.012 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.495 HG23 ' OD1' ' A' ' 85' ' ' ASN . 3.8 mp -102.86 118.32 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.136 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.48 121.32 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -108.65 129.41 55.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.662 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.689 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.3 t80 -139.8 96.22 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.16 -125.55 36.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.2 p -91.77 6.74 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.319 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.48 132.43 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.3 p -137.22 157.06 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.39 147.57 19.16 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 76' ' ' ILE . 4.2 m-80 -131.99 133.38 44.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.439 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.2 p -131.54 160.4 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.304 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.429 ' C ' HD22 ' A' ' 88' ' ' LEU . 96.1 mt -98.98 121.96 50.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.18 0.514 . . . . 0.0 111.062 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 88' ' ' LEU . 4.4 mm? -100.73 134.32 43.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.514 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.52 ' N ' ' OG1' ' A' ' 15' ' ' THR . 93.5 m -110.94 134.03 52.9 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.915 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.763 HG21 ' O ' ' A' ' 70' ' ' SER . 83.6 t -82.84 100.78 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.898 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 14.0 t-20 . . . . . 0 C--N 1.329 -0.306 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.343 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.857 0.36 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -139.6 162.71 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.285 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.2 tp -84.16 108.4 17.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 m -76.65 -48.04 20.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.828 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -155.74 164.12 38.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.76 ' CG2' HD21 ' A' ' 5' ' ' LEU . 36.9 pt -124.99 144.25 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.843 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.0 t -136.72 146.11 45.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.494 HG13 HG21 ' A' ' 86' ' ' THR . 11.3 mm -93.67 139.75 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.967 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -98.68 165.24 15.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.2 Cg_exo -38.25 166.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 124.017 3.145 . . . . 0.0 111.402 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' ASN . 95.9 mt -111.55 116.55 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 118.753 0.706 . . . . 0.0 109.995 0.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' ILE . 68.5 m-20 33.13 -134.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.872 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.41 93.74 2.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.113 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 52.7 p30 -157.37 147.1 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 111.718 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.805 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -98.67 148.61 23.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.085 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 88.7 tttt -137.95 137.84 38.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.931 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.0 143.9 37.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.7 152.61 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.8 153.05 27.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.949 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.3 129.55 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.867 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.23 131.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.461 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.72 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.5 m -118.51 128.42 54.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 0.0 110.364 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.24 149.31 25.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.116 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -54.42 -15.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.495 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.56 -1.58 38.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.66 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.68 86.73 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 36' ' ' LYS . 17.3 m -86.09 156.59 20.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 110.582 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 35' ' ' THR . 98.6 mttt -128.27 150.46 50.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.395 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.36 17.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 42.3 p-10 -77.19 126.01 30.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.423 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 43' ' ' VAL . 69.4 mt -109.78 14.31 23.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 m -59.78 -30.08 68.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.087 0.47 . . . . 0.0 109.898 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.2 p -90.33 -10.42 44.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.17 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 -26.16 13.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.9 m -93.05 151.45 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -108.63 123.74 49.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.591 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 31.9 m95 -93.85 138.82 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 p -151.05 160.56 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.984 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.4 t -132.13 143.46 50.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.847 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -61.66 -32.94 73.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.698 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 36.1 m-20 -75.83 63.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -69.97 -42.71 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -34.19 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.691 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -104.15 2.41 31.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -157.32 148.99 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.198 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.76 141.71 46.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.925 0.393 . . . . 0.0 110.694 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.0 p -112.09 114.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.993 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.5 t -139.55 108.48 6.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -147.75 132.84 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.654 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.495 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.93 178.43 4.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.8 m -54.39 -35.58 63.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.617 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.42 -24.68 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.487 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 61.4 p -104.6 16.47 26.01 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.224 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -49.59 120.55 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.784 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.531 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 104.36 32.34 4.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 65' ' ' VAL . 2.2 tt -118.24 118.05 30.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 64' ' ' LEU . 40.7 t -122.24 134.5 65.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 p -105.3 132.12 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.46 108.24 2.41 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 90.5 mt -64.53 -42.92 96.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.304 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.37 119.75 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.645 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 p -163.2 166.0 23.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.52 -71.41 1.1 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.499 ' OD1' HG23 ' A' ' 89' ' ' THR . 44.7 m-80 -128.37 83.07 67.22 Favored Pre-proline 0 C--N 1.333 -0.146 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 90' ' ' VAL . 57.4 Cg_endo -82.58 158.57 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.532 2.155 . . . . 0.0 110.225 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.511 ' C ' HD12 ' A' ' 75' ' ' ILE . 52.4 m -118.88 126.88 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.0 mp -101.05 126.1 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.882 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.751 HG23 ' OD1' ' A' ' 85' ' ' ASN . 89.3 mt -114.97 128.73 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.144 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.7 132.86 49.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -119.0 130.48 55.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.562 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.697 ' HB2' HG12 ' A' ' 43' ' ' VAL . 62.1 t80 -139.72 106.7 5.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.722 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.68 -125.08 31.41 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.7 p -92.6 8.21 39.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.371 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 135.74 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.6 p -146.89 151.82 37.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.986 0.422 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.73 146.57 18.37 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.751 ' OD1' HG23 ' A' ' 76' ' ' ILE . 5.5 m-20 -125.02 137.5 54.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.01 0.433 . . . . 0.0 111.237 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 HG13 ' A' ' 10' ' ' ILE . 71.9 p -135.58 157.03 47.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.305 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.1 mm -96.72 127.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.013 0.435 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.73 147.7 37.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.571 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.499 HG23 ' OD1' ' A' ' 72' ' ' ASN . 91.2 m -125.49 132.34 52.67 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.917 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.443 HG23 ' CD ' ' A' ' 73' ' ' PRO . 96.5 t -83.48 107.86 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.895 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.372 179.608 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.778 0.323 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -139.28 163.23 33.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.91 112.16 9.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.302 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -74.92 -42.72 57.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 p -153.26 163.54 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.3 tt -119.13 134.4 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 t -131.78 148.03 52.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.745 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 mt -113.11 129.51 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.972 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.75 164.74 15.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -39.51 157.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.349 2.699 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 14' ' ' ASN . 89.9 mt -87.02 156.54 3.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 C-N-CA 123.998 0.919 . . . . 0.0 110.444 1.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 13' ' ' ILE . 98.9 m-20 -42.51 -97.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.725 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -165.89 96.13 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.355 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 81.9 m-20 -154.75 147.5 24.36 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.692 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 88' ' ' LEU . 51.6 mm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.757 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 22' ' ' SER . 79.0 t . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.022 0.439 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.539 ' N ' HG12 ' A' ' 21' ' ' VAL . 6.6 m -110.2 122.37 47.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.631 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HZ3' ' H ' ' A' ' 16' ' ' ASN . 29.5 ttpt -112.46 137.68 50.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 15.0 tt0 -110.05 141.79 42.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.847 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.23 152.01 48.59 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.068 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.35 147.28 37.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.7 127.6 55.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.738 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.5 129.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.156 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.64 17.25 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 m -116.87 127.44 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.25 146.73 28.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 p -54.12 -16.81 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -78.73 -3.73 45.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.7 78.55 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 36' ' ' LYS . 24.1 m -83.21 157.32 22.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.738 0.304 . . . . 0.0 110.799 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' THR . 53.6 mtmt -130.55 149.22 52.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.28 152.24 20.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.69 122.35 26.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.2 mt -105.49 7.9 33.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.5 m -55.74 -31.9 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.6 p -88.28 -9.92 51.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 -29.09 11.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.599 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.575 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -87.37 147.93 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.268 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.7 m -106.78 117.9 35.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.822 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m95 -87.41 140.1 29.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -147.75 164.96 31.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.161 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -135.45 143.61 46.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.327 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.67 -33.03 74.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.348 0.595 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.682 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 96.2 m-20 -80.72 65.0 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 94.2 mm-40 -69.08 -43.81 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.466 . . . . 0.0 109.888 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.6 p -70.81 -33.14 70.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.937 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 79.3 mt-30 -104.0 9.38 36.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.505 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.59 153.98 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.73 142.86 48.14 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.4 p -119.49 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -138.24 108.78 6.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.54 ' HB3' ' H ' ' A' ' 64' ' ' LEU . 16.0 p30 -132.66 128.8 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 -179.45 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.553 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.0 p -64.33 -16.91 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.388 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -89.08 -35.27 16.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 p -114.96 31.04 6.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.601 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -41.36 120.85 1.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 110.91 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.93 49.25 2.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.54 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 44.6 tp -118.52 121.24 39.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.648 0.261 . . . . 0.0 110.535 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.36 133.55 67.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -118.72 129.18 55.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.784 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.66 8.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.0 mt -90.61 -40.96 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.574 0.226 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . . . -122.75 152.52 40.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -80.45 167.72 19.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.89 -136.1 7.78 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -130.06 81.13 69.57 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.573 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.79 153.98 58.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.867 2.378 . . . . 0.0 110.368 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -126.81 122.7 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -93.0 130.32 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' OD1' ' A' ' 85' ' ' ASN . 94.4 mt -120.86 119.75 60.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.123 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.04 123.47 45.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -115.77 126.4 53.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 43' ' ' VAL . 83.9 t80 -129.69 103.69 6.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.982 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.63 -122.32 27.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -92.24 4.87 52.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.544 0.211 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.48 129.88 74.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 89.9 p -137.81 150.52 47.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.24 142.7 14.19 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 76' ' ' ILE . 64.8 m-20 -109.98 144.92 37.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 p -132.99 155.62 48.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.14 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.56 127.57 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.941 0.401 . . . . 0.0 111.13 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 17' ' ' ILE . 41.9 tp -104.81 134.64 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.709 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.5 m -113.25 128.98 56.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 111.403 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.14 106.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.133 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.54 HD21 ' CG ' ' A' ' 16' ' ' ASN . 25.3 p-10 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.352 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.52 97.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.03 144.16 48.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.534 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.1 p -128.77 162.39 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.1 112.17 2.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.449 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 t -74.66 -42.18 58.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 p -153.15 160.59 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.759 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -114.26 133.37 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.032 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.3 m -132.57 148.57 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.348 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mt -111.59 132.38 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.029 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 163.85 17.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -43.49 167.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 123.581 2.854 . . . . 0.0 112.13 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 14' ' ' ASN . 4.7 mm -87.44 162.17 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 110.234 1.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 13' ' ' ILE . 94.1 m-20 -48.92 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.797 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 p -85.7 96.03 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' H ' ' NZ ' ' A' ' 23' ' ' LYS . 79.4 m-20 -155.25 143.33 20.1 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.667 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.92 133.13 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.631 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -82.35 165.02 20.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.744 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -39.04 -69.17 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 20' ' ' THR . 35.1 m -150.5 59.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' N ' ' A' ' 22' ' ' SER . 19.1 t -130.38 171.3 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.652 ' N ' HG12 ' A' ' 21' ' ' VAL . 26.3 p -88.93 150.13 22.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.183 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' NZ ' ' H ' ' A' ' 16' ' ' ASN . 83.9 tttt -136.7 128.87 29.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.452 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -110.06 144.64 38.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.45 151.03 49.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -111.42 146.79 36.55 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.915 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.74 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.742 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.65 132.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.413 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.09 146.89 16.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -114.79 125.89 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 110.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -83.59 148.5 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.024 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.0 p -55.09 -14.82 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.492 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.81 -2.34 46.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.7 83.59 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 36' ' ' LYS . 20.4 m -86.35 157.37 19.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.868 0.366 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -130.31 149.71 51.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.394 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.34 153.87 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -85.55 122.01 29.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 43' ' ' VAL . 92.4 mt -104.48 2.18 30.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.2 m -45.72 -33.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.438 . . . . 0.0 110.286 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.4 p -88.15 -19.01 27.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.71 -21.75 19.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.635 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.3 m -98.21 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.328 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.3 m -103.38 122.99 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.711 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 12.6 m95 -92.33 141.42 28.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -153.41 166.54 32.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.989 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -132.32 140.29 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -40.0 87.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -89.4 87.59 7.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.171 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -81.53 -25.78 35.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.18 0.514 . . . . 0.0 109.801 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 t -69.43 -34.47 74.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -100.55 2.79 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.235 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.68 146.43 13.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.07 138.37 52.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 65' ' ' VAL . 47.2 t -111.67 113.19 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.779 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -141.29 114.99 9.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -156.1 133.91 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.955 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -69.97 -178.28 1.54 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.614 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -59.19 -33.52 71.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.642 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -85.78 -7.07 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.759 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 21.5 p -118.1 0.2 11.75 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.628 0.251 . . . . 0.0 111.268 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -41.42 114.16 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.573 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.91 27.69 2.44 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.697 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 2.6 tp -117.88 120.67 38.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.914 0.388 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 55' ' ' VAL . 54.8 t -130.07 134.77 62.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.069 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -111.95 126.44 55.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -122.96 109.51 1.38 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.758 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.8 mt -64.58 -45.89 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.251 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 161.89 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.8 p -137.86 -2.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.6 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.22 3.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -154.17 80.63 4.78 Favored Pre-proline 0 N--CA 1.453 -0.29 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.203 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.16 147.53 16.43 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.797 2.331 . . . . 0.0 110.725 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 120.33 35.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.465 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.45 ' CG1' HD22 ' A' ' 88' ' ' LEU . 33.4 mm -97.49 126.36 50.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.471 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 ' OD1' ' A' ' 85' ' ' ASN . 91.6 mt -110.37 127.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.067 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.84 128.2 52.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -118.94 126.28 51.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.0 t80 -129.85 103.28 6.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.114 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.51 -123.87 31.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.0 p -91.2 6.12 46.36 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.828 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.82 133.57 69.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.4 p -140.36 152.07 45.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 142.05 13.4 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.721 ' OD1' HG23 ' A' ' 76' ' ' ILE . 79.6 m-20 -108.88 142.29 39.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 110.767 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t -142.36 150.88 41.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.821 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 88' ' ' LEU . 73.4 mt -108.52 128.49 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 88' ' ' LEU . 11.1 mp -103.66 133.15 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.927 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -96.99 142.64 28.71 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.586 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.69 106.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.201 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -140.12 117.94 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -93.76 136.14 34.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.603 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.6 p -66.48 -36.77 83.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -161.51 163.04 30.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.54 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.518 179.883 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -62.56 -41.29 98.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.701 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 51.62 175.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.3 p -131.01 163.8 26.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.603 ' C ' HD13 ' A' ' 5' ' ' LEU . 3.1 tm? -81.22 111.08 17.31 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.49 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -77.53 -53.52 7.51 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.468 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -145.81 156.56 43.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 19.5 tt -127.8 130.34 70.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.013 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.8 p -133.01 148.39 52.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.76 140.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.053 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 163.79 17.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -37.16 155.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.41 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.1 mm -86.63 159.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 123.928 0.891 . . . . 0.0 110.083 1.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 15' ' ' THR . 5.0 p30 -41.13 -98.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.979 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -153.84 94.39 1.76 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.109 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -156.36 140.63 16.58 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.663 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mm -120.79 131.98 71.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.406 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -82.2 167.13 19.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 20' ' ' THR . 80.4 p -37.47 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.457 ' N ' ' OG1' ' A' ' 19' ' ' THR . 79.3 p -134.3 62.47 1.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.06 163.13 32.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.231 0.538 . . . . 0.0 110.872 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.426 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 3.8 m -88.36 142.72 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.411 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -134.89 130.04 35.32 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 110.62 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -109.74 144.83 37.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.38 153.43 47.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.115 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -111.06 152.2 27.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.63 128.94 55.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.685 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.67 133.51 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.186 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.36 151.59 18.48 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.7 m -118.84 127.77 53.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.922 0.392 . . . . 0.0 110.577 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.43 151.54 24.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.109 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.6 p -54.54 -14.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.519 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.91 0.85 37.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 3.06 90.67 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.524 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.6 m -86.13 160.21 19.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.334 . . . . 0.0 110.696 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 35' ' ' THR . 99.5 mttt -130.85 151.94 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.93 152.71 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 44.1 p-10 -80.85 124.27 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.658 ' O ' HG13 ' A' ' 43' ' ' VAL . 65.9 mt -112.45 12.58 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.0 m -58.2 -34.88 70.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.9 p -88.76 -7.86 55.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.56 -29.09 11.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.918 0.389 . . . . 0.0 110.719 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 79' ' ' TYR . 7.2 m -89.9 152.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.214 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 m -107.13 126.42 52.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.798 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.561 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 33.8 m95 -95.55 134.74 38.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.517 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.5 t -141.56 150.64 42.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -120.2 141.16 50.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.179 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.9 p -67.08 -32.96 74.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.1 m120 -84.9 69.75 10.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.333 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.13 -38.82 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -68.57 -34.82 76.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.135 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -107.4 9.58 29.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.89 144.44 16.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.097 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -129.33 145.74 51.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.882 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.6 p -125.88 114.41 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.037 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.0 t -139.29 105.92 5.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.759 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.81 130.66 18.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.091 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -67.64 -175.11 0.49 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.52 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 t -59.84 -35.82 75.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.474 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.97 -18.87 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 34.8 p -103.31 3.58 35.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.09 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -41.1 114.2 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.769 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.83 29.54 2.82 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -115.3 114.69 25.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.195 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' N ' HD13 ' A' ' 64' ' ' LEU . 46.7 t -128.06 136.6 59.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.426 ' HG1' ' HG ' ' A' ' 22' ' ' SER . 51.8 m -112.65 127.74 56.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.795 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.02 106.5 3.1 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 36.4 mm -63.99 -43.83 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.195 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 128.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 90' ' ' VAL . 25.0 t -167.54 -177.44 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.638 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.23 -53.24 0.43 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -142.79 82.73 12.08 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.461 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.29 155.65 16.79 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.94 2.426 . . . . 0.0 110.618 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.0 m -124.51 121.85 35.97 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.818 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.432 HG12 HD12 ' A' ' 88' ' ' LEU . 38.9 mm -101.82 129.14 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.8 mt -116.59 128.79 73.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.79 132.04 45.38 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -121.08 129.03 53.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.966 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.709 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.5 t80 -138.27 113.18 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.3 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 51.76 -125.61 27.04 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.5 p -93.97 8.59 40.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.78 132.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -136.7 153.9 50.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.4 143.39 14.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.654 ' OD1' HG23 ' A' ' 76' ' ' ILE . 10.2 m-20 -115.1 142.77 46.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.985 0.421 . . . . 0.0 111.069 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -143.78 144.04 31.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.89 128.12 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 110.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 HG12 ' A' ' 75' ' ' ILE . 56.1 mt -112.12 149.29 32.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.1 m -118.66 143.42 46.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.958 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 72.8 t -86.86 104.81 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.526 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 99.3 m-20 -140.73 143.21 34.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.439 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.5 135.45 38.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.396 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 94' ' ' ASP . 29.3 p -103.14 -68.89 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' N ' ' OG1' ' A' ' 93' ' ' THR . 67.5 t0 -78.66 90.58 4.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.598 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.82 94.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.84 162.43 32.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.6 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -135.75 163.87 29.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.245 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -68.43 110.93 4.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -74.98 -42.01 58.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 p -153.96 160.79 42.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.3 tt -120.44 127.97 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -130.28 149.62 51.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.608 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.0 134.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.051 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.06 163.62 17.98 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.885 0.374 . . . . 0.0 111.338 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.422 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 Cg_endo -43.87 172.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 124.083 3.189 . . . . 0.0 111.292 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 75.9 mt -102.63 110.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.581 0.753 . . . . 0.0 109.956 0.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.7 m120 35.78 -153.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.912 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.2 p -144.59 95.74 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.155 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -152.94 160.49 43.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 90' ' ' VAL . 89.6 mt -137.26 129.94 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 93' ' ' THR . 73.2 m-20 -102.48 165.39 11.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.783 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 21' ' ' VAL . 67.5 p -38.26 113.07 0.26 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.555 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m 39.68 61.97 1.3 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.034 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 19' ' ' THR . 84.9 t -131.46 138.83 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.332 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -90.39 147.64 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.135 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ILE . 63.6 tttm -141.8 132.46 25.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -109.84 142.55 40.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.86 152.72 47.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.808 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.08 153.9 27.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.951 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.17 129.94 55.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.911 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.53 130.14 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.6 148.59 16.79 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.0 m -113.9 125.88 54.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -81.19 146.09 30.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.145 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.5 p -51.93 -20.38 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.398 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.85 -5.54 44.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -0.36 76.75 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 6.7 m -85.55 156.38 20.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.555 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -126.37 153.17 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.12 157.77 21.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.756 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -82.55 129.19 34.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.332 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.665 ' O ' HG13 ' A' ' 43' ' ' VAL . 95.3 mt -113.7 11.97 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.6 m -59.89 -31.61 69.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.5 p -90.93 -6.6 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.125 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -105.74 -27.48 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.566 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.4 m -90.52 155.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.242 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.9 m -111.62 124.14 51.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.583 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 26.7 m95 -96.1 137.82 34.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.214 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.6 p -145.67 161.37 40.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.935 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.1 t -133.82 146.16 50.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.95 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -69.29 -31.61 70.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 80.3 m-20 -77.87 64.09 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.6 -42.25 74.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -72.69 -33.79 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -102.88 9.28 38.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.258 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -168.82 148.58 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.12 144.42 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.954 0.407 . . . . 0.0 110.699 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 55' ' ' VAL . 11.4 p -121.3 112.91 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.95 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.5 p -140.9 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.854 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -153.33 131.95 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 -176.38 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -57.52 -36.74 71.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.563 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.93 -33.85 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.474 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -100.51 11.29 39.8 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -43.7 115.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.61 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 110.15 37.6 1.79 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -116.97 115.49 25.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 64' ' ' LEU . 24.7 t -126.61 133.79 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -117.24 122.97 45.48 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.15 114.0 4.49 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 88.8 mt -65.79 -44.86 92.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.55 119.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.725 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.8 m -158.77 175.85 13.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.74 -67.61 0.83 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -131.48 80.71 66.59 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.581 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.7 Cg_exo -71.78 152.79 58.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.396 2.064 . . . . 0.0 110.27 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -118.45 124.19 47.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.157 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.1 mm -100.91 122.38 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG23 ' OD1' ' A' ' 85' ' ' ASN . 34.7 mm -108.45 128.43 64.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.95 129.73 55.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -119.47 129.53 54.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.608 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -128.02 105.04 8.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.757 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 49.9 -120.28 7.82 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 98.1 p -90.6 6.14 44.98 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.257 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.14 131.31 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 p -136.24 148.34 48.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.62 143.85 14.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.562 ' OD1' HG23 ' A' ' 76' ' ' ILE . 72.3 m-20 -108.14 140.32 41.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.206 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 87' ' ' ILE . 84.8 m -133.49 158.76 42.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.322 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.488 ' N ' HG22 ' A' ' 86' ' ' THR . 79.4 mt -108.49 124.0 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.81 132.49 56.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.7 m -116.12 138.09 51.56 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.872 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.581 HG23 ' CD ' ' A' ' 73' ' ' PRO . 65.6 t -83.78 111.47 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.993 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -139.21 139.31 37.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.421 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -79.36 143.46 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 95' ' ' THR . 91.8 m -120.27 129.09 53.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 25.0 p-10 -91.92 0.67 57.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.79 ' H ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.557 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.19 -38.05 89.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.703 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . . . -73.8 150.69 40.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -97.88 163.75 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.702 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.1 tp -86.53 115.08 23.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.712 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -75.44 -51.79 12.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.833 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.3 p -160.35 162.96 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.823 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.702 ' CG2' HD21 ' A' ' 5' ' ' LEU . 18.6 pt -123.51 140.92 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.896 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -130.76 149.29 52.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -91.5 142.43 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.056 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -102.34 165.43 13.84 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -178.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.6 Cg_exo -38.3 163.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 124.008 3.139 . . . . 0.0 111.397 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' C ' ' A' ' 14' ' ' ASN . 4.3 mm -99.63 114.52 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.496 0.718 . . . . 0.0 110.021 0.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 13' ' ' ILE . 23.8 t-20 28.47 -115.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 14' ' ' ASN . 24.4 p -155.58 91.79 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.07 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -156.26 140.94 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.8 mt -135.17 139.59 46.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.768 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -95.85 159.41 14.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 21' ' ' VAL . 5.9 p -64.11 137.59 58.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.539 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.29 42.55 22.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 19' ' ' THR . 71.9 t -133.45 155.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.288 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.743 ' OG ' HD21 ' A' ' 64' ' ' LEU . 14.1 t -112.77 131.49 55.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -128.57 138.06 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -110.26 144.72 38.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.85 153.71 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.869 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.74 153.47 26.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.89 129.36 53.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.881 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -111.96 127.49 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.481 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.18 143.51 18.0 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -116.03 122.2 44.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' C ' ' N ' ' A' ' 33' ' ' ASP . 94.4 m-85 -80.69 149.3 29.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.107 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -55.63 -9.74 0.57 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 3' ' ' ALA . 73.2 m-20 -86.92 1.01 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.5 0.89 88.04 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 36' ' ' LYS . 10.8 m -84.16 158.32 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 35' ' ' THR . 99.3 mttt -133.16 151.32 51.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.308 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.3 154.57 21.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.83 119.87 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.427 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' VAL . 84.9 mt -108.23 14.8 24.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.0 m -60.53 -29.21 68.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.82 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.7 p -91.18 -9.0 47.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.173 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.61 -28.6 11.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 79' ' ' TYR . 15.3 m -87.66 149.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.5 m -106.66 122.63 46.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.773 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 28.3 m95 -92.47 137.33 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.245 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -151.07 160.92 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.963 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 t -137.88 147.8 44.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -63.97 -35.13 79.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 7.4 m-20 -71.35 63.6 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.352 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 77.9 mt-30 -69.71 -43.61 72.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.6 m -72.9 -33.59 66.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.22 1.19 49.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.167 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.7 154.27 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.175 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -139.04 145.88 40.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.793 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.1 p -112.75 116.3 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.993 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 m -138.98 110.02 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.82 132.52 11.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.654 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.32 -177.11 2.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 96.0 p -58.9 -27.1 64.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.579 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -88.97 -12.67 40.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.481 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 80.1 p -116.38 0.76 12.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HA ' HD22 ' A' ' 57' ' ' ASN . 73.1 mttt -40.17 111.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.738 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.52 27.71 2.3 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.743 HD21 ' OG ' ' A' ' 22' ' ' SER . 6.1 tt -119.31 119.31 33.65 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.61 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 64' ' ' LEU . 48.7 t -125.24 135.37 64.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -115.75 127.28 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.92 117.08 4.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 95.4 mt -63.38 -42.67 97.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.287 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 177.72 118.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.745 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.756 ' O ' HG21 ' A' ' 90' ' ' VAL . 6.6 p -160.88 166.74 27.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.724 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.68 -67.9 0.9 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.87 81.66 51.71 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.12 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.18 148.8 16.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.495 2.13 . . . . 0.0 110.226 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 75' ' ' ILE . 24.6 m -107.1 124.21 49.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.132 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.7 mp -100.16 131.3 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.902 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.1 mt -117.92 125.76 74.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.257 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.6 133.73 47.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -118.01 132.02 56.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.677 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.688 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.3 t80 -136.93 111.27 8.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.718 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.43 -125.83 37.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.7 p -93.05 5.25 52.16 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.322 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 79' ' ' TYR . 50.2 t -125.67 133.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -130.84 156.74 44.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.48 147.22 16.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' HG23 ' A' ' 76' ' ' ILE . 2.9 m-20 -123.3 135.63 54.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.015 0.436 . . . . 0.0 111.135 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -140.71 153.34 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.54 126.36 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 111.122 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.566 HD12 HD13 ' A' ' 75' ' ' ILE . 85.5 mt -110.05 147.25 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.506 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.3 m -120.91 142.74 49.42 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.879 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.756 HG21 ' O ' ' A' ' 70' ' ' SER . 76.5 t -82.69 103.92 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.923 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -134.49 152.38 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.92 143.65 26.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.1 m -120.69 129.82 53.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.526 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -94.99 114.16 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.439 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.561 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.87 79.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.78 147.92 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -121.5 164.31 17.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 8' ' ' ILE . 39.0 tp -78.53 109.37 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.41 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -75.87 -45.13 37.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -148.09 167.18 25.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.835 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 5' ' ' LEU . 96.8 mt -118.0 132.83 66.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.983 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -127.87 147.78 50.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.395 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.92 137.27 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.61 163.71 17.61 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.063 0.459 . . . . 0.0 111.314 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -37.31 155.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 123.515 2.81 . . . . 0.0 112.199 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.688 HD12 ' HE2' ' A' ' 23' ' ' LYS . 91.4 mt -87.71 159.16 3.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 123.926 0.89 . . . . 0.0 110.127 0.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' ILE . 87.7 m-20 -48.56 -90.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.3 p -141.52 92.9 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -156.78 161.61 39.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 111.799 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -143.43 148.18 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.624 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -75.7 164.51 26.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.841 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 20' ' ' THR . 71.8 p -39.35 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.539 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' OG1' ' A' ' 19' ' ' THR . 31.7 p -131.61 23.52 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.062 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 22' ' ' SER . 2.4 t -95.75 -160.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.062 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.979 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.8 m -112.75 148.17 35.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.688 ' HE2' HD12 ' A' ' 13' ' ' ILE . 64.3 tttm -133.77 131.36 39.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.58 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -110.6 146.05 36.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.102 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.89 155.09 44.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.164 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -109.18 145.71 35.34 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.754 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.55 130.25 56.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.79 132.96 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.21 146.92 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.7 m -112.38 128.19 56.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.55 149.26 24.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.975 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -54.94 -17.82 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.629 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -77.74 -6.95 55.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.497 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.25 1.29 72.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 36' ' ' LYS . 87.3 m -80.69 157.7 25.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.747 0.308 . . . . 0.0 110.784 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mtmt -126.6 145.23 50.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.369 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.11 156.67 29.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.876 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 39' ' ' LEU . 91.1 m-20 -87.88 127.08 35.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.256 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.1 mp -112.53 14.03 20.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.36 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.5 m -57.11 -32.59 66.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.053 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.8 p -88.12 -9.91 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.436 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.426 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -101.18 -26.2 13.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.1 m -91.93 152.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.5 m -109.96 119.74 40.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 19.1 m95 -89.59 140.76 29.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.519 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 p -149.29 160.56 43.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.893 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -134.37 143.24 47.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.1 p -62.41 -34.49 76.86 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 7.1 m120 -71.8 62.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -68.61 -43.54 76.19 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.9 p -70.54 -33.57 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.0 7.46 36.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.1 148.77 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -134.27 142.1 47.2 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 65' ' ' VAL . 22.0 t -108.65 114.57 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 m -139.36 110.36 6.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.91 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.15 134.21 13.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.892 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.01 -176.92 1.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -58.75 -35.16 72.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.638 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -83.36 -20.49 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.649 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.5 p -104.48 4.03 32.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.099 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -42.36 115.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.855 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 114.44 33.26 1.79 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 3.7 tp -118.21 125.39 50.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 55' ' ' VAL . 56.0 t -129.31 133.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -114.86 121.78 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.6 116.57 5.09 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 92.2 mt -65.42 -44.54 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.463 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.96 120.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.691 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 30.0 t -157.9 -173.78 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -114.27 -65.37 0.43 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -134.31 80.55 52.1 Favored Pre-proline 0 C--N 1.332 -0.174 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.32 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HD3' HG23 ' A' ' 90' ' ' VAL . 14.5 Cg_exo -70.23 147.19 59.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.801 2.334 . . . . 0.0 110.626 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.4 m -110.78 115.84 30.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.738 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.73 126.61 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.593 HG23 ' OD1' ' A' ' 85' ' ' ASN . 97.4 mt -117.15 127.34 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.157 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.76 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -118.9 130.26 55.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.949 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.8 t80 -137.43 110.03 7.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.69 -128.98 48.96 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.3 p -94.04 9.71 36.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.969 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 8' ' ' ILE . 47.7 t -129.05 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.872 0.368 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -139.8 151.92 46.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.64 142.44 13.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.593 ' OD1' HG23 ' A' ' 76' ' ' ILE . 57.3 m-20 -111.43 152.71 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.114 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 162.88 39.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.309 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.41 126.37 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 111.039 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -112.94 128.47 56.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.73 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.9 m -107.51 145.79 32.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.031 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' HD3' ' A' ' 73' ' ' PRO . 64.2 t -83.8 117.47 29.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -141.2 129.23 21.99 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.518 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -79.73 135.03 36.42 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.755 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.5 p -103.41 -55.6 2.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -78.23 80.56 4.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.475 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.429 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.23 56.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.665 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.57 145.09 55.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.639 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 5' ' ' LEU . 20.7 m -90.24 162.3 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.279 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 4' ' ' THR . 57.6 tp -86.99 114.87 23.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -72.49 -46.37 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.78 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 p -157.63 164.8 36.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -124.38 131.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.933 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.2 m -132.77 148.71 52.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.538 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.0 mm -98.77 139.2 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.095 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.63 163.22 18.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 111.506 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -36.39 158.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.096 3.197 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' HE3' ' A' ' 23' ' ' LYS . 96.3 mt -84.72 158.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 123.501 0.721 . . . . 0.0 109.972 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 13' ' ' ILE . 92.2 m-20 -37.81 -92.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.824 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 93.25 1.03 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.105 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -154.57 140.29 18.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.328 0.585 . . . . 0.0 111.678 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 88' ' ' LEU . 3.3 mm -137.53 132.72 45.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.892 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.09 165.66 12.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.836 0.351 . . . . 0.0 110.734 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.937 ' O ' HG23 ' A' ' 21' ' ' VAL . 65.4 p -49.29 127.84 15.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.564 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.529 ' C ' ' O ' ' A' ' 19' ' ' THR . 0.0 OUTLIER 30.0 63.76 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.998 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 19' ' ' THR . 53.3 t -131.72 134.63 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.379 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -79.9 136.28 36.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.118 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 13' ' ' ILE . 87.3 tttt -137.93 135.85 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 110.963 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -112.3 145.58 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.339 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.42 152.62 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.853 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -110.62 142.44 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.968 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.19 128.82 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.909 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.72 128.97 72.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.481 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.97 147.18 16.59 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -115.01 129.52 56.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -87.31 149.39 24.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.112 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -55.98 -15.3 3.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.448 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.3 -1.58 49.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.567 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 1.88 85.36 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.8 m -85.36 145.59 27.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.641 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.91 148.59 42.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.71 154.71 20.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.4 125.1 31.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.343 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.5 mt -106.99 7.24 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -50.07 -31.95 14.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.2 p -87.99 -9.32 53.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.197 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.7 -28.57 10.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.558 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.5 m -87.81 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 m -106.04 123.85 48.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.76 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.474 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 38.0 m95 -92.82 134.53 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -148.37 170.3 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.935 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.1 t -136.26 146.88 47.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.786 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -66.15 -33.76 76.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 0.0 109.37 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -94.89 84.21 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 53' ' ' ALA . 30.1 mm100 -85.84 -22.79 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 t -71.02 -34.32 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.639 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.82 4.3 37.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -160.68 152.8 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.227 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -132.66 136.03 46.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.018 0.437 . . . . 0.0 110.701 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.3 p -107.04 113.28 43.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.988 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.7 t -138.98 104.49 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.634 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -131.75 127.27 36.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -178.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.82 -179.56 2.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 t -58.86 -44.95 91.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.596 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 57.1 mp0 -83.46 -7.97 59.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.505 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.4 p -113.0 8.8 18.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.357 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -42.13 114.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.68 29.04 3.01 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 64' ' ' LEU . 28.5 tp -118.02 121.0 39.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.575 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.14 134.11 67.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 p -102.47 131.47 49.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.24 105.28 2.05 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.6 mt -63.05 -44.72 99.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 170.66 121.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -160.07 168.59 25.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.92 -49.09 1.19 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -149.69 82.73 6.6 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -84.24 159.05 13.15 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.488 2.125 . . . . 0.0 110.184 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.0 m -118.32 123.95 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 mm -98.29 125.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.938 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.2 mm -112.8 126.52 70.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.106 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.99 125.6 47.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 m -113.88 126.11 54.81 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.693 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.589 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.4 t80 -134.64 87.76 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.41 -124.78 22.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -89.04 4.92 46.69 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.314 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.45 136.55 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 p -142.15 157.08 45.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . -127.45 142.93 13.93 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -123.14 130.84 53.3 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.204 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -136.71 157.18 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.341 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.7 mt -97.56 124.57 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.971 0.415 . . . . 0.0 111.179 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 17' ' ' ILE . 67.2 tp -107.93 135.57 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.568 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.3 m -119.09 139.69 51.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.918 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.3 t -88.1 101.7 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.0 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -137.0 149.61 47.6 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.357 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' NZ ' ' C ' ' A' ' 95' ' ' THR . 44.4 tttm -72.76 136.3 45.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 32.7 m -44.13 -72.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 93' ' ' THR . 97.9 m-20 -139.49 -65.02 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.433 ' C ' ' NZ ' ' A' ' 92' ' ' LYS . 4.9 t . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.659 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ALA . 9.5 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 45.48 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.47 139.94 51.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -93.05 143.0 26.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.1 tp -60.57 116.65 4.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.404 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.3 t -75.92 -42.97 47.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -156.8 165.69 35.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.047 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.95 133.21 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -135.38 147.85 49.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 86' ' ' THR . 15.1 mm -95.33 143.41 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.761 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.49 164.38 16.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.34 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.0 Cg_exo -37.27 164.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 123.326 2.684 . . . . 0.0 112.871 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' ASN . 86.7 mt -107.6 114.98 47.74 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 125.074 1.35 . . . . 0.0 110.798 -0.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' ILE . 97.3 m-20 33.96 -120.95 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.604 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 p -149.16 95.78 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.906 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 60.5 t30 -150.3 147.84 28.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.591 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.8 mt -138.4 132.23 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.735 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 21' ' ' VAL . 99.2 m-20 -104.54 133.21 49.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 21' ' ' VAL . 8.7 p -65.3 152.39 43.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.282 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.605 HG22 HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER 67.91 -16.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.707 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 20' ' ' THR . 46.3 t -118.6 138.39 49.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.52 0.676 . . . . 0.0 111.422 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 m -96.37 141.45 29.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.936 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -120.47 140.6 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -109.34 143.54 38.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.71 153.62 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.181 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -111.03 152.35 26.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.66 129.91 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.583 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.97 128.41 67.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.07 143.41 14.52 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.498 ' HG1' ' HZ3' ' A' ' 36' ' ' LYS . 52.7 m -115.48 129.2 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.871 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -88.1 146.44 25.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.861 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.0 p -53.73 -15.79 1.4 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.748 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.02 -3.22 51.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.571 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.07 85.95 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 m -77.64 139.74 39.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 110.714 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HZ3' ' HG1' ' A' ' 30' ' ' THR . 68.7 mmtt -110.99 139.47 46.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.45 25.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.085 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.533 ' C ' HD22 ' A' ' 39' ' ' LEU . 50.2 t0 -90.1 126.04 35.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.735 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.5 mm? -103.81 9.2 37.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -53.45 -30.32 40.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.898 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.4 p -89.82 -9.11 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.22 -22.75 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.3 m -95.12 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -104.29 120.32 40.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.637 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.0 m95 -89.07 134.72 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.536 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 p -143.21 162.49 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.885 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -135.94 144.64 45.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 111.235 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 p -67.78 -33.34 74.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.333 0.587 . . . . 0.0 109.527 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 16.2 m120 -77.58 62.47 2.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.566 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.09 -42.33 84.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.054 0.454 . . . . 0.0 109.956 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -69.85 -34.4 73.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -103.62 6.01 36.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.374 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -159.57 147.26 17.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.324 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -132.46 142.64 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 110.807 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 55' ' ' VAL . 6.6 p -122.59 114.29 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 67.8 p -139.53 117.05 11.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.632 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -155.29 134.4 12.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.22 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -75.03 178.8 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.751 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.2 p -54.3 -27.25 34.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.621 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -87.47 -25.28 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.717 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 18.6 p -103.87 8.27 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.655 0.265 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -42.16 115.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.962 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 109.83 35.94 2.12 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.9 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 25.0 tp -118.27 126.12 51.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.724 0.262 . . . . 0.0 110.514 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.74 133.7 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 111.051 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 m -102.66 127.84 49.61 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.67 102.1 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.678 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.7 mt -65.26 -44.17 95.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.908 0.385 . . . . 0.0 110.069 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 167.75 118.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 t -160.42 170.82 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.45 -55.24 0.76 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -140.66 82.2 16.11 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' HG23 ' A' ' 90' ' ' VAL . 71.0 Cg_endo -83.04 155.46 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.69 2.26 . . . . 0.0 110.732 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 75' ' ' ILE . 95.5 m -121.27 123.9 43.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.971 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.873 HD13 HD22 ' A' ' 88' ' ' LEU . 2.1 mp -102.43 129.7 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.734 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.0 127.23 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.091 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.9 129.4 49.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.7 m -113.37 129.7 56.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.607 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.8 t80 -132.35 87.27 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.265 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.65 -125.2 25.5 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.3 p -87.18 3.97 44.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.539 0.209 . . . . 0.0 110.931 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.69 133.65 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.759 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -139.79 154.34 47.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.593 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.43 147.96 17.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.3 m120 -126.25 130.55 51.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.97 0.414 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 81.8 p -134.55 151.09 50.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.577 ' C ' HD12 ' A' ' 88' ' ' LEU . 78.6 mt -97.92 127.01 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 0.0 110.799 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.873 HD22 HD13 ' A' ' 75' ' ' ILE . 10.5 mp -109.48 145.73 35.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -114.65 134.95 54.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.498 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 73' ' ' PRO . 71.4 t -84.4 104.27 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.084 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 99.3 m-20 -140.18 155.8 46.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.514 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.01 154.66 31.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.479 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 96.5 m -60.68 -46.26 91.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.673 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 36.1 p-10 -132.78 132.26 42.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.606 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.91 60.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.749 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.67 163.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.58 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.1 m -119.0 139.55 51.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.278 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.75 122.79 15.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -74.62 -43.3 56.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.9 p -159.29 162.39 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.531 HD11 HG12 ' A' ' 82' ' ' VAL . 96.6 mt -112.45 129.59 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -125.27 148.59 48.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.527 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 86' ' ' THR . 26.2 mm -104.18 139.75 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.027 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -101.19 162.31 20.94 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 0.0 111.302 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.3 Cg_exo -35.15 163.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 124.104 3.202 . . . . 0.0 111.322 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' ASN . 88.4 mt -109.09 108.13 24.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.599 0.759 . . . . 0.0 110.045 0.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 33.7 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.2 OUTLIER -127.76 97.47 4.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.147 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -154.5 160.08 41.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.258 0.551 . . . . 0.0 111.606 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 91' ' ' ASN . 47.4 mm -124.4 132.39 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.718 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 19' ' ' THR . 2.7 m-80 -78.44 165.92 23.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 18' ' ' ASN . 80.7 p -38.55 -60.73 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 t -156.38 55.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.1 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' SER . 14.2 t -128.54 162.98 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.326 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.9 m -86.02 152.27 23.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.067 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -137.5 135.01 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.9 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -111.27 143.43 42.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -130.08 153.2 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.896 179.048 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -119.8 146.59 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.771 0.32 . . . . 0.0 110.942 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.55 129.77 55.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.827 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.55 128.85 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.79 144.14 17.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 m -113.22 125.79 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.469 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.432 ' C ' ' N ' ' A' ' 33' ' ' ASP . 97.1 m-85 -83.4 143.84 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.15 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -49.92 -14.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.426 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.432 ' N ' ' C ' ' A' ' 31' ' ' TYR . 89.0 m-20 -81.48 0.76 36.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.568 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.05 1.45 90.61 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -84.32 151.3 24.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.661 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.02 148.19 48.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.371 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.12 27.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.764 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.87 124.67 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.6 mt -111.0 12.89 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.175 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.7 m -59.39 -26.38 65.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.081 0.467 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 95.2 p -93.55 -7.76 43.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.237 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.6 -26.4 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.49 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -90.63 149.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.4 m -106.45 126.39 52.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.711 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.529 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 23.3 m95 -95.79 137.47 34.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.262 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 p -148.9 168.6 22.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -139.24 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.838 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -62.34 -39.42 93.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.401 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -91.13 88.47 6.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.328 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -88.86 -22.45 23.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 p -70.83 -32.19 69.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.34 1.97 36.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.161 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.07 148.43 15.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.126 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -127.87 139.15 52.79 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.745 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.6 p -114.93 111.19 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.033 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 t -139.67 103.87 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -139.57 130.29 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.623 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.541 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.3 -177.1 2.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -58.32 -34.91 71.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.568 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.8 mp0 -85.58 -22.3 28.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.534 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 42.0 p -101.76 15.0 30.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.238 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -44.81 115.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.72 34.66 3.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -118.93 113.06 20.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.547 ' N ' HD13 ' A' ' 64' ' ' LEU . 50.5 t -128.55 138.4 54.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.803 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -106.44 125.81 51.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.29 103.07 1.62 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.8 mt -64.12 -44.96 97.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.334 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 149.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 5.4 t -179.15 -175.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.673 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.594 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -108.75 -62.47 0.54 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -136.26 80.5 40.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.123 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.4 Cg_exo -71.3 153.98 61.47 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.507 2.138 . . . . 0.0 110.248 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.5 m -125.19 110.95 14.7 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.225 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 mm -96.07 126.51 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.79 128.65 76.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.08 135.48 39.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.0 m -122.1 132.14 54.33 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.669 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.652 ' HB2' HG12 ' A' ' 43' ' ' VAL . 77.1 t80 -136.59 107.96 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 48.87 -119.88 6.37 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.4 p -93.22 6.97 46.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 8' ' ' ILE . 53.0 t -126.27 129.73 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.912 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -136.74 153.5 50.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 110.904 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.63 142.21 13.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.1 m-20 -121.8 139.11 54.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.936 0.398 . . . . 0.0 111.244 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.578 HG21 HG13 ' A' ' 10' ' ' ILE . 41.6 p -137.65 167.53 21.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.323 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.4 123.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 17' ' ' ILE . 50.5 tp -109.12 130.32 55.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.5 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 m -116.11 141.27 48.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.961 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG23 ' CD ' ' A' ' 73' ' ' PRO . 26.1 t -84.87 121.02 36.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' ILE . 29.3 t-20 -142.04 126.66 17.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.08 123.36 38.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 99.7 m -62.5 -48.83 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.467 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.53 71.15 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.508 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.624 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.31 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.26 154.56 41.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -131.53 164.47 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.61 HD21 HG12 ' A' ' 8' ' ' ILE . 46.2 tp -64.89 105.81 1.1 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.631 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.6 m -76.21 -40.5 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 p -151.61 165.73 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.61 HG12 HD21 ' A' ' 5' ' ' LEU . 96.7 mt -115.48 132.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.889 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 m -123.02 149.07 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.627 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.0 mt -118.25 132.58 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.14 164.24 15.89 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' SER . 57.8 Cg_exo -36.21 162.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.047 3.164 . . . . 0.0 111.396 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ASN . 3.5 mt -93.71 163.75 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.485 0.714 . . . . 0.0 109.99 0.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.576 ' CG ' HD21 ' A' ' 16' ' ' ASN . 32.6 p30 -48.01 -172.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 89' ' ' THR . 53.5 p -85.29 93.51 8.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.576 HD21 ' CG ' ' A' ' 14' ' ' ASN . 66.6 m-80 -154.45 142.02 19.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.319 0.58 . . . . 0.0 111.651 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.6 mm -135.85 134.25 51.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.746 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -101.79 157.17 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.822 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 21' ' ' VAL . 80.8 p -39.22 121.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 19' ' ' THR . 11.3 p 31.87 66.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 19' ' ' THR . 54.5 t -131.41 137.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 m -82.42 136.92 34.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.104 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.68 132.91 39.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -112.02 144.73 40.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.91 153.8 47.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.802 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -112.53 138.63 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.923 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.34 124.39 52.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.952 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.79 129.45 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.386 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.19 142.11 16.46 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.0 m -109.2 122.69 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 110.417 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -83.84 146.34 28.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.128 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.2 p -52.14 -14.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.413 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.67 -3.94 49.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 2.27 82.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 36' ' ' LYS . 22.0 m -85.7 153.79 22.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -123.74 151.09 43.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.31 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.29 156.27 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 39' ' ' LEU . 34.8 p-10 -86.78 123.78 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.0 mp -111.34 18.22 19.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.03 -30.42 70.3 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.9 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.0 p -89.61 -8.28 52.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.192 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.7 t -104.7 -27.9 11.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 39' ' ' LEU . 16.5 m -88.11 150.6 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.268 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -108.52 117.64 34.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 18.8 m95 -87.25 136.64 32.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.7 p -141.2 162.66 34.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.987 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -138.45 143.31 39.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.888 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -68.94 -36.42 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 99.1 m-20 -74.42 69.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.29 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.03 -43.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.4 m -70.04 -33.91 72.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.644 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.59 6.64 34.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -164.98 146.47 7.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.166 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -131.79 146.77 52.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.76 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.3 p -122.46 114.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.963 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.4 p -140.93 111.47 6.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.08 131.44 11.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.53 -177.03 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.9 t -56.3 -41.75 76.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.591 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -74.46 -31.39 62.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.522 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.2 p -95.22 2.49 54.94 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 57' ' ' ASN . 53.7 mttt -41.31 116.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.81 33.8 1.8 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.57 118.92 32.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.31 135.72 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.773 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -112.17 128.85 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.53 134.77 12.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.659 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.01 -66.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' SER . . . -144.8 142.05 29.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.643 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 1.1 t 163.32 175.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -109.69 -48.69 0.78 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -140.64 81.12 17.45 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD3' HG23 ' A' ' 90' ' ' VAL . 26.3 Cg_exo -64.18 144.07 85.74 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 0.0 110.242 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.0 m -118.29 121.31 40.1 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.78 129.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.704 HG23 ' OD1' ' A' ' 85' ' ' ASN . 86.8 mt -110.8 128.09 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.163 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.5 131.17 54.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -115.65 133.91 55.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.633 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 43' ' ' VAL . 87.8 t80 -136.53 94.2 2.97 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.7 -123.23 32.2 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.6 p -89.91 6.77 40.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.33 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 8' ' ' ILE . 48.0 t -126.17 135.31 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 p -140.0 156.85 46.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.0 110.92 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.8 143.92 15.58 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.704 ' OD1' HG23 ' A' ' 76' ' ' ILE . 65.6 m-20 -111.24 139.88 46.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.1 m -135.8 141.72 44.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.277 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.18 128.99 63.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.064 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.04 147.76 28.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.529 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.422 ' H ' ' HB ' ' A' ' 15' ' ' THR . 59.0 m -111.9 138.0 49.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.982 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 73' ' ' PRO . 43.0 t -83.25 104.48 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.904 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -136.0 130.77 34.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.416 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HE2' HG22 ' A' ' 19' ' ' THR . 97.4 mttt -94.86 153.96 17.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.899 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -79.97 34.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.588 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -74.99 121.57 22.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.527 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.597 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.47 148.95 50.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.63 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.95 179.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.631 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -133.99 162.39 32.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 8' ' ' ILE . 3.7 tt -88.04 109.53 19.92 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -76.47 -53.09 8.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.775 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.8 p -156.46 169.79 23.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.906 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 5' ' ' LEU . 35.9 pt -130.69 144.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.849 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -135.81 149.12 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.674 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mm -95.29 141.77 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.36 165.55 14.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 120.762 0.315 . . . . 0.0 111.431 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 11' ' ' SER . 46.5 Cg_exo -38.19 165.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.095 3.197 . . . . 0.0 111.314 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 14' ' ' ASN . 78.7 mt -110.14 117.78 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.461 0.705 . . . . 0.0 110.008 0.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 13' ' ' ILE . 64.1 t30 27.05 -131.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.756 0.312 . . . . 0.0 110.88 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -142.81 93.4 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.178 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -155.26 135.16 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.226 0.536 . . . . 0.0 111.66 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -156.35 141.45 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.789 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -107.53 164.81 11.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.737 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.5 p -67.34 143.49 56.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.81 4.5 5.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.053 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.33 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 m -104.32 145.48 30.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.102 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -131.11 140.22 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.901 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -109.54 143.48 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.383 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.606 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.14 152.96 48.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.881 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -111.08 149.75 30.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.923 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.79 127.8 55.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.825 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.38 128.34 69.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.461 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.12 148.35 17.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.8 m -119.6 130.09 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 0.0 110.432 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -89.08 149.33 23.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.122 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -55.3 -10.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.434 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.12 -0.75 57.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.56 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.7 87.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.6 m -84.22 146.26 27.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 110.654 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.13 146.98 48.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.08 156.12 28.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.834 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.15 122.97 28.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.635 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.0 mt -107.42 9.2 29.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.211 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.6 m -55.0 -30.55 59.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.113 0.482 . . . . 0.0 109.866 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -89.67 -9.8 48.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.133 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -102.87 -26.35 13.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.599 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -93.72 144.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.302 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 123.13 47.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.606 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 10.8 m95 -92.94 136.46 33.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.277 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.3 t -139.93 144.86 37.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.888 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.7 t -113.4 140.15 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.3 p -62.82 -40.09 96.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.742 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 93.0 m-20 -71.64 70.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.322 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -74.45 -40.33 61.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.2 p -71.02 -32.89 69.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.643 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.55 11.05 27.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -166.89 148.86 6.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.197 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -134.05 147.08 50.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.696 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 65' ' ' VAL . 23.4 t -110.21 113.32 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.008 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -139.86 105.63 5.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.29 131.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.673 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.508 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.94 -176.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -56.48 -42.91 79.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.572 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.16 -27.18 60.71 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.533 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 51.9 p -99.44 2.18 44.81 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.35 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' HD22 ' A' ' 57' ' ' ASN . 23.5 mttt -40.34 114.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.627 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 112.81 39.72 1.15 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -119.44 127.89 53.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.305 . . . . 0.0 110.624 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 55' ' ' VAL . 37.5 t -127.12 133.34 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.751 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -113.57 120.65 41.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.58 107.92 2.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.26 -45.4 93.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -169.72 118.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 p -164.25 168.15 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.15 -68.55 0.93 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.583 ' OD1' HG23 ' A' ' 89' ' ' THR . 80.7 m-20 -131.68 80.83 65.39 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 90' ' ' VAL . 16.6 Cg_exo -69.7 151.24 69.39 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.465 2.11 . . . . 0.0 110.218 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 m -120.01 124.12 45.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.272 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 88' ' ' LEU . 38.4 mm -102.13 126.67 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.963 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.696 HG23 ' OD1' ' A' ' 85' ' ' ASN . 91.4 mt -114.04 122.78 68.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.87 41.29 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -119.77 127.84 53.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.631 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.683 ' HB2' HG12 ' A' ' 43' ' ' VAL . 67.8 t80 -136.97 118.77 15.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.08 -125.4 30.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.5 p -97.55 8.64 44.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' TYR . 44.6 t -126.36 136.54 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.7 p -135.41 150.76 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.45 142.19 13.29 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.696 ' OD1' HG23 ' A' ' 76' ' ' ILE . 14.3 m-20 -113.06 151.18 31.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.461 . . . . 0.0 111.198 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -144.66 156.5 44.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.3 mm -108.87 123.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 75' ' ' ILE . 89.6 mt -115.59 145.81 42.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.583 HG23 ' OD1' ' A' ' 72' ' ' ASN . 75.8 m -120.04 143.16 48.24 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.504 HG23 ' HD3' ' A' ' 73' ' ' PRO . 92.2 t -84.69 104.21 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 90.5 m-20 -140.87 151.18 44.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.411 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.91 148.27 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.903 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.609 HG22 ' N ' ' A' ' 94' ' ' ASP . 51.5 m -84.56 -97.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.609 ' N ' HG22 ' A' ' 93' ' ' THR . 88.1 m-20 56.53 20.25 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.578 ' H ' HG22 ' A' ' 93' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.602 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 147.11 49.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.4 148.57 45.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -92.16 164.64 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.66 118.24 25.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.0 110.612 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -75.65 -36.13 60.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -154.66 161.72 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.247 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -113.4 132.96 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.196 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -129.55 148.35 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.501 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.06 133.71 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.075 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.09 165.68 13.75 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.383 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -38.49 158.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.544 2.829 . . . . 0.0 112.019 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 91.2 mt -87.23 154.85 3.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 123.942 0.897 . . . . 0.0 110.578 1.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CG ' HG22 ' A' ' 15' ' ' THR . 52.2 t30 -53.56 -113.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.548 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -134.58 92.04 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.981 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' H ' ' HZ1' ' A' ' 23' ' ' LYS . 71.6 m-80 -157.45 158.73 36.36 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.528 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.444 ' CG2' HG13 ' A' ' 90' ' ' VAL . 1.6 tp -145.63 144.94 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.481 ' HB2' HG21 ' A' ' 21' ' ' VAL . 99.1 m-20 -113.26 162.15 16.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.7 0.286 . . . . 0.0 110.48 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.4 p -38.95 107.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.5 p 36.9 72.36 0.11 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 19' ' ' THR . 55.0 t -130.22 153.76 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.982 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 m -83.37 139.78 32.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.755 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HZ3' ' HG ' ' A' ' 88' ' ' LEU . 88.0 tttt -127.93 118.9 24.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.983 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.97 142.71 44.04 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.54 152.67 48.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.503 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -116.54 138.95 51.01 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.45 126.78 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.968 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.85 130.83 74.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.53 142.58 17.59 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.4 m -108.11 125.08 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 110.64 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -82.81 147.4 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.414 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p -54.32 -16.48 2.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.49 -5.19 46.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.32 1.14 79.01 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 36' ' ' LYS . 36.1 m -86.7 160.63 18.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 0.0 110.686 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' N ' HG22 ' A' ' 35' ' ' THR . 68.5 mttm -130.67 151.62 50.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.9 156.49 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -84.77 123.33 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.101 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.63 ' O ' HG13 ' A' ' 43' ' ' VAL . 79.2 mt -108.78 0.41 20.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.57 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -49.15 -33.45 12.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -86.63 -13.53 45.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.515 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -100.03 -21.9 15.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.656 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -96.98 149.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -107.69 124.36 49.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.617 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.0 m95 -94.24 139.25 31.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.672 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -142.62 169.58 17.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -140.58 139.12 34.89 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.7 p -62.91 -32.69 74.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.8 m-80 -84.73 68.46 10.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.6 mm-40 -69.74 -41.34 75.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.997 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -70.75 -34.47 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.339 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.551 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 31.3 mt-30 -100.01 2.79 43.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.053 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.75 145.38 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.157 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -127.23 140.54 52.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.8 p -120.64 113.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.094 0.473 . . . . 0.0 109.968 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -140.16 106.64 5.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.311 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -148.64 131.8 16.39 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.44 -176.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.651 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -58.74 -43.78 90.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.023 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.86 -33.81 72.76 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -96.38 5.56 50.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.51 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -42.28 115.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.632 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.87 32.14 2.13 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -117.31 115.26 24.91 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' N ' HD13 ' A' ' 64' ' ' LEU . 42.5 t -127.63 133.97 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.896 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -116.04 126.2 53.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.619 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.96 113.8 4.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 40.5 mm -65.33 -43.92 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.04 120.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.789 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.3 p -157.85 172.36 18.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.49 -53.63 0.92 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -150.05 82.64 6.43 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.836 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.91 155.87 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.556 2.171 . . . . 0.0 110.711 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.482 ' C ' HD12 ' A' ' 75' ' ' ILE . 64.7 m -119.24 123.37 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -99.26 123.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.596 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' OD1' ' A' ' 85' ' ' ASN . 85.7 mt -111.14 125.69 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 134.62 47.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.1 m -124.08 130.54 52.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 111.14 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 43' ' ' VAL . 58.3 t80 -136.19 108.81 7.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.49 -122.16 28.89 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.7 p -97.94 5.43 48.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.488 0.185 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.41 133.75 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.5 p -140.38 150.73 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.55 142.68 13.98 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 76' ' ' ILE . 50.8 m-20 -108.9 143.4 38.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.044 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -136.71 143.95 43.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.547 ' C ' HD12 ' A' ' 88' ' ' LEU . 21.8 mm -102.62 126.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.252 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 75' ' ' ILE . 10.7 mp -108.42 141.71 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.516 ' N ' ' OG1' ' A' ' 15' ' ' THR . 60.5 m -118.16 137.51 52.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.421 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 70' ' ' SER . 72.5 t -85.21 112.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -141.06 128.93 21.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.727 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.32 119.27 32.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.641 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.7 p -67.35 -38.34 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 54.12 55.97 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.3 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.464 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -95.9 30.83 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.713 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 41.71 -168.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -139.46 160.68 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.743 HD21 ' CG2' ' A' ' 8' ' ' ILE . 47.0 tp -87.49 107.3 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.67 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -75.37 -46.19 34.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.763 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 p -157.37 164.78 37.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.743 ' CG2' HD21 ' A' ' 5' ' ' LEU . 45.8 pt -123.04 147.6 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.866 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 10.8 p -137.28 149.0 46.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.06 136.22 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -98.93 165.36 15.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.445 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.5 Cg_exo -37.26 165.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 124.055 3.17 . . . . 0.0 111.363 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 14' ' ' ASN . 74.4 mt -106.94 113.12 42.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.491 0.716 . . . . 0.0 110.031 0.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 13' ' ' ILE . 79.1 m-20 28.77 -126.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.461 ' CB ' HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -149.92 95.55 2.32 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.137 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 3.8 p30 -155.62 136.84 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 111.617 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.0 mm -122.87 132.55 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.761 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -80.61 167.38 20.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.863 0.363 . . . . 0.0 110.81 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' NZ ' ' A' ' 92' ' ' LYS . 30.8 p -36.03 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.565 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 20' ' ' THR . 7.5 t -113.93 66.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.089 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 22' ' ' SER . 54.9 t -131.94 160.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 t -108.25 124.32 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -115.5 139.71 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tt0 -110.16 146.83 34.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.368 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.95 152.99 47.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -112.07 151.57 29.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.35 128.45 51.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.869 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.2 t -120.24 130.59 74.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.22 151.94 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -114.79 126.67 55.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -83.76 150.59 25.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.136 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -55.1 -13.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.469 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.81 -4.03 57.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.665 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 4.05 79.61 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 36' ' ' LYS . 18.2 m -88.51 154.54 20.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 35' ' ' THR . 99.1 mttt -125.53 146.66 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.285 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.77 41.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.96 121.14 29.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.369 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.672 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.6 mp -107.41 11.64 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.146 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 m -57.27 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.791 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.9 p -90.49 -11.47 40.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.34 -29.69 11.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.551 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 39' ' ' LEU . 5.2 m -87.22 153.68 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 m -110.6 124.57 52.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.726 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.735 ' O ' HG11 ' A' ' 55' ' ' VAL . 29.3 m95 -94.84 133.57 38.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 55' ' ' VAL . 20.9 p -147.08 161.36 41.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 t -136.17 146.98 47.46 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.95 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.0 p -65.69 -35.78 81.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 6.1 m120 -69.08 65.9 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.32 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' ALA . 75.5 mt-30 -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.9 t -71.45 -34.52 70.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -98.85 3.75 47.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -169.09 154.62 6.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.182 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -133.92 143.36 48.19 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.745 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 ' O ' ' A' ' 45' ' ' TRP . 98.8 t -109.61 113.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.055 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.8 p -138.76 103.1 4.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.05 121.73 42.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.656 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.7 169.6 16.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 m -55.63 -35.61 66.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.607 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 54.7 mp0 -87.31 -7.44 57.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.536 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.8 p -131.54 31.54 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.268 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 68.0 mttm -47.16 117.11 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.79 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.51 43.54 2.7 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.9 tp -118.01 122.32 42.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.767 0.317 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 55' ' ' VAL . 40.0 t -128.54 132.75 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -116.48 127.22 54.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.01 120.02 4.84 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.54 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 178.02 139.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.683 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 13.6 t -173.4 177.44 2.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.723 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -101.13 -69.42 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -133.88 81.45 52.25 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.178 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HD3' HG23 ' A' ' 90' ' ' VAL . 15.3 Cg_exo -70.29 153.41 66.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.462 2.108 . . . . 0.0 110.253 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 75' ' ' ILE . 53.1 m -119.73 112.05 18.78 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.5 mp -94.67 127.32 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.991 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.0 mt -114.53 129.73 70.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.162 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.29 125.96 43.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -114.41 125.65 54.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.8 t80 -134.33 114.29 12.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.68 -127.08 39.51 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -94.93 8.58 42.34 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.349 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.29 130.45 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.7 p -137.42 150.83 47.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.74 142.66 13.85 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.2 m-20 -108.18 140.85 40.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.265 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -132.84 155.0 49.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.247 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.34 123.49 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD12 ' CB ' ' A' ' 15' ' ' THR . 44.9 tp -114.21 128.05 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.551 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.4 m -112.12 139.85 47.29 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.9 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.52 HG23 ' HD3' ' A' ' 73' ' ' PRO . 67.5 t -82.65 102.07 8.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.961 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' ILE . 27.8 m120 -123.79 151.34 43.42 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.614 ' NZ ' HG22 ' A' ' 19' ' ' THR . 67.7 mttm -94.77 153.71 17.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.971 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -99.4 66.36 1.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.592 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 45.66 46.79 11.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.498 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.571 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 2' ' ' ALA . 30.2 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 1' ' ' SER . . . -153.67 149.88 28.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.714 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.44 -162.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.599 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -138.66 164.82 28.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.671 HD11 ' O ' ' A' ' 7' ' ' SER . 63.9 tp -71.52 107.62 4.51 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.62 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -75.39 -38.31 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.8 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.671 ' O ' HD11 ' A' ' 5' ' ' LEU . 32.4 p -150.49 162.75 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.69 133.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.859 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.8 t -129.5 146.58 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.65 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.84 134.45 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.67 163.55 17.9 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.438 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' SER . 6.5 Cg_endo -43.2 172.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.069 3.179 . . . . 0.0 111.283 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 82.9 mt -103.88 110.79 31.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.02 0.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' THR . 19.0 p30 35.19 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -139.79 95.7 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.122 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.66 159.29 39.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 111.653 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.744 HD11 HD21 ' A' ' 88' ' ' LEU . 96.5 mt -136.17 129.88 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.723 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' THR . 99.6 m-20 -98.35 164.54 12.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 110.732 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.834 ' O ' HG23 ' A' ' 21' ' ' VAL . 6.1 p -37.95 117.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.499 ' C ' ' O ' ' A' ' 19' ' ' THR . 6.5 p 32.44 65.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.012 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 19' ' ' THR . 44.7 t -131.06 142.35 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 66' ' ' THR . 58.0 m -98.14 118.98 35.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.065 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -113.12 136.81 52.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.72 143.4 41.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.53 153.93 47.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.884 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.41 147.82 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.09 129.01 56.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.905 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.88 132.42 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.499 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.77 149.52 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -120.12 125.46 48.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.43 151.07 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.11 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.4 p -53.94 -14.59 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.524 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -85.2 6.0 27.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.59 3.16 82.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 m -83.42 139.35 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.954 0.407 . . . . 0.0 110.661 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.07 147.24 44.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.369 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.12 164.71 37.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.952 0.406 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 29.1 p-10 -88.41 123.08 32.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.339 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 43' ' ' VAL . 88.9 mt -106.64 13.02 28.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -60.48 -31.59 70.61 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.87 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -90.32 -4.6 57.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.03 -27.94 9.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 39' ' ' LEU . 19.7 m -90.6 142.94 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.0 m -103.31 116.18 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.744 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.8 m95 -83.91 133.7 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.228 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -137.0 163.82 29.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -134.83 140.94 46.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.885 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -64.23 -34.57 78.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.8 m120 -83.65 71.38 10.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 53' ' ' ALA . 87.0 mt-30 -74.23 -40.38 62.45 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 m -69.91 -33.68 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.607 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -103.74 3.31 34.02 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.35 150.1 21.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.176 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.14 145.24 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.739 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.0 p -122.39 115.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 32.9 t -140.43 114.47 9.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.74 132.82 13.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.579 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.97 -177.67 2.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.1 p -57.79 -30.3 65.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.507 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.93 -12.49 44.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 52.5 p -114.74 4.06 14.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.255 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -41.16 112.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 116.41 33.37 1.47 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -117.01 121.48 41.48 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 110.627 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.0 t -124.24 134.63 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.849 HG22 ' OG ' ' A' ' 22' ' ' SER . 41.2 p -112.35 125.98 54.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.0 103.29 1.88 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.02 -44.99 99.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.733 0.301 . . . . 0.0 110.247 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 179.89 118.16 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.722 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.6 p -161.04 167.8 25.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.722 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.31 -54.16 0.91 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -149.31 81.08 7.51 Favored Pre-proline 0 C--N 1.334 -0.105 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.141 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.53 158.76 19.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 0.0 110.204 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -116.37 124.49 50.19 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 mm -100.08 121.18 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.62 HG23 ' OD1' ' A' ' 85' ' ' ASN . 80.0 mt -111.93 126.09 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.225 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 133.76 48.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -113.68 133.4 55.34 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.549 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 43' ' ' VAL . 72.9 t80 -131.56 86.41 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.677 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.95 -123.94 19.4 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -88.55 5.64 41.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.289 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -137.78 152.71 49.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.12 17.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.62 ' OD1' HG23 ' A' ' 76' ' ' ILE . 22.2 m-20 -110.37 145.78 36.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.172 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.5 p -134.71 154.28 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.379 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.0 mt -100.59 121.57 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 111.177 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 17' ' ' ILE . 53.7 tp -109.47 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.6 m -117.6 138.44 51.94 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.91 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 70' ' ' SER . 88.1 t -83.4 107.76 15.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -139.2 139.41 37.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.333 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -79.06 144.12 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.4 m -119.87 128.66 53.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.64 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.96 43.25 31.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.83 147.54 47.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.739 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.27 149.47 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.633 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -139.21 163.27 32.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.254 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 8' ' ' ILE . 53.3 tp -68.93 111.03 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -80.05 -46.29 16.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.815 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 p -154.17 163.15 40.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.805 ' CG2' HD21 ' A' ' 5' ' ' LEU . 32.9 pt -123.22 146.3 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.846 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 p -139.12 148.49 43.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.664 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.62 137.18 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.55 164.98 14.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.403 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.7 Cg_exo -37.49 166.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.981 3.121 . . . . 0.0 111.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' ASN . 72.3 mt -112.18 111.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 C-N-CA 123.457 0.703 . . . . 0.0 110.044 0.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' ILE . 2.6 m-20 34.37 -153.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.721 0.295 . . . . 0.0 110.855 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.559 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.1 OUTLIER -136.58 96.72 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.193 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 15' ' ' THR . 79.7 m-20 -157.26 155.92 31.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.321 0.581 . . . . 0.0 111.684 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.583 ' CD1' HD21 ' A' ' 88' ' ' LEU . 2.9 mp -138.59 131.82 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.82 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.535 ' OD1' HG23 ' A' ' 93' ' ' THR . 93.7 m-20 -88.74 167.0 13.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.848 0.356 . . . . 0.0 110.744 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.636 ' O ' HG23 ' A' ' 21' ' ' VAL . 82.4 p -39.42 110.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.449 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.7 p 42.09 62.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.081 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 19' ' ' THR . 70.0 t -130.36 139.25 51.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.344 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.6 p -92.29 138.06 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.05 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -131.78 139.76 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.932 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 24.0 tt0 -109.43 144.93 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.421 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -126.94 152.78 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.969 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' C ' ' HG ' ' A' ' 11' ' ' SER . 42.5 m-85 -113.24 148.79 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.09 130.26 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.916 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.43 131.04 71.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.464 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.97 17.21 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.5 m -113.89 129.47 56.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 110.488 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.51 144.0 27.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.074 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p -52.22 -14.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.49 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 49.5 t0 -79.71 -6.86 58.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 -0.59 68.95 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.7 m -86.61 160.38 18.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.883 0.373 . . . . 0.0 110.649 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.53 ' N ' HG22 ' A' ' 35' ' ' THR . 99.0 mttt -131.71 151.15 51.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.313 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.01 160.2 35.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -86.64 119.61 27.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.393 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.674 ' O ' HG13 ' A' ' 43' ' ' VAL . 91.6 mt -104.84 12.31 32.74 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.159 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -59.04 -28.2 66.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.841 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.5 p -91.32 -10.3 41.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -104.14 -27.39 12.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 79' ' ' TYR . 10.4 m -88.2 150.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.174 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -106.04 126.47 52.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 55' ' ' VAL . 49.9 m95 -97.3 135.24 39.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 m -148.14 168.88 21.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.3 t -137.93 147.36 44.27 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.79 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -68.08 -34.69 76.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 32.4 m-20 -77.57 69.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' ALA . 85.0 mt-30 -72.45 -43.2 64.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.6 p -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.54 9.91 39.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.171 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -171.11 152.91 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 45' ' ' TRP . 7.1 p -109.4 113.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.039 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -139.76 104.39 4.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.696 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.633 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -118.81 123.97 46.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.08 172.22 12.18 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -58.6 -31.03 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.609 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.38 -11.88 47.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.526 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -131.38 31.07 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.27 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.7 mttt -43.48 116.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.801 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.559 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.22 45.05 2.45 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 55.1 tp -117.25 123.27 46.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 55' ' ' VAL . 24.2 t -127.25 136.08 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -110.46 128.52 55.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.34 107.86 2.81 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.1 mt -64.35 -43.71 97.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.79 117.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.697 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.4 p -159.13 166.36 31.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.671 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 72' ' ' ASN . . . -95.08 -65.95 0.99 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 2.8 m120 -138.57 80.6 26.08 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.13 158.26 23.47 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.501 2.134 . . . . 0.0 110.286 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 m -113.29 128.28 56.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 mm -100.44 120.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mm -109.26 126.42 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.99 126.15 50.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.7 m -115.45 125.8 53.55 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.692 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.679 ' HB2' HG12 ' A' ' 43' ' ' VAL . 45.2 t80 -134.8 90.6 2.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.05 -129.81 18.58 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.9 p -87.97 3.35 49.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.307 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.71 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 p -140.98 150.15 42.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.58 142.38 14.71 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.0 OUTLIER -118.84 130.41 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 111.16 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.3 p -134.67 156.68 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.278 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.75 124.29 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' CD1' ' A' ' 17' ' ' ILE . 7.4 tt -111.55 151.32 28.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.436 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.6 m -132.72 145.3 50.92 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.974 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 70' ' ' SER . 91.2 t -83.87 127.19 40.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.919 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -139.39 122.93 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.356 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.23 128.38 38.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.535 HG23 ' OD1' ' A' ' 18' ' ' ASN . 16.8 p -67.58 -36.29 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.525 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 95' ' ' THR . 26.6 t0 58.42 -179.21 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.489 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.493 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 58.3 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.671 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.86 20.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.708 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' A' ' 1' ' ' SER . . . -125.94 168.22 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.612 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -130.36 164.4 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.312 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 5' ' ' LEU . 47.9 tp -81.03 107.76 14.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.563 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.776 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.67 162.98 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.893 0.378 . . . . 0.0 110.819 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -125.05 133.97 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 t -132.91 148.49 52.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.58 130.71 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.1 162.75 19.58 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 8.1 Cg_endo -44.11 172.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 124.038 3.159 . . . . 0.0 111.348 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 14' ' ' ASN . 76.5 mt -102.53 118.23 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.487 0.715 . . . . 0.0 109.958 0.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 t-20 30.61 -146.59 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.754 0.312 . . . . 0.0 110.911 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 p -152.88 95.4 1.98 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.06 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.96 160.75 43.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 90' ' ' VAL . 97.5 mt -134.43 132.8 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.791 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' THR . 40.8 m-80 -100.24 166.71 10.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 110.771 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 21' ' ' VAL . 18.3 p -37.71 111.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.557 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 1.7 m 38.95 62.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.08 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 19' ' ' THR . 66.8 t -131.34 139.86 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.377 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -96.95 123.62 40.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 64.5 tttm -112.78 144.03 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -110.37 143.46 40.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.36 151.57 49.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.898 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' A' ' 11' ' ' SER . 56.8 m-85 -113.7 155.41 25.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.718 0.294 . . . . 0.0 110.907 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.1 130.64 53.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.925 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.3 t -113.44 131.03 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.76 151.22 17.27 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 m -117.84 126.07 51.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -81.16 151.57 28.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.102 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.1 p -55.3 -18.25 6.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -76.67 -4.1 41.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.42 0.23 82.55 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 36' ' ' LYS . 92.5 m -83.39 162.09 21.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -131.1 148.68 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.355 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.68 20.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -78.1 124.96 28.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 43' ' ' VAL . 93.9 mt -108.8 13.48 24.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.9 m -60.83 -30.14 69.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.809 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -90.85 -9.54 45.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.253 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.08 -26.57 13.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 39' ' ' LEU . 13.8 m -91.09 152.02 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.228 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -109.88 123.5 49.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.684 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.54 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 22.8 m95 -93.58 137.49 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.9 t -145.03 167.75 21.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.017 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -142.23 139.95 32.14 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.862 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.2 -26.38 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -78.79 65.16 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.336 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 88.6 mt-30 -67.15 -49.84 63.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.8 p -71.71 -33.67 68.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.612 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -93.65 -2.43 54.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.73 151.76 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.156 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -131.23 136.42 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.71 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 55' ' ' VAL . 3.9 p -107.83 113.07 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -138.71 104.12 5.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -132.45 128.23 37.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.664 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.72 -177.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 t -61.84 -42.33 98.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.649 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.9 mp0 -83.16 -12.41 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.532 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.2 p -110.73 8.88 22.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.185 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -41.58 112.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.73 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.4 31.18 2.25 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.04 122.15 41.49 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.703 0.287 . . . . 0.0 110.573 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.32 134.4 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -104.74 125.72 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.04 102.86 2.39 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 93.9 mt -62.32 -44.77 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.71 0.291 . . . . 0.0 110.264 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 173.4 118.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -162.43 167.02 24.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.25 -67.18 0.83 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -128.24 81.16 71.04 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.06 159.26 15.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.43 2.087 . . . . 0.0 110.149 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -123.22 129.58 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.4 mm -102.11 129.59 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.656 HG23 ' OD1' ' A' ' 85' ' ' ASN . 86.3 mt -115.79 126.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.51 135.92 43.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.5 m -121.81 128.44 51.68 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.682 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' HB2' HG12 ' A' ' 43' ' ' VAL . 65.6 t80 -128.94 88.75 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.63 -119.8 11.81 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.9 p -91.62 1.16 57.34 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.317 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.21 132.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.6 p -135.44 154.09 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.05 146.93 18.51 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.656 ' OD1' HG23 ' A' ' 76' ' ' ILE . 71.5 m-20 -110.89 144.72 39.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.216 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.8 p -134.05 158.54 43.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.9 mm -98.64 124.55 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.016 0.436 . . . . 0.0 111.134 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 17' ' ' ILE . 50.9 tp -114.15 135.02 54.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.504 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -125.75 132.13 52.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.893 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.631 HG22 HD12 ' A' ' 17' ' ' ILE . 89.6 t -84.05 109.16 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.952 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 92' ' ' LYS . 54.6 t-20 -139.63 129.52 24.81 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.353 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 62.0 mmtt -90.99 127.08 36.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 96.8 m -63.76 -46.79 83.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.484 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.14 -50.24 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.612 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.62 145.65 18.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.707 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.84 146.83 52.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -91.13 163.89 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.262 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mt -81.79 124.05 29.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.555 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -74.35 -41.0 61.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.4 p -157.26 161.84 39.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.2 tt -124.67 128.71 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.886 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -134.24 150.28 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.55 147.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.061 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.32 165.1 15.06 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 120.8 0.333 . . . . 0.0 111.376 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' SER . 52.0 Cg_exo -37.35 164.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 124.02 3.147 . . . . 0.0 111.384 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.5 mm -110.2 127.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.476 0.71 . . . . 0.0 109.952 0.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 13' ' ' ILE . 43.6 t30 29.72 -139.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -135.05 93.98 3.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 20.5 p30 -158.02 162.0 38.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 111.674 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.53 160.53 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.805 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -105.11 140.65 37.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -81.91 -26.17 34.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.458 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 p -104.53 -12.99 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.093 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 22' ' ' SER . 33.7 t -132.69 169.31 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.687 ' N ' HG12 ' A' ' 21' ' ' VAL . 24.0 m -110.42 147.59 33.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -122.65 147.15 46.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.0 tt0 -111.52 145.19 39.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.42 149.67 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.884 179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -110.18 147.86 32.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.937 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.87 128.86 56.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.889 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.71 131.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.431 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.02 149.07 18.0 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -117.2 126.02 52.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 110.43 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -84.63 147.68 26.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -53.26 -15.22 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.41 -1.65 46.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.557 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.96 88.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -85.62 142.47 29.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 0.0 110.593 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.37 148.97 41.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.363 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.59 152.44 16.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -77.64 124.69 28.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.697 ' O ' HG13 ' A' ' 43' ' ' VAL . 72.9 mt -106.03 13.63 28.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.43 -29.28 69.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 0.0 109.879 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 p -86.93 -18.33 31.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -30.28 12.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.532 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.0 m -87.29 141.35 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.15 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.3 m -101.06 124.23 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.657 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.669 ' O ' HG11 ' A' ' 55' ' ' VAL . 25.4 m95 -91.74 133.13 35.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.225 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -147.74 163.37 36.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t -137.41 148.73 46.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.2 p -68.32 -25.63 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.8 m120 -87.58 69.64 9.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.8 mm-40 -78.34 -36.33 46.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 m -69.69 -34.37 73.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.652 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -104.15 8.47 36.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.89 153.57 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.199 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -130.23 137.17 49.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.887 0.375 . . . . 0.0 110.808 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 45' ' ' TRP . 57.6 t -107.76 113.14 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.021 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -140.17 104.4 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.799 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.48 125.16 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.42 8.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 m -58.92 -38.79 79.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.626 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -86.65 -19.21 29.62 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.496 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.8 p -109.58 21.87 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.359 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.579 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 35.8 pttt -40.71 118.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 47.63 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 42.1 tp -121.45 116.97 25.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.624 HG22 HG22 ' A' ' 55' ' ' VAL . 38.9 t -123.23 134.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.0 130.48 48.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.87 135.11 12.54 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 91.4 mt -99.64 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 110.33 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -175.88 120.11 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 90' ' ' VAL . 7.8 p -161.74 175.24 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.58 -79.25 1.45 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -126.58 81.42 68.42 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 90' ' ' VAL . 21.1 Cg_exo -68.39 150.37 75.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.511 2.141 . . . . 0.0 110.171 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -116.62 113.13 22.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.186 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 88' ' ' LEU . 8.3 mm -86.47 126.14 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 85' ' ' ASN . 98.1 mt -120.08 122.78 69.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.123 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.68 129.1 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.5 m -119.14 132.75 56.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.663 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.696 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.2 t80 -137.76 91.57 2.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.752 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.4 -122.29 26.47 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.5 p -90.54 4.11 52.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.376 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.64 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.0 p -147.86 153.54 39.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.46 141.06 12.37 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.699 ' OD1' HG23 ' A' ' 76' ' ' ILE . 9.1 m-20 -115.55 148.81 39.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.969 0.414 . . . . 0.0 111.143 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 t -149.86 154.92 39.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.705 ' C ' HD12 ' A' ' 88' ' ' LEU . 71.4 mt -102.9 126.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 111.09 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 87' ' ' ILE . 11.1 mp -118.82 149.56 41.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.555 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 m -114.58 146.75 40.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.019 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.559 HG21 ' OG ' ' A' ' 70' ' ' SER . 61.4 t -82.78 103.52 10.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.005 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -144.38 155.33 43.72 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.387 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -94.34 142.98 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.457 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 56.1 m -100.98 -63.28 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 93' ' ' THR . 90.9 m-20 -144.59 120.77 10.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 95' ' ' THR . 1.3 t . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.54 94.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.69 145.55 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.518 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -100.37 164.48 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.508 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -76.76 125.92 30.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.407 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -85.77 -45.71 11.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.9 p -155.48 166.82 32.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.351 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.3 pt -119.25 147.22 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.1 m -134.05 149.22 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.677 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.04 128.61 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.759 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.35 165.87 13.34 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.577 -178.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.496 ' C ' HD12 ' A' ' 13' ' ' ILE . 59.7 Cg_exo -39.06 166.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.581 2.854 . . . . 0.0 112.058 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 13' ' ' ILE . 2.4 mp -104.55 110.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 110.402 -0.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ILE . 27.2 p30 31.41 -149.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 O-C-N 123.919 0.762 . . . . 0.0 110.717 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 95.99 2.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -154.99 161.76 41.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.785 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 90' ' ' VAL . 95.7 mt -132.53 131.35 60.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -94.49 166.06 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.751 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.71 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.1 p -37.98 106.03 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.7 p 38.8 65.74 0.61 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 19' ' ' THR . 60.7 t -130.89 161.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 32.8 t -110.76 127.91 55.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.731 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -117.65 142.21 47.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 20.5 tt0 -108.92 144.5 36.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.86 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.13 150.18 50.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.984 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.49 ' C ' ' HG ' ' A' ' 11' ' ' SER . 49.5 m-85 -115.52 143.4 45.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.667 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.72 128.12 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.868 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -112.29 128.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.4 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.91 144.8 15.85 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -115.27 125.86 53.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.914 0.388 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.407 ' C ' ' N ' ' A' ' 33' ' ' ASP . 85.0 m-85 -86.2 147.86 25.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.295 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -54.38 -10.24 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 31' ' ' TYR . 31.2 t0 -84.23 -3.64 58.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.597 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.29 3.56 81.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 36' ' ' LYS . 31.9 m -83.18 154.91 24.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 35' ' ' THR . 27.8 mmtp -122.35 141.23 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 150.21 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' LEU . 48.4 t0 -85.84 118.86 25.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.7 mp -106.15 8.97 32.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.2 m -49.86 -33.61 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.7 p -87.53 -13.05 44.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.304 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.506 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -97.84 -23.25 15.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.9 m -96.95 138.47 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.381 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -99.09 125.22 44.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.835 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 20.5 m95 -93.57 139.49 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.531 ' HA ' HG21 ' A' ' 55' ' ' VAL . 30.4 p -151.45 165.79 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.146 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -136.39 144.33 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.33 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -65.03 -32.56 74.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 71.6 m-20 -77.52 66.53 3.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -68.87 -43.95 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.01 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.7 p -70.11 -32.92 71.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.326 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -102.73 2.48 35.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.326 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -160.78 150.33 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.298 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -132.46 138.51 47.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.763 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 65' ' ' VAL . 97.6 t -107.82 113.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -137.9 106.47 5.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.903 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -133.03 126.01 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 111.105 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.06 171.53 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.8 p -59.11 -28.06 66.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.293 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -85.82 -11.53 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.639 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.2 p -130.47 31.47 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.464 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.6 mttt -48.01 125.46 9.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.044 0.449 . . . . 0.0 110.949 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.47 40.05 4.29 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.045 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.505 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 31.3 tp -117.54 122.63 44.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.908 0.354 . . . . 0.0 110.522 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 55' ' ' VAL . 43.0 t -129.8 137.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.271 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -119.05 127.03 53.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.91 119.3 6.47 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.7 mt -64.29 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 172.35 120.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -162.17 172.72 15.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -61.49 0.76 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.68 82.17 51.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.567 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.441 ' HB3' HD22 ' A' ' 49' ' ' ASN . 73.7 Cg_endo -80.82 159.52 21.4 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.501 2.134 . . . . 0.0 110.828 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -124.51 127.22 47.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.218 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.6 mm -100.06 126.02 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.945 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mm -108.07 122.97 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.121 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.16 118.62 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.724 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -114.26 124.59 52.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.617 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.5 t80 -128.29 117.1 20.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.35 -124.63 33.76 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -98.03 5.93 48.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.01 131.23 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 110.659 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -135.91 153.48 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.15 155.73 22.22 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.7 m-20 -114.37 147.33 39.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.853 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.9 p -135.02 155.4 50.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.066 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -96.97 121.59 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.962 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.71 134.44 54.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 m -124.31 137.7 54.46 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.966 0.412 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.648 HG22 HD12 ' A' ' 17' ' ' ILE . 67.6 t -85.5 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.215 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' ILE . 63.7 t30 -138.15 135.9 36.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.535 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 116.95 29.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.449 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 99.5 m -62.23 -47.19 85.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -89.46 77.91 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 95' ' ' THR . 8.6 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.499 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.65 155.98 47.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.09 152.73 41.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 p -132.3 162.43 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.45 103.97 2.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.707 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.412 ' N ' HD13 ' A' ' 5' ' ' LEU . 4.5 t -75.47 -49.01 20.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 p -152.2 151.56 31.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.69 134.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.854 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 m -130.87 149.25 52.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.582 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.75 134.69 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.01 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.1 164.76 15.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.843 0.354 . . . . 0.0 111.327 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -37.91 157.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.005 3.136 . . . . 0.0 111.373 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.8 mm -85.78 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 123.536 0.734 . . . . 0.0 109.985 0.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -38.46 -92.65 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.702 0.287 . . . . 0.0 110.919 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -150.26 93.78 2.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.079 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 64.2 t30 -156.02 129.02 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 111.653 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -137.81 135.62 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.83 151.96 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.863 0.363 . . . . 0.0 110.741 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -64.97 135.81 56.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.571 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.5 13.84 9.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.117 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.29 137.82 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.394 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -110.38 128.91 55.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.084 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -113.3 145.83 40.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.032 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.2 tt0 -110.09 143.88 39.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.54 153.13 47.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -114.58 149.84 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.909 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.57 127.49 54.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.918 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.9 t -114.37 130.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.5 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.48 148.28 16.96 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 m -114.26 128.19 56.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.451 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -83.73 149.75 26.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.059 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -55.85 -16.28 4.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.407 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.79 -1.56 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.582 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.52 83.05 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 36' ' ' LYS . 21.2 m -86.3 156.85 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.846 0.355 . . . . 0.0 110.681 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mttp -130.81 151.89 50.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.02 158.55 28.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -80.74 120.95 25.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.357 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 43' ' ' VAL . 81.4 mt -104.8 5.54 33.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.165 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -57.09 -21.94 35.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 0.0 109.896 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.3 p -94.38 -11.38 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.261 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -107.06 -27.63 10.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 79' ' ' TYR . 5.1 m -85.77 143.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.6 m -102.06 123.43 45.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.787 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.572 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 30.6 m95 -92.57 135.44 34.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.31 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -149.03 163.6 37.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.0 t -139.24 146.41 40.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.815 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.2 p -66.28 -33.19 75.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.341 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -78.34 68.97 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.377 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' ALA . 97.9 mt-30 -77.25 -38.18 51.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -72.28 -34.01 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.604 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -98.45 3.76 48.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.01 159.07 5.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.158 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.41 147.74 52.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.701 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.8 p -117.36 113.1 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.023 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -140.11 104.86 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.776 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.574 ' CG ' ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -116.94 124.14 48.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.54 170.75 13.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -56.73 -33.61 66.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.508 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.56 -10.51 48.55 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.527 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.0 p -130.03 32.21 4.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.228 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -47.19 121.36 3.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.818 -179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 93.64 47.34 2.99 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.574 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 45.9 tp -118.92 120.41 37.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -126.56 135.46 63.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -113.01 130.59 56.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.05 110.94 2.87 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.04 -43.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.38 118.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.772 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.763 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.5 p -160.42 166.26 29.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.719 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.46 -48.02 1.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -157.29 81.87 3.18 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.44 158.61 17.02 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.468 2.112 . . . . 0.0 110.238 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.4 m -114.26 130.09 56.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -98.92 119.81 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.012 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.495 HG23 ' OD1' ' A' ' 85' ' ' ASN . 3.8 mp -102.86 118.32 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.136 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.48 121.32 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -108.65 129.41 55.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.662 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.689 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.3 t80 -139.8 96.22 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.16 -125.55 36.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.2 p -91.77 6.74 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.319 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.48 132.43 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.3 p -137.22 157.06 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.39 147.57 19.16 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 76' ' ' ILE . 4.2 m-80 -131.99 133.38 44.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.439 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.2 p -131.54 160.4 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.304 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.429 ' C ' HD22 ' A' ' 88' ' ' LEU . 96.1 mt -98.98 121.96 50.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.18 0.514 . . . . 0.0 111.062 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 88' ' ' LEU . 4.4 mm? -100.73 134.32 43.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.514 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.52 ' N ' ' OG1' ' A' ' 15' ' ' THR . 93.5 m -110.94 134.03 52.9 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.915 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.763 HG21 ' O ' ' A' ' 70' ' ' SER . 83.6 t -82.84 100.78 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.898 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 14.0 t-20 -143.0 155.74 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.343 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -70.85 144.58 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.946 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.4 m -62.25 -48.09 81.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.58 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -151.2 127.63 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.571 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.46 143.01 56.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.745 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.07 -173.73 3.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -139.6 162.71 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.285 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.2 tp -84.16 108.4 17.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 m -76.65 -48.04 20.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.828 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -155.74 164.12 38.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.76 ' CG2' HD21 ' A' ' 5' ' ' LEU . 36.9 pt -124.99 144.25 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.843 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.0 t -136.72 146.11 45.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.494 HG13 HG21 ' A' ' 86' ' ' THR . 11.3 mm -93.67 139.75 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.967 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -98.68 165.24 15.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.2 Cg_exo -38.25 166.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 124.017 3.145 . . . . 0.0 111.402 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' ASN . 95.9 mt -111.55 116.55 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 118.753 0.706 . . . . 0.0 109.995 0.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' ILE . 68.5 m-20 33.13 -134.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.872 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.41 93.74 2.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.113 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 52.7 p30 -157.37 147.1 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 111.718 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.8 132.03 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -87.58 166.93 14.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.739 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.826 ' O ' HG23 ' A' ' 21' ' ' VAL . 54.8 p -58.69 138.99 56.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' O ' ' A' ' 19' ' ' THR . 34.2 p 39.33 44.19 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 19' ' ' THR . 54.9 t -131.22 139.41 51.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.314 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -98.67 148.61 23.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.085 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 88.7 tttt -137.95 137.84 38.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.931 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.0 143.9 37.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.7 152.61 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.8 153.05 27.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.949 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.3 129.55 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.867 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.23 131.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.461 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.72 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.5 m -118.51 128.42 54.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 0.0 110.364 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.24 149.31 25.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.116 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -54.42 -15.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.495 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.56 -1.58 38.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.66 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.68 86.73 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 36' ' ' LYS . 17.3 m -86.09 156.59 20.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 110.582 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 35' ' ' THR . 98.6 mttt -128.27 150.46 50.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.395 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.36 17.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 42.3 p-10 -77.19 126.01 30.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.423 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 43' ' ' VAL . 69.4 mt -109.78 14.31 23.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 m -59.78 -30.08 68.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.087 0.47 . . . . 0.0 109.898 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.2 p -90.33 -10.42 44.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.17 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 -26.16 13.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.9 m -93.05 151.45 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -108.63 123.74 49.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.591 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 31.9 m95 -93.85 138.82 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 p -151.05 160.56 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.984 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.4 t -132.13 143.46 50.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.847 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -61.66 -32.94 73.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.698 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 36.1 m-20 -75.83 63.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -69.97 -42.71 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -34.19 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.691 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -104.15 2.41 31.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -157.32 148.99 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.198 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.76 141.71 46.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.925 0.393 . . . . 0.0 110.694 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.0 p -112.09 114.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.993 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.5 t -139.55 108.48 6.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -147.75 132.84 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.654 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.495 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.93 178.43 4.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.8 m -54.39 -35.58 63.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.617 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.42 -24.68 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.487 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 61.4 p -104.6 16.47 26.01 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.224 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -49.59 120.55 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.784 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.531 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 104.36 32.34 4.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 65' ' ' VAL . 2.2 tt -118.24 118.05 30.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 64' ' ' LEU . 40.7 t -122.24 134.5 65.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 p -105.3 132.12 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.46 108.24 2.41 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 90.5 mt -64.53 -42.92 96.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.304 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.37 119.75 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.645 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 p -163.2 166.0 23.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.52 -71.41 1.1 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.499 ' OD1' HG23 ' A' ' 89' ' ' THR . 44.7 m-80 -128.37 83.07 67.22 Favored Pre-proline 0 C--N 1.333 -0.146 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 90' ' ' VAL . 57.4 Cg_endo -82.58 158.57 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.532 2.155 . . . . 0.0 110.225 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.511 ' C ' HD12 ' A' ' 75' ' ' ILE . 52.4 m -118.88 126.88 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.0 mp -101.05 126.1 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.882 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.751 HG23 ' OD1' ' A' ' 85' ' ' ASN . 89.3 mt -114.97 128.73 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.144 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.7 132.86 49.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -119.0 130.48 55.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.562 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.697 ' HB2' HG12 ' A' ' 43' ' ' VAL . 62.1 t80 -139.72 106.7 5.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.722 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.68 -125.08 31.41 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.7 p -92.6 8.21 39.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.371 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 135.74 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.6 p -146.89 151.82 37.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.986 0.422 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.73 146.57 18.37 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.751 ' OD1' HG23 ' A' ' 76' ' ' ILE . 5.5 m-20 -125.02 137.5 54.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.01 0.433 . . . . 0.0 111.237 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 HG13 ' A' ' 10' ' ' ILE . 71.9 p -135.58 157.03 47.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.305 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.1 mm -96.72 127.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.013 0.435 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.73 147.7 37.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.571 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.499 HG23 ' OD1' ' A' ' 72' ' ' ASN . 91.2 m -125.49 132.34 52.67 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.917 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.443 HG23 ' CD ' ' A' ' 73' ' ' PRO . 96.5 t -83.48 107.86 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.895 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.16 155.17 50.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.372 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -84.97 137.0 33.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -117.63 125.94 51.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.571 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -63.8 -41.5 97.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.422 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 95' ' ' THR . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -62.21 -39.73 93.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.577 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 70.73 -175.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -139.28 163.23 33.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.91 112.16 9.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.302 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -74.92 -42.72 57.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 p -153.26 163.54 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.3 tt -119.13 134.4 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 t -131.78 148.03 52.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.745 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 mt -113.11 129.51 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.972 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.75 164.74 15.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -39.51 157.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.349 2.699 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 14' ' ' ASN . 89.9 mt -87.02 156.54 3.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 C-N-CA 123.998 0.919 . . . . 0.0 110.444 1.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 13' ' ' ILE . 98.9 m-20 -42.51 -97.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.725 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -165.89 96.13 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.355 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 81.9 m-20 -154.75 147.5 24.36 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.692 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 88' ' ' LEU . 51.6 mm -122.53 130.97 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.757 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -103.28 166.44 10.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.623 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.2 p -37.45 98.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.921 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.6 m 40.02 72.94 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 22' ' ' SER . 79.0 t -131.59 160.35 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.022 0.439 . . . . 0.0 110.993 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.539 ' N ' HG12 ' A' ' 21' ' ' VAL . 6.6 m -110.2 122.37 47.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.631 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HZ3' ' H ' ' A' ' 16' ' ' ASN . 29.5 ttpt -112.46 137.68 50.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 15.0 tt0 -110.05 141.79 42.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.847 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.23 152.01 48.59 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.068 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.35 147.28 37.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.7 127.6 55.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.738 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.5 129.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.156 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.64 17.25 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 m -116.87 127.44 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.25 146.73 28.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 p -54.12 -16.81 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -78.73 -3.73 45.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.7 78.55 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 36' ' ' LYS . 24.1 m -83.21 157.32 22.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.738 0.304 . . . . 0.0 110.799 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' THR . 53.6 mtmt -130.55 149.22 52.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.28 152.24 20.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.69 122.35 26.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.2 mt -105.49 7.9 33.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.5 m -55.74 -31.9 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.6 p -88.28 -9.92 51.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 -29.09 11.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.599 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.575 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -87.37 147.93 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.268 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.7 m -106.78 117.9 35.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.822 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m95 -87.41 140.1 29.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -147.75 164.96 31.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.161 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -135.45 143.61 46.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.327 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.67 -33.03 74.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.348 0.595 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.682 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 96.2 m-20 -80.72 65.0 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 94.2 mm-40 -69.08 -43.81 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.466 . . . . 0.0 109.888 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.6 p -70.81 -33.14 70.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.937 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 79.3 mt-30 -104.0 9.38 36.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.505 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.59 153.98 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.73 142.86 48.14 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.4 p -119.49 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -138.24 108.78 6.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.54 ' HB3' ' H ' ' A' ' 64' ' ' LEU . 16.0 p30 -132.66 128.8 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 -179.45 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.553 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.0 p -64.33 -16.91 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.388 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -89.08 -35.27 16.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 p -114.96 31.04 6.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.601 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -41.36 120.85 1.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 110.91 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.93 49.25 2.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 44.6 tp -118.52 121.24 39.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.648 0.261 . . . . 0.0 110.535 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.36 133.55 67.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -118.72 129.18 55.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.784 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.66 8.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.0 mt -90.61 -40.96 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.574 0.226 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . . . -122.75 152.52 40.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -80.45 167.72 19.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.89 -136.1 7.78 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -130.06 81.13 69.57 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.573 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.79 153.98 58.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.867 2.378 . . . . 0.0 110.368 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -126.81 122.7 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -93.0 130.32 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' OD1' ' A' ' 85' ' ' ASN . 94.4 mt -120.86 119.75 60.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.123 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.04 123.47 45.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -115.77 126.4 53.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 43' ' ' VAL . 83.9 t80 -129.69 103.69 6.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.982 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.63 -122.32 27.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -92.24 4.87 52.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.544 0.211 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.48 129.88 74.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 89.9 p -137.81 150.52 47.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.24 142.7 14.19 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 76' ' ' ILE . 64.8 m-20 -109.98 144.92 37.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 p -132.99 155.62 48.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.14 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.56 127.57 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.941 0.401 . . . . 0.0 111.13 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 17' ' ' ILE . 41.9 tp -104.81 134.64 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.709 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.5 m -113.25 128.98 56.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 111.403 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.14 106.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.133 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.54 HD21 ' CG ' ' A' ' 16' ' ' ASN . 25.3 p-10 -136.61 127.41 27.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.352 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -94.64 136.92 34.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 m -63.55 -44.76 93.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 55.93 52.94 9.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.483 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.693 0.283 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.1 p -128.77 162.39 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.1 112.17 2.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.449 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 t -74.66 -42.18 58.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 p -153.15 160.59 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.759 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -114.26 133.37 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.032 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.3 m -132.57 148.57 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.348 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mt -111.59 132.38 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.029 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 163.85 17.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -43.49 167.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 123.581 2.854 . . . . 0.0 112.13 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 14' ' ' ASN . 4.7 mm -87.44 162.17 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 110.234 1.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 13' ' ' ILE . 94.1 m-20 -48.92 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.797 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 p -85.7 96.03 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' H ' ' NZ ' ' A' ' 23' ' ' LYS . 79.4 m-20 -155.25 143.33 20.1 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.667 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.1 mm . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.631 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' N ' ' A' ' 22' ' ' SER . 19.1 t . . . . . 0 C--O 1.238 0.491 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.652 ' N ' HG12 ' A' ' 21' ' ' VAL . 26.3 p -88.93 150.13 22.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.183 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' NZ ' ' H ' ' A' ' 16' ' ' ASN . 83.9 tttt -136.7 128.87 29.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.452 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -110.06 144.64 38.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.45 151.03 49.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -111.42 146.79 36.55 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.915 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.74 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.742 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.65 132.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.413 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.09 146.89 16.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -114.79 125.89 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 110.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -83.59 148.5 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.024 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.0 p -55.09 -14.82 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.492 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.81 -2.34 46.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.7 83.59 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 36' ' ' LYS . 20.4 m -86.35 157.37 19.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.868 0.366 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -130.31 149.71 51.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.394 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.34 153.87 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -85.55 122.01 29.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 43' ' ' VAL . 92.4 mt -104.48 2.18 30.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.2 m -45.72 -33.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.438 . . . . 0.0 110.286 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.4 p -88.15 -19.01 27.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.71 -21.75 19.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.635 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.3 m -98.21 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.328 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.3 m -103.38 122.99 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.711 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 12.6 m95 -92.33 141.42 28.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -153.41 166.54 32.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.989 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -132.32 140.29 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -40.0 87.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -89.4 87.59 7.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.171 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -81.53 -25.78 35.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.18 0.514 . . . . 0.0 109.801 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 t -69.43 -34.47 74.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -100.55 2.79 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.235 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.68 146.43 13.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.07 138.37 52.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 65' ' ' VAL . 47.2 t -111.67 113.19 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.779 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -141.29 114.99 9.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -156.1 133.91 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.955 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -69.97 -178.28 1.54 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.614 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -59.19 -33.52 71.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.642 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -85.78 -7.07 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.759 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 21.5 p -118.1 0.2 11.75 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.628 0.251 . . . . 0.0 111.268 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -41.42 114.16 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.573 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.91 27.69 2.44 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.697 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 2.6 tp -117.88 120.67 38.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.914 0.388 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 55' ' ' VAL . 54.8 t -130.07 134.77 62.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.069 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -111.95 126.44 55.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -122.96 109.51 1.38 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.758 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.8 mt -64.58 -45.89 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.251 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 161.89 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.8 p -137.86 -2.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.6 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.22 3.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -154.17 80.63 4.78 Favored Pre-proline 0 N--CA 1.453 -0.29 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.203 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.16 147.53 16.43 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.797 2.331 . . . . 0.0 110.725 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 120.33 35.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.465 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.45 ' CG1' HD22 ' A' ' 88' ' ' LEU . 33.4 mm -97.49 126.36 50.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.471 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.871 HG23 ' ND2' ' A' ' 85' ' ' ASN . 91.6 mt -110.37 127.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.067 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.84 128.2 52.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -118.94 126.28 51.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.0 t80 -129.85 103.28 6.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.114 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.51 -123.87 31.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.0 p -91.2 6.12 46.36 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.828 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.82 133.57 69.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.4 p -140.36 152.07 45.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 142.05 13.4 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.871 ' ND2' HG23 ' A' ' 76' ' ' ILE . 9.8 m120 -108.88 142.29 39.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 110.767 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t -142.36 150.88 41.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.821 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 88' ' ' LEU . 73.4 mt -108.52 128.49 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 88' ' ' LEU . 11.1 mp -103.66 133.15 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.927 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -96.99 142.64 28.71 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.586 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 89.8 t -84.69 106.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.201 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 16.5 m120 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.837 0.351 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.3 p -131.01 163.8 26.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.603 ' C ' HD13 ' A' ' 5' ' ' LEU . 3.1 tm? -81.22 111.08 17.31 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.49 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -77.53 -53.52 7.51 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.468 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -145.81 156.56 43.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 19.5 tt -127.8 130.34 70.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.013 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.8 p -133.01 148.39 52.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.76 140.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.053 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 163.79 17.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -37.16 155.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.41 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.1 mm -86.63 159.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 123.928 0.891 . . . . 0.0 110.083 1.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 15' ' ' THR . 5.0 p30 -41.13 -98.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.979 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -153.84 94.39 1.76 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.109 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.425 HD22 ' HB2' ' A' ' 91' ' ' ASN . 29.0 m120 -156.36 140.63 16.58 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.663 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--O 1.232 0.169 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.406 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.237 0.398 0 CA-C-O 121.231 0.538 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.426 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 3.8 m -88.36 142.72 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.411 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -134.89 130.04 35.32 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 110.62 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -109.74 144.83 37.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.38 153.43 47.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.115 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -111.06 152.2 27.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.63 128.94 55.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.685 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.67 133.51 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.186 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.36 151.59 18.48 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.7 m -118.84 127.77 53.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.922 0.392 . . . . 0.0 110.577 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.43 151.54 24.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.109 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.6 p -54.54 -14.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.519 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.91 0.85 37.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 3.06 90.67 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.524 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.6 m -86.13 160.21 19.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.334 . . . . 0.0 110.696 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 35' ' ' THR . 99.5 mttt -130.85 151.94 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.93 152.71 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 44.1 p-10 -80.85 124.27 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.658 ' O ' HG13 ' A' ' 43' ' ' VAL . 65.9 mt -112.45 12.58 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.0 m -58.2 -34.88 70.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.9 p -88.76 -7.86 55.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.56 -29.09 11.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.918 0.389 . . . . 0.0 110.719 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 79' ' ' TYR . 7.2 m -89.9 152.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.214 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 m -107.13 126.42 52.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.798 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.561 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 33.8 m95 -95.55 134.74 38.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.517 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.5 t -141.56 150.64 42.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -120.2 141.16 50.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.179 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.9 p -67.08 -32.96 74.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 83.6 m-20 -84.9 69.75 10.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.333 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.13 -38.82 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -68.57 -34.82 76.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.135 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -107.4 9.58 29.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.89 144.44 16.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.097 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -129.33 145.74 51.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.882 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.6 p -125.88 114.41 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.037 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.0 t -139.29 105.92 5.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.759 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.81 130.66 18.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.091 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -67.64 -175.11 0.49 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.52 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 t -59.84 -35.82 75.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.474 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.97 -18.87 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 34.8 p -103.31 3.58 35.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.09 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -41.1 114.2 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.769 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.83 29.54 2.82 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -115.3 114.69 25.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.195 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' N ' HD13 ' A' ' 64' ' ' LEU . 46.7 t -128.06 136.6 59.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.426 ' HG1' ' HG ' ' A' ' 22' ' ' SER . 51.8 m -112.65 127.74 56.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.795 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.02 106.5 3.1 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 36.4 mm -63.99 -43.83 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.195 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 128.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 90' ' ' VAL . 25.0 t -167.54 -177.44 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.638 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 72' ' ' ASN . . . -114.23 -53.24 0.43 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 71' ' ' GLY . 23.5 m120 -142.79 82.73 12.08 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.461 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.29 155.65 16.79 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.94 2.426 . . . . 0.0 110.618 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.0 m -124.51 121.85 35.97 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.818 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.432 HG12 HD12 ' A' ' 88' ' ' LEU . 38.9 mm -101.82 129.14 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.8 mt -116.59 128.79 73.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.79 132.04 45.38 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -121.08 129.03 53.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.966 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.709 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.5 t80 -138.27 113.18 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.3 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 51.76 -125.61 27.04 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.5 p -93.97 8.59 40.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.78 132.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -136.7 153.9 50.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.4 143.39 14.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.654 ' OD1' HG23 ' A' ' 76' ' ' ILE . 10.2 m-20 -115.1 142.77 46.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.985 0.421 . . . . 0.0 111.069 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -143.78 144.04 31.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.89 128.12 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 110.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 HG12 ' A' ' 75' ' ' ILE . 56.1 mt -112.12 149.29 32.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.1 m -118.66 143.42 46.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.958 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 72.8 t -86.86 104.81 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.526 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 99.3 m-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.439 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.684 0.278 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -135.75 163.87 29.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.245 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -68.43 110.93 4.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -74.98 -42.01 58.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 p -153.96 160.79 42.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.3 tt -120.44 127.97 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -130.28 149.62 51.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.608 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.0 134.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.051 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.06 163.62 17.98 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.885 0.374 . . . . 0.0 111.338 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.422 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 Cg_endo -43.87 172.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 124.083 3.189 . . . . 0.0 111.292 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 75.9 mt -102.63 110.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.581 0.753 . . . . 0.0 109.956 0.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.7 m120 35.78 -153.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.912 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.2 p -144.59 95.74 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.155 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -152.94 160.49 43.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 90' ' ' VAL . 89.6 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -90.39 147.64 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.135 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ILE . 63.6 tttm -141.8 132.46 25.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -109.84 142.55 40.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.86 152.72 47.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.808 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.08 153.9 27.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.951 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.17 129.94 55.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.911 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.53 130.14 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.6 148.59 16.79 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.0 m -113.9 125.88 54.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -81.19 146.09 30.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.145 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.5 p -51.93 -20.38 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.398 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.85 -5.54 44.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -0.36 76.75 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 6.7 m -85.55 156.38 20.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.555 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -126.37 153.17 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.12 157.77 21.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.756 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -82.55 129.19 34.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.332 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.665 ' O ' HG13 ' A' ' 43' ' ' VAL . 95.3 mt -113.7 11.97 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.6 m -59.89 -31.61 69.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.5 p -90.93 -6.6 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.125 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -105.74 -27.48 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.566 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.4 m -90.52 155.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.242 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.9 m -111.62 124.14 51.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.583 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 26.7 m95 -96.1 137.82 34.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.214 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.6 p -145.67 161.37 40.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.935 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.1 t -133.82 146.16 50.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.95 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -69.29 -31.61 70.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 80.3 m-20 -77.87 64.09 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.6 -42.25 74.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -72.69 -33.79 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -102.88 9.28 38.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.258 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -168.82 148.58 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.12 144.42 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.954 0.407 . . . . 0.0 110.699 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 55' ' ' VAL . 11.4 p -121.3 112.91 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.95 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.5 p -140.9 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.854 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -153.33 131.95 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 -176.38 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -57.52 -36.74 71.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.563 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.93 -33.85 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.474 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -100.51 11.29 39.8 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -43.7 115.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.61 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 110.15 37.6 1.79 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -116.97 115.49 25.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 64' ' ' LEU . 24.7 t -126.61 133.79 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -117.24 122.97 45.48 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.15 114.0 4.49 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 88.8 mt -65.79 -44.86 92.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.55 119.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.725 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.8 m -158.77 175.85 13.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.74 -67.61 0.83 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -131.48 80.71 66.59 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.581 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.7 Cg_exo -71.78 152.79 58.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.396 2.064 . . . . 0.0 110.27 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -118.45 124.19 47.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.157 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.1 mm -100.91 122.38 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 ' ND2' ' A' ' 85' ' ' ASN . 34.7 mm -108.45 128.43 64.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.95 129.73 55.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -119.47 129.53 54.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.608 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -128.02 105.04 8.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.757 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 49.9 -120.28 7.82 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 98.1 p -90.6 6.14 44.98 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.257 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.14 131.31 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 p -136.24 148.34 48.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.62 143.85 14.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.721 ' ND2' HG23 ' A' ' 76' ' ' ILE . 6.4 m120 -108.14 140.32 41.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.206 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 87' ' ' ILE . 84.8 m -133.49 158.76 42.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.322 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.488 ' N ' HG22 ' A' ' 86' ' ' THR . 79.4 mt -108.49 124.0 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.81 132.49 56.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.7 m -116.12 138.09 51.56 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.872 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.581 HG23 ' CD ' ' A' ' 73' ' ' PRO . 65.6 t -83.78 111.47 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.993 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.5 t30 . . . . . 0 C--N 1.33 -0.24 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.421 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.865 0.364 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -97.88 163.75 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.702 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.1 tp -86.53 115.08 23.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.712 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -75.44 -51.79 12.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.833 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.3 p -160.35 162.96 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.823 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.702 ' CG2' HD21 ' A' ' 5' ' ' LEU . 18.6 pt -123.51 140.92 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.896 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -130.76 149.29 52.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -91.5 142.43 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.056 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -102.34 165.43 13.84 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -178.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.6 Cg_exo -38.3 163.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 124.008 3.139 . . . . 0.0 111.397 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' C ' ' A' ' 14' ' ' ASN . 4.3 mm -99.63 114.52 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.496 0.718 . . . . 0.0 110.021 0.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 13' ' ' ILE . 23.8 t-20 28.47 -115.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.524 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 24.4 p -155.58 91.79 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.07 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 15' ' ' THR . 34.9 m120 -156.26 140.94 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.8 mt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.768 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 22' ' ' SER . 71.9 t . . . . . 0 CA--C 1.523 -0.061 0 CA-C-O 121.005 0.431 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.743 ' OG ' HD21 ' A' ' 64' ' ' LEU . 14.1 t -112.77 131.49 55.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -128.57 138.06 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -110.26 144.72 38.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.85 153.71 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.869 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.74 153.47 26.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.89 129.36 53.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.881 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -111.96 127.49 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.481 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.18 143.51 18.0 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -116.03 122.2 44.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' C ' ' N ' ' A' ' 33' ' ' ASP . 94.4 m-85 -80.69 149.3 29.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.107 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -55.63 -9.74 0.57 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 3' ' ' ALA . 73.2 m-20 -86.92 1.01 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.5 0.89 88.04 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 36' ' ' LYS . 10.8 m -84.16 158.32 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 35' ' ' THR . 99.3 mttt -133.16 151.32 51.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.308 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.3 154.57 21.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.83 119.87 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.427 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' VAL . 84.9 mt -108.23 14.8 24.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.0 m -60.53 -29.21 68.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.82 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.7 p -91.18 -9.0 47.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.173 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.61 -28.6 11.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 79' ' ' TYR . 15.3 m -87.66 149.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.5 m -106.66 122.63 46.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.773 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 28.3 m95 -92.47 137.33 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.245 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -151.07 160.92 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.963 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 t -137.88 147.8 44.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -63.97 -35.13 79.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -71.35 63.6 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.352 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 77.9 mt-30 -69.71 -43.61 72.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.6 m -72.9 -33.59 66.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.22 1.19 49.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.167 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.7 154.27 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.175 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -139.04 145.88 40.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.793 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.1 p -112.75 116.3 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.993 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 m -138.98 110.02 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.82 132.52 11.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.654 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.32 -177.11 2.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 96.0 p -58.9 -27.1 64.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.579 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -88.97 -12.67 40.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.481 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 80.1 p -116.38 0.76 12.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HA ' HD22 ' A' ' 57' ' ' ASN . 73.1 mttt -40.17 111.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.738 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.52 27.71 2.3 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.743 HD21 ' OG ' ' A' ' 22' ' ' SER . 6.1 tt -119.31 119.31 33.65 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.61 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 64' ' ' LEU . 48.7 t -125.24 135.37 64.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -115.75 127.28 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.92 117.08 4.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 95.4 mt -63.38 -42.67 97.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.287 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 177.72 118.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.745 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.756 ' O ' HG21 ' A' ' 90' ' ' VAL . 6.6 p -160.88 166.74 27.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.724 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.68 -67.9 0.9 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.87 81.66 51.71 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.12 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.18 148.8 16.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.495 2.13 . . . . 0.0 110.226 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 75' ' ' ILE . 24.6 m -107.1 124.21 49.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.132 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.7 mp -100.16 131.3 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.902 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.1 mt -117.92 125.76 74.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.257 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.6 133.73 47.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -118.01 132.02 56.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.677 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.688 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.3 t80 -136.93 111.27 8.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.718 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.43 -125.83 37.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.7 p -93.05 5.25 52.16 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.322 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 79' ' ' TYR . 50.2 t -125.67 133.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -130.84 156.74 44.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.48 147.22 16.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' HG23 ' A' ' 76' ' ' ILE . 2.9 m-20 -123.3 135.63 54.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.015 0.436 . . . . 0.0 111.135 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -140.71 153.34 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.54 126.36 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 111.122 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.566 HD12 HD13 ' A' ' 75' ' ' ILE . 85.5 mt -110.05 147.25 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.506 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.3 m -120.91 142.74 49.42 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.879 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.756 HG21 ' O ' ' A' ' 70' ' ' SER . 76.5 t -82.69 103.92 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.923 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.3 m120 . . . . . 0 C--N 1.33 -0.267 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.395 179.66 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.672 0.272 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -121.5 164.31 17.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 8' ' ' ILE . 39.0 tp -78.53 109.37 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.41 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -75.87 -45.13 37.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -148.09 167.18 25.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.835 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 5' ' ' LEU . 96.8 mt -118.0 132.83 66.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.983 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -127.87 147.78 50.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.395 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.92 137.27 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.61 163.71 17.61 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.063 0.459 . . . . 0.0 111.314 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -37.31 155.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 123.515 2.81 . . . . 0.0 112.199 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.688 HD12 ' HE2' ' A' ' 23' ' ' LYS . 91.4 mt -87.71 159.16 3.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 123.926 0.89 . . . . 0.0 110.127 0.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' ILE . 87.7 m-20 -48.56 -90.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 74.3 p -141.52 92.9 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 15' ' ' THR . 24.8 m120 -156.78 161.61 39.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 111.799 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.455 -0.218 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.624 179.71 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 22' ' ' SER . 2.4 t . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.979 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.8 m -112.75 148.17 35.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.688 ' HE2' HD12 ' A' ' 13' ' ' ILE . 64.3 tttm -133.77 131.36 39.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.58 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -110.6 146.05 36.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.102 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.89 155.09 44.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.164 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -109.18 145.71 35.34 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.754 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.55 130.25 56.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.79 132.96 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.21 146.92 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.7 m -112.38 128.19 56.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.55 149.26 24.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.975 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -54.94 -17.82 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.629 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -77.74 -6.95 55.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.497 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.25 1.29 72.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 36' ' ' LYS . 87.3 m -80.69 157.7 25.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.747 0.308 . . . . 0.0 110.784 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mtmt -126.6 145.23 50.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.369 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.11 156.67 29.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.876 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 39' ' ' LEU . 91.1 m-20 -87.88 127.08 35.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.256 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.1 mp -112.53 14.03 20.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.36 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.5 m -57.11 -32.59 66.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.053 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.8 p -88.12 -9.91 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.436 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.426 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -101.18 -26.2 13.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.1 m -91.93 152.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.5 m -109.96 119.74 40.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 19.1 m95 -89.59 140.76 29.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.519 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 p -149.29 160.56 43.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.893 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -134.37 143.24 47.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.1 p -62.41 -34.49 76.86 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 95.7 m-20 -71.8 62.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -68.61 -43.54 76.19 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.9 p -70.54 -33.57 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.0 7.46 36.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.1 148.77 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -134.27 142.1 47.2 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 65' ' ' VAL . 22.0 t -108.65 114.57 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 m -139.36 110.36 6.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.91 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.15 134.21 13.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.892 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.01 -176.92 1.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -58.75 -35.16 72.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.638 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -83.36 -20.49 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.649 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.5 p -104.48 4.03 32.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.099 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -42.36 115.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.855 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 114.44 33.26 1.79 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 3.7 tp -118.21 125.39 50.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 55' ' ' VAL . 56.0 t -129.31 133.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -114.86 121.78 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.6 116.57 5.09 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 92.2 mt -65.42 -44.54 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.463 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.96 120.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.691 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 30.0 t -157.9 -173.78 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -114.27 -65.37 0.43 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.31 80.55 52.1 Favored Pre-proline 0 C--N 1.332 -0.174 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.32 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HD3' HG23 ' A' ' 90' ' ' VAL . 14.5 Cg_exo -70.23 147.19 59.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.801 2.334 . . . . 0.0 110.626 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.4 m -110.78 115.84 30.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.738 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.73 126.61 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.746 HG23 ' ND2' ' A' ' 85' ' ' ASN . 97.4 mt -117.15 127.34 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.157 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.76 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -118.9 130.26 55.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.949 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.8 t80 -137.43 110.03 7.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.69 -128.98 48.96 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.3 p -94.04 9.71 36.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.969 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 8' ' ' ILE . 47.7 t -129.05 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.872 0.368 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -139.8 151.92 46.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.64 142.44 13.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.746 ' ND2' HG23 ' A' ' 76' ' ' ILE . 7.0 m120 -111.43 152.71 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.114 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 162.88 39.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.309 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.41 126.37 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 111.039 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -112.94 128.47 56.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.73 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.9 m -107.51 145.79 32.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.031 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' HD3' ' A' ' 73' ' ' PRO . 64.2 t -83.8 117.47 29.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 C--O 1.233 0.197 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.518 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 5' ' ' LEU . 20.7 m -90.24 162.3 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.279 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 4' ' ' THR . 57.6 tp -86.99 114.87 23.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -72.49 -46.37 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.78 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 p -157.63 164.8 36.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -124.38 131.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.933 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.2 m -132.77 148.71 52.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.538 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.0 mm -98.77 139.2 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.095 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.63 163.22 18.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 111.506 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -36.39 158.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.096 3.197 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' HE3' ' A' ' 23' ' ' LYS . 96.3 mt -84.72 158.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 123.501 0.721 . . . . 0.0 109.972 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 13' ' ' ILE . 92.2 m-20 -37.81 -92.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.824 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.506 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -160.25 93.25 1.03 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.105 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 15' ' ' THR . 22.7 m120 -154.57 140.29 18.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.328 0.585 . . . . 0.0 111.678 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 88' ' ' LEU . 3.3 mm . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.892 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.937 0.398 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -79.9 136.28 36.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.118 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 13' ' ' ILE . 87.3 tttt -137.93 135.85 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 110.963 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -112.3 145.58 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.339 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.42 152.62 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.853 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -110.62 142.44 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.968 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.19 128.82 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.909 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.72 128.97 72.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.481 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.97 147.18 16.59 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -115.01 129.52 56.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -87.31 149.39 24.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.112 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -55.98 -15.3 3.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.448 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.3 -1.58 49.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.567 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 1.88 85.36 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.8 m -85.36 145.59 27.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.641 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.91 148.59 42.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.71 154.71 20.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.4 125.1 31.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.343 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.5 mt -106.99 7.24 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -50.07 -31.95 14.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.2 p -87.99 -9.32 53.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.197 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.7 -28.57 10.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.558 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.5 m -87.81 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 m -106.04 123.85 48.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.76 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.474 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 38.0 m95 -92.82 134.53 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -148.37 170.3 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.935 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.435 ' H ' ' NE2' ' A' ' 50' ' ' GLN . 41.1 t -136.26 146.88 47.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.786 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -66.15 -33.76 76.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 0.0 109.37 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -94.89 84.21 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 47' ' ' SER . 98.5 mm-40 -85.84 -22.79 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 t -71.02 -34.32 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.639 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.82 4.3 37.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -160.68 152.8 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.227 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -132.66 136.03 46.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.018 0.437 . . . . 0.0 110.701 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.3 p -107.04 113.28 43.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.988 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.7 t -138.98 104.49 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.862 HD22 ' H ' ' A' ' 63' ' ' GLY . 31.0 p30 -131.75 127.27 36.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.82 -179.56 2.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 t -58.86 -44.95 91.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.596 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 57.1 mp0 -83.46 -7.97 59.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.505 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.4 p -113.0 8.8 18.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.357 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -42.13 114.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.862 ' H ' HD22 ' A' ' 57' ' ' ASN . . . 113.68 29.04 3.01 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 64' ' ' LEU . 28.5 tp -118.02 121.0 39.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.575 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.14 134.11 67.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 p -102.47 131.47 49.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.24 105.28 2.05 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.6 mt -63.05 -44.72 99.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 170.66 121.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -160.07 168.59 25.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.92 -49.09 1.19 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -149.69 82.73 6.6 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -84.24 159.05 13.15 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.488 2.125 . . . . 0.0 110.184 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.0 m -118.32 123.95 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 mm -98.29 125.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.938 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.2 mm -112.8 126.52 70.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.106 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.99 125.6 47.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 m -113.88 126.11 54.81 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.693 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.589 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.4 t80 -134.64 87.76 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.41 -124.78 22.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -89.04 4.92 46.69 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.314 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.45 136.55 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 p -142.15 157.08 45.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . -127.45 142.93 13.93 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -123.14 130.84 53.3 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.204 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -136.71 157.18 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.341 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.7 mt -97.56 124.57 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.971 0.415 . . . . 0.0 111.179 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 17' ' ' ILE . 67.2 tp -107.93 135.57 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.568 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.3 m -119.09 139.69 51.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.918 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.3 t -88.1 101.7 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.0 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.357 179.354 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.855 0.36 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -93.05 143.0 26.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.1 tp -60.57 116.65 4.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.404 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.3 t -75.92 -42.97 47.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -156.8 165.69 35.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.047 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.95 133.21 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -135.38 147.85 49.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 86' ' ' THR . 15.1 mm -95.33 143.41 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.761 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.49 164.38 16.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.34 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.0 Cg_exo -37.27 164.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 123.326 2.684 . . . . 0.0 112.871 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' ASN . 86.7 mt -107.6 114.98 47.74 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 125.074 1.35 . . . . 0.0 110.798 -0.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' ILE . 97.3 m-20 33.96 -120.95 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.604 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 p -149.16 95.78 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.906 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 60.5 t30 -150.3 147.84 28.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.591 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.333 -0.137 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.735 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.52 0.676 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 m -96.37 141.45 29.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.936 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -120.47 140.6 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -109.34 143.54 38.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.71 153.62 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.181 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -111.03 152.35 26.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.66 129.91 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.583 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.97 128.41 67.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.07 143.41 14.52 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.498 ' HG1' ' HZ3' ' A' ' 36' ' ' LYS . 52.7 m -115.48 129.2 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.871 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -88.1 146.44 25.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.861 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.0 p -53.73 -15.79 1.4 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.748 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.02 -3.22 51.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.571 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.07 85.95 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 m -77.64 139.74 39.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 110.714 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HZ3' ' HG1' ' A' ' 30' ' ' THR . 68.7 mmtt -110.99 139.47 46.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.45 25.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.085 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.533 ' C ' HD22 ' A' ' 39' ' ' LEU . 50.2 t0 -90.1 126.04 35.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.735 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.5 mm? -103.81 9.2 37.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -53.45 -30.32 40.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.898 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.4 p -89.82 -9.11 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.22 -22.75 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.3 m -95.12 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -104.29 120.32 40.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.637 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.0 m95 -89.07 134.72 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.536 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 p -143.21 162.49 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.885 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -135.94 144.64 45.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 111.235 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 p -67.78 -33.34 74.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.333 0.587 . . . . 0.0 109.527 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 16.2 m120 -77.58 62.47 2.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.566 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.09 -42.33 84.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.054 0.454 . . . . 0.0 109.956 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -69.85 -34.4 73.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -103.62 6.01 36.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.374 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -159.57 147.26 17.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.324 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -132.46 142.64 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 110.807 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 55' ' ' VAL . 6.6 p -122.59 114.29 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 67.8 p -139.53 117.05 11.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.632 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -155.29 134.4 12.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.22 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -75.03 178.8 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.751 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.2 p -54.3 -27.25 34.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.621 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -87.47 -25.28 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.717 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 18.6 p -103.87 8.27 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.655 0.265 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -42.16 115.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.962 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 109.83 35.94 2.12 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.9 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 25.0 tp -118.27 126.12 51.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.724 0.262 . . . . 0.0 110.514 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.74 133.7 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 111.051 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 m -102.66 127.84 49.61 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.67 102.1 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.678 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.7 mt -65.26 -44.17 95.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.908 0.385 . . . . 0.0 110.069 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 167.75 118.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 t -160.42 170.82 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.45 -55.24 0.76 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -140.66 82.2 16.11 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' HG23 ' A' ' 90' ' ' VAL . 71.0 Cg_endo -83.04 155.46 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.69 2.26 . . . . 0.0 110.732 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 75' ' ' ILE . 95.5 m -121.27 123.9 43.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.971 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.873 HD13 HD22 ' A' ' 88' ' ' LEU . 2.1 mp -102.43 129.7 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.734 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.0 127.23 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.091 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.9 129.4 49.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.7 m -113.37 129.7 56.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.607 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.8 t80 -132.35 87.27 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.265 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.65 -125.2 25.5 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.3 p -87.18 3.97 44.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.539 0.209 . . . . 0.0 110.931 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.69 133.65 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.759 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -139.79 154.34 47.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.593 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.43 147.96 17.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.3 m120 -126.25 130.55 51.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.97 0.414 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 81.8 p -134.55 151.09 50.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.577 ' C ' HD12 ' A' ' 88' ' ' LEU . 78.6 mt -97.92 127.01 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 0.0 110.799 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.873 HD22 HD13 ' A' ' 75' ' ' ILE . 10.5 mp -109.48 145.73 35.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -114.65 134.95 54.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.498 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 73' ' ' PRO . 71.4 t -84.4 104.27 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.084 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 99.3 m-20 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.843 0.354 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.1 m -119.0 139.55 51.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.278 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.75 122.79 15.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -74.62 -43.3 56.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.9 p -159.29 162.39 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.531 HD11 HG12 ' A' ' 82' ' ' VAL . 96.6 mt -112.45 129.59 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -125.27 148.59 48.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.527 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 86' ' ' THR . 26.2 mm -104.18 139.75 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.027 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -101.19 162.31 20.94 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 0.0 111.302 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.3 Cg_exo -35.15 163.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 124.104 3.202 . . . . 0.0 111.322 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' ASN . 88.4 mt -109.09 108.13 24.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.599 0.759 . . . . 0.0 110.045 0.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 33.7 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.2 OUTLIER -127.76 97.47 4.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.147 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -154.5 160.08 41.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.258 0.551 . . . . 0.0 111.606 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 91' ' ' ASN . 47.4 mm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.718 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' SER . 14.2 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.912 0.387 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.9 m -86.02 152.27 23.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.067 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -137.5 135.01 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.9 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -111.27 143.43 42.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -130.08 153.2 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.896 179.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -119.8 146.59 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.771 0.32 . . . . 0.0 110.942 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.55 129.77 55.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.827 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.55 128.85 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.79 144.14 17.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 m -113.22 125.79 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.469 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.432 ' C ' ' N ' ' A' ' 33' ' ' ASP . 97.1 m-85 -83.4 143.84 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.15 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -49.92 -14.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.426 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.432 ' N ' ' C ' ' A' ' 31' ' ' TYR . 89.0 m-20 -81.48 0.76 36.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.568 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.05 1.45 90.61 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -84.32 151.3 24.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.661 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.02 148.19 48.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.371 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.12 27.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.764 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.87 124.67 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.6 mt -111.0 12.89 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.175 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.7 m -59.39 -26.38 65.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.081 0.467 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 95.2 p -93.55 -7.76 43.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.237 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.6 -26.4 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.49 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -90.63 149.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.4 m -106.45 126.39 52.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.711 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.529 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 23.3 m95 -95.79 137.47 34.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.262 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 p -148.9 168.6 22.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -139.24 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.838 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -62.34 -39.42 93.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.401 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -91.13 88.47 6.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.328 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -88.86 -22.45 23.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 p -70.83 -32.19 69.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.34 1.97 36.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.161 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.07 148.43 15.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.126 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -127.87 139.15 52.79 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.745 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.6 p -114.93 111.19 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.033 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 t -139.67 103.87 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -139.57 130.29 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.623 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.541 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.3 -177.1 2.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -58.32 -34.91 71.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.568 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.8 mp0 -85.58 -22.3 28.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.534 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 42.0 p -101.76 15.0 30.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.238 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -44.81 115.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.72 34.66 3.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -118.93 113.06 20.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.547 ' N ' HD13 ' A' ' 64' ' ' LEU . 50.5 t -128.55 138.4 54.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.803 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -106.44 125.81 51.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.29 103.07 1.62 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.8 mt -64.12 -44.96 97.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.334 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 149.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 5.4 t -179.15 -175.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.673 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.594 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -108.75 -62.47 0.54 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -136.26 80.5 40.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.123 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.4 Cg_exo -71.3 153.98 61.47 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.507 2.138 . . . . 0.0 110.248 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.5 m -125.19 110.95 14.7 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.225 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 mm -96.07 126.51 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.79 128.65 76.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.08 135.48 39.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.0 m -122.1 132.14 54.33 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.669 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.652 ' HB2' HG12 ' A' ' 43' ' ' VAL . 77.1 t80 -136.59 107.96 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 48.87 -119.88 6.37 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.4 p -93.22 6.97 46.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 8' ' ' ILE . 53.0 t -126.27 129.73 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.912 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -136.74 153.5 50.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 110.904 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.63 142.21 13.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.1 m-20 -121.8 139.11 54.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.936 0.398 . . . . 0.0 111.244 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.578 HG21 HG13 ' A' ' 10' ' ' ILE . 41.6 p -137.65 167.53 21.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.323 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.4 123.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 17' ' ' ILE . 50.5 tp -109.12 130.32 55.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.5 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 m -116.11 141.27 48.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.961 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.458 HG23 ' CD ' ' A' ' 73' ' ' PRO . 26.1 t -84.87 121.02 36.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' ILE . 29.3 t-20 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.878 0.371 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -131.53 164.47 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.61 HD21 HG12 ' A' ' 8' ' ' ILE . 46.2 tp -64.89 105.81 1.1 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.631 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.6 m -76.21 -40.5 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 p -151.61 165.73 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.61 HG12 HD21 ' A' ' 5' ' ' LEU . 96.7 mt -115.48 132.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.889 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 m -123.02 149.07 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.627 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.0 mt -118.25 132.58 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.14 164.24 15.89 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' SER . 57.8 Cg_exo -36.21 162.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.047 3.164 . . . . 0.0 111.396 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ASN . 3.5 mt -93.71 163.75 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.485 0.714 . . . . 0.0 109.99 0.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' O ' ' A' ' 13' ' ' ILE . 32.6 p30 -48.01 -172.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 89' ' ' THR . 53.5 p -85.29 93.51 8.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.439 HD22 ' HB2' ' A' ' 91' ' ' ASN . 27.8 m120 -154.45 142.02 19.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.319 0.58 . . . . 0.0 111.651 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.746 -179.827 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.933 0.396 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 m -82.42 136.92 34.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.104 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.68 132.91 39.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -112.02 144.73 40.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.91 153.8 47.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.802 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -112.53 138.63 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.923 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.34 124.39 52.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.952 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.79 129.45 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.386 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.19 142.11 16.46 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.0 m -109.2 122.69 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 110.417 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -83.84 146.34 28.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.128 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.2 p -52.14 -14.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.413 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.67 -3.94 49.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 2.27 82.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 36' ' ' LYS . 22.0 m -85.7 153.79 22.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -123.74 151.09 43.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.31 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.29 156.27 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 39' ' ' LEU . 34.8 p-10 -86.78 123.78 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.0 mp -111.34 18.22 19.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.03 -30.42 70.3 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.9 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.0 p -89.61 -8.28 52.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.192 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.7 t -104.7 -27.9 11.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 39' ' ' LEU . 16.5 m -88.11 150.6 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.268 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -108.52 117.64 34.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 18.8 m95 -87.25 136.64 32.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.7 p -141.2 162.66 34.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.987 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -138.45 143.31 39.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.888 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -68.94 -36.42 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 99.1 m-20 -74.42 69.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.29 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.03 -43.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.4 m -70.04 -33.91 72.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.644 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.59 6.64 34.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -164.98 146.47 7.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.166 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -131.79 146.77 52.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.76 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.3 p -122.46 114.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.963 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.4 p -140.93 111.47 6.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.08 131.44 11.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.53 -177.03 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.9 t -56.3 -41.75 76.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.591 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -74.46 -31.39 62.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.522 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.2 p -95.22 2.49 54.94 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 57' ' ' ASN . 53.7 mttt -41.31 116.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.81 33.8 1.8 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.57 118.92 32.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.31 135.72 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.773 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -112.17 128.85 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.53 134.77 12.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.659 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.01 -66.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' SER . . . -144.8 142.05 29.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.643 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 1.1 t 163.32 175.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -109.69 -48.69 0.78 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -140.64 81.12 17.45 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD3' HG23 ' A' ' 90' ' ' VAL . 26.3 Cg_exo -64.18 144.07 85.74 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 0.0 110.242 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.0 m -118.29 121.31 40.1 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.78 129.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.844 HG23 ' ND2' ' A' ' 85' ' ' ASN . 86.8 mt -110.8 128.09 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.163 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.5 131.17 54.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -115.65 133.91 55.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.633 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 43' ' ' VAL . 87.8 t80 -136.53 94.2 2.97 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.7 -123.23 32.2 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.6 p -89.91 6.77 40.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.33 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 8' ' ' ILE . 48.0 t -126.17 135.31 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 p -140.0 156.85 46.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.0 110.92 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.8 143.92 15.58 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.844 ' ND2' HG23 ' A' ' 76' ' ' ILE . 12.5 m120 -111.24 139.88 46.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.1 m -135.8 141.72 44.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.277 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.18 128.99 63.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.064 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.04 147.76 28.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.529 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.422 ' H ' ' HB ' ' A' ' 15' ' ' THR . 59.0 m -111.9 138.0 49.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.982 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 73' ' ' PRO . 43.0 t -83.25 104.48 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.904 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 10.4 m120 . . . . . 0 C--N 1.331 -0.225 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.416 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.871 0.367 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -133.99 162.39 32.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 8' ' ' ILE . 3.7 tt -88.04 109.53 19.92 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -76.47 -53.09 8.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.775 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.8 p -156.46 169.79 23.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.906 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 5' ' ' LEU . 35.9 pt -130.69 144.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.849 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -135.81 149.12 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.674 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mm -95.29 141.77 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.36 165.55 14.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 120.762 0.315 . . . . 0.0 111.431 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 11' ' ' SER . 46.5 Cg_exo -38.19 165.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.095 3.197 . . . . 0.0 111.314 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 14' ' ' ASN . 78.7 mt -110.14 117.78 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.461 0.705 . . . . 0.0 110.008 0.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 13' ' ' ILE . 3.9 t-20 27.05 -131.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.756 0.312 . . . . 0.0 110.88 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -142.81 93.4 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.178 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -155.26 135.16 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.226 0.536 . . . . 0.0 111.66 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.789 179.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.947 0.403 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 m -104.32 145.48 30.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.102 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -131.11 140.22 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.901 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -109.54 143.48 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.383 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.606 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.14 152.96 48.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.881 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -111.08 149.75 30.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.923 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.79 127.8 55.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.825 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.38 128.34 69.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.461 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.12 148.35 17.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.8 m -119.6 130.09 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 0.0 110.432 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -89.08 149.33 23.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.122 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -55.3 -10.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.434 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.12 -0.75 57.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.56 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.7 87.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.6 m -84.22 146.26 27.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 110.654 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.13 146.98 48.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.08 156.12 28.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.834 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.15 122.97 28.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.635 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.0 mt -107.42 9.2 29.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.211 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.6 m -55.0 -30.55 59.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.113 0.482 . . . . 0.0 109.866 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -89.67 -9.8 48.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.133 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -102.87 -26.35 13.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.599 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -93.72 144.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.302 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 123.13 47.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.606 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 10.8 m95 -92.94 136.46 33.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.277 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.3 t -139.93 144.86 37.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.888 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.7 t -113.4 140.15 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.3 p -62.82 -40.09 96.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.742 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 93.0 m-20 -71.64 70.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.322 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -74.45 -40.33 61.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.2 p -71.02 -32.89 69.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.643 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.55 11.05 27.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -166.89 148.86 6.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.197 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -134.05 147.08 50.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.696 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 65' ' ' VAL . 23.4 t -110.21 113.32 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.008 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -139.86 105.63 5.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.29 131.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.673 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.508 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.94 -176.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -56.48 -42.91 79.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.572 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.16 -27.18 60.71 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.533 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 51.9 p -99.44 2.18 44.81 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.35 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' HD22 ' A' ' 57' ' ' ASN . 23.5 mttt -40.34 114.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.627 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 112.81 39.72 1.15 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -119.44 127.89 53.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.305 . . . . 0.0 110.624 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 55' ' ' VAL . 37.5 t -127.12 133.34 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.751 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -113.57 120.65 41.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.58 107.92 2.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.26 -45.4 93.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -169.72 118.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 p -164.25 168.15 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.15 -68.55 0.93 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.733 ' ND2' HG23 ' A' ' 89' ' ' THR . 19.2 m120 -131.68 80.83 65.39 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 90' ' ' VAL . 16.6 Cg_exo -69.7 151.24 69.39 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.465 2.11 . . . . 0.0 110.218 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 m -120.01 124.12 45.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.272 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 88' ' ' LEU . 38.4 mm -102.13 126.67 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.963 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.696 HG23 ' OD1' ' A' ' 85' ' ' ASN . 91.4 mt -114.04 122.78 68.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.87 41.29 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -119.77 127.84 53.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.631 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.683 ' HB2' HG12 ' A' ' 43' ' ' VAL . 67.8 t80 -136.97 118.77 15.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.08 -125.4 30.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.5 p -97.55 8.64 44.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' TYR . 44.6 t -126.36 136.54 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.7 p -135.41 150.76 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.45 142.19 13.29 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.696 ' OD1' HG23 ' A' ' 76' ' ' ILE . 14.3 m-20 -113.06 151.18 31.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.461 . . . . 0.0 111.198 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -144.66 156.5 44.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.3 mm -108.87 123.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 75' ' ' ILE . 89.6 mt -115.59 145.81 42.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.733 HG23 ' ND2' ' A' ' 72' ' ' ASN . 75.8 m -120.04 143.16 48.24 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.504 HG23 ' HD3' ' A' ' 73' ' ' PRO . 92.2 t -84.69 104.21 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 90.5 m-20 . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.411 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -92.16 164.64 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.66 118.24 25.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.0 110.612 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -75.65 -36.13 60.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -154.66 161.72 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.247 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -113.4 132.96 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.196 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -129.55 148.35 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.501 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.06 133.71 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.075 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.09 165.68 13.75 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.383 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -38.49 158.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.544 2.829 . . . . 0.0 112.019 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 91.2 mt -87.23 154.85 3.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 123.942 0.897 . . . . 0.0 110.578 1.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CG ' HG22 ' A' ' 15' ' ' THR . 52.2 t30 -53.56 -113.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.548 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -134.58 92.04 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.981 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' H ' ' HZ1' ' A' ' 23' ' ' LYS . 71.6 m-80 -157.45 158.73 36.36 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.528 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.444 ' CG2' HG13 ' A' ' 90' ' ' VAL . 1.6 tp . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 m -83.37 139.78 32.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.755 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HZ3' ' HG ' ' A' ' 88' ' ' LEU . 88.0 tttt -127.93 118.9 24.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.983 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.97 142.71 44.04 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.54 152.67 48.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.503 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -116.54 138.95 51.01 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.45 126.78 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.968 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.85 130.83 74.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.53 142.58 17.59 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.4 m -108.11 125.08 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 110.64 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -82.81 147.4 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.414 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p -54.32 -16.48 2.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.49 -5.19 46.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.32 1.14 79.01 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 36' ' ' LYS . 36.1 m -86.7 160.63 18.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 0.0 110.686 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.539 ' N ' HG22 ' A' ' 35' ' ' THR . 68.5 mttm -130.67 151.62 50.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.9 156.49 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -84.77 123.33 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.101 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.63 ' O ' HG13 ' A' ' 43' ' ' VAL . 79.2 mt -108.78 0.41 20.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.57 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -49.15 -33.45 12.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -86.63 -13.53 45.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.515 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -100.03 -21.9 15.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.656 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -96.98 149.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -107.69 124.36 49.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.617 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.0 m95 -94.24 139.25 31.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.672 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -142.62 169.58 17.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -140.58 139.12 34.89 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.7 p -62.91 -32.69 74.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.8 m-80 -84.73 68.46 10.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.6 mm-40 -69.74 -41.34 75.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.997 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -70.75 -34.47 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.339 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 49' ' ' ASN . 89.9 mt-30 -100.01 2.79 43.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.053 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.75 145.38 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.157 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -127.23 140.54 52.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.8 p -120.64 113.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.094 0.473 . . . . 0.0 109.968 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -140.16 106.64 5.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.311 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -148.64 131.8 16.39 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.44 -176.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.651 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -58.74 -43.78 90.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.023 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.86 -33.81 72.76 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -96.38 5.56 50.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.51 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -42.28 115.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.632 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.87 32.14 2.13 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -117.31 115.26 24.91 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' N ' HD13 ' A' ' 64' ' ' LEU . 42.5 t -127.63 133.97 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.896 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -116.04 126.2 53.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.619 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.96 113.8 4.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 40.5 mm -65.33 -43.92 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.04 120.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.789 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.3 p -157.85 172.36 18.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.49 -53.63 0.92 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -150.05 82.64 6.43 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.836 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.91 155.87 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.556 2.171 . . . . 0.0 110.711 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.482 ' C ' HD12 ' A' ' 75' ' ' ILE . 64.7 m -119.24 123.37 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -99.26 123.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.596 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' OD1' ' A' ' 85' ' ' ASN . 85.7 mt -111.14 125.69 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 134.62 47.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.1 m -124.08 130.54 52.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 111.14 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 43' ' ' VAL . 58.3 t80 -136.19 108.81 7.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.49 -122.16 28.89 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.7 p -97.94 5.43 48.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.488 0.185 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.41 133.75 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.5 p -140.38 150.73 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.55 142.68 13.98 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 76' ' ' ILE . 50.8 m-20 -108.9 143.4 38.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.044 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -136.71 143.95 43.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.547 ' C ' HD12 ' A' ' 88' ' ' LEU . 21.8 mm -102.62 126.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.252 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 75' ' ' ILE . 10.7 mp -108.42 141.71 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.516 ' N ' ' OG1' ' A' ' 15' ' ' THR . 60.5 m -118.16 137.51 52.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.421 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 70' ' ' SER . 72.5 t -85.21 112.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.727 179.853 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -139.46 160.68 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.743 HD21 ' CG2' ' A' ' 8' ' ' ILE . 47.0 tp -87.49 107.3 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.67 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -75.37 -46.19 34.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.763 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 p -157.37 164.78 37.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.743 ' CG2' HD21 ' A' ' 5' ' ' LEU . 45.8 pt -123.04 147.6 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.866 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 10.8 p -137.28 149.0 46.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.06 136.22 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -98.93 165.36 15.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.445 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.5 Cg_exo -37.26 165.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 124.055 3.17 . . . . 0.0 111.363 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 14' ' ' ASN . 74.4 mt -106.94 113.12 42.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.491 0.716 . . . . 0.0 110.031 0.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 13' ' ' ILE . 79.1 m-20 28.77 -126.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.461 ' CB ' HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -149.92 95.55 2.32 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.137 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 3.8 p30 -155.62 136.84 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 111.617 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.0 mm . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.761 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 22' ' ' SER . 54.9 t . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 t -108.25 124.32 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -115.5 139.71 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tt0 -110.16 146.83 34.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.368 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.95 152.99 47.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -112.07 151.57 29.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.35 128.45 51.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.869 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.2 t -120.24 130.59 74.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.22 151.94 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -114.79 126.67 55.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -83.76 150.59 25.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.136 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -55.1 -13.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.469 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.81 -4.03 57.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.665 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 4.05 79.61 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 36' ' ' LYS . 18.2 m -88.51 154.54 20.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 35' ' ' THR . 99.1 mttt -125.53 146.66 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.285 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.77 41.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.96 121.14 29.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.369 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.672 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.6 mp -107.41 11.64 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.146 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 m -57.27 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.791 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.9 p -90.49 -11.47 40.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.34 -29.69 11.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.551 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 39' ' ' LEU . 5.2 m -87.22 153.68 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 m -110.6 124.57 52.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.726 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.735 ' O ' HG11 ' A' ' 55' ' ' VAL . 29.3 m95 -94.84 133.57 38.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 55' ' ' VAL . 20.9 p -147.08 161.36 41.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 t -136.17 146.98 47.46 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.95 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.0 p -65.69 -35.78 81.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 87.8 m-20 -69.08 65.9 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.32 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' ALA . 75.5 mt-30 -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.9 t -71.45 -34.52 70.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -98.85 3.75 47.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -169.09 154.62 6.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.182 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -133.92 143.36 48.19 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.745 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 ' O ' ' A' ' 45' ' ' TRP . 98.8 t -109.61 113.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.055 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.8 p -138.76 103.1 4.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.05 121.73 42.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.656 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.7 169.6 16.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 m -55.63 -35.61 66.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.607 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 54.7 mp0 -87.31 -7.44 57.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.536 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.8 p -131.54 31.54 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.268 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 68.0 mttm -47.16 117.11 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.79 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.51 43.54 2.7 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.9 tp -118.01 122.32 42.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.767 0.317 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 55' ' ' VAL . 40.0 t -128.54 132.75 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -116.48 127.22 54.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.01 120.02 4.84 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.54 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 178.02 139.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.683 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 13.6 t -173.4 177.44 2.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.723 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -101.13 -69.42 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -133.88 81.45 52.25 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.178 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HD3' HG23 ' A' ' 90' ' ' VAL . 15.3 Cg_exo -70.29 153.41 66.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.462 2.108 . . . . 0.0 110.253 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 75' ' ' ILE . 53.1 m -119.73 112.05 18.78 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.5 mp -94.67 127.32 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.991 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.0 mt -114.53 129.73 70.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.162 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.29 125.96 43.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -114.41 125.65 54.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.8 t80 -134.33 114.29 12.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.68 -127.08 39.51 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -94.93 8.58 42.34 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.349 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.29 130.45 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.7 p -137.42 150.83 47.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.74 142.66 13.85 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.2 m-20 -108.18 140.85 40.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.265 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -132.84 155.0 49.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.247 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.34 123.49 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD12 ' CB ' ' A' ' 15' ' ' THR . 44.9 tp -114.21 128.05 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.551 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.4 m -112.12 139.85 47.29 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.9 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.52 HG23 ' HD3' ' A' ' 73' ' ' PRO . 67.5 t -82.65 102.07 8.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.961 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' ILE . 27.8 m120 . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.815 0.34 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -138.66 164.82 28.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.671 HD11 ' O ' ' A' ' 7' ' ' SER . 63.9 tp -71.52 107.62 4.51 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.62 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -75.39 -38.31 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.8 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.671 ' O ' HD11 ' A' ' 5' ' ' LEU . 32.4 p -150.49 162.75 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.69 133.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.859 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.8 t -129.5 146.58 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.65 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.84 134.45 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.67 163.55 17.9 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.438 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' SER . 6.5 Cg_endo -43.2 172.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.069 3.179 . . . . 0.0 111.283 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 82.9 mt -103.88 110.79 31.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.02 0.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' THR . 19.0 p30 35.19 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -139.79 95.7 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.122 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.66 159.29 39.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 111.653 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.744 HD11 HD21 ' A' ' 88' ' ' LEU . 96.5 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.723 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.9 0.381 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 66' ' ' THR . 58.0 m -98.14 118.98 35.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.065 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -113.12 136.81 52.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.72 143.4 41.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.53 153.93 47.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.884 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.41 147.82 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.09 129.01 56.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.905 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.88 132.42 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.499 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.77 149.52 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -120.12 125.46 48.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.43 151.07 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.11 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.4 p -53.94 -14.59 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.524 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -85.2 6.0 27.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.59 3.16 82.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 m -83.42 139.35 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.954 0.407 . . . . 0.0 110.661 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.07 147.24 44.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.369 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.12 164.71 37.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.952 0.406 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 29.1 p-10 -88.41 123.08 32.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.339 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 43' ' ' VAL . 88.9 mt -106.64 13.02 28.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -60.48 -31.59 70.61 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.87 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -90.32 -4.6 57.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.03 -27.94 9.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 39' ' ' LEU . 19.7 m -90.6 142.94 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.0 m -103.31 116.18 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.744 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.8 m95 -83.91 133.7 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.228 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -137.0 163.82 29.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -134.83 140.94 46.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.885 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -64.23 -34.57 78.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.8 m120 -83.65 71.38 10.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 53' ' ' ALA . 87.0 mt-30 -74.23 -40.38 62.45 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 m -69.91 -33.68 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.607 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -103.74 3.31 34.02 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.35 150.1 21.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.176 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.14 145.24 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.739 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.0 p -122.39 115.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 32.9 t -140.43 114.47 9.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.74 132.82 13.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.579 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.97 -177.67 2.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.1 p -57.79 -30.3 65.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.507 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.93 -12.49 44.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 52.5 p -114.74 4.06 14.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.255 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -41.16 112.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 116.41 33.37 1.47 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -117.01 121.48 41.48 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 110.627 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.0 t -124.24 134.63 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.849 HG22 ' OG ' ' A' ' 22' ' ' SER . 41.2 p -112.35 125.98 54.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.0 103.29 1.88 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.02 -44.99 99.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.733 0.301 . . . . 0.0 110.247 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 179.89 118.16 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.722 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.6 p -161.04 167.8 25.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.722 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.31 -54.16 0.91 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -149.31 81.08 7.51 Favored Pre-proline 0 C--N 1.334 -0.105 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.141 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.53 158.76 19.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 0.0 110.204 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -116.37 124.49 50.19 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 mm -100.08 121.18 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.773 HG23 ' ND2' ' A' ' 85' ' ' ASN . 80.0 mt -111.93 126.09 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.225 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 133.76 48.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -113.68 133.4 55.34 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.549 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 43' ' ' VAL . 72.9 t80 -131.56 86.41 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.677 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.95 -123.94 19.4 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -88.55 5.64 41.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.289 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -137.78 152.71 49.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.12 17.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.773 ' ND2' HG23 ' A' ' 76' ' ' ILE . 5.5 m120 -110.37 145.78 36.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.172 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.5 p -134.71 154.28 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.379 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.0 mt -100.59 121.57 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 111.177 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 17' ' ' ILE . 53.7 tp -109.47 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.6 m -117.6 138.44 51.94 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.91 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 70' ' ' SER . 88.1 t -83.4 107.76 15.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--N 1.331 -0.234 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.333 179.391 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.748 0.308 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -139.21 163.27 32.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.254 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 8' ' ' ILE . 53.3 tp -68.93 111.03 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -80.05 -46.29 16.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.815 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 p -154.17 163.15 40.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.805 ' CG2' HD21 ' A' ' 5' ' ' LEU . 32.9 pt -123.22 146.3 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.846 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 p -139.12 148.49 43.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.664 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.62 137.18 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.55 164.98 14.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.403 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.7 Cg_exo -37.49 166.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.981 3.121 . . . . 0.0 111.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' ASN . 72.3 mt -112.18 111.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 C-N-CA 123.457 0.703 . . . . 0.0 110.044 0.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' ILE . 1.4 m120 34.37 -153.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.721 0.295 . . . . 0.0 110.855 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.559 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.1 OUTLIER -136.58 96.72 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.193 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 15' ' ' THR . 79.7 m-20 -157.26 155.92 31.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.321 0.581 . . . . 0.0 111.684 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.583 ' CD1' HD21 ' A' ' 88' ' ' LEU . 2.9 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.82 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.932 0.396 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.6 p -92.29 138.06 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.05 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -131.78 139.76 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.932 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 24.0 tt0 -109.43 144.93 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.421 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -126.94 152.78 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.969 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' C ' ' HG ' ' A' ' 11' ' ' SER . 42.5 m-85 -113.24 148.79 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.09 130.26 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.916 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.43 131.04 71.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.464 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.97 17.21 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.5 m -113.89 129.47 56.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 110.488 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.51 144.0 27.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.074 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p -52.22 -14.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.49 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 49.5 t0 -79.71 -6.86 58.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 -0.59 68.95 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.7 m -86.61 160.38 18.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.883 0.373 . . . . 0.0 110.649 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.53 ' N ' HG22 ' A' ' 35' ' ' THR . 99.0 mttt -131.71 151.15 51.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.313 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.01 160.2 35.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -86.64 119.61 27.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.393 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.674 ' O ' HG13 ' A' ' 43' ' ' VAL . 91.6 mt -104.84 12.31 32.74 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.159 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -59.04 -28.2 66.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.841 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.5 p -91.32 -10.3 41.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -104.14 -27.39 12.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 79' ' ' TYR . 10.4 m -88.2 150.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.174 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -106.04 126.47 52.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 55' ' ' VAL . 49.9 m95 -97.3 135.24 39.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 m -148.14 168.88 21.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.3 t -137.93 147.36 44.27 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.79 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -68.08 -34.69 76.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 32.4 m-20 -77.57 69.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' ALA . 85.0 mt-30 -72.45 -43.2 64.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.6 p -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.54 9.91 39.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.171 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -171.11 152.91 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 45' ' ' TRP . 7.1 p -109.4 113.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.039 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -139.76 104.39 4.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.696 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.633 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -118.81 123.97 46.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.08 172.22 12.18 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -58.6 -31.03 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.609 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.38 -11.88 47.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.526 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -131.38 31.07 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.27 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.537 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.7 mttt -43.48 116.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.801 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.559 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.22 45.05 2.45 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 55.1 tp -117.25 123.27 46.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 55' ' ' VAL . 24.2 t -127.25 136.08 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -110.46 128.52 55.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.34 107.86 2.81 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.1 mt -64.35 -43.71 97.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.79 117.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.697 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.4 p -159.13 166.36 31.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.671 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 72' ' ' ASN . . . -95.08 -65.95 0.99 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 2.8 m120 -138.57 80.6 26.08 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.13 158.26 23.47 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.501 2.134 . . . . 0.0 110.286 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 m -113.29 128.28 56.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 mm -100.44 120.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mm -109.26 126.42 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.99 126.15 50.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.7 m -115.45 125.8 53.55 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.692 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.679 ' HB2' HG12 ' A' ' 43' ' ' VAL . 45.2 t80 -134.8 90.6 2.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.05 -129.81 18.58 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.9 p -87.97 3.35 49.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.307 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.71 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 p -140.98 150.15 42.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.58 142.38 14.71 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.0 OUTLIER -118.84 130.41 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 111.16 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.3 p -134.67 156.68 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.278 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.75 124.29 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' CD1' ' A' ' 17' ' ' ILE . 7.4 tt -111.55 151.32 28.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.436 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.6 m -132.72 145.3 50.92 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.974 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 70' ' ' SER . 91.2 t -83.87 127.19 40.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.919 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.356 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -130.36 164.4 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.312 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 5' ' ' LEU . 47.9 tp -81.03 107.76 14.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.563 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.776 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.67 162.98 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.893 0.378 . . . . 0.0 110.819 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -125.05 133.97 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 t -132.91 148.49 52.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.58 130.71 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.1 162.75 19.58 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 8.1 Cg_endo -44.11 172.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 124.038 3.159 . . . . 0.0 111.348 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 14' ' ' ASN . 76.5 mt -102.53 118.23 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.487 0.715 . . . . 0.0 109.958 0.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 t-20 30.61 -146.59 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.754 0.312 . . . . 0.0 110.911 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 p -152.88 95.4 1.98 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.06 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.96 160.75 43.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 90' ' ' VAL . 97.5 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.791 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -96.95 123.62 40.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 64.5 tttm -112.78 144.03 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -110.37 143.46 40.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.36 151.57 49.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.898 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' A' ' 11' ' ' SER . 56.8 m-85 -113.7 155.41 25.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.718 0.294 . . . . 0.0 110.907 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.1 130.64 53.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.925 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.3 t -113.44 131.03 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.76 151.22 17.27 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 m -117.84 126.07 51.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -81.16 151.57 28.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.102 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.1 p -55.3 -18.25 6.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -76.67 -4.1 41.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.42 0.23 82.55 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 36' ' ' LYS . 92.5 m -83.39 162.09 21.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -131.1 148.68 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.355 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.68 20.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -78.1 124.96 28.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 43' ' ' VAL . 93.9 mt -108.8 13.48 24.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.9 m -60.83 -30.14 69.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.809 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -90.85 -9.54 45.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.253 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.08 -26.57 13.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 39' ' ' LEU . 13.8 m -91.09 152.02 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.228 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -109.88 123.5 49.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.684 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.54 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 22.8 m95 -93.58 137.49 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.9 t -145.03 167.75 21.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.017 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -142.23 139.95 32.14 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.862 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.2 -26.38 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -78.79 65.16 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.336 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 88.6 mt-30 -67.15 -49.84 63.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.8 p -71.71 -33.67 68.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.612 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -93.65 -2.43 54.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.73 151.76 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.156 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -131.23 136.42 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.71 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 55' ' ' VAL . 3.9 p -107.83 113.07 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -138.71 104.12 5.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.874 HD22 ' H ' ' A' ' 63' ' ' GLY . 29.9 p30 -132.45 128.23 37.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.664 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.72 -177.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 t -61.84 -42.33 98.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.649 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.9 mp0 -83.16 -12.41 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.532 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.2 p -110.73 8.88 22.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.185 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -41.58 112.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.73 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.874 ' H ' HD22 ' A' ' 57' ' ' ASN . . . 114.4 31.18 2.25 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.04 122.15 41.49 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.703 0.287 . . . . 0.0 110.573 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.32 134.4 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -104.74 125.72 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.04 102.86 2.39 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 93.9 mt -62.32 -44.77 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.71 0.291 . . . . 0.0 110.264 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 173.4 118.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -162.43 167.02 24.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.25 -67.18 0.83 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -128.24 81.16 71.04 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.06 159.26 15.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.43 2.087 . . . . 0.0 110.149 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -123.22 129.58 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.4 mm -102.11 129.59 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.806 HG23 ' ND2' ' A' ' 85' ' ' ASN . 86.3 mt -115.79 126.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.51 135.92 43.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.5 m -121.81 128.44 51.68 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.682 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' HB2' HG12 ' A' ' 43' ' ' VAL . 65.6 t80 -128.94 88.75 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.63 -119.8 11.81 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.9 p -91.62 1.16 57.34 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.317 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.21 132.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.6 p -135.44 154.09 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.05 146.93 18.51 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.806 ' ND2' HG23 ' A' ' 76' ' ' ILE . 5.7 m120 -110.89 144.72 39.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.216 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.8 p -134.05 158.54 43.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.9 mm -98.64 124.55 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.016 0.436 . . . . 0.0 111.134 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 17' ' ' ILE . 50.9 tp -114.15 135.02 54.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.504 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -125.75 132.13 52.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.893 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.631 HG22 HD12 ' A' ' 17' ' ' ILE . 89.6 t -84.05 109.16 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.952 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.353 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.847 0.356 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -91.13 163.89 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.262 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mt -81.79 124.05 29.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.555 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -74.35 -41.0 61.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.4 p -157.26 161.84 39.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.2 tt -124.67 128.71 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.886 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -134.24 150.28 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.55 147.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.061 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.32 165.1 15.06 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 120.8 0.333 . . . . 0.0 111.376 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' SER . 52.0 Cg_exo -37.35 164.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 124.02 3.147 . . . . 0.0 111.384 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.5 mm -110.2 127.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.476 0.71 . . . . 0.0 109.952 0.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 13' ' ' ILE . 43.6 t30 29.72 -139.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -135.05 93.98 3.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 20.5 p30 -158.02 162.0 38.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 111.674 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.805 179.652 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 22' ' ' SER . 33.7 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.892 0.377 . . . . 0.0 111.395 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.687 ' N ' HG12 ' A' ' 21' ' ' VAL . 24.0 m -110.42 147.59 33.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -122.65 147.15 46.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.0 tt0 -111.52 145.19 39.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.42 149.67 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.884 179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -110.18 147.86 32.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.937 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.87 128.86 56.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.889 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.71 131.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.431 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.02 149.07 18.0 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -117.2 126.02 52.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 110.43 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -84.63 147.68 26.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -53.26 -15.22 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.41 -1.65 46.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.557 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.96 88.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -85.62 142.47 29.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 0.0 110.593 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.37 148.97 41.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.363 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.59 152.44 16.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -77.64 124.69 28.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.697 ' O ' HG13 ' A' ' 43' ' ' VAL . 72.9 mt -106.03 13.63 28.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.43 -29.28 69.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 0.0 109.879 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 p -86.93 -18.33 31.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -30.28 12.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.532 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.0 m -87.29 141.35 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.15 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.3 m -101.06 124.23 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.657 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.669 ' O ' HG11 ' A' ' 55' ' ' VAL . 25.4 m95 -91.74 133.13 35.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.225 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -147.74 163.37 36.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t -137.41 148.73 46.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.2 p -68.32 -25.63 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.8 m120 -87.58 69.64 9.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.8 mm-40 -78.34 -36.33 46.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 m -69.69 -34.37 73.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.652 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -104.15 8.47 36.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.89 153.57 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.199 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -130.23 137.17 49.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.887 0.375 . . . . 0.0 110.808 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 45' ' ' TRP . 57.6 t -107.76 113.14 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.021 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -140.17 104.4 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.799 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.48 125.16 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.42 8.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 m -58.92 -38.79 79.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.626 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -86.65 -19.21 29.62 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.496 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.8 p -109.58 21.87 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.359 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.579 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 35.8 pttt -40.71 118.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 47.63 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 42.1 tp -121.45 116.97 25.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.624 HG22 HG22 ' A' ' 55' ' ' VAL . 38.9 t -123.23 134.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.0 130.48 48.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.87 135.11 12.54 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 91.4 mt -99.64 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 110.33 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -175.88 120.11 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 90' ' ' VAL . 7.8 p -161.74 175.24 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.58 -79.25 1.45 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -126.58 81.42 68.42 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 90' ' ' VAL . 21.1 Cg_exo -68.39 150.37 75.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.511 2.141 . . . . 0.0 110.171 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -116.62 113.13 22.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.186 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 88' ' ' LEU . 8.3 mm -86.47 126.14 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 85' ' ' ASN . 98.1 mt -120.08 122.78 69.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.123 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.68 129.1 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.5 m -119.14 132.75 56.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.663 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.696 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.2 t80 -137.76 91.57 2.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.752 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.4 -122.29 26.47 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.5 p -90.54 4.11 52.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.376 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.64 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.0 p -147.86 153.54 39.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.46 141.06 12.37 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.699 ' OD1' HG23 ' A' ' 76' ' ' ILE . 9.1 m-20 -115.55 148.81 39.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.969 0.414 . . . . 0.0 111.143 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 t -149.86 154.92 39.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.705 ' C ' HD12 ' A' ' 88' ' ' LEU . 71.4 mt -102.9 126.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 111.09 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 87' ' ' ILE . 11.1 mp -118.82 149.56 41.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.555 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 m -114.58 146.75 40.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.019 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.559 HG21 ' OG ' ' A' ' 70' ' ' SER . 61.4 t -82.78 103.52 10.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.005 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p30 . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.387 179.486 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.824 0.345 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -100.37 164.48 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.508 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -76.76 125.92 30.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.407 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -85.77 -45.71 11.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.9 p -155.48 166.82 32.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.351 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.3 pt -119.25 147.22 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.1 m -134.05 149.22 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.677 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.04 128.61 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.759 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.35 165.87 13.34 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.577 -178.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.496 ' C ' HD12 ' A' ' 13' ' ' ILE . 59.7 Cg_exo -39.06 166.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.581 2.854 . . . . 0.0 112.058 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 13' ' ' ILE . 2.4 mp -104.55 110.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 110.402 -0.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ILE . 27.2 p30 31.41 -149.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 O-C-N 123.919 0.762 . . . . 0.0 110.717 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 95.99 2.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -154.99 161.76 41.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.785 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 90' ' ' VAL . 95.7 mt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 22' ' ' SER . 60.7 t . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.918 0.389 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 32.8 t -110.76 127.91 55.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.731 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -117.65 142.21 47.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 20.5 tt0 -108.92 144.5 36.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.86 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.13 150.18 50.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.984 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.49 ' C ' ' HG ' ' A' ' 11' ' ' SER . 49.5 m-85 -115.52 143.4 45.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.667 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.72 128.12 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.868 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -112.29 128.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.4 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.91 144.8 15.85 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -115.27 125.86 53.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.914 0.388 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.407 ' C ' ' N ' ' A' ' 33' ' ' ASP . 85.0 m-85 -86.2 147.86 25.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.295 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -54.38 -10.24 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 31' ' ' TYR . 31.2 t0 -84.23 -3.64 58.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.597 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.29 3.56 81.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 36' ' ' LYS . 31.9 m -83.18 154.91 24.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 35' ' ' THR . 27.8 mmtp -122.35 141.23 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 150.21 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' LEU . 48.4 t0 -85.84 118.86 25.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.7 mp -106.15 8.97 32.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.2 m -49.86 -33.61 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.7 p -87.53 -13.05 44.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.304 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.506 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -97.84 -23.25 15.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.9 m -96.95 138.47 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.381 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -99.09 125.22 44.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.835 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 20.5 m95 -93.57 139.49 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.531 ' HA ' HG21 ' A' ' 55' ' ' VAL . 30.4 p -151.45 165.79 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.146 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -136.39 144.33 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.33 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -65.03 -32.56 74.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 71.6 m-20 -77.52 66.53 3.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -68.87 -43.95 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.01 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.7 p -70.11 -32.92 71.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.326 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -102.73 2.48 35.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.326 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -160.78 150.33 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.298 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -132.46 138.51 47.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.763 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 65' ' ' VAL . 97.6 t -107.82 113.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -137.9 106.47 5.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.903 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.85 HD22 ' H ' ' A' ' 63' ' ' GLY . 33.6 p30 -133.03 126.01 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 111.105 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.06 171.53 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.8 p -59.11 -28.06 66.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.293 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -85.82 -11.53 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.639 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.2 p -130.47 31.47 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.464 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.6 mttt -48.01 125.46 9.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.044 0.449 . . . . 0.0 110.949 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.85 ' H ' HD22 ' A' ' 57' ' ' ASN . . . 95.47 40.05 4.29 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.045 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.505 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 31.3 tp -117.54 122.63 44.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.908 0.354 . . . . 0.0 110.522 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 55' ' ' VAL . 43.0 t -129.8 137.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.271 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -119.05 127.03 53.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.91 119.3 6.47 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.7 mt -64.29 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 172.35 120.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -162.17 172.72 15.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -61.49 0.76 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.68 82.17 51.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.567 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.441 ' HB3' HD22 ' A' ' 49' ' ' ASN . 73.7 Cg_endo -80.82 159.52 21.4 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.501 2.134 . . . . 0.0 110.828 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -124.51 127.22 47.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.218 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.6 mm -100.06 126.02 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.945 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mm -108.07 122.97 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.121 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.16 118.62 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.724 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -114.26 124.59 52.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.617 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.5 t80 -128.29 117.1 20.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.35 -124.63 33.76 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -98.03 5.93 48.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.01 131.23 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 110.659 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -135.91 153.48 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.15 155.73 22.22 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.7 m-20 -114.37 147.33 39.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.853 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.9 p -135.02 155.4 50.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.066 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -96.97 121.59 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.962 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.71 134.44 54.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 m -124.31 137.7 54.46 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.966 0.412 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.648 HG22 HD12 ' A' ' 17' ' ' ILE . 67.6 t -85.5 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.215 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' ILE . 63.7 t30 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.535 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.369 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 p -132.3 162.43 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.45 103.97 2.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.707 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.412 ' N ' HD13 ' A' ' 5' ' ' LEU . 4.5 t -75.47 -49.01 20.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 p -152.2 151.56 31.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.69 134.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.854 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 m -130.87 149.25 52.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.582 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.75 134.69 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.01 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.1 164.76 15.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.843 0.354 . . . . 0.0 111.327 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -37.91 157.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.005 3.136 . . . . 0.0 111.373 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.8 mm -85.78 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 123.536 0.734 . . . . 0.0 109.985 0.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -38.46 -92.65 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.702 0.287 . . . . 0.0 110.919 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -150.26 93.78 2.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.079 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 64.2 t30 -156.02 129.02 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 111.653 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.832 -179.591 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.888 0.375 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -110.38 128.91 55.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.084 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -113.3 145.83 40.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.032 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.2 tt0 -110.09 143.88 39.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.54 153.13 47.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -114.58 149.84 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.909 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.57 127.49 54.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.918 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.9 t -114.37 130.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.5 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.48 148.28 16.96 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 m -114.26 128.19 56.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.451 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -83.73 149.75 26.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.059 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -55.85 -16.28 4.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.407 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.79 -1.56 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.582 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.52 83.05 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 36' ' ' LYS . 21.2 m -86.3 156.85 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.846 0.355 . . . . 0.0 110.681 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mttp -130.81 151.89 50.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.02 158.55 28.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -80.74 120.95 25.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.357 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 43' ' ' VAL . 81.4 mt -104.8 5.54 33.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.165 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -57.09 -21.94 35.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 0.0 109.896 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.3 p -94.38 -11.38 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.261 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -107.06 -27.63 10.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 79' ' ' TYR . 5.1 m -85.77 143.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.6 m -102.06 123.43 45.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.787 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.572 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 30.6 m95 -92.57 135.44 34.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.31 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -149.03 163.6 37.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.0 t -139.24 146.41 40.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.815 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.2 p -66.28 -33.19 75.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.341 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -78.34 68.97 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.377 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' ALA . 97.9 mt-30 -77.25 -38.18 51.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -72.28 -34.01 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.604 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -98.45 3.76 48.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.01 159.07 5.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.158 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.41 147.74 52.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.701 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.8 p -117.36 113.1 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.023 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -140.11 104.86 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.776 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.574 ' CG ' ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -116.94 124.14 48.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.54 170.75 13.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -56.73 -33.61 66.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.508 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.56 -10.51 48.55 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.527 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.0 p -130.03 32.21 4.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.228 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -47.19 121.36 3.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.818 -179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 93.64 47.34 2.99 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.574 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 45.9 tp -118.92 120.41 37.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -126.56 135.46 63.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -113.01 130.59 56.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.05 110.94 2.87 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.04 -43.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.38 118.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.772 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.763 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.5 p -160.42 166.26 29.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.719 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.46 -48.02 1.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -157.29 81.87 3.18 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.44 158.61 17.02 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.468 2.112 . . . . 0.0 110.238 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.4 m -114.26 130.09 56.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -98.92 119.81 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.012 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.495 HG23 ' OD1' ' A' ' 85' ' ' ASN . 3.8 mp -102.86 118.32 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.136 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.48 121.32 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -108.65 129.41 55.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.662 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.689 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.3 t80 -139.8 96.22 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.16 -125.55 36.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.2 p -91.77 6.74 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.319 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.48 132.43 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.3 p -137.22 157.06 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.39 147.57 19.16 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 76' ' ' ILE . 4.2 m-80 -131.99 133.38 44.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.439 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.2 p -131.54 160.4 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.304 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.429 ' C ' HD22 ' A' ' 88' ' ' LEU . 96.1 mt -98.98 121.96 50.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.18 0.514 . . . . 0.0 111.062 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 88' ' ' LEU . 4.4 mm? -100.73 134.32 43.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.514 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.52 ' N ' ' OG1' ' A' ' 15' ' ' THR . 93.5 m -110.94 134.03 52.9 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.915 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.763 HG21 ' O ' ' A' ' 70' ' ' SER . 83.6 t -82.84 100.78 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.898 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 14.0 t-20 . . . . . 0 C--N 1.329 -0.306 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.343 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.857 0.36 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -139.6 162.71 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.285 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.2 tp -84.16 108.4 17.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 m -76.65 -48.04 20.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.828 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -155.74 164.12 38.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.76 ' CG2' HD21 ' A' ' 5' ' ' LEU . 36.9 pt -124.99 144.25 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.843 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.0 t -136.72 146.11 45.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.494 HG13 HG21 ' A' ' 86' ' ' THR . 11.3 mm -93.67 139.75 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.967 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -98.68 165.24 15.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.2 Cg_exo -38.25 166.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 124.017 3.145 . . . . 0.0 111.402 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' ASN . 95.9 mt -111.55 116.55 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 118.753 0.706 . . . . 0.0 109.995 0.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' ILE . 68.5 m-20 33.13 -134.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.872 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.41 93.74 2.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.113 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 52.7 p30 -157.37 147.1 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 111.718 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.805 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -98.67 148.61 23.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.085 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 88.7 tttt -137.95 137.84 38.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.931 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.0 143.9 37.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.7 152.61 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.8 153.05 27.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.949 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.3 129.55 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.867 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.23 131.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.461 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.72 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.5 m -118.51 128.42 54.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 0.0 110.364 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.24 149.31 25.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.116 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -54.42 -15.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.495 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.56 -1.58 38.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.66 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.68 86.73 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 36' ' ' LYS . 17.3 m -86.09 156.59 20.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 110.582 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 35' ' ' THR . 98.6 mttt -128.27 150.46 50.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.395 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.36 17.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 42.3 p-10 -77.19 126.01 30.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.423 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 43' ' ' VAL . 69.4 mt -109.78 14.31 23.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 m -59.78 -30.08 68.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.087 0.47 . . . . 0.0 109.898 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.2 p -90.33 -10.42 44.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.17 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 -26.16 13.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.9 m -93.05 151.45 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -108.63 123.74 49.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.591 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 31.9 m95 -93.85 138.82 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 p -151.05 160.56 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.984 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.4 t -132.13 143.46 50.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.847 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -61.66 -32.94 73.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.698 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.3 m120 -75.83 63.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -69.97 -42.71 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -34.19 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.691 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -104.15 2.41 31.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -157.32 148.99 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.198 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.76 141.71 46.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.925 0.393 . . . . 0.0 110.694 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.0 p -112.09 114.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.993 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.5 t -139.55 108.48 6.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -147.75 132.84 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.654 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.495 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.93 178.43 4.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.8 m -54.39 -35.58 63.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.617 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.42 -24.68 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.487 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 61.4 p -104.6 16.47 26.01 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.224 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -49.59 120.55 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.784 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.531 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 104.36 32.34 4.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 65' ' ' VAL . 2.2 tt -118.24 118.05 30.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 64' ' ' LEU . 40.7 t -122.24 134.5 65.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 p -105.3 132.12 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.46 108.24 2.41 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 90.5 mt -64.53 -42.92 96.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.304 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.37 119.75 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.645 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 p -163.2 166.0 23.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.52 -71.41 1.1 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.647 ' ND2' HG23 ' A' ' 89' ' ' THR . 19.5 m120 -128.37 83.07 67.22 Favored Pre-proline 0 C--N 1.333 -0.146 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 90' ' ' VAL . 57.4 Cg_endo -82.58 158.57 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.532 2.155 . . . . 0.0 110.225 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.511 ' C ' HD12 ' A' ' 75' ' ' ILE . 52.4 m -118.88 126.88 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.0 mp -101.05 126.1 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.882 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.751 HG23 ' OD1' ' A' ' 85' ' ' ASN . 89.3 mt -114.97 128.73 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.144 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.7 132.86 49.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -119.0 130.48 55.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.562 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.697 ' HB2' HG12 ' A' ' 43' ' ' VAL . 62.1 t80 -139.72 106.7 5.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.722 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.68 -125.08 31.41 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.7 p -92.6 8.21 39.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.371 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 135.74 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.6 p -146.89 151.82 37.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.986 0.422 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.73 146.57 18.37 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.751 ' OD1' HG23 ' A' ' 76' ' ' ILE . 5.5 m-20 -125.02 137.5 54.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.01 0.433 . . . . 0.0 111.237 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 HG13 ' A' ' 10' ' ' ILE . 71.9 p -135.58 157.03 47.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.305 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.1 mm -96.72 127.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.013 0.435 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.73 147.7 37.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.571 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.647 HG23 ' ND2' ' A' ' 72' ' ' ASN . 91.2 m -125.49 132.34 52.67 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.917 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.443 HG23 ' CD ' ' A' ' 73' ' ' PRO . 96.5 t -83.48 107.86 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.895 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.372 179.608 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.778 0.323 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -139.28 163.23 33.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.91 112.16 9.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.302 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -74.92 -42.72 57.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 p -153.26 163.54 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.3 tt -119.13 134.4 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 t -131.78 148.03 52.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.745 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 mt -113.11 129.51 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.972 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.75 164.74 15.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -39.51 157.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.349 2.699 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 14' ' ' ASN . 89.9 mt -87.02 156.54 3.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 C-N-CA 123.998 0.919 . . . . 0.0 110.444 1.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 13' ' ' ILE . 98.9 m-20 -42.51 -97.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.725 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -165.89 96.13 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.355 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 81.9 m-20 -154.75 147.5 24.36 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.692 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 88' ' ' LEU . 51.6 mm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.757 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 22' ' ' SER . 79.0 t . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.022 0.439 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.539 ' N ' HG12 ' A' ' 21' ' ' VAL . 6.6 m -110.2 122.37 47.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.631 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HZ3' ' H ' ' A' ' 16' ' ' ASN . 29.5 ttpt -112.46 137.68 50.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 15.0 tt0 -110.05 141.79 42.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.847 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.23 152.01 48.59 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.068 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.35 147.28 37.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.7 127.6 55.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.738 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.5 129.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.156 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.64 17.25 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 m -116.87 127.44 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.25 146.73 28.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 p -54.12 -16.81 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -78.73 -3.73 45.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.7 78.55 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 36' ' ' LYS . 24.1 m -83.21 157.32 22.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.738 0.304 . . . . 0.0 110.799 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' THR . 53.6 mtmt -130.55 149.22 52.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.28 152.24 20.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.69 122.35 26.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.2 mt -105.49 7.9 33.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.5 m -55.74 -31.9 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.6 p -88.28 -9.92 51.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 -29.09 11.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.599 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.575 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -87.37 147.93 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.268 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.7 m -106.78 117.9 35.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.822 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m95 -87.41 140.1 29.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -147.75 164.96 31.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.161 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -135.45 143.61 46.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.327 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.67 -33.03 74.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.348 0.595 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.682 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 96.2 m-20 -80.72 65.0 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 94.2 mm-40 -69.08 -43.81 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.466 . . . . 0.0 109.888 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.6 p -70.81 -33.14 70.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.937 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 79.3 mt-30 -104.0 9.38 36.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.505 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.59 153.98 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.73 142.86 48.14 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.4 p -119.49 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -138.24 108.78 6.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.54 ' HB3' ' H ' ' A' ' 64' ' ' LEU . 16.0 p30 -132.66 128.8 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 -179.45 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.553 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.0 p -64.33 -16.91 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.388 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -89.08 -35.27 16.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 p -114.96 31.04 6.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.601 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -41.36 120.85 1.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 110.91 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.93 49.25 2.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.54 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 44.6 tp -118.52 121.24 39.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.648 0.261 . . . . 0.0 110.535 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.36 133.55 67.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -118.72 129.18 55.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.784 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.66 8.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.0 mt -90.61 -40.96 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.574 0.226 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . . . -122.75 152.52 40.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -80.45 167.72 19.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.89 -136.1 7.78 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -130.06 81.13 69.57 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.573 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.79 153.98 58.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.867 2.378 . . . . 0.0 110.368 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -126.81 122.7 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -93.0 130.32 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' OD1' ' A' ' 85' ' ' ASN . 94.4 mt -120.86 119.75 60.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.123 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.04 123.47 45.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -115.77 126.4 53.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 43' ' ' VAL . 83.9 t80 -129.69 103.69 6.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.982 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.63 -122.32 27.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -92.24 4.87 52.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.544 0.211 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.48 129.88 74.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 89.9 p -137.81 150.52 47.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.24 142.7 14.19 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 76' ' ' ILE . 64.8 m-20 -109.98 144.92 37.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 p -132.99 155.62 48.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.14 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.56 127.57 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.941 0.401 . . . . 0.0 111.13 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 17' ' ' ILE . 41.9 tp -104.81 134.64 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.709 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.5 m -113.25 128.98 56.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 111.403 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.14 106.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.133 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.54 HD21 ' CG ' ' A' ' 16' ' ' ASN . 25.3 p-10 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.352 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.52 97.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.03 144.16 48.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.534 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.1 p -128.77 162.39 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.453 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.1 112.17 2.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.449 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.4 t -74.66 -42.18 58.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 p -153.15 160.59 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.759 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.9 tt -114.26 133.37 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.032 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.3 m -132.57 148.57 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.348 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mt -111.59 132.38 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.029 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 163.85 17.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.341 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -43.49 167.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 123.581 2.854 . . . . 0.0 112.13 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 14' ' ' ASN . 4.7 mm -87.44 162.17 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 110.234 1.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' N ' HG22 ' A' ' 13' ' ' ILE . 94.1 m-20 -48.92 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.797 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 p -85.7 96.03 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' H ' ' NZ ' ' A' ' 23' ' ' LYS . 79.4 m-20 -155.25 143.33 20.1 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.667 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.92 133.13 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.631 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -82.35 165.02 20.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.744 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 p -39.04 -69.17 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 20' ' ' THR . 35.1 m -150.5 59.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' N ' ' A' ' 22' ' ' SER . 19.1 t -130.38 171.3 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.652 ' N ' HG12 ' A' ' 21' ' ' VAL . 26.3 p -88.93 150.13 22.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.183 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' NZ ' ' H ' ' A' ' 16' ' ' ASN . 83.9 tttt -136.7 128.87 29.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.452 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -110.06 144.64 38.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.166 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.45 151.03 49.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -111.42 146.79 36.55 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.915 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.74 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.742 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.65 132.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.413 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.09 146.89 16.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -114.79 125.89 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 110.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -83.59 148.5 27.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.024 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.0 p -55.09 -14.82 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.492 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -80.81 -2.34 46.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.626 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.7 83.59 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 36' ' ' LYS . 20.4 m -86.35 157.37 19.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.868 0.366 . . . . 0.0 110.865 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.464 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -130.31 149.71 51.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.394 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.34 153.87 28.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -85.55 122.01 29.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' HG13 ' A' ' 43' ' ' VAL . 92.4 mt -104.48 2.18 30.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.46 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.2 m -45.72 -33.25 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.438 . . . . 0.0 110.286 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.4 p -88.15 -19.01 27.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.71 -21.75 19.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.635 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.3 m -98.21 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.328 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.3 m -103.38 122.99 45.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.711 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 12.6 m95 -92.33 141.42 28.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -153.41 166.54 32.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.989 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -132.32 140.29 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -40.0 87.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -89.4 87.59 7.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.171 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -81.53 -25.78 35.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.18 0.514 . . . . 0.0 109.801 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.0 t -69.43 -34.47 74.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -100.55 2.79 42.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.235 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.68 146.43 13.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.29 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -128.07 138.37 52.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 65' ' ' VAL . 47.2 t -111.67 113.19 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.779 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -141.29 114.99 9.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -156.1 133.91 11.13 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.955 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -69.97 -178.28 1.54 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.614 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -59.19 -33.52 71.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.642 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -85.78 -7.07 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.759 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 21.5 p -118.1 0.2 11.75 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.628 0.251 . . . . 0.0 111.268 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -41.42 114.16 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.573 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.91 27.69 2.44 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.697 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 2.6 tp -117.88 120.67 38.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.914 0.388 . . . . 0.0 110.535 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 55' ' ' VAL . 54.8 t -130.07 134.77 62.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.069 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -111.95 126.44 55.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -122.96 109.51 1.38 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.758 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.8 mt -64.58 -45.89 94.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.251 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 161.89 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.8 p -137.86 -2.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.6 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.22 3.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -154.17 80.63 4.78 Favored Pre-proline 0 N--CA 1.453 -0.29 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.203 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.16 147.53 16.43 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.797 2.331 . . . . 0.0 110.725 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.9 m -120.81 120.33 35.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.465 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.45 ' CG1' HD22 ' A' ' 88' ' ' LEU . 33.4 mm -97.49 126.36 50.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.471 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.871 HG23 ' ND2' ' A' ' 85' ' ' ASN . 91.6 mt -110.37 127.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.067 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.84 128.2 52.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.8 m -118.94 126.28 51.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.0 t80 -129.85 103.28 6.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.114 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.51 -123.87 31.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.0 p -91.2 6.12 46.36 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.828 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.82 133.57 69.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.707 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 99.4 p -140.36 152.07 45.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.35 142.05 13.4 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.871 ' ND2' HG23 ' A' ' 76' ' ' ILE . 9.8 m120 -108.88 142.29 39.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 110.767 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t -142.36 150.88 41.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.821 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 88' ' ' LEU . 73.4 mt -108.52 128.49 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.305 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 88' ' ' LEU . 11.1 mp -103.66 133.15 49.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.927 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -96.99 142.64 28.71 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.586 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 89.8 t -84.69 106.16 14.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.201 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 16.5 m120 -140.12 117.94 11.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.509 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -93.76 136.14 34.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.603 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.6 p -66.48 -36.77 83.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.418 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -161.51 163.04 30.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.54 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.518 179.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -62.56 -41.29 98.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.701 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 51.62 175.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.422 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.3 p -131.01 163.8 26.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.603 ' C ' HD13 ' A' ' 5' ' ' LEU . 3.1 tm? -81.22 111.08 17.31 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.49 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -77.53 -53.52 7.51 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.468 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.7 p -145.81 156.56 43.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' ILE . 19.5 tt -127.8 130.34 70.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.013 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.8 p -133.01 148.39 52.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -95.76 140.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.053 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 163.79 17.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -37.16 155.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.41 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.1 mm -86.63 159.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 C-N-CA 123.928 0.891 . . . . 0.0 110.083 1.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 15' ' ' THR . 5.0 p30 -41.13 -98.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.979 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -153.84 94.39 1.76 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.109 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.425 HD22 ' HB2' ' A' ' 91' ' ' ASN . 29.0 m120 -156.36 140.63 16.58 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.663 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mm -120.79 131.98 71.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.406 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -82.2 167.13 19.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 20' ' ' THR . 80.4 p -37.47 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.457 ' N ' ' OG1' ' A' ' 19' ' ' THR . 79.3 p -134.3 62.47 1.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.06 163.13 32.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.231 0.538 . . . . 0.0 110.872 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.426 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 3.8 m -88.36 142.72 27.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.411 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -134.89 130.04 35.32 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 110.62 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -109.74 144.83 37.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.38 153.43 47.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.115 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -111.06 152.2 27.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.63 128.94 55.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.685 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.67 133.51 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.186 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.36 151.59 18.48 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.7 m -118.84 127.77 53.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.922 0.392 . . . . 0.0 110.577 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -84.43 151.54 24.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.109 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.6 p -54.54 -14.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.519 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.91 0.85 37.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.52 3.06 90.67 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.524 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.6 m -86.13 160.21 19.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.334 . . . . 0.0 110.696 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.524 ' N ' HG22 ' A' ' 35' ' ' THR . 99.5 mttt -130.85 151.94 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.93 152.71 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 44.1 p-10 -80.85 124.27 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.658 ' O ' HG13 ' A' ' 43' ' ' VAL . 65.9 mt -112.45 12.58 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.0 m -58.2 -34.88 70.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 81.9 p -88.76 -7.86 55.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.56 -29.09 11.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.918 0.389 . . . . 0.0 110.719 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 79' ' ' TYR . 7.2 m -89.9 152.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.214 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 m -107.13 126.42 52.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.798 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.561 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 33.8 m95 -95.55 134.74 38.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.517 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.5 t -141.56 150.64 42.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -120.2 141.16 50.17 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.179 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.9 p -67.08 -32.96 74.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 83.6 m-20 -84.9 69.75 10.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.333 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.13 -38.82 72.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -68.57 -34.82 76.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.135 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -107.4 9.58 29.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.234 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.89 144.44 16.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.097 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -129.33 145.74 51.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.882 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.6 p -125.88 114.41 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.031 0.443 . . . . 0.0 110.037 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.0 t -139.29 105.92 5.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.759 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.81 130.66 18.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.091 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -67.64 -175.11 0.49 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.52 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.6 t -59.84 -35.82 75.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.474 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -83.97 -18.87 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 34.8 p -103.31 3.58 35.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.09 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -41.1 114.2 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.769 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.83 29.54 2.82 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -115.3 114.69 25.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.195 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' N ' HD13 ' A' ' 64' ' ' LEU . 46.7 t -128.06 136.6 59.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.426 ' HG1' ' HG ' ' A' ' 22' ' ' SER . 51.8 m -112.65 127.74 56.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.795 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.02 106.5 3.1 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 36.4 mm -63.99 -43.83 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.195 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 128.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 90' ' ' VAL . 25.0 t -167.54 -177.44 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.638 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' ND2' ' A' ' 72' ' ' ASN . . . -114.23 -53.24 0.43 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 71' ' ' GLY . 23.5 m120 -142.79 82.73 12.08 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.461 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.29 155.65 16.79 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.94 2.426 . . . . 0.0 110.618 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.0 m -124.51 121.85 35.97 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.818 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.432 HG12 HD12 ' A' ' 88' ' ' LEU . 38.9 mm -101.82 129.14 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.258 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.8 mt -116.59 128.79 73.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.79 132.04 45.38 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.8 m -121.08 129.03 53.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.966 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.709 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.5 t80 -138.27 113.18 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.3 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 51.76 -125.61 27.04 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.5 p -93.97 8.59 40.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.938 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.78 132.07 70.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -136.7 153.9 50.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.871 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.4 143.39 14.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.654 ' OD1' HG23 ' A' ' 76' ' ' ILE . 10.2 m-20 -115.1 142.77 46.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.985 0.421 . . . . 0.0 111.069 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -143.78 144.04 31.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.055 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.4 mt -102.89 128.12 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 110.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD12 HG12 ' A' ' 75' ' ' ILE . 56.1 mt -112.12 149.29 32.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.1 m -118.66 143.42 46.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.958 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 91' ' ' ASN . 72.8 t -86.86 104.81 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.526 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 99.3 m-20 -140.73 143.21 34.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.439 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.5 135.45 38.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.396 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 94' ' ' ASP . 29.3 p -103.14 -68.89 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' N ' ' OG1' ' A' ' 93' ' ' THR . 67.5 t0 -78.66 90.58 4.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.598 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.82 94.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.84 162.43 32.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.6 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -135.75 163.87 29.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.245 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -68.43 110.93 4.37 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 t -74.98 -42.01 58.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 p -153.96 160.79 42.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.3 tt -120.44 127.97 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -130.28 149.62 51.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.608 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 mt -100.0 134.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.051 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.06 163.62 17.98 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.885 0.374 . . . . 0.0 111.338 -178.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.422 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 Cg_endo -43.87 172.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 124.083 3.189 . . . . 0.0 111.292 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' CE ' ' A' ' 23' ' ' LYS . 75.9 mt -102.63 110.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.581 0.753 . . . . 0.0 109.956 0.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.7 m120 35.78 -153.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.912 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.2 p -144.59 95.74 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.155 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -152.94 160.49 43.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 90' ' ' VAL . 89.6 mt -137.26 129.94 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.809 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 93' ' ' THR . 73.2 m-20 -102.48 165.39 11.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 0.0 110.783 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 21' ' ' VAL . 67.5 p -38.26 113.07 0.26 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.555 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m 39.68 61.97 1.3 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.034 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 19' ' ' THR . 84.9 t -131.46 138.83 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.332 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -90.39 147.64 23.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.135 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' CE ' ' O ' ' A' ' 13' ' ' ILE . 63.6 tttm -141.8 132.46 25.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -109.84 142.55 40.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.86 152.72 47.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.808 179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.08 153.9 27.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.951 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.17 129.94 55.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.911 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.53 130.14 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.468 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.6 148.59 16.79 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.0 m -113.9 125.88 54.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.443 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -81.19 146.09 30.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.145 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.5 p -51.93 -20.38 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.398 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.85 -5.54 44.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -0.36 76.75 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 36' ' ' LYS . 6.7 m -85.55 156.38 20.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.555 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 35' ' ' THR . 99.5 mttt -126.37 153.17 45.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.12 157.77 21.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.756 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -82.55 129.19 34.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.332 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.665 ' O ' HG13 ' A' ' 43' ' ' VAL . 95.3 mt -113.7 11.97 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.159 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.6 m -59.89 -31.61 69.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.5 p -90.93 -6.6 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.125 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -105.74 -27.48 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.566 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.4 m -90.52 155.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.242 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.9 m -111.62 124.14 51.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.583 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 26.7 m95 -96.1 137.82 34.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.214 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.6 p -145.67 161.37 40.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.935 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.1 t -133.82 146.16 50.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.95 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.1 p -69.29 -31.61 70.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 80.3 m-20 -77.87 64.09 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -69.6 -42.25 74.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -72.69 -33.79 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.667 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -102.88 9.28 38.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.258 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -168.82 148.58 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.12 144.42 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.954 0.407 . . . . 0.0 110.699 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 55' ' ' VAL . 11.4 p -121.3 112.91 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.95 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.5 p -140.9 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.854 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -153.33 131.95 12.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 -176.38 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -57.52 -36.74 71.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.563 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.93 -33.85 62.03 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.474 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.6 p -100.51 11.29 39.8 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.338 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -43.7 115.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.61 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 110.15 37.6 1.79 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -116.97 115.49 25.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.855 0.36 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.628 ' N ' HD13 ' A' ' 64' ' ' LEU . 24.7 t -126.61 133.79 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -117.24 122.97 45.48 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.15 114.0 4.49 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 88.8 mt -65.79 -44.86 92.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.55 119.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.725 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.8 m -158.77 175.85 13.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.74 -67.61 0.83 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -131.48 80.71 66.59 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.581 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.7 Cg_exo -71.78 152.79 58.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.396 2.064 . . . . 0.0 110.27 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.6 m -118.45 124.19 47.02 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.157 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.1 mm -100.91 122.38 52.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.922 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 ' ND2' ' A' ' 85' ' ' ASN . 34.7 mm -108.45 128.43 64.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.95 129.73 55.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -119.47 129.53 54.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.608 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -128.02 105.04 8.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.757 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 49.9 -120.28 7.82 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 98.1 p -90.6 6.14 44.98 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.257 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.4 t -124.14 131.31 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 p -136.24 148.34 48.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.62 143.85 14.98 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.721 ' ND2' HG23 ' A' ' 76' ' ' ILE . 6.4 m120 -108.14 140.32 41.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.206 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 87' ' ' ILE . 84.8 m -133.49 158.76 42.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.322 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.488 ' N ' HG22 ' A' ' 86' ' ' THR . 79.4 mt -108.49 124.0 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.81 132.49 56.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.7 m -116.12 138.09 51.56 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.872 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.581 HG23 ' CD ' ' A' ' 73' ' ' PRO . 65.6 t -83.78 111.47 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.993 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -139.21 139.31 37.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.421 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -79.36 143.46 35.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 95' ' ' THR . 91.8 m -120.27 129.09 53.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 25.0 p-10 -91.92 0.67 57.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.79 ' H ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.557 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.19 -38.05 89.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.703 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . . . -73.8 150.69 40.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.599 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -97.88 163.75 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.702 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.1 tp -86.53 115.08 23.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.712 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -75.44 -51.79 12.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.833 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.3 p -160.35 162.96 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.823 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.702 ' CG2' HD21 ' A' ' 5' ' ' LEU . 18.6 pt -123.51 140.92 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.896 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -130.76 149.29 52.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.607 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -91.5 142.43 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.056 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -102.34 165.43 13.84 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 120.743 0.306 . . . . 0.0 111.443 -178.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.6 Cg_exo -38.3 163.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 124.008 3.139 . . . . 0.0 111.397 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' C ' ' A' ' 14' ' ' ASN . 4.3 mm -99.63 114.52 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.496 0.718 . . . . 0.0 110.021 0.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 13' ' ' ILE . 23.8 t-20 28.47 -115.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.764 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.524 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 24.4 p -155.58 91.79 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.07 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 15' ' ' THR . 34.9 m120 -156.26 140.94 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.8 mt -135.17 139.59 46.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.768 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -95.85 159.41 14.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 21' ' ' VAL . 5.9 p -64.11 137.59 58.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.539 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.29 42.55 22.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.02 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 19' ' ' THR . 71.9 t -133.45 155.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.288 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.743 ' OG ' HD21 ' A' ' 64' ' ' LEU . 14.1 t -112.77 131.49 55.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -128.57 138.06 52.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -110.26 144.72 38.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.332 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.85 153.71 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.869 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.74 153.47 26.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.905 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.89 129.36 53.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.881 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -111.96 127.49 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.481 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.18 143.51 18.0 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -116.03 122.2 44.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' C ' ' N ' ' A' ' 33' ' ' ASP . 94.4 m-85 -80.69 149.3 29.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.107 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -55.63 -9.74 0.57 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 3' ' ' ALA . 73.2 m-20 -86.92 1.01 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.5 0.89 88.04 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 36' ' ' LYS . 10.8 m -84.16 158.32 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 35' ' ' THR . 99.3 mttt -133.16 151.32 51.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.308 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.3 154.57 21.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -78.83 119.87 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.427 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' VAL . 84.9 mt -108.23 14.8 24.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.0 m -60.53 -29.21 68.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.82 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.7 p -91.18 -9.0 47.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.173 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.61 -28.6 11.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 79' ' ' TYR . 15.3 m -87.66 149.94 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.5 m -106.66 122.63 46.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.773 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 28.3 m95 -92.47 137.33 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.245 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -151.07 160.92 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.963 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 t -137.88 147.8 44.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.913 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -63.97 -35.13 79.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -71.35 63.6 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.352 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 77.9 mt-30 -69.71 -43.61 72.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.6 m -72.9 -33.59 66.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -97.22 1.19 49.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.167 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.7 154.27 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.175 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -139.04 145.88 40.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.793 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.1 p -112.75 116.3 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.993 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.8 m -138.98 110.02 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.82 132.52 11.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.654 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.32 -177.11 2.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 96.0 p -58.9 -27.1 64.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.579 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -88.97 -12.67 40.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.481 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 80.1 p -116.38 0.76 12.88 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HA ' HD22 ' A' ' 57' ' ' ASN . 73.1 mttt -40.17 111.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.738 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.52 27.71 2.3 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.743 HD21 ' OG ' ' A' ' 22' ' ' SER . 6.1 tt -119.31 119.31 33.65 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.61 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 64' ' ' LEU . 48.7 t -125.24 135.37 64.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.7 m -115.75 127.28 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.92 117.08 4.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 95.4 mt -63.38 -42.67 97.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.287 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 177.72 118.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.745 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.756 ' O ' HG21 ' A' ' 90' ' ' VAL . 6.6 p -160.88 166.74 27.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.724 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.68 -67.9 0.9 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.87 81.66 51.71 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.12 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -81.18 148.8 16.98 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.495 2.13 . . . . 0.0 110.226 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 75' ' ' ILE . 24.6 m -107.1 124.21 49.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.132 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.7 mp -100.16 131.3 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.902 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG23 ' OD1' ' A' ' 85' ' ' ASN . 95.1 mt -117.92 125.76 74.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.257 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.6 133.73 47.11 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.3 m -118.01 132.02 56.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.677 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.688 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.3 t80 -136.93 111.27 8.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.718 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.43 -125.83 37.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.7 p -93.05 5.25 52.16 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.322 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 79' ' ' TYR . 50.2 t -125.67 133.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -130.84 156.74 44.5 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.48 147.22 16.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' HG23 ' A' ' 76' ' ' ILE . 2.9 m-20 -123.3 135.63 54.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.015 0.436 . . . . 0.0 111.135 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -140.71 153.34 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.54 126.36 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 111.122 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.566 HD12 HD13 ' A' ' 75' ' ' ILE . 85.5 mt -110.05 147.25 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.506 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.3 m -120.91 142.74 49.42 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.879 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.756 HG21 ' O ' ' A' ' 70' ' ' SER . 76.5 t -82.69 103.92 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.923 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -134.49 152.38 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.92 143.65 26.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.1 m -120.69 129.82 53.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.526 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -94.99 114.16 25.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.439 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.561 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.96 -35.87 79.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.78 147.92 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 m -121.5 164.31 17.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 8' ' ' ILE . 39.0 tp -78.53 109.37 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.41 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -75.87 -45.13 37.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.446 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -148.09 167.18 25.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.835 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 5' ' ' LEU . 96.8 mt -118.0 132.83 66.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.983 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -127.87 147.78 50.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.395 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.92 137.27 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.61 163.71 17.61 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.063 0.459 . . . . 0.0 111.314 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -37.31 155.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 123.515 2.81 . . . . 0.0 112.199 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.688 HD12 ' HE2' ' A' ' 23' ' ' LYS . 91.4 mt -87.71 159.16 3.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 123.926 0.89 . . . . 0.0 110.127 0.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' ILE . 87.7 m-20 -48.56 -90.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 74.3 p -141.52 92.9 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 15' ' ' THR . 24.8 m120 -156.78 161.61 39.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 111.799 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.7 tt -143.43 148.18 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.624 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -75.7 164.51 26.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.841 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 20' ' ' THR . 71.8 p -39.35 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.539 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' OG1' ' A' ' 19' ' ' THR . 31.7 p -131.61 23.52 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.062 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 22' ' ' SER . 2.4 t -95.75 -160.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.062 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.979 ' H ' HG12 ' A' ' 21' ' ' VAL . 3.8 m -112.75 148.17 35.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.688 ' HE2' HD12 ' A' ' 13' ' ' ILE . 64.3 tttm -133.77 131.36 39.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.58 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -110.6 146.05 36.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.102 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.89 155.09 44.73 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.164 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -109.18 145.71 35.34 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.754 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.55 130.25 56.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.79 132.96 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.21 146.92 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.7 m -112.38 128.19 56.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.516 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -87.55 149.26 24.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.975 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.0 p -54.94 -17.82 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.629 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -77.74 -6.95 55.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.497 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.25 1.29 72.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 36' ' ' LYS . 87.3 m -80.69 157.7 25.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.747 0.308 . . . . 0.0 110.784 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mtmt -126.6 145.23 50.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.369 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.11 156.67 29.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.876 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 39' ' ' LEU . 91.1 m-20 -87.88 127.08 35.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.256 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.1 mp -112.53 14.03 20.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.36 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.5 m -57.11 -32.59 66.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.053 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.8 p -88.12 -9.91 51.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.436 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.426 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -101.18 -26.2 13.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.1 m -91.93 152.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.5 m -109.96 119.74 40.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 19.1 m95 -89.59 140.76 29.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.519 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 p -149.29 160.56 43.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.893 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 t -134.37 143.24 47.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.1 p -62.41 -34.49 76.86 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 95.7 m-20 -71.8 62.08 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -68.61 -43.54 76.19 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.9 p -70.54 -33.57 71.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.0 7.46 36.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.1 148.77 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -134.27 142.1 47.2 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.687 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 65' ' ' VAL . 22.0 t -108.65 114.57 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.1 m -139.36 110.36 6.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.91 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.15 134.21 13.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.892 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.01 -176.92 1.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.2 m -58.75 -35.16 72.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.638 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -83.36 -20.49 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.649 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.5 p -104.48 4.03 32.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.099 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -42.36 115.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.855 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 114.44 33.26 1.79 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 3.7 tp -118.21 125.39 50.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.285 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 55' ' ' VAL . 56.0 t -129.31 133.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -114.86 121.78 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.6 116.57 5.09 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 92.2 mt -65.42 -44.54 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.463 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.96 120.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.691 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 30.0 t -157.9 -173.78 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.84 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -114.27 -65.37 0.43 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.31 80.55 52.1 Favored Pre-proline 0 C--N 1.332 -0.174 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.32 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HD3' HG23 ' A' ' 90' ' ' VAL . 14.5 Cg_exo -70.23 147.19 59.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.801 2.334 . . . . 0.0 110.626 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.4 m -110.78 115.84 30.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.738 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.73 126.61 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.746 HG23 ' ND2' ' A' ' 85' ' ' ASN . 97.4 mt -117.15 127.34 74.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.157 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.76 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -118.9 130.26 55.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.949 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 43' ' ' VAL . 69.8 t80 -137.43 110.03 7.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.69 -128.98 48.96 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.3 p -94.04 9.71 36.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.969 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 8' ' ' ILE . 47.7 t -129.05 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.872 0.368 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -139.8 151.92 46.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.64 142.44 13.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.746 ' ND2' HG23 ' A' ' 76' ' ' ILE . 7.0 m120 -111.43 152.71 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.968 0.413 . . . . 0.0 111.114 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 162.88 39.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.309 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.5 mm -106.41 126.37 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 111.039 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -112.94 128.47 56.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.73 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.9 m -107.51 145.79 32.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.031 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' HD3' ' A' ' 73' ' ' PRO . 64.2 t -83.8 117.47 29.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.073 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -141.2 129.23 21.99 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.518 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -79.73 135.03 36.42 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.755 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.5 p -103.41 -55.6 2.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -78.23 80.56 4.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.475 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.429 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.55 141.23 56.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.665 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.57 145.09 55.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.639 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 5' ' ' LEU . 20.7 m -90.24 162.3 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.279 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' N ' HG22 ' A' ' 4' ' ' THR . 57.6 tp -86.99 114.87 23.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.668 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -72.49 -46.37 55.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.78 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 p -157.63 164.8 36.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.0 tt -124.38 131.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.933 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.2 m -132.77 148.71 52.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.538 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.0 mm -98.77 139.2 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.095 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.63 163.22 18.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 111.506 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -36.39 158.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.096 3.197 . . . . 0.0 111.358 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' HE3' ' A' ' 23' ' ' LYS . 96.3 mt -84.72 158.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 123.501 0.721 . . . . 0.0 109.972 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 13' ' ' ILE . 92.2 m-20 -37.81 -92.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.824 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.506 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -160.25 93.25 1.03 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.105 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 15' ' ' THR . 22.7 m120 -154.57 140.29 18.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.328 0.585 . . . . 0.0 111.678 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 HD21 ' A' ' 88' ' ' LEU . 3.3 mm -137.53 132.72 45.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.892 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.09 165.66 12.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.836 0.351 . . . . 0.0 110.734 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.937 ' O ' HG23 ' A' ' 21' ' ' VAL . 65.4 p -49.29 127.84 15.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.564 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.529 ' C ' ' O ' ' A' ' 19' ' ' THR . 0.0 OUTLIER 30.0 63.76 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.998 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 19' ' ' THR . 53.3 t -131.72 134.63 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.379 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -79.9 136.28 36.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.118 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HE3' HD12 ' A' ' 13' ' ' ILE . 87.3 tttt -137.93 135.85 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.977 0.418 . . . . 0.0 110.963 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -112.3 145.58 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.339 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.42 152.62 47.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.853 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -110.62 142.44 42.48 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.968 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.19 128.82 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.909 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.72 128.97 72.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.481 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.97 147.18 16.59 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -115.01 129.52 56.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.459 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -87.31 149.39 24.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.112 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -55.98 -15.3 3.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.448 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.3 -1.58 49.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.567 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 1.88 85.36 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.8 m -85.36 145.59 27.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.641 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.91 148.59 42.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.71 154.71 20.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.4 125.1 31.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.343 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.5 mt -106.99 7.24 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -50.07 -31.95 14.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.142 0.496 . . . . 0.0 109.914 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.2 p -87.99 -9.32 53.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.197 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -105.7 -28.57 10.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.558 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 39' ' ' LEU . 3.5 m -87.81 149.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.1 m -106.04 123.85 48.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.76 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.474 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 38.0 m95 -92.82 134.53 34.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -148.37 170.3 18.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.935 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.435 ' H ' ' NE2' ' A' ' 50' ' ' GLN . 41.1 t -136.26 146.88 47.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.786 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -66.15 -33.76 76.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 0.0 109.37 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -94.89 84.21 4.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 47' ' ' SER . 98.5 mm-40 -85.84 -22.79 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.7 t -71.02 -34.32 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.639 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.82 4.3 37.66 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -160.68 152.8 20.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.227 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -132.66 136.03 46.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.018 0.437 . . . . 0.0 110.701 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 55' ' ' VAL . 7.3 p -107.04 113.28 43.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.988 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.7 t -138.98 104.49 5.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.862 HD22 ' H ' ' A' ' 63' ' ' GLY . 31.0 p30 -131.75 127.27 36.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -70.82 -179.56 2.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 t -58.86 -44.95 91.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.596 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 57.1 mp0 -83.46 -7.97 59.45 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.505 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.4 p -113.0 8.8 18.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.357 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -42.13 114.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.854 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.862 ' H ' HD22 ' A' ' 57' ' ' ASN . . . 113.68 29.04 3.01 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 64' ' ' LEU . 28.5 tp -118.02 121.0 39.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.575 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.14 134.11 67.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.9 p -102.47 131.47 49.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.24 105.28 2.05 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.6 mt -63.05 -44.72 99.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.692 0.282 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 170.66 121.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.727 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -160.07 168.59 25.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.92 -49.09 1.19 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -149.69 82.73 6.6 Favored Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -84.24 159.05 13.15 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.488 2.125 . . . . 0.0 110.184 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.0 m -118.32 123.95 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 mm -98.29 125.47 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.938 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.2 mm -112.8 126.52 70.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.106 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.99 125.6 47.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 m -113.88 126.11 54.81 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.693 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.589 ' HB2' HG12 ' A' ' 43' ' ' VAL . 64.4 t80 -134.64 87.76 2.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.41 -124.78 22.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -89.04 4.92 46.69 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.314 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.45 136.55 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 p -142.15 157.08 45.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . -127.45 142.93 13.93 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -123.14 130.84 53.3 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.204 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p -136.71 157.18 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.341 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.7 mt -97.56 124.57 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.971 0.415 . . . . 0.0 111.179 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 17' ' ' ILE . 67.2 tp -107.93 135.57 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.568 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.3 m -119.09 139.69 51.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.918 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.3 t -88.1 101.7 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.0 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -137.0 149.61 47.6 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.357 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' NZ ' ' C ' ' A' ' 95' ' ' THR . 44.4 tttm -72.76 136.3 45.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.466 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 32.7 m -44.13 -72.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 93' ' ' THR . 97.9 m-20 -139.49 -65.02 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.505 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.433 ' C ' ' NZ ' ' A' ' 92' ' ' LYS . 4.9 t . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.659 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ALA . 9.5 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 45.48 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.47 139.94 51.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -93.05 143.0 26.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.389 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.1 tp -60.57 116.65 4.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.404 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.3 t -75.92 -42.97 47.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 p -156.8 165.69 35.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.047 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.95 133.21 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -135.38 147.85 49.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 86' ' ' THR . 15.1 mm -95.33 143.41 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.761 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.49 164.38 16.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.34 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.0 Cg_exo -37.27 164.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 123.326 2.684 . . . . 0.0 112.871 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' ASN . 86.7 mt -107.6 114.98 47.74 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 125.074 1.35 . . . . 0.0 110.798 -0.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' ILE . 97.3 m-20 33.96 -120.95 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.604 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 p -149.16 95.78 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.906 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 60.5 t30 -150.3 147.84 28.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.591 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.8 mt -138.4 132.23 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.735 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 21' ' ' VAL . 99.2 m-20 -104.54 133.21 49.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.543 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 21' ' ' VAL . 8.7 p -65.3 152.39 43.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.282 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.605 HG22 HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER 67.91 -16.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.707 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 20' ' ' THR . 46.3 t -118.6 138.39 49.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.52 0.676 . . . . 0.0 111.422 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 m -96.37 141.45 29.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.936 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -120.47 140.6 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.59 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -109.34 143.54 38.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.71 153.62 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.181 178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -111.03 152.35 26.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.66 129.91 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.583 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.97 128.41 67.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.07 143.41 14.52 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.498 ' HG1' ' HZ3' ' A' ' 36' ' ' LYS . 52.7 m -115.48 129.2 56.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.871 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -88.1 146.44 25.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.861 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.0 p -53.73 -15.79 1.4 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.748 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.02 -3.22 51.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.571 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.07 85.95 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 m -77.64 139.74 39.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 110.714 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HZ3' ' HG1' ' A' ' 30' ' ' THR . 68.7 mmtt -110.99 139.47 46.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.252 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.45 25.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.085 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.533 ' C ' HD22 ' A' ' 39' ' ' LEU . 50.2 t0 -90.1 126.04 35.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.735 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.5 mm? -103.81 9.2 37.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.7 m -53.45 -30.32 40.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.898 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.4 p -89.82 -9.11 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.676 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.22 -22.75 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.3 m -95.12 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -104.29 120.32 40.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.637 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.0 m95 -89.07 134.72 33.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.536 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 p -143.21 162.49 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.885 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.0 t -135.94 144.64 45.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.891 0.377 . . . . 0.0 111.235 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 p -67.78 -33.34 74.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.333 0.587 . . . . 0.0 109.527 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 16.2 m120 -77.58 62.47 2.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.566 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.09 -42.33 84.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.054 0.454 . . . . 0.0 109.956 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 t -69.85 -34.4 73.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -103.62 6.01 36.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.374 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -159.57 147.26 17.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.324 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -132.46 142.64 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 110.807 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 55' ' ' VAL . 6.6 p -122.59 114.29 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 67.8 p -139.53 117.05 11.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.632 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -155.29 134.4 12.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.22 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -75.03 178.8 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.751 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.2 p -54.3 -27.25 34.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.621 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -87.47 -25.28 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.717 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 18.6 p -103.87 8.27 36.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.655 0.265 . . . . 0.0 111.304 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -42.16 115.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.962 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 109.83 35.94 2.12 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.9 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' OD1' ' A' ' 57' ' ' ASN . 25.0 tp -118.27 126.12 51.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.724 0.262 . . . . 0.0 110.514 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.74 133.7 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 111.051 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 m -102.66 127.84 49.61 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -101.67 102.1 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.678 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 96.7 mt -65.26 -44.17 95.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.908 0.385 . . . . 0.0 110.069 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 167.75 118.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 t -160.42 170.82 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.45 -55.24 0.76 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -140.66 82.2 16.11 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.625 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' HG23 ' A' ' 90' ' ' VAL . 71.0 Cg_endo -83.04 155.46 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.69 2.26 . . . . 0.0 110.732 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 75' ' ' ILE . 95.5 m -121.27 123.9 43.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.971 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.873 HD13 HD22 ' A' ' 88' ' ' LEU . 2.1 mp -102.43 129.7 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.734 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.0 127.23 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.091 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.9 129.4 49.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.7 m -113.37 129.7 56.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.607 ' HB2' HG12 ' A' ' 43' ' ' VAL . 71.8 t80 -132.35 87.27 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.265 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.65 -125.2 25.5 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.3 p -87.18 3.97 44.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.539 0.209 . . . . 0.0 110.931 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.69 133.65 68.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.759 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.0 p -139.79 154.34 47.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.593 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.43 147.96 17.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.3 m120 -126.25 130.55 51.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.97 0.414 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 81.8 p -134.55 151.09 50.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.577 ' C ' HD12 ' A' ' 88' ' ' LEU . 78.6 mt -97.92 127.01 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 0.0 110.799 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.873 HD22 HD13 ' A' ' 75' ' ' ILE . 10.5 mp -109.48 145.73 35.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -114.65 134.95 54.67 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.498 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 73' ' ' PRO . 71.4 t -84.4 104.27 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.084 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 99.3 m-20 -140.18 155.8 46.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.514 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.01 154.66 31.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.479 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 96.5 m -60.68 -46.26 91.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.673 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 36.1 p-10 -132.78 132.26 42.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.606 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.91 60.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.749 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.67 163.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.58 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.1 m -119.0 139.55 51.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.278 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.75 122.79 15.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -74.62 -43.3 56.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 92.9 p -159.29 162.39 36.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.531 HD11 HG12 ' A' ' 82' ' ' VAL . 96.6 mt -112.45 129.59 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.873 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.1 m -125.27 148.59 48.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.527 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 86' ' ' THR . 26.2 mm -104.18 139.75 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.027 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -101.19 162.31 20.94 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 0.0 111.302 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' SER . 59.3 Cg_exo -35.15 163.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 124.104 3.202 . . . . 0.0 111.322 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' ASN . 88.4 mt -109.09 108.13 24.56 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.599 0.759 . . . . 0.0 110.045 0.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' ILE . 6.9 m120 33.7 -154.51 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.2 OUTLIER -127.76 97.47 4.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.147 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -154.5 160.08 41.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.258 0.551 . . . . 0.0 111.606 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 91' ' ' ASN . 47.4 mm -124.4 132.39 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.718 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 19' ' ' THR . 2.7 m-80 -78.44 165.92 23.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 18' ' ' ASN . 80.7 p -38.55 -60.73 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 t -156.38 55.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.1 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 22' ' ' SER . 14.2 t -128.54 162.98 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.326 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.9 m -86.02 152.27 23.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.067 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -137.5 135.01 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.9 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -111.27 143.43 42.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.434 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -130.08 153.2 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.896 179.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -119.8 146.59 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.771 0.32 . . . . 0.0 110.942 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.55 129.77 55.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.827 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.55 128.85 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.54 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.79 144.14 17.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 m -113.22 125.79 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.469 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.432 ' C ' ' N ' ' A' ' 33' ' ' ASP . 97.1 m-85 -83.4 143.84 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.15 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -49.92 -14.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.426 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.432 ' N ' ' C ' ' A' ' 31' ' ' TYR . 89.0 m-20 -81.48 0.76 36.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.568 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.05 1.45 90.61 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -84.32 151.3 24.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.661 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.02 148.19 48.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.371 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.51 156.12 27.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.764 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.87 124.67 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.6 mt -111.0 12.89 22.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 110.175 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.7 m -59.39 -26.38 65.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.081 0.467 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 95.2 p -93.55 -7.76 43.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.237 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.6 -26.4 10.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.49 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.652 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -90.63 149.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.4 m -106.45 126.39 52.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.711 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.529 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 23.3 m95 -95.79 137.47 34.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.262 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 p -148.9 168.6 22.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.981 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.9 t -139.24 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.838 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -62.34 -39.42 93.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.401 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -91.13 88.47 6.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.328 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -88.86 -22.45 23.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.8 p -70.83 -32.19 69.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.34 1.97 36.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.161 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.07 148.43 15.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.126 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -127.87 139.15 52.79 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.745 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.6 p -114.93 111.19 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.033 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 t -139.67 103.87 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -139.57 130.29 25.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.623 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.541 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.3 -177.1 2.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -58.32 -34.91 71.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.568 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.8 mp0 -85.58 -22.3 28.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.534 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 42.0 p -101.76 15.0 30.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.238 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -44.81 115.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.799 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.72 34.66 3.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -118.93 113.06 20.42 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.738 0.304 . . . . 0.0 110.641 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.547 ' N ' HD13 ' A' ' 64' ' ' LEU . 50.5 t -128.55 138.4 54.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.803 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -106.44 125.81 51.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.29 103.07 1.62 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 97.8 mt -64.12 -44.96 97.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.334 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 169.52 149.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 5.4 t -179.15 -175.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.673 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.594 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -108.75 -62.47 0.54 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -136.26 80.5 40.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.123 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' CD ' HG23 ' A' ' 90' ' ' VAL . 12.4 Cg_exo -71.3 153.98 61.47 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.507 2.138 . . . . 0.0 110.248 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.5 m -125.19 110.95 14.7 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.225 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.8 mm -96.07 126.51 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.79 128.65 76.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.08 135.48 39.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.0 m -122.1 132.14 54.33 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.669 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.652 ' HB2' HG12 ' A' ' 43' ' ' VAL . 77.1 t80 -136.59 107.96 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 48.87 -119.88 6.37 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.4 p -93.22 6.97 46.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 8' ' ' ILE . 53.0 t -126.27 129.73 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.912 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.1 p -136.74 153.5 50.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 110.904 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.63 142.21 13.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.1 m-20 -121.8 139.11 54.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.936 0.398 . . . . 0.0 111.244 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.578 HG21 HG13 ' A' ' 10' ' ' ILE . 41.6 p -137.65 167.53 21.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.323 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.4 123.96 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 17' ' ' ILE . 50.5 tp -109.12 130.32 55.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.5 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 m -116.11 141.27 48.35 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.961 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG23 ' CD ' ' A' ' 73' ' ' PRO . 26.1 t -84.87 121.02 36.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' ILE . 29.3 t-20 -142.04 126.66 17.93 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.08 123.36 38.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 99.7 m -62.5 -48.83 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.467 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.53 71.15 2.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.508 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.624 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.31 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.719 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.26 154.56 41.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -131.53 164.47 25.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.61 HD21 HG12 ' A' ' 8' ' ' ILE . 46.2 tp -64.89 105.81 1.1 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.631 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.6 m -76.21 -40.5 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.814 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 p -151.61 165.73 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.61 HG12 HD21 ' A' ' 5' ' ' LEU . 96.7 mt -115.48 132.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.889 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 m -123.02 149.07 44.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.627 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.0 mt -118.25 132.58 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.14 164.24 15.89 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 120.797 0.332 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' SER . 57.8 Cg_exo -36.21 162.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 124.047 3.164 . . . . 0.0 111.396 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ASN . 3.5 mt -93.71 163.75 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.485 0.714 . . . . 0.0 109.99 0.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' O ' ' A' ' 13' ' ' ILE . 32.6 p30 -48.01 -172.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' H ' ' A' ' 89' ' ' THR . 53.5 p -85.29 93.51 8.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.082 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.439 HD22 ' HB2' ' A' ' 91' ' ' ASN . 27.8 m120 -154.45 142.02 19.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.319 0.58 . . . . 0.0 111.651 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.6 mm -135.85 134.25 51.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.746 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -101.79 157.17 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.822 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 21' ' ' VAL . 80.8 p -39.22 121.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.509 ' C ' ' O ' ' A' ' 19' ' ' THR . 11.3 p 31.87 66.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.002 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 19' ' ' THR . 54.5 t -131.41 137.97 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.3 m -82.42 136.92 34.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.104 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -134.68 132.91 39.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.9 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -112.02 144.73 40.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.364 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.91 153.8 47.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.802 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -112.53 138.63 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.923 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.34 124.39 52.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.952 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.79 129.45 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.386 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.19 142.11 16.46 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.0 m -109.2 122.69 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.076 0.465 . . . . 0.0 110.417 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -83.84 146.34 28.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.128 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.2 p -52.14 -14.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.413 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.67 -3.94 49.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.38 2.27 82.9 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 36' ' ' LYS . 22.0 m -85.7 153.79 22.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.665 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -123.74 151.09 43.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.31 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.29 156.27 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 39' ' ' LEU . 34.8 p-10 -86.78 123.78 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.345 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.0 mp -111.34 18.22 19.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 0.0 110.232 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.03 -30.42 70.3 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.9 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.0 p -89.61 -8.28 52.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.192 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.7 t -104.7 -27.9 11.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 39' ' ' LEU . 16.5 m -88.11 150.6 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.268 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -108.52 117.64 34.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.588 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 18.8 m95 -87.25 136.64 32.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 79.7 p -141.2 162.66 34.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.987 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -138.45 143.31 39.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.888 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -68.94 -36.42 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 99.1 m-20 -74.42 69.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.29 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.03 -43.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.4 m -70.04 -33.91 72.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.644 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.59 6.64 34.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.157 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -164.98 146.47 7.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.166 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -131.79 146.77 52.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.76 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.3 p -122.46 114.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.963 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.4 p -140.93 111.47 6.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -154.08 131.44 11.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.53 -177.03 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.9 t -56.3 -41.75 76.44 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.591 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -74.46 -31.39 62.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.522 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 19.2 p -95.22 2.49 54.94 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 57' ' ' ASN . 53.7 mttt -41.31 116.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.81 33.8 1.8 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.57 118.92 32.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.31 135.72 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.773 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.7 m -112.17 128.85 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.53 134.77 12.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.659 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.01 -66.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' SER . . . -144.8 142.05 29.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.643 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 1.1 t 163.32 175.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -109.69 -48.69 0.78 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -140.64 81.12 17.45 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD3' HG23 ' A' ' 90' ' ' VAL . 26.3 Cg_exo -64.18 144.07 85.74 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 0.0 110.242 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.0 m -118.29 121.31 40.1 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.78 129.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.844 HG23 ' ND2' ' A' ' 85' ' ' ASN . 86.8 mt -110.8 128.09 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.163 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.5 131.17 54.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -115.65 133.91 55.56 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.633 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB2' HG12 ' A' ' 43' ' ' VAL . 87.8 t80 -136.53 94.2 2.97 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.7 -123.23 32.2 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.6 p -89.91 6.77 40.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.33 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 8' ' ' ILE . 48.0 t -126.17 135.31 64.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 p -140.0 156.85 46.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.427 . . . . 0.0 110.92 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.8 143.92 15.58 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.844 ' ND2' HG23 ' A' ' 76' ' ' ILE . 12.5 m120 -111.24 139.88 46.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.1 m -135.8 141.72 44.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.277 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.18 128.99 63.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.064 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.04 147.76 28.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.529 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.422 ' H ' ' HB ' ' A' ' 15' ' ' THR . 59.0 m -111.9 138.0 49.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.982 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 73' ' ' PRO . 43.0 t -83.25 104.48 11.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.904 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 90' ' ' VAL . 10.4 m120 -136.0 130.77 34.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.416 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HE2' HG22 ' A' ' 19' ' ' THR . 97.4 mttt -94.86 153.96 17.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.899 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -79.97 34.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.588 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -74.99 121.57 22.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.527 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.597 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.47 148.95 50.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.63 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.95 179.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.631 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -133.99 162.39 32.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 8' ' ' ILE . 3.7 tt -88.04 109.53 19.92 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.625 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -76.47 -53.09 8.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.775 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.8 p -156.46 169.79 23.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.906 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 5' ' ' LEU . 35.9 pt -130.69 144.93 36.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.849 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.4 t -135.81 149.12 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.674 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mm -95.29 141.77 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -100.36 165.55 14.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 120.762 0.315 . . . . 0.0 111.431 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 11' ' ' SER . 46.5 Cg_exo -38.19 165.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.095 3.197 . . . . 0.0 111.314 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' O ' ' C ' ' A' ' 14' ' ' ASN . 78.7 mt -110.14 117.78 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.461 0.705 . . . . 0.0 110.008 0.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 13' ' ' ILE . 3.9 t-20 27.05 -131.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.756 0.312 . . . . 0.0 110.88 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.446 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -142.81 93.4 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.178 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -155.26 135.16 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.226 0.536 . . . . 0.0 111.66 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -156.35 141.45 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.789 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -107.53 164.81 11.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.737 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.5 p -67.34 143.49 56.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.81 4.5 5.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.053 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.33 134.86 63.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.292 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 m -104.32 145.48 30.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.102 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -131.11 140.22 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.901 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -109.54 143.48 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.383 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.606 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.14 152.96 48.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.881 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -111.08 149.75 30.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.923 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.79 127.8 55.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.825 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.38 128.34 69.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.461 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.12 148.35 17.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.8 m -119.6 130.09 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 0.0 110.432 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -89.08 149.33 23.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.122 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.3 p -55.3 -10.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.434 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.12 -0.75 57.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.56 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.7 87.44 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.6 m -84.22 146.26 27.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 110.654 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.13 146.98 48.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.08 156.12 28.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.834 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.15 122.97 28.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.635 ' O ' HG13 ' A' ' 43' ' ' VAL . 90.0 mt -107.42 9.2 29.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.211 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.6 m -55.0 -30.55 59.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.113 0.482 . . . . 0.0 109.866 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.1 p -89.67 -9.8 48.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.133 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -102.87 -26.35 13.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.599 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -93.72 144.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.302 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 123.13 47.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.606 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 10.8 m95 -92.94 136.46 33.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.277 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.3 t -139.93 144.86 37.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.888 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.7 t -113.4 140.15 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.891 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.3 p -62.82 -40.09 96.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.742 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 93.0 m-20 -71.64 70.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.322 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -74.45 -40.33 61.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.2 p -71.02 -32.89 69.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.643 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.55 11.05 27.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -166.89 148.86 6.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.197 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -134.05 147.08 50.88 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.696 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 65' ' ' VAL . 23.4 t -110.21 113.32 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.008 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -139.86 105.63 5.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.29 131.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.673 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.508 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -68.94 -176.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 m -56.48 -42.91 79.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.572 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.16 -27.18 60.71 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.533 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 51.9 p -99.44 2.18 44.81 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.35 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' HD22 ' A' ' 57' ' ' ASN . 23.5 mttt -40.34 114.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.627 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 112.81 39.72 1.15 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -119.44 127.89 53.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.305 . . . . 0.0 110.624 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 55' ' ' VAL . 37.5 t -127.12 133.34 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.751 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -113.57 120.65 41.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.58 107.92 2.34 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.26 -45.4 93.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -169.72 118.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 p -164.25 168.15 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.15 -68.55 0.93 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.733 ' ND2' HG23 ' A' ' 89' ' ' THR . 19.2 m120 -131.68 80.83 65.39 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 90' ' ' VAL . 16.6 Cg_exo -69.7 151.24 69.39 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.465 2.11 . . . . 0.0 110.218 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 m -120.01 124.12 45.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.272 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 88' ' ' LEU . 38.4 mm -102.13 126.67 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.963 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.696 HG23 ' OD1' ' A' ' 85' ' ' ASN . 91.4 mt -114.04 122.78 68.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.196 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.87 41.29 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -119.77 127.84 53.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.631 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.683 ' HB2' HG12 ' A' ' 43' ' ' VAL . 67.8 t80 -136.97 118.77 15.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.08 -125.4 30.75 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.5 p -97.55 8.64 44.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.322 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' TYR . 44.6 t -126.36 136.54 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.7 p -135.41 150.76 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.45 142.19 13.29 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.696 ' OD1' HG23 ' A' ' 76' ' ' ILE . 14.3 m-20 -113.06 151.18 31.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.461 . . . . 0.0 111.198 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 t -144.66 156.5 44.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.3 mm -108.87 123.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 75' ' ' ILE . 89.6 mt -115.59 145.81 42.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.733 HG23 ' ND2' ' A' ' 72' ' ' ASN . 75.8 m -120.04 143.16 48.24 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.504 HG23 ' HD3' ' A' ' 73' ' ' PRO . 92.2 t -84.69 104.21 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 90' ' ' VAL . 90.5 m-20 -140.87 151.18 44.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.411 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -75.91 148.27 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.903 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.609 HG22 ' N ' ' A' ' 94' ' ' ASP . 51.5 m -84.56 -97.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.465 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.609 ' N ' HG22 ' A' ' 93' ' ' THR . 88.1 m-20 56.53 20.25 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.578 ' H ' HG22 ' A' ' 93' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.602 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 147.11 49.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.4 148.57 45.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -92.16 164.64 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.66 118.24 25.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.0 110.612 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -75.65 -36.13 60.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 p -154.66 161.72 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.247 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -113.4 132.96 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.196 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 m -129.55 148.35 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.501 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.06 133.71 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.075 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.09 165.68 13.75 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.383 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -38.49 158.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 123.544 2.829 . . . . 0.0 112.019 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 91.2 mt -87.23 154.85 3.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 123.942 0.897 . . . . 0.0 110.578 1.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CG ' HG22 ' A' ' 15' ' ' THR . 52.2 t30 -53.56 -113.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.548 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -134.58 92.04 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.981 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' H ' ' HZ1' ' A' ' 23' ' ' LYS . 71.6 m-80 -157.45 158.73 36.36 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.528 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.444 ' CG2' HG13 ' A' ' 90' ' ' VAL . 1.6 tp -145.63 144.94 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.481 ' HB2' HG21 ' A' ' 21' ' ' VAL . 99.1 m-20 -113.26 162.15 16.36 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.7 0.286 . . . . 0.0 110.48 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 21' ' ' VAL . 21.4 p -38.95 107.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.5 p 36.9 72.36 0.11 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 19' ' ' THR . 55.0 t -130.22 153.76 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.982 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.6 m -83.37 139.78 32.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.755 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HZ3' ' HG ' ' A' ' 88' ' ' LEU . 88.0 tttt -127.93 118.9 24.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.983 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -111.97 142.71 44.04 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.54 152.67 48.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.503 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -116.54 138.95 51.01 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.45 126.78 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.968 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.85 130.83 74.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.53 142.58 17.59 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.4 m -108.11 125.08 51.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 0.0 110.64 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -82.81 147.4 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.414 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p -54.32 -16.48 2.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -76.49 -5.19 46.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.32 1.14 79.01 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 36' ' ' LYS . 36.1 m -86.7 160.63 18.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 0.0 110.686 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.539 ' N ' HG22 ' A' ' 35' ' ' THR . 68.5 mttm -130.67 151.62 50.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.9 156.49 31.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -84.77 123.33 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.101 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.63 ' O ' HG13 ' A' ' 43' ' ' VAL . 79.2 mt -108.78 0.41 20.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.57 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -49.15 -33.45 12.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -86.63 -13.53 45.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.515 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -100.03 -21.9 15.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.903 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.656 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.6 m -96.98 149.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -107.69 124.36 49.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.617 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 25.0 m95 -94.24 139.25 31.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 110.672 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -142.62 169.58 17.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -140.58 139.12 34.89 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.7 p -62.91 -32.69 74.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.8 m-80 -84.73 68.46 10.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.6 mm-40 -69.74 -41.34 75.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.997 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -70.75 -34.47 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.339 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 49' ' ' ASN . 89.9 mt-30 -100.01 2.79 43.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.053 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.75 145.38 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.157 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -127.23 140.54 52.16 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' VAL . 9.8 p -120.64 113.66 40.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.094 0.473 . . . . 0.0 109.968 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -140.16 106.64 5.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.311 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -148.64 131.8 16.39 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.44 -176.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.651 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -58.74 -43.78 90.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.023 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.86 -33.81 72.76 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.4 p -96.38 5.56 50.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.51 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -42.28 115.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.632 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 113.87 32.14 2.13 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.74 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -117.31 115.26 24.91 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' N ' HD13 ' A' ' 64' ' ' LEU . 42.5 t -127.63 133.97 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.896 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -116.04 126.2 53.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.619 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.96 113.8 4.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 40.5 mm -65.33 -43.92 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.24 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 175.04 120.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.789 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.3 p -157.85 172.36 18.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.49 -53.63 0.92 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -150.05 82.64 6.43 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.836 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.91 155.87 15.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.556 2.171 . . . . 0.0 110.711 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.482 ' C ' HD12 ' A' ' 75' ' ' ILE . 64.7 m -119.24 123.37 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 110.709 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.654 HD13 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -99.26 123.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.596 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.717 HG23 ' OD1' ' A' ' 85' ' ' ASN . 85.7 mt -111.14 125.69 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 134.62 47.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.1 m -124.08 130.54 52.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 111.14 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 43' ' ' VAL . 58.3 t80 -136.19 108.81 7.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.943 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.49 -122.16 28.89 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 90.7 p -97.94 5.43 48.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.488 0.185 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.41 133.75 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.5 p -140.38 150.73 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.55 142.68 13.98 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 76' ' ' ILE . 50.8 m-20 -108.9 143.4 38.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.044 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -136.71 143.95 43.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.547 ' C ' HD12 ' A' ' 88' ' ' LEU . 21.8 mm -102.62 126.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.252 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 75' ' ' ILE . 10.7 mp -108.42 141.71 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.516 ' N ' ' OG1' ' A' ' 15' ' ' THR . 60.5 m -118.16 137.51 52.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.421 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 70' ' ' SER . 72.5 t -85.21 112.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -141.06 128.93 21.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.727 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.32 119.27 32.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.641 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.7 p -67.35 -38.34 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 54.12 55.97 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.3 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.464 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -95.9 30.83 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.713 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 41.71 -168.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -139.46 160.68 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.743 HD21 ' CG2' ' A' ' 8' ' ' ILE . 47.0 tp -87.49 107.3 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.67 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -75.37 -46.19 34.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.763 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 p -157.37 164.78 37.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.743 ' CG2' HD21 ' A' ' 5' ' ' LEU . 45.8 pt -123.04 147.6 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.866 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 10.8 p -137.28 149.0 46.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.06 136.22 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -98.93 165.36 15.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 111.445 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.5 Cg_exo -37.26 165.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 124.055 3.17 . . . . 0.0 111.363 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' C ' ' A' ' 14' ' ' ASN . 74.4 mt -106.94 113.12 42.6 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 C-N-CA 123.491 0.716 . . . . 0.0 110.031 0.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 13' ' ' ILE . 79.1 m-20 28.77 -126.86 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.461 ' CB ' HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -149.92 95.55 2.32 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.137 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 3.8 p30 -155.62 136.84 13.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.338 0.589 . . . . 0.0 111.617 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' ASN . 51.0 mm -122.87 132.55 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.761 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' THR . 1.0 OUTLIER -80.61 167.38 20.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.863 0.363 . . . . 0.0 110.81 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' NZ ' ' A' ' 92' ' ' LYS . 30.8 p -36.03 -91.21 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.565 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 20' ' ' THR . 7.5 t -113.93 66.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.089 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 22' ' ' SER . 54.9 t -131.94 160.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 t -108.25 124.32 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.114 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -115.5 139.71 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tt0 -110.16 146.83 34.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.368 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -127.95 152.99 47.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -112.07 151.57 29.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.988 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.35 128.45 51.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.869 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' O ' ' OG ' ' A' ' 9' ' ' SER . 53.2 t -120.24 130.59 74.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.22 151.94 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -114.79 126.67 55.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -83.76 150.59 25.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.136 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p -55.1 -13.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.469 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -82.81 -4.03 57.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.665 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 4.05 79.61 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 36' ' ' LYS . 18.2 m -88.51 154.54 20.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.883 0.373 . . . . 0.0 110.636 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 35' ' ' THR . 99.1 mttt -125.53 146.66 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.285 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.77 41.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.96 121.14 29.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.369 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.672 ' O ' HG13 ' A' ' 43' ' ' VAL . 4.6 mp -107.41 11.64 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.146 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 m -57.27 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.791 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.9 p -90.49 -11.47 40.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.149 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.34 -29.69 11.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.551 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 39' ' ' LEU . 5.2 m -87.22 153.68 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.1 m -110.6 124.57 52.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.726 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.735 ' O ' HG11 ' A' ' 55' ' ' VAL . 29.3 m95 -94.84 133.57 38.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.206 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.532 ' HA ' HG21 ' A' ' 55' ' ' VAL . 20.9 p -147.08 161.36 41.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 t -136.17 146.98 47.46 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.95 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.0 p -65.69 -35.78 81.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 87.8 m-20 -69.08 65.9 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.32 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 53' ' ' ALA . 75.5 mt-30 -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.9 t -71.45 -34.52 70.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -98.85 3.75 47.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.287 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -169.09 154.62 6.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.182 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -133.92 143.36 48.19 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.745 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 ' O ' ' A' ' 45' ' ' TRP . 98.8 t -109.61 113.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.055 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.8 p -138.76 103.1 4.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.05 121.73 42.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.656 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.7 169.6 16.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.6 m -55.63 -35.61 66.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.607 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 54.7 mp0 -87.31 -7.44 57.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.536 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.8 p -131.54 31.54 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.268 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 68.0 mttm -47.16 117.11 1.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.79 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.51 43.54 2.7 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 40.9 tp -118.01 122.32 42.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.767 0.317 . . . . 0.0 110.654 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 55' ' ' VAL . 40.0 t -128.54 132.75 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -116.48 127.22 54.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.01 120.02 4.84 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.54 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 178.02 139.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.683 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 13.6 t -173.4 177.44 2.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.723 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 70' ' ' SER . . . -101.13 -69.42 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -133.88 81.45 52.25 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.555 -0.458 . . . . 0.0 112.178 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HD3' HG23 ' A' ' 90' ' ' VAL . 15.3 Cg_exo -70.29 153.41 66.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.462 2.108 . . . . 0.0 110.253 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 75' ' ' ILE . 53.1 m -119.73 112.05 18.78 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.225 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.5 mp -94.67 127.32 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.991 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.0 mt -114.53 129.73 70.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.162 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.29 125.96 43.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -114.41 125.65 54.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.8 t80 -134.33 114.29 12.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.68 -127.08 39.51 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -94.93 8.58 42.34 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.349 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.29 130.45 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.7 p -137.42 150.83 47.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.74 142.66 13.85 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.2 m-20 -108.18 140.85 40.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.97 0.415 . . . . 0.0 111.265 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.1 p -132.84 155.0 49.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.247 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.34 123.49 47.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD12 ' CB ' ' A' ' 15' ' ' THR . 44.9 tp -114.21 128.05 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.551 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.4 m -112.12 139.85 47.29 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.9 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.52 HG23 ' HD3' ' A' ' 73' ' ' PRO . 67.5 t -82.65 102.07 8.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.961 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' ILE . 27.8 m120 -123.79 151.34 43.42 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.614 ' NZ ' HG22 ' A' ' 19' ' ' THR . 67.7 mttm -94.77 153.71 17.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.971 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -99.4 66.36 1.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.592 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 45.66 46.79 11.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.498 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.571 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 2' ' ' ALA . 30.2 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 1' ' ' SER . . . -153.67 149.88 28.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.714 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.44 -162.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.599 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -138.66 164.82 28.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.671 HD11 ' O ' ' A' ' 7' ' ' SER . 63.9 tp -71.52 107.62 4.51 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.62 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -75.39 -38.31 60.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.8 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.671 ' O ' HD11 ' A' ' 5' ' ' LEU . 32.4 p -150.49 162.75 40.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.69 133.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.859 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.8 t -129.5 146.58 51.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.65 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.84 134.45 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -100.67 163.55 17.9 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.438 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 11' ' ' SER . 6.5 Cg_endo -43.2 172.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.069 3.179 . . . . 0.0 111.283 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 82.9 mt -103.88 110.79 31.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.02 0.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 15' ' ' THR . 19.0 p30 35.19 -152.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.875 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -139.79 95.7 2.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.122 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.66 159.29 39.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.226 0.536 . . . . 0.0 111.653 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.744 HD11 HD21 ' A' ' 88' ' ' LEU . 96.5 mt -136.17 129.88 47.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.723 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' THR . 99.6 m-20 -98.35 164.54 12.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 110.732 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.834 ' O ' HG23 ' A' ' 21' ' ' VAL . 6.1 p -37.95 117.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.499 ' C ' ' O ' ' A' ' 19' ' ' THR . 6.5 p 32.44 65.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.012 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 19' ' ' THR . 44.7 t -131.06 142.35 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 66' ' ' THR . 58.0 m -98.14 118.98 35.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.065 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -113.12 136.81 52.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.72 143.4 41.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -129.53 153.93 47.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.884 179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -111.41 147.82 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.09 129.01 56.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.905 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -114.88 132.42 64.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.499 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.77 149.52 17.46 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -120.12 125.46 48.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 110.453 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.43 151.07 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.11 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.4 p -53.94 -14.59 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.524 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -85.2 6.0 27.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.59 3.16 82.72 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 m -83.42 139.35 33.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.954 0.407 . . . . 0.0 110.661 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.07 147.24 44.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.369 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.12 164.71 37.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.952 0.406 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 29.1 p-10 -88.41 123.08 32.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.339 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 43' ' ' VAL . 88.9 mt -106.64 13.02 28.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.0 m -60.48 -31.59 70.61 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.87 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -90.32 -4.6 57.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.232 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.03 -27.94 9.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 39' ' ' LEU . 19.7 m -90.6 142.94 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.25 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.0 m -103.31 116.18 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.744 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 16.8 m95 -83.91 133.7 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.228 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -137.0 163.82 29.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.1 t -134.83 140.94 46.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.885 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -64.23 -34.57 78.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.733 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.8 m120 -83.65 71.38 10.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 53' ' ' ALA . 87.0 mt-30 -74.23 -40.38 62.45 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.4 m -69.91 -33.68 72.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.607 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -103.74 3.31 34.02 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -158.35 150.1 21.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.176 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.14 145.24 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.739 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.0 p -122.39 115.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.936 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 32.9 t -140.43 114.47 9.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -152.74 132.82 13.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.579 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.97 -177.67 2.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.1 p -57.79 -30.3 65.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.507 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -87.93 -12.49 44.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.51 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 52.5 p -114.74 4.06 14.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.255 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -41.16 112.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.786 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 116.41 33.37 1.47 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -117.01 121.48 41.48 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 110.627 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.0 t -124.24 134.63 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.849 HG22 ' OG ' ' A' ' 22' ' ' SER . 41.2 p -112.35 125.98 54.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.0 103.29 1.88 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.02 -44.99 99.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.733 0.301 . . . . 0.0 110.247 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 179.89 118.16 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.692 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.722 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.6 p -161.04 167.8 25.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.722 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.31 -54.16 0.91 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -149.31 81.08 7.51 Favored Pre-proline 0 C--N 1.334 -0.105 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.141 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.53 158.76 19.41 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 0.0 110.204 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -116.37 124.49 50.19 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 mm -100.08 121.18 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.773 HG23 ' ND2' ' A' ' 85' ' ' ASN . 80.0 mt -111.93 126.09 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.225 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 133.76 48.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -113.68 133.4 55.34 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.549 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.602 ' HB2' HG12 ' A' ' 43' ' ' VAL . 72.9 t80 -131.56 86.41 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.677 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.95 -123.94 19.4 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -88.55 5.64 41.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.289 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.03 133.18 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -137.78 152.71 49.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.07 145.12 17.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.773 ' ND2' HG23 ' A' ' 76' ' ' ILE . 5.5 m120 -110.37 145.78 36.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.172 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 74.5 p -134.71 154.28 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.379 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.0 mt -100.59 121.57 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 111.177 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 17' ' ' ILE . 53.7 tp -109.47 130.7 55.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.6 m -117.6 138.44 51.94 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.91 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 70' ' ' SER . 88.1 t -83.4 107.76 15.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -139.2 139.41 37.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.333 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -79.06 144.12 34.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.948 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.4 m -119.87 128.66 53.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.64 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 53.96 43.25 31.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.83 147.54 47.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.739 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.27 149.47 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.633 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -139.21 163.27 32.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.254 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.805 HD21 ' CG2' ' A' ' 8' ' ' ILE . 53.3 tp -68.93 111.03 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.632 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -80.05 -46.29 16.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.815 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 p -154.17 163.15 40.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.805 ' CG2' HD21 ' A' ' 5' ' ' LEU . 32.9 pt -123.22 146.3 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.846 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 p -139.12 148.49 43.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.664 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.62 137.18 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -103.55 164.98 14.33 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.403 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 11' ' ' SER . 56.7 Cg_exo -37.49 166.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.981 3.121 . . . . 0.0 111.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' ASN . 72.3 mt -112.18 111.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 C-N-CA 123.457 0.703 . . . . 0.0 110.044 0.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' ILE . 1.4 m120 34.37 -153.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.721 0.295 . . . . 0.0 110.855 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.559 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.1 OUTLIER -136.58 96.72 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.193 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 15' ' ' THR . 79.7 m-20 -157.26 155.92 31.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.321 0.581 . . . . 0.0 111.684 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.583 ' CD1' HD21 ' A' ' 88' ' ' LEU . 2.9 mp -138.59 131.82 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.82 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.535 ' OD1' HG23 ' A' ' 93' ' ' THR . 93.7 m-20 -88.74 167.0 13.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.848 0.356 . . . . 0.0 110.744 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.636 ' O ' HG23 ' A' ' 21' ' ' VAL . 82.4 p -39.42 110.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.449 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.7 p 42.09 62.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.081 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 19' ' ' THR . 70.0 t -130.36 139.25 51.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.344 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.6 p -92.29 138.06 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.05 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -131.78 139.76 49.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.932 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 24.0 tt0 -109.43 144.93 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.421 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -126.94 152.78 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.969 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' C ' ' HG ' ' A' ' 11' ' ' SER . 42.5 m-85 -113.24 148.79 34.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.09 130.26 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.916 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.43 131.04 71.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.464 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.97 17.21 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.5 m -113.89 129.47 56.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.981 0.42 . . . . 0.0 110.488 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -86.51 144.0 27.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.074 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p -52.22 -14.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.49 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 49.5 t0 -79.71 -6.86 58.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.22 -0.59 68.95 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 36' ' ' LYS . 23.7 m -86.61 160.38 18.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.883 0.373 . . . . 0.0 110.649 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.53 ' N ' HG22 ' A' ' 35' ' ' THR . 99.0 mttt -131.71 151.15 51.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.313 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.01 160.2 35.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.909 0.385 . . . . 0.0 110.757 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -86.64 119.61 27.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.393 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.674 ' O ' HG13 ' A' ' 43' ' ' VAL . 91.6 mt -104.84 12.31 32.74 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.159 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.7 m -59.04 -28.2 66.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.841 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.5 p -91.32 -10.3 41.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -104.14 -27.39 12.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 79' ' ' TYR . 10.4 m -88.2 150.85 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.174 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 m -106.04 126.47 52.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 55' ' ' VAL . 49.9 m95 -97.3 135.24 39.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.2 m -148.14 168.88 21.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.3 t -137.93 147.36 44.27 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.79 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -68.08 -34.69 76.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 32.4 m-20 -77.57 69.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' ALA . 85.0 mt-30 -72.45 -43.2 64.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.6 p -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.534 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -102.54 9.91 39.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.171 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -171.11 152.91 3.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 45' ' ' TRP . 7.1 p -109.4 113.67 44.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.039 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.3 t -139.76 104.39 4.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.696 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.633 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -118.81 123.97 46.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.08 172.22 12.18 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -58.6 -31.03 67.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.609 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.38 -11.88 47.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.526 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.8 p -131.38 31.07 4.4 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.27 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.7 mttt -43.48 116.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.801 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.559 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 98.22 45.05 2.45 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 55.1 tp -117.25 123.27 46.2 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.708 0.29 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 HG23 ' A' ' 55' ' ' VAL . 24.2 t -127.25 136.08 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.832 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.7 m -110.46 128.52 55.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.34 107.86 2.81 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.1 mt -64.35 -43.71 97.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.79 117.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.697 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 90' ' ' VAL . 15.4 p -159.13 166.36 31.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.671 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 72' ' ' ASN . . . -95.08 -65.95 0.99 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 2.8 m120 -138.57 80.6 26.08 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.13 158.26 23.47 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.501 2.134 . . . . 0.0 110.286 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 m -113.29 128.28 56.42 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 mm -100.44 120.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mm -109.26 126.42 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.119 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.99 126.15 50.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.7 m -115.45 125.8 53.55 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.692 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.679 ' HB2' HG12 ' A' ' 43' ' ' VAL . 45.2 t80 -134.8 90.6 2.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.05 -129.81 18.58 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.9 p -87.97 3.35 49.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.307 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.71 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 p -140.98 150.15 42.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.58 142.38 14.71 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.0 OUTLIER -118.84 130.41 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 111.16 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.3 p -134.67 156.68 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.278 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.75 124.29 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.583 HD21 ' CD1' ' A' ' 17' ' ' ILE . 7.4 tt -111.55 151.32 28.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.436 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.6 m -132.72 145.3 50.92 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.974 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 70' ' ' SER . 91.2 t -83.87 127.19 40.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.919 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -139.39 122.93 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.356 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.23 128.38 38.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.535 HG23 ' OD1' ' A' ' 18' ' ' ASN . 16.8 p -67.58 -36.29 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.525 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 95' ' ' THR . 26.6 t0 58.42 -179.21 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.489 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.493 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 58.3 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.671 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 3' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.86 20.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.708 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' A' ' 1' ' ' SER . . . -125.94 168.22 14.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.612 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -130.36 164.4 24.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.312 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 5' ' ' LEU . 47.9 tp -81.03 107.76 14.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.563 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -75.56 -39.53 58.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.776 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.67 162.98 40.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.893 0.378 . . . . 0.0 110.819 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -125.05 133.97 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 t -132.91 148.49 52.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.616 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.58 130.71 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.1 162.75 19.58 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 120.779 0.323 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' ILE . 8.1 Cg_endo -44.11 172.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 124.038 3.159 . . . . 0.0 111.348 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 14' ' ' ASN . 76.5 mt -102.53 118.23 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.487 0.715 . . . . 0.0 109.958 0.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 13' ' ' ILE . 2.8 t-20 30.61 -146.59 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.754 0.312 . . . . 0.0 110.911 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 p -152.88 95.4 1.98 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.06 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.96 160.75 43.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.237 0.541 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.631 HD12 HG22 ' A' ' 90' ' ' VAL . 97.5 mt -134.43 132.8 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.791 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.497 ' ND2' ' H ' ' A' ' 93' ' ' THR . 11.9 m120 -100.24 166.71 10.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 110.771 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 21' ' ' VAL . 18.3 p -37.71 111.64 0.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.557 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 1.7 m 38.95 62.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.08 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 19' ' ' THR . 66.8 t -131.34 139.86 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.377 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -96.95 123.62 40.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 64.5 tttm -112.78 144.03 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -110.37 143.46 40.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.36 151.57 49.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.898 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' A' ' 11' ' ' SER . 56.8 m-85 -113.7 155.41 25.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.718 0.294 . . . . 0.0 110.907 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.1 130.64 53.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.925 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.3 t -113.44 131.03 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.447 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.76 151.22 17.27 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.6 m -117.84 126.07 51.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.029 0.442 . . . . 0.0 110.425 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -81.16 151.57 28.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.102 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.1 p -55.3 -18.25 6.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -76.67 -4.1 41.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.586 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.42 0.23 82.55 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 36' ' ' LYS . 92.5 m -83.39 162.09 21.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 0.0 110.583 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.568 ' N ' HG22 ' A' ' 35' ' ' THR . 99.2 mttt -131.1 148.68 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.355 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.68 20.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.947 0.403 . . . . 0.0 110.802 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -78.1 124.96 28.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.664 ' O ' HG13 ' A' ' 43' ' ' VAL . 93.9 mt -108.8 13.48 24.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.9 m -60.83 -30.14 69.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.809 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -90.85 -9.54 45.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.253 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.08 -26.57 13.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 39' ' ' LEU . 13.8 m -91.09 152.02 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.228 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -109.88 123.5 49.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.684 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.54 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 22.8 m95 -93.58 137.49 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.9 t -145.03 167.75 21.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.017 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -142.23 139.95 32.14 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.862 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.2 -26.38 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -78.79 65.16 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.336 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 88.6 mt-30 -67.15 -49.84 63.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.8 p -71.71 -33.67 68.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.612 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -93.65 -2.43 54.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' ASN . . . -167.73 151.76 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.156 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -131.23 136.42 48.21 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.71 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 55' ' ' VAL . 3.9 p -107.83 113.07 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -138.71 104.12 5.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.874 HD22 ' H ' ' A' ' 63' ' ' GLY . 29.9 p30 -132.45 128.23 37.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.664 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -71.72 -177.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.6 t -61.84 -42.33 98.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.649 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 55.9 mp0 -83.16 -12.41 56.98 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.532 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 81.2 p -110.73 8.88 22.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.185 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -41.58 112.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.73 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.874 ' H ' HD22 ' A' ' 57' ' ' ASN . . . 114.4 31.18 2.25 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.04 122.15 41.49 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.703 0.287 . . . . 0.0 110.573 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -128.32 134.4 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.1 m -104.74 125.72 51.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.04 102.86 2.39 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 93.9 mt -62.32 -44.77 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.71 0.291 . . . . 0.0 110.264 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 173.4 118.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -162.43 167.02 24.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.25 -67.18 0.83 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -128.24 81.16 71.04 Favored Pre-proline 0 CA--C 1.529 0.148 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -83.06 159.26 15.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.43 2.087 . . . . 0.0 110.149 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -123.22 129.58 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.4 mm -102.11 129.59 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.806 HG23 ' ND2' ' A' ' 85' ' ' ASN . 86.3 mt -115.79 126.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.51 135.92 43.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.5 m -121.81 128.44 51.68 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.682 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' HB2' HG12 ' A' ' 43' ' ' VAL . 65.6 t80 -128.94 88.75 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.63 -119.8 11.81 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.9 p -91.62 1.16 57.34 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.317 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.21 132.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.6 p -135.44 154.09 51.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.05 146.93 18.51 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.806 ' ND2' HG23 ' A' ' 76' ' ' ILE . 5.7 m120 -110.89 144.72 39.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.963 0.411 . . . . 0.0 111.216 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.8 p -134.05 158.54 43.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.9 mm -98.64 124.55 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.016 0.436 . . . . 0.0 111.134 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 17' ' ' ILE . 50.9 tp -114.15 135.02 54.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.504 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -125.75 132.13 52.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.893 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.631 HG22 HD12 ' A' ' 17' ' ' ILE . 89.6 t -84.05 109.16 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.952 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 92' ' ' LYS . 54.6 t-20 -139.63 129.52 24.81 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.353 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 62.0 mmtt -90.99 127.08 36.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.497 ' H ' ' ND2' ' A' ' 18' ' ' ASN . 96.8 m -63.76 -46.79 83.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.14 -50.24 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.502 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.612 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.62 145.65 18.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.707 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.84 146.83 52.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -91.13 163.89 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.262 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 mt -81.79 124.05 29.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.555 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -74.35 -41.0 61.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.4 p -157.26 161.84 39.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 8' ' ' ILE . 18.2 tt -124.67 128.71 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.886 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -134.24 150.28 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.55 147.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.061 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.32 165.1 15.06 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 120.8 0.333 . . . . 0.0 111.376 -179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' SER . 52.0 Cg_exo -37.35 164.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 124.02 3.147 . . . . 0.0 111.384 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.5 mm -110.2 127.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.476 0.71 . . . . 0.0 109.952 0.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 13' ' ' ILE . 43.6 t30 29.72 -139.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.787 0.327 . . . . 0.0 110.829 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 15' ' ' THR . 0.6 OUTLIER -135.05 93.98 3.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.151 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 20.5 p30 -158.02 162.0 38.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 111.674 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.53 160.53 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.805 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -105.11 140.65 37.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 p -81.91 -26.17 34.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.458 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 p -104.53 -12.99 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.093 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.687 HG12 ' N ' ' A' ' 22' ' ' SER . 33.7 t -132.69 169.31 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.687 ' N ' HG12 ' A' ' 21' ' ' VAL . 24.0 m -110.42 147.59 33.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 87.7 tttt -122.65 147.15 46.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.0 tt0 -111.52 145.19 39.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.42 149.67 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.884 179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -110.18 147.86 32.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.937 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.87 128.86 56.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.889 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.71 131.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.431 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.02 149.07 18.0 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.9 m -117.2 126.02 52.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 110.43 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -84.63 147.68 26.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -53.26 -15.22 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.41 -1.65 46.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.557 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.96 88.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -85.62 142.47 29.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 0.0 110.593 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.37 148.97 41.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.363 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.59 152.44 16.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -77.64 124.69 28.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.697 ' O ' HG13 ' A' ' 43' ' ' VAL . 72.9 mt -106.03 13.63 28.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.9 m -61.43 -29.28 69.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 0.0 109.879 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 p -86.93 -18.33 31.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -30.28 12.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.532 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 39' ' ' LEU . 11.0 m -87.29 141.35 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.15 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.3 m -101.06 124.23 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.657 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.669 ' O ' HG11 ' A' ' 55' ' ' VAL . 25.4 m95 -91.74 133.13 35.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.225 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 p -147.74 163.37 36.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 t -137.41 148.73 46.4 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.912 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.2 p -68.32 -25.63 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.8 m120 -87.58 69.64 9.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 95.8 mm-40 -78.34 -36.33 46.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 m -69.69 -34.37 73.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.652 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -104.15 8.47 36.34 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -165.89 153.57 10.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.199 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -130.23 137.17 49.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.887 0.375 . . . . 0.0 110.808 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 45' ' ' TRP . 57.6 t -107.76 113.14 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.021 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -140.17 104.4 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.799 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.48 125.16 44.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.617 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 178.42 8.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 m -58.92 -38.79 79.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.626 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -86.65 -19.21 29.62 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.496 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.8 p -109.58 21.87 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.359 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.579 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 35.8 pttt -40.71 118.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.74 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 47.63 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.544 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 42.1 tp -121.45 116.97 25.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.731 0.3 . . . . 0.0 110.623 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.624 HG22 HG22 ' A' ' 55' ' ' VAL . 38.9 t -123.23 134.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.0 130.48 48.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.87 135.11 12.54 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 91.4 mt -99.64 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 110.33 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -175.88 120.11 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 90' ' ' VAL . 7.8 p -161.74 175.24 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.58 -79.25 1.45 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -126.58 81.42 68.42 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 90' ' ' VAL . 21.1 Cg_exo -68.39 150.37 75.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.511 2.141 . . . . 0.0 110.171 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -116.62 113.13 22.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.186 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 88' ' ' LEU . 8.3 mm -86.47 126.14 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 85' ' ' ASN . 98.1 mt -120.08 122.78 69.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.123 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.68 129.1 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.5 m -119.14 132.75 56.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.663 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.696 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.2 t80 -137.76 91.57 2.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.752 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.4 -122.29 26.47 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.5 p -90.54 4.11 52.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.376 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.0 t -122.64 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.0 p -147.86 153.54 39.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.46 141.06 12.37 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.699 ' OD1' HG23 ' A' ' 76' ' ' ILE . 9.1 m-20 -115.55 148.81 39.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.969 0.414 . . . . 0.0 111.143 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 t -149.86 154.92 39.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.705 ' C ' HD12 ' A' ' 88' ' ' LEU . 71.4 mt -102.9 126.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 111.09 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.705 HD12 ' C ' ' A' ' 87' ' ' ILE . 11.1 mp -118.82 149.56 41.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.555 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.0 m -114.58 146.75 40.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.019 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.559 HG21 ' OG ' ' A' ' 70' ' ' SER . 61.4 t -82.78 103.52 10.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.005 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -144.38 155.33 43.72 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.387 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -94.34 142.98 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.457 ' O ' ' OD1' ' A' ' 94' ' ' ASP . 56.1 m -100.98 -63.28 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 93' ' ' THR . 90.9 m-20 -144.59 120.77 10.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 95' ' ' THR . 1.3 t . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.54 94.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.69 145.55 54.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.518 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -100.37 164.48 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.508 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -76.76 125.92 30.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.407 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -85.77 -45.71 11.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.987 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.9 p -155.48 166.82 32.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.351 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.3 pt -119.25 147.22 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.1 m -134.05 149.22 51.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.677 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.04 128.61 55.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.759 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -101.35 165.87 13.34 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.577 -178.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.496 ' C ' HD12 ' A' ' 13' ' ' ILE . 59.7 Cg_exo -39.06 166.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.581 2.854 . . . . 0.0 112.058 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 13' ' ' ILE . 2.4 mp -104.55 110.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 124.626 1.17 . . . . 0.0 110.402 -0.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' ILE . 27.2 p30 31.41 -149.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 O-C-N 123.919 0.762 . . . . 0.0 110.717 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 95.99 2.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -154.99 161.76 41.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.785 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.648 HD12 HG22 ' A' ' 90' ' ' VAL . 95.7 mt -132.53 131.35 60.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -94.49 166.06 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.751 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.71 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.1 p -37.98 106.03 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.7 p 38.8 65.74 0.61 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 19' ' ' THR . 60.7 t -130.89 161.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 32.8 t -110.76 127.91 55.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.731 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -117.65 142.21 47.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 20.5 tt0 -108.92 144.5 36.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.86 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CD1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.13 150.18 50.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.984 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.49 ' C ' ' HG ' ' A' ' 11' ' ' SER . 49.5 m-85 -115.52 143.4 45.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.667 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.72 128.12 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.868 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -112.29 128.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.4 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.91 144.8 15.85 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.9 m -115.27 125.86 53.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.914 0.388 . . . . 0.0 110.447 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.407 ' C ' ' N ' ' A' ' 33' ' ' ASP . 85.0 m-85 -86.2 147.86 25.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.295 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 p -54.38 -10.24 0.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.756 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 31' ' ' TYR . 31.2 t0 -84.23 -3.64 58.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.597 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.29 3.56 81.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 36' ' ' LYS . 31.9 m -83.18 154.91 24.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 35' ' ' THR . 27.8 mmtp -122.35 141.23 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.166 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 150.21 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' LEU . 48.4 t0 -85.84 118.86 25.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' O ' HG13 ' A' ' 43' ' ' VAL . 10.7 mp -106.15 8.97 32.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.2 m -49.86 -33.61 17.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.7 p -87.53 -13.05 44.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.304 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.506 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -97.84 -23.25 15.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 79' ' ' TYR . 3.9 m -96.95 138.47 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.381 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -99.09 125.22 44.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.835 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CE3' ' CD1' ' A' ' 25' ' ' PHE . 20.5 m95 -93.57 139.49 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.637 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.531 ' HA ' HG21 ' A' ' 55' ' ' VAL . 30.4 p -151.45 165.79 33.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.146 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.2 t -136.39 144.33 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.33 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -65.03 -32.56 74.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 71.6 m-20 -77.52 66.53 3.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -68.87 -43.95 74.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.01 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.7 p -70.11 -32.92 71.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.326 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -102.73 2.48 35.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.326 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -160.78 150.33 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.298 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -132.46 138.51 47.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.763 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 65' ' ' VAL . 97.6 t -107.82 113.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -137.9 106.47 5.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.903 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.85 HD22 ' H ' ' A' ' 63' ' ' GLY . 33.6 p30 -133.03 126.01 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.014 0.435 . . . . 0.0 111.105 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.06 171.53 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.8 p -59.11 -28.06 66.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.293 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -85.82 -11.53 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.639 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.2 p -130.47 31.47 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.464 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 98.6 mttt -48.01 125.46 9.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.044 0.449 . . . . 0.0 110.949 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.85 ' H ' HD22 ' A' ' 57' ' ' ASN . . . 95.47 40.05 4.29 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.045 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.505 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 31.3 tp -117.54 122.63 44.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.908 0.354 . . . . 0.0 110.522 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 55' ' ' VAL . 43.0 t -129.8 137.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.271 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.0 m -119.05 127.03 53.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -100.91 119.3 6.47 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 94.7 mt -64.29 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 110.363 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 172.35 120.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.53 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.1 t -162.17 172.72 15.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.858 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -61.49 0.76 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.68 82.17 51.49 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.567 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.441 ' HB3' HD22 ' A' ' 49' ' ' ASN . 73.7 Cg_endo -80.82 159.52 21.4 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.501 2.134 . . . . 0.0 110.828 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 m -124.51 127.22 47.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.218 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.6 mm -100.06 126.02 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.945 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mm -108.07 122.97 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.121 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.16 118.62 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.724 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.6 m -114.26 124.59 52.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.813 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.617 ' HB2' HG12 ' A' ' 43' ' ' VAL . 53.5 t80 -128.29 117.1 20.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.35 -124.63 33.76 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -98.03 5.93 48.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.5 t -123.01 131.23 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.747 0.308 . . . . 0.0 110.659 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.1 p -135.91 153.48 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.15 155.73 22.22 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 85' ' ' ASN . 1.7 m-20 -114.37 147.33 39.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.853 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.9 p -135.02 155.4 50.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.066 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -96.97 121.59 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.962 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.9 tp -113.71 134.44 54.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 m -124.31 137.7 54.46 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.966 0.412 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.648 HG22 HD12 ' A' ' 17' ' ' ILE . 67.6 t -85.5 110.68 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.215 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' ILE . 63.7 t30 -138.15 135.9 36.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.535 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 116.95 29.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.449 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 99.5 m -62.23 -47.19 85.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -89.46 77.91 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 95' ' ' THR . 8.6 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.499 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.65 155.98 47.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.709 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.09 152.73 41.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.3 p -132.3 162.43 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.202 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.45 103.97 2.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.707 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.412 ' N ' HD13 ' A' ' 5' ' ' LEU . 4.5 t -75.47 -49.01 20.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 p -152.2 151.56 31.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.69 134.51 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.854 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 m -130.87 149.25 52.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.582 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.75 134.69 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.01 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.1 164.76 15.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.843 0.354 . . . . 0.0 111.327 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -37.91 157.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.005 3.136 . . . . 0.0 111.373 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' ASN . 9.8 mm -85.78 148.92 4.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 123.536 0.734 . . . . 0.0 109.985 0.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' ILE . 98.9 m-20 -38.46 -92.65 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.702 0.287 . . . . 0.0 110.919 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -150.26 93.78 2.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.079 179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 64.2 t30 -156.02 129.02 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.32 0.581 . . . . 0.0 111.653 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -137.81 135.62 45.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.701 HD21 ' N ' ' A' ' 93' ' ' THR . 4.2 m-80 -108.83 151.96 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.863 0.363 . . . . 0.0 110.741 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -64.97 135.81 56.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.571 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.5 13.84 9.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.117 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.29 137.82 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.394 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -110.38 128.91 55.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.084 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -113.3 145.83 40.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.032 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 18.2 tt0 -110.09 143.88 39.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.54 153.13 47.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -114.58 149.84 35.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.909 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.57 127.49 54.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.918 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.9 t -114.37 130.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.5 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.48 148.28 16.96 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.0 m -114.26 128.19 56.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.024 0.44 . . . . 0.0 110.451 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -83.73 149.75 26.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.059 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -55.85 -16.28 4.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.407 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.79 -1.56 43.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.582 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.52 83.05 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 36' ' ' LYS . 21.2 m -86.3 156.85 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.846 0.355 . . . . 0.0 110.681 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 35' ' ' THR . 54.4 mttp -130.81 151.89 50.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.02 158.55 28.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 0.0 110.801 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -80.74 120.95 25.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.357 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 43' ' ' VAL . 81.4 mt -104.8 5.54 33.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.165 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -57.09 -21.94 35.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.19 0.519 . . . . 0.0 109.896 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.3 p -94.38 -11.38 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.261 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -107.06 -27.63 10.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.564 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 79' ' ' TYR . 5.1 m -85.77 143.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.239 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.6 m -102.06 123.43 45.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.787 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.572 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 30.6 m95 -92.57 135.44 34.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.31 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -149.03 163.6 37.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.0 t -139.24 146.41 40.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.815 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.2 p -66.28 -33.19 75.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.341 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -78.34 68.97 4.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.377 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' ALA . 97.9 mt-30 -77.25 -38.18 51.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -72.28 -34.01 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.604 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -98.45 3.76 48.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -171.01 159.07 5.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.158 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.41 147.74 52.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.701 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.8 p -117.36 113.1 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.023 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -140.11 104.86 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.776 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.574 ' CG ' ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -116.94 124.14 48.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 -178.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.54 170.75 13.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.5 m -56.73 -33.61 66.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.508 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.56 -10.51 48.55 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.527 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.0 p -130.03 32.21 4.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.228 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -47.19 121.36 3.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.818 -179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 57' ' ' ASN . . . 93.64 47.34 2.99 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.574 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 45.9 tp -118.92 120.41 37.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.76 0.314 . . . . 0.0 110.596 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -126.56 135.46 63.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -113.01 130.59 56.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.05 110.94 2.87 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.04 -43.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -179.38 118.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.772 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.763 ' O ' HG21 ' A' ' 90' ' ' VAL . 46.5 p -160.42 166.26 29.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.719 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.46 -48.02 1.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -157.29 81.87 3.18 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.44 158.61 17.02 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.468 2.112 . . . . 0.0 110.238 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.4 m -114.26 130.09 56.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -98.92 119.81 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.012 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.495 HG23 ' OD1' ' A' ' 85' ' ' ASN . 3.8 mp -102.86 118.32 49.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.136 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.48 121.32 41.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -108.65 129.41 55.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.662 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.689 ' HB2' HG12 ' A' ' 43' ' ' VAL . 57.3 t80 -139.8 96.22 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.16 -125.55 36.36 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.2 p -91.77 6.74 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.319 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.48 132.43 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.3 p -137.22 157.06 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.39 147.57 19.16 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 76' ' ' ILE . 4.2 m-80 -131.99 133.38 44.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.439 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 82.2 p -131.54 160.4 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.304 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.429 ' C ' HD22 ' A' ' 88' ' ' LEU . 96.1 mt -98.98 121.96 50.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.18 0.514 . . . . 0.0 111.062 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 88' ' ' LEU . 4.4 mm? -100.73 134.32 43.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.514 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.52 ' N ' ' OG1' ' A' ' 15' ' ' THR . 93.5 m -110.94 134.03 52.9 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.915 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.763 HG21 ' O ' ' A' ' 70' ' ' SER . 83.6 t -82.84 100.78 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.898 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 14.0 t-20 -143.0 155.74 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.343 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -70.85 144.58 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.946 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.701 ' N ' HD21 ' A' ' 18' ' ' ASN . 98.4 m -62.25 -48.09 81.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -151.2 127.63 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.571 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.46 143.01 56.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.745 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.07 -173.73 3.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -139.6 162.71 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.285 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 8' ' ' ILE . 35.2 tp -84.16 108.4 17.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.656 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 m -76.65 -48.04 20.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.828 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.1 p -155.74 164.12 38.98 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.76 ' CG2' HD21 ' A' ' 5' ' ' LEU . 36.9 pt -124.99 144.25 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.843 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.0 t -136.72 146.11 45.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.599 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.494 HG13 HG21 ' A' ' 86' ' ' THR . 11.3 mm -93.67 139.75 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.967 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -98.68 165.24 15.43 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 120.829 0.347 . . . . 0.0 111.397 -179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 11' ' ' SER . 50.2 Cg_exo -38.25 166.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 124.017 3.145 . . . . 0.0 111.402 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' ASN . 95.9 mt -111.55 116.55 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 118.753 0.706 . . . . 0.0 109.995 0.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' ILE . 68.5 m-20 33.13 -134.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.872 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.41 93.74 2.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.113 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 52.7 p30 -157.37 147.1 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.195 0.521 . . . . 0.0 111.718 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.8 132.03 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -87.58 166.93 14.36 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.739 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.826 ' O ' HG23 ' A' ' 21' ' ' VAL . 54.8 p -58.69 138.99 56.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' O ' ' A' ' 19' ' ' THR . 34.2 p 39.33 44.19 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.07 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 19' ' ' THR . 54.9 t -131.22 139.41 51.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.314 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -98.67 148.61 23.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.085 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 13' ' ' ILE . 88.7 tttt -137.95 137.84 38.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.931 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.0 143.9 37.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.7 152.61 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.8 153.05 27.14 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.949 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.3 129.55 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.867 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.23 131.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.461 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.72 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.5 m -118.51 128.42 54.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.014 0.435 . . . . 0.0 110.364 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -86.24 149.31 25.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.116 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -54.42 -15.43 1.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.495 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -79.56 -1.58 38.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.66 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.68 86.73 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 36' ' ' LYS . 17.3 m -86.09 156.59 20.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 110.582 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 35' ' ' THR . 98.6 mttt -128.27 150.46 50.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.395 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.36 17.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.845 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 42.3 p-10 -77.19 126.01 30.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.423 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 43' ' ' VAL . 69.4 mt -109.78 14.31 23.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 m -59.78 -30.08 68.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.087 0.47 . . . . 0.0 109.898 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.2 p -90.33 -10.42 44.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.17 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 -26.16 13.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HB2' ' A' ' 79' ' ' TYR . 6.9 m -93.05 151.45 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -108.63 123.74 49.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.682 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.591 ' CE3' ' CE1' ' A' ' 25' ' ' PHE . 31.9 m95 -93.85 138.82 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 p -151.05 160.56 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.984 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.4 t -132.13 143.46 50.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.847 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.0 p -61.66 -32.94 73.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.698 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.3 m120 -75.83 63.71 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -69.97 -42.71 72.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -34.19 74.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.691 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -104.15 2.41 31.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -157.32 148.99 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.198 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.76 141.71 46.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.925 0.393 . . . . 0.0 110.694 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 55' ' ' VAL . 8.0 p -112.09 114.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.993 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.5 t -139.55 108.48 6.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -147.75 132.84 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.654 -179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.495 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -73.93 178.43 4.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.8 m -54.39 -35.58 63.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.617 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.42 -24.68 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.487 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 58' ' ' ALA . 61.4 p -104.6 16.47 26.01 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.224 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -49.59 120.55 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.784 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.531 ' H ' ' ND2' ' A' ' 57' ' ' ASN . . . 104.36 32.34 4.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 65' ' ' VAL . 2.2 tt -118.24 118.05 30.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.71 0.29 . . . . 0.0 110.613 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 64' ' ' LEU . 40.7 t -122.24 134.5 65.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 p -105.3 132.12 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -110.46 108.24 2.41 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 90.5 mt -64.53 -42.92 96.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.798 0.332 . . . . 0.0 110.304 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . 171.37 119.75 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.645 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.5 p -163.2 166.0 23.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.52 -71.41 1.1 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.647 ' ND2' HG23 ' A' ' 89' ' ' THR . 19.5 m120 -128.37 83.07 67.22 Favored Pre-proline 0 C--N 1.333 -0.146 0 C-N-CA 120.53 -0.468 . . . . 0.0 112.149 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 90' ' ' VAL . 57.4 Cg_endo -82.58 158.57 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.532 2.155 . . . . 0.0 110.225 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.511 ' C ' HD12 ' A' ' 75' ' ' ILE . 52.4 m -118.88 126.88 52.81 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.767 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.0 mp -101.05 126.1 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.882 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.751 HG23 ' OD1' ' A' ' 85' ' ' ASN . 89.3 mt -114.97 128.73 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.144 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.7 132.86 49.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -119.0 130.48 55.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.562 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.697 ' HB2' HG12 ' A' ' 43' ' ' VAL . 62.1 t80 -139.72 106.7 5.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.722 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 53.68 -125.08 31.41 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.7 p -92.6 8.21 39.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.371 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 135.74 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.95 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.6 p -146.89 151.82 37.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.986 0.422 . . . . 0.0 110.898 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.73 146.57 18.37 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.751 ' OD1' HG23 ' A' ' 76' ' ' ILE . 5.5 m-20 -125.02 137.5 54.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.01 0.433 . . . . 0.0 111.237 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 HG13 ' A' ' 10' ' ' ILE . 71.9 p -135.58 157.03 47.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.305 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.1 mm -96.72 127.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.013 0.435 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.73 147.7 37.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.571 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.647 HG23 ' ND2' ' A' ' 72' ' ' ASN . 91.2 m -125.49 132.34 52.67 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.917 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.443 HG23 ' CD ' ' A' ' 73' ' ' PRO . 96.5 t -83.48 107.86 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.895 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.16 155.17 50.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.372 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -84.97 137.0 33.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -117.63 125.94 51.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.571 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -63.8 -41.5 97.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.422 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 95' ' ' THR . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -62.21 -39.73 93.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.577 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 70.73 -175.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.631 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -139.28 163.23 33.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.91 112.16 9.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.302 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 t -74.92 -42.72 57.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 p -153.26 163.54 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.3 tt -119.13 134.4 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.3 t -131.78 148.03 52.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.745 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 mt -113.11 129.51 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.972 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.75 164.74 15.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -39.51 157.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.349 2.699 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 14' ' ' ASN . 89.9 mt -87.02 156.54 3.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 C-N-CA 123.998 0.919 . . . . 0.0 110.444 1.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 13' ' ' ILE . 98.9 m-20 -42.51 -97.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.725 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -165.89 96.13 0.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.355 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' H ' ' HZ3' ' A' ' 23' ' ' LYS . 81.9 m-20 -154.75 147.5 24.36 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.692 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 88' ' ' LEU . 51.6 mm -122.53 130.97 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.757 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -103.28 166.44 10.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.623 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.2 p -37.45 98.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.921 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 23.6 m 40.02 72.94 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 22' ' ' SER . 79.0 t -131.59 160.35 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.022 0.439 . . . . 0.0 110.993 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.539 ' N ' HG12 ' A' ' 21' ' ' VAL . 6.6 m -110.2 122.37 47.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.631 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HZ3' ' H ' ' A' ' 16' ' ' ASN . 29.5 ttpt -112.46 137.68 50.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 15.0 tt0 -110.05 141.79 42.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.847 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -128.23 152.01 48.59 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.068 178.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -113.35 147.28 37.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.7 127.6 55.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.738 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.5 129.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.156 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.39 149.64 17.25 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 m -116.87 127.44 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.25 146.73 28.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 p -54.12 -16.81 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.766 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -78.73 -3.73 45.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.7 78.55 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 36' ' ' LYS . 24.1 m -83.21 157.32 22.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.738 0.304 . . . . 0.0 110.799 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' THR . 53.6 mtmt -130.55 149.22 52.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.28 152.24 20.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.69 122.35 26.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 43' ' ' VAL . 89.2 mt -105.49 7.9 33.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 95.5 m -55.74 -31.9 62.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.6 p -88.28 -9.92 51.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 -29.09 11.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.599 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.575 HG12 ' HB2' ' A' ' 79' ' ' TYR . 11.3 m -87.37 147.93 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.268 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.7 m -106.78 117.9 35.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.822 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m95 -87.41 140.1 29.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -147.75 164.96 31.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.161 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.5 t -135.45 143.61 46.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.327 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.1 p -66.67 -33.03 74.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.348 0.595 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.682 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 96.2 m-20 -80.72 65.0 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 53' ' ' ALA . 94.2 mm-40 -69.08 -43.81 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.08 0.466 . . . . 0.0 109.888 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.6 p -70.81 -33.14 70.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.937 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 79.3 mt-30 -104.0 9.38 36.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.505 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 49' ' ' ASN . . . -167.59 153.98 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.73 142.86 48.14 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.895 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 55' ' ' VAL . 2.4 p -119.49 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -138.24 108.78 6.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.54 ' HB3' ' H ' ' A' ' 64' ' ' LEU . 16.0 p30 -132.66 128.8 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.033 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 -179.45 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.553 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.0 p -64.33 -16.91 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.388 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -89.08 -35.27 16.41 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 p -114.96 31.04 6.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.601 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -41.36 120.85 1.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.89 0.376 . . . . 0.0 110.91 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.93 49.25 2.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' H ' ' HB3' ' A' ' 57' ' ' ASN . 44.6 tp -118.52 121.24 39.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.648 0.261 . . . . 0.0 110.535 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.36 133.55 67.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -118.72 129.18 55.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.784 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.66 8.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.0 mt -90.61 -40.96 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.574 0.226 . . . . 0.0 110.578 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . . . -122.75 152.52 40.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.647 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -80.45 167.72 19.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.676 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.89 -136.1 7.78 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -130.06 81.13 69.57 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.573 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.79 153.98 58.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.867 2.378 . . . . 0.0 110.368 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.8 m -126.81 122.7 35.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.0 mm -93.0 130.32 42.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.802 HG23 ' OD1' ' A' ' 85' ' ' ASN . 94.4 mt -120.86 119.75 60.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.123 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.04 123.47 45.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -115.77 126.4 53.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 43' ' ' VAL . 83.9 t80 -129.69 103.69 6.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.982 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.63 -122.32 27.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 p -92.24 4.87 52.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.544 0.211 . . . . 0.0 110.973 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.48 129.88 74.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 89.9 p -137.81 150.52 47.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.817 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.24 142.7 14.19 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 76' ' ' ILE . 64.8 m-20 -109.98 144.92 37.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 p -132.99 155.62 48.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.14 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.56 127.57 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.941 0.401 . . . . 0.0 111.13 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 17' ' ' ILE . 41.9 tp -104.81 134.64 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.709 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.5 m -113.25 128.98 56.64 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.969 0.414 . . . . 0.0 111.403 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.4 t -86.14 106.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.133 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.54 HD21 ' CG ' ' A' ' 16' ' ' ASN . 25.3 p-10 -136.61 127.41 27.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.352 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -94.64 136.92 34.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 m -63.55 -44.76 93.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 55.93 52.94 9.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.483 180.0 . . . . . . . . 1 1 . 1 stop_ save_